[
  {
    "text": "Sex Differences Among Patients Treated With Balloon Pulmonary Angioplasty for",
    "entities": []
  },
  {
    "text": "Chronic Thromboembolic Pulmonary Hypertension.",
    "entities": []
  },
  {
    "text": "Author information:",
    "entities": []
  },
  {
    "text": "(1)Division of Cardiology, Linkou Medical Center Chang Gung Memorial Hospital",
    "entities": [
      {
        "text": "Cardiology",
        "label": "GPE"
      },
      {
        "text": "Linkou Medical",
        "label": "ORG"
      },
      {
        "text": "Chang Gung Memorial Hospital",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(3)Division of Pulmonary, Critical Care and Sleep Medicine, San Diego Health",
    "entities": [
      {
        "text": "Pulmonary, Critical Care",
        "label": "ORG"
      },
      {
        "text": "Sleep Medicine",
        "label": "PERSON"
      },
      {
        "text": "San Diego Health",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "System University of California California La Jolla USA.",
    "entities": [
      {
        "text": "System University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(4)Division of Cardiovascular Medicine, San Diego Health System University of",
    "entities": [
      {
        "text": "Cardiovascular Medicine",
        "label": "ORG"
      },
      {
        "text": "San Diego Health System University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Studies have shown sex differences in the outcomes of chronic thromboembolic",
    "entities": []
  },
  {
    "text": "pulmonary hypertension (CTEPH) and in patients who have undergone pulmonary",
    "entities": [
      {
        "text": "pulmonary",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "endarterectomy. Limited data exist regarding outcomes of balloon pulmonary",
    "entities": []
  },
  {
    "text": "angioplasty (BPA) for female versus male subjects. In this analysis cohort, a",
    "entities": [
      {
        "text": "angioplasty",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "total of 767 sessions of BPA were performed on 144 patients of which 83 (58%)",
    "entities": [
      {
        "text": "767",
        "label": "CARDINAL"
      },
      {
        "text": "BPA",
        "label": "ORG"
      },
      {
        "text": "144",
        "label": "CARDINAL"
      },
      {
        "text": "83",
        "label": "CARDINAL"
      },
      {
        "text": "58%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "were female. There were no differences in age, body mass index and comorbidities",
    "entities": []
  },
  {
    "text": "between males and females. However, females had worse baseline functional class,",
    "entities": []
  },
  {
    "text": "higher median N-terminal pro-brain natriuretic peptide and a shorter 6-min walk",
    "entities": [
      {
        "text": "6",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "test. At baseline, males were more likely to be on pulmonary hypertension (PH)",
    "entities": []
  },
  {
    "text": "medical treatment before BPA (92% vs 76%, p = 0.008), and females had",
    "entities": [
      {
        "text": "BPA",
        "label": "ORG"
      },
      {
        "text": "92%",
        "label": "PERCENT"
      },
      {
        "text": "76%",
        "label": "PERCENT"
      },
      {
        "text": "0.008",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "significantly higher pulmonary vascular resistance (PVR) (5.5 \u00b1 3.0 wu vs",
    "entities": [
      {
        "text": "PVR",
        "label": "ORG"
      },
      {
        "text": "5.5",
        "label": "CARDINAL"
      },
      {
        "text": "3.0",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "3.9 \u00b1 1.9 wu, p < 0.001). After BPA, the improvements in mean pulmonary artery",
    "entities": [
      {
        "text": "3.9",
        "label": "CARDINAL"
      },
      {
        "text": "1.9 wu",
        "label": "PERCENT"
      },
      {
        "text": "p < 0.001",
        "label": "ORG"
      },
      {
        "text": "BPA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "pressure and PVR from baseline were comparable in both groups. The requirement",
    "entities": [
      {
        "text": "PVR",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "for PH medical therapy significantly reduced after BPA for males (92% vs. 80%,",
    "entities": [
      {
        "text": "92%",
        "label": "PERCENT"
      },
      {
        "text": "80%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "p = 0.008) but not for females. Functional class improved in both groups after",
    "entities": [
      {
        "text": "0.008",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "BPA. There were no significant differences in complication rates per BPA session",
    "entities": []
  },
  {
    "text": "between male and female patients (9% and 12%, p = 0.104). Female CTEPH patients",
    "entities": [
      {
        "text": "9% and 12%",
        "label": "PERCENT"
      },
      {
        "text": "0.104",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "had a worse baseline clinical profile including higher PVR. Female patients were",
    "entities": [
      {
        "text": "PVR",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "also more likely to remain on PH medical therapy after BPA. There were no",
    "entities": []
  },
  {
    "text": "significant differences observed in hemodynamic response to BPA and in",
    "entities": []
  },
  {
    "text": "complication rates between male and female patients.",
    "entities": []
  },
  {
    "text": "\u00a9 2025 The Author(s). Pulmonary Circulation published by John Wiley & Sons Ltd",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "Pulmonary Circulation",
        "label": "PERSON"
      },
      {
        "text": "John Wiley & Sons Ltd",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "on behalf of Pulmonary Vascular Research Institute.",
    "entities": [
      {
        "text": "Pulmonary Vascular Research Institute",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: N.H.K. has received payment for consultation",
    "entities": [
      {
        "text": "N.H.K.",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "services and/or speaking from Bayer, Johnson & Johnson, and Merck. The remaining",
    "entities": [
      {
        "text": "Bayer, Johnson & Johnson",
        "label": "ORG"
      },
      {
        "text": "Merck",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "authors declare no conflicts of interest.",
    "entities": []
  },
  {
    "text": "Antihypertensive medications and cancer risk: Evidence from 0.27 million",
    "entities": [
      {
        "text": "0.27 million",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "patients with newly diagnosed hypertension.",
    "entities": []
  },
  {
    "text": "(1)Department of Epidemiology and Biostatistics, School of Public Health, Peking",
    "entities": [
      {
        "text": "Epidemiology and Biostatistics, School of Public Health",
        "label": "ORG"
      },
      {
        "text": "Peking",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "University Health Science Center, Beijing, China.",
    "entities": [
      {
        "text": "University Health Science Center",
        "label": "ORG"
      },
      {
        "text": "Beijing",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Key Laboratory of Epidemiology of Major Diseases (Peking University),",
    "entities": [
      {
        "text": "2)Key Laboratory of Epidemiology of Major Diseases",
        "label": "ORG"
      },
      {
        "text": "Peking University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Ministry of Education, Beijing, China.",
    "entities": [
      {
        "text": "Ministry of Education",
        "label": "ORG"
      },
      {
        "text": "Beijing",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Department of Epidemiology, Biostatistics and Occupational Health, McGill",
    "entities": [
      {
        "text": "Epidemiology, Biostatistics and Occupational Health",
        "label": "ORG"
      },
      {
        "text": "McGill",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "University, Montreal, QC, Canada.",
    "entities": [
      {
        "text": "Montreal",
        "label": "GPE"
      },
      {
        "text": "QC",
        "label": "GPE"
      },
      {
        "text": "Canada",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Medical Informatics Center, Department of Epidemiology and Biostatistics,",
    "entities": [
      {
        "text": "4)Medical",
        "label": "CARDINAL"
      },
      {
        "text": "Informatics Center, Department of Epidemiology and Biostatistics",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "School of Public Health, Health Science Center, Peking University, Beijing,",
    "entities": [
      {
        "text": "School of Public Health",
        "label": "ORG"
      },
      {
        "text": "Health Science Center",
        "label": "ORG"
      },
      {
        "text": "Peking University",
        "label": "ORG"
      },
      {
        "text": "Beijing",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(5)Department of Data Center, Yinzhou District Center for Disease Control and",
    "entities": [
      {
        "text": "5)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Data Center",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Prevention, Ningbo, China.",
    "entities": [
      {
        "text": "Ningbo",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(6)Institute for Artificial Intelligence, Peking University, Beijing, China.",
    "entities": [
      {
        "text": "Artificial Intelligence",
        "label": "ORG"
      },
      {
        "text": "Peking University",
        "label": "ORG"
      },
      {
        "text": "Beijing",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(7)Research Center of Clinical Epidemiology, Peking University Third Hospital,",
    "entities": [
      {
        "text": "Center of Clinical Epidemiology",
        "label": "ORG"
      },
      {
        "text": "Peking University Third Hospital",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "BACKGROUND: Whether specific antihypertensive treatments increase cancer risk in",
    "entities": []
  },
  {
    "text": "patients with hypertension is still controversial. We aimed to estimate the",
    "entities": []
  },
  {
    "text": "associations of different antihypertensive treatments with cancer risk in",
    "entities": []
  },
  {
    "text": "real-world settings.",
    "entities": []
  },
  {
    "text": "METHODS: A longitudinal cohort study was designed in a population of 1.2 million",
    "entities": [
      {
        "text": "1.2 million",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "individuals from the CHinese Electronic health Records Research in Yinzhou",
    "entities": [
      {
        "text": "CHinese Electronic",
        "label": "ORG"
      },
      {
        "text": "Records Research",
        "label": "ORG"
      },
      {
        "text": "Yinzhou",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(CHERRY). Propensity score matching (PSM) and the Cox regression model were used",
    "entities": []
  },
  {
    "text": "to estimate the associations. Several sensitivity analyses were then performed",
    "entities": []
  },
  {
    "text": "to reduce potential residual confounding.",
    "entities": []
  },
  {
    "text": "RESULTS: From 2009 to 2019, a total of 270,320 patients with newly diagnosed",
    "entities": [
      {
        "text": "2009",
        "label": "DATE"
      },
      {
        "text": "2019",
        "label": "DATE"
      },
      {
        "text": "270,320",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "hypertension were included in this study. With a median follow-up time of",
    "entities": []
  },
  {
    "text": "7.7 years, 14,264 cases of cancer occurred. There were no significant",
    "entities": [
      {
        "text": "7.7 years",
        "label": "DATE"
      },
      {
        "text": "14,264",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "associations of angiotensin-converting enzyme inhibitors (ACEIs), angiotensin",
    "entities": []
  },
  {
    "text": "receptor blockers (ARBs), \u03b2-blockers, or thiazide diuretics (TDs) with cancer",
    "entities": []
  },
  {
    "text": "risk (p > 0.05). Compared with other antihypertensive treatments, the use of",
    "entities": [
      {
        "text": "0.05",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "calcium channel blockers (CCBs) was significantly associated with a marginally",
    "entities": []
  },
  {
    "text": "mild increase in the risk of all cancers (hazard ratio, HR = 1.05; 95% CI: 1.01,",
    "entities": [
      {
        "text": "1.05",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "1.01",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "1.09; p = 0.017). However, this association was no longer observed in",
    "entities": [
      {
        "text": "1.09",
        "label": "CARDINAL"
      },
      {
        "text": "0.017",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "sensitivity analyses excluding patients with less than 1, 2, or 3 years of",
    "entities": [
      {
        "text": "less than 1",
        "label": "CARDINAL"
      },
      {
        "text": "2",
        "label": "DATE"
      },
      {
        "text": "3 years",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "follow-up. Nevertheless, the association between CCBs and the risk of endocrine",
    "entities": []
  },
  {
    "text": "cancer, especially thyroid cancer, still exists.",
    "entities": []
  },
  {
    "text": "CONCLUSION: Despite previous controversy, in this study, we found no clinically",
    "entities": []
  },
  {
    "text": "meaningful cancer risk associated with antihypertensive medications. However,",
    "entities": []
  },
  {
    "text": "the association of CCBs with specific cancer still requires further research.",
    "entities": []
  },
  {
    "text": "These findings should be interpreted with caution due to the potential residual",
    "entities": []
  },
  {
    "text": "confounding.",
    "entities": []
  },
  {
    "text": "Conflict of interest statement: The authors declare that the research was",
    "entities": []
  },
  {
    "text": "conducted in the absence of any commercial or financial relationships that could",
    "entities": []
  },
  {
    "text": "be construed as a potential conflict of interest.",
    "entities": []
  },
  {
    "text": "10.1177/30502225251355916. eCollection 2025 Jan-Dec.",
    "entities": [
      {
        "text": "10.1177/30502225251355916",
        "label": "CARDINAL"
      },
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "Jan-Dec.",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "Current Practice of Children With Primary Hypertension: A Survey of",
    "entities": []
  },
  {
    "text": "Pediatricians in Thailand.",
    "entities": [
      {
        "text": "Pediatricians",
        "label": "NORP"
      },
      {
        "text": "Thailand",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(1)Mahidol University, Bangkok, Thailand.",
    "entities": [
      {
        "text": "1)Mahidol University",
        "label": "ORG"
      },
      {
        "text": "Bangkok",
        "label": "GPE"
      },
      {
        "text": "Thailand",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "BACKGROUND: Being able to detect, assess, and manage children with primary",
    "entities": []
  },
  {
    "text": "hypertension is one of the requirements of the Thai pediatric residency training",
    "entities": [
      {
        "text": "Thai",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "curriculum. The present study aimed to survey the practice of pediatric primary",
    "entities": []
  },
  {
    "text": "hypertension care by Thai pediatricians.",
    "entities": [
      {
        "text": "Thai",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "MATERIALS AND METHODS: Participants' demographic information, educational",
    "entities": []
  },
  {
    "text": "background, and practice, including diagnosis, investigation, and treatment in",
    "entities": []
  },
  {
    "text": "children with primary hypertension at an outpatient setting, were all included",
    "entities": []
  },
  {
    "text": "in the surveys and were distributed to pediatric residents, general",
    "entities": []
  },
  {
    "text": "pediatricians, and pediatric subspecialists in Thailand using the online survey.",
    "entities": [
      {
        "text": "Thailand",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "The results were defined as appropriate answers if they were aligned with the",
    "entities": []
  },
  {
    "text": "guidelines recommended by the American Academy of Pediatrics.",
    "entities": [
      {
        "text": "the American Academy of Pediatrics",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "RESULTS: 342 (79 males) with a mean age of 37.6 years and a mean duration since",
    "entities": [
      {
        "text": "342",
        "label": "CARDINAL"
      },
      {
        "text": "79",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "residency training of 10.4 years were included. The proportion of participants",
    "entities": [
      {
        "text": "10.4 years",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "who answered appropriately was 188 (55%), 190 (55.6%), and 169 (49.4%) in the",
    "entities": [
      {
        "text": "188",
        "label": "CARDINAL"
      },
      {
        "text": "55%",
        "label": "PERCENT"
      },
      {
        "text": "190",
        "label": "CARDINAL"
      },
      {
        "text": "55.6%",
        "label": "PERCENT"
      },
      {
        "text": "169",
        "label": "CARDINAL"
      },
      {
        "text": "49.4%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "diagnosis, investigation, and treatment parts, respectively. However, only 43",
    "entities": [
      {
        "text": "only 43",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "(12.6%) participants could answer appropriately for all 3 parts. Compared to the",
    "entities": [
      {
        "text": "12.6%",
        "label": "PERCENT"
      },
      {
        "text": "3",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "inappropriate group, experience in diagnosis was higher in the appropriate group",
    "entities": []
  },
  {
    "text": "(44.2% vs 28.4%, P-value = 0.036), but the duration since residency",
    "entities": [
      {
        "text": "44.2%",
        "label": "PERCENT"
      },
      {
        "text": "28.4%",
        "label": "PERCENT"
      },
      {
        "text": "0.036",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "training < 5 years and being a nephrologist were not different between the 2",
    "entities": [
      {
        "text": "5 years",
        "label": "DATE"
      },
      {
        "text": "2",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "groups (41.9% vs 43.5%, P = .849 and 7 vs 6%, P = .807, respectively).",
    "entities": [
      {
        "text": "41.9%",
        "label": "PERCENT"
      },
      {
        "text": "43.5%",
        "label": "PERCENT"
      },
      {
        "text": ".849",
        "label": "CARDINAL"
      },
      {
        "text": "7",
        "label": "CARDINAL"
      },
      {
        "text": "6%",
        "label": "PERCENT"
      },
      {
        "text": ".807",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "CONCLUSIONS: Experience in diagnosis, rather than the duration after the",
    "entities": []
  },
  {
    "text": "residency training or being a nephrologist, had a favorable impact on the",
    "entities": []
  },
  {
    "text": "appropriate practices of children with primary hypertension among Thai",
    "entities": [
      {
        "text": "Thai",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "\u00a9 The Author(s) 2025.",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: The author(s) declared no potential conflicts of",
    "entities": []
  },
  {
    "text": "interest with respect to the research, authorship, and/or publication of this",
    "entities": []
  },
  {
    "text": "An effective short form of the 20-item University of California Los Angeles",
    "entities": [
      {
        "text": "20",
        "label": "CARDINAL"
      },
      {
        "text": "University of California Los Angeles",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Loneliness Scale version 3: item response theory and network psychometrics.",
    "entities": [
      {
        "text": "3",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "(1)Department of Biostatistics, Vanderbilt University, Nashville, Tennessee,",
    "entities": [
      {
        "text": "Biostatistics, Vanderbilt University",
        "label": "ORG"
      },
      {
        "text": "Nashville",
        "label": "GPE"
      },
      {
        "text": "Tennessee",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)University of Wisconsin-Madison, Madison, Wisconsin, USA.",
    "entities": [
      {
        "text": "2)University",
        "label": "CARDINAL"
      },
      {
        "text": "Wisconsin",
        "label": "GPE"
      },
      {
        "text": "Madison",
        "label": "PERSON"
      },
      {
        "text": "Wisconsin",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Division of Biostatistics and Bioinformatics, Herbert Wertheim School of",
    "entities": [
      {
        "text": "Biostatistics and Bioinformatics",
        "label": "ORG"
      },
      {
        "text": "Herbert Wertheim School",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Public Health and Human Longevity Science, UC San Diego, San Diego, California,",
    "entities": [
      {
        "text": "UC",
        "label": "GPE"
      },
      {
        "text": "San Diego",
        "label": "GPE"
      },
      {
        "text": "San Diego",
        "label": "GPE"
      },
      {
        "text": "California",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Division of Geriatric Psychiatry, UC San Diego, San Diego, California, USA.",
    "entities": [
      {
        "text": "Geriatric Psychiatry",
        "label": "ORG"
      },
      {
        "text": "UC",
        "label": "GPE"
      },
      {
        "text": "San Diego",
        "label": "GPE"
      },
      {
        "text": "San Diego",
        "label": "GPE"
      },
      {
        "text": "California",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Loneliness is a complex and usually unpleasant emotional response to isolation,",
    "entities": []
  },
  {
    "text": "which has been considered the latest global health epidemic exacerbated by the",
    "entities": []
  },
  {
    "text": "coronavirus disease 2019 pandemic, affecting nearly two-thirds of older adults.",
    "entities": [
      {
        "text": "2019",
        "label": "DATE"
      },
      {
        "text": "nearly two-thirds",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Some profound health implications carried by loneliness include depression,",
    "entities": []
  },
  {
    "text": "cognitive impairment, hypertension and frailty. Across the world, there is no",
    "entities": []
  },
  {
    "text": "consensus definition of loneliness, and its measure is based on the",
    "entities": []
  },
  {
    "text": "phenomenological perspective of the individual. The 20-item University of",
    "entities": [
      {
        "text": "20",
        "label": "CARDINAL"
      },
      {
        "text": "University of\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "California Los Angeles Loneliness Scale version 3 (UCLA-20) is the most common",
    "entities": [
      {
        "text": "California",
        "label": "GPE"
      },
      {
        "text": "Los Angeles Loneliness Scale",
        "label": "ORG"
      },
      {
        "text": "3",
        "label": "CARDINAL"
      },
      {
        "text": "UCLA-20",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "measure. This scale demonstrates acceptable psychometric properties but is too",
    "entities": []
  },
  {
    "text": "long and complex for a phone interview. This paper addresses the increasing need",
    "entities": []
  },
  {
    "text": "to shorten this scale by adopting classical item response theory and network",
    "entities": []
  },
  {
    "text": "psychometrics to advance scale development. Through an item reduction analysis,",
    "entities": []
  },
  {
    "text": "we trimmed the original scale into an effective short form, which is as valid as",
    "entities": []
  },
  {
    "text": "the original one. With respondents' time at a premium in most research nowadays,",
    "entities": []
  },
  {
    "text": "this short-form scale is an efficient and practical alternative to the original",
    "entities": []
  },
  {
    "text": "Copyright \u00a9 Author(s) (or their employer(s)) 2025. Re-use permitted under CC",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "CC",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "BY-NC. No commercial re-use. See rights and permissions. Published by BMJ Group.",
    "entities": [
      {
        "text": "NC",
        "label": "GPE"
      },
      {
        "text": "BMJ Group",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: None declared.",
    "entities": []
  },
  {
    "text": "Predicting hemorrhage expansion in patients with hypertensive intracerebral",
    "entities": []
  },
  {
    "text": "hemorrhage: the HE-VSD-A2TP score.",
    "entities": []
  },
  {
    "text": "(1)Department of Emergency Medicine, The Second Affiliated Hospital and Yuying",
    "entities": [
      {
        "text": "Emergency Medicine",
        "label": "ORG"
      },
      {
        "text": "The Second Affiliated Hospital",
        "label": "ORG"
      },
      {
        "text": "Yuying",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.",
    "entities": [
      {
        "text": "Wenzhou Medical University",
        "label": "ORG"
      },
      {
        "text": "Wenzhou",
        "label": "GPE"
      },
      {
        "text": "Zhejiang",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Department of Ultrasound Imaging, The First Affiliated Hospital of Wenzhou",
    "entities": [
      {
        "text": "Ultrasound Imaging",
        "label": "ORG"
      },
      {
        "text": "The First Affiliated Hospital",
        "label": "ORG"
      },
      {
        "text": "Wenzhou",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Medical University, Wenzhou, Zhejiang, China.",
    "entities": [
      {
        "text": "Medical University",
        "label": "ORG"
      },
      {
        "text": "Wenzhou",
        "label": "GPE"
      },
      {
        "text": "Zhejiang",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Department of Radiotherapy, The First Affiliated Hospital of Wenzhou Medical",
    "entities": [
      {
        "text": "Radiotherapy",
        "label": "ORG"
      },
      {
        "text": "The First Affiliated Hospital",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "University, Wenzhou, Zhejiang, China.",
    "entities": [
      {
        "text": "Wenzhou",
        "label": "GPE"
      },
      {
        "text": "Zhejiang",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Department of Cardiovascular and Thoracic Surgery, The Second Affiliated",
    "entities": [
      {
        "text": "Cardiovascular",
        "label": "ORG"
      },
      {
        "text": "Thoracic Surgery",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou,",
    "entities": [
      {
        "text": "Yuying Children's Hospital of Wenzhou Medical University",
        "label": "ORG"
      },
      {
        "text": "Wenzhou",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "BACKGROUND: Hematoma expansion (HE) in hypertensive intracerebral hemorrhage",
    "entities": [
      {
        "text": "Hematoma",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(HICH) is significantly associated with patient mortality. Early identification",
    "entities": []
  },
  {
    "text": "of HE would be planning for appropriate and aggressive management for improving",
    "entities": []
  },
  {
    "text": "outcome and containing HE. Existing HE prediction models show variable accuracy",
    "entities": []
  },
  {
    "text": "across settings. To address this limitation, we developed and validate a new",
    "entities": []
  },
  {
    "text": "predictive model to enhance the accuracy of HE in patients with HICH.",
    "entities": []
  },
  {
    "text": "METHODS: We conducted a retrospective cohort study using data from two centers.",
    "entities": [
      {
        "text": "two",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "The primary outcome was the occurrence of HE within 24 h of symptom onset,",
    "entities": [
      {
        "text": "24",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "defined as an increase in hematoma volume \u226533% or \u226512.5 mL on follow-up imaging.",
    "entities": [
      {
        "text": "hematoma",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Logistic regression was used to identify independent predictors of HE, and the",
    "entities": []
  },
  {
    "text": "HE-VSD-A2TP score system was developed and validated.",
    "entities": []
  },
  {
    "text": "RESULTS: Five hundred and sixty seven patients in the derivation cohort and 378",
    "entities": [
      {
        "text": "Five hundred and sixty seven",
        "label": "QUANTITY"
      },
      {
        "text": "378",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "patients in the validation cohort. The HE-VSD-A2TP score included age,",
    "entities": []
  },
  {
    "text": "uncontrolled blood pressure, hematoma volume, irregularity/lobulation shape,",
    "entities": [
      {
        "text": "hematoma volume",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "non-homogeneous density, presentation within 6 h from symptom onset to CT, and",
    "entities": [
      {
        "text": "6",
        "label": "CARDINAL"
      },
      {
        "text": "CT",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "the use of anticoagulation/antiplatelet therapy. The HE-VSD-A2TP score",
    "entities": []
  },
  {
    "text": "demonstrated superior discrimination in predicting HE compared to existing",
    "entities": []
  },
  {
    "text": "models like PREDICT, 9-point, and BRAIN scores, with an AUC of 0.871(95%CI",
    "entities": [
      {
        "text": "9",
        "label": "CARDINAL"
      },
      {
        "text": "BRAIN",
        "label": "ORG"
      },
      {
        "text": "0.871(95%CI",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "0.839-0.904) in the derivation cohort and 0.858 (95%CI 0.819-0.897) in the",
    "entities": [
      {
        "text": "0.839",
        "label": "CARDINAL"
      },
      {
        "text": "0.858",
        "label": "CARDINAL"
      },
      {
        "text": "0.819-0.897",
        "label": "PRODUCT"
      }
    ]
  },
  {
    "text": "validation cohort. The score also showed excellent calibration and outperformed",
    "entities": []
  },
  {
    "text": "other models in terms of sensitivity, specificity, likelihood ratios, negative",
    "entities": []
  },
  {
    "text": "predictive value, and positive predictive value. With regard to clinical",
    "entities": []
  },
  {
    "text": "usefulness, the decision curve analysis (DCA) of HE-VSD-A2TP showed higher net",
    "entities": []
  },
  {
    "text": "benefit than PREDICT, 9-point, and BRAIN scores in the both cohorts.",
    "entities": [
      {
        "text": "9",
        "label": "CARDINAL"
      },
      {
        "text": "BRAIN",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "CONCLUSION: The HE-VSD-A2TP score was validated to be an effective tool for",
    "entities": []
  },
  {
    "text": "identifying patients at risk of HE in patients with HICH. It was a valuable tool",
    "entities": []
  },
  {
    "text": "for guiding clinical management strategies and potentially improving patient",
    "entities": []
  },
  {
    "text": "Association between triglyceride glucose-waist-adjusted waist index and incident",
    "entities": []
  },
  {
    "text": "stroke in Chinese adults: a prospective cohort study.",
    "entities": [
      {
        "text": "Chinese",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "(1)Department of General Practice Medicine, The First Affiliated Hospital, Sun",
    "entities": [
      {
        "text": "General Practice Medicine",
        "label": "ORG"
      },
      {
        "text": "The First Affiliated Hospital",
        "label": "ORG"
      },
      {
        "text": "Sun",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Yat-sen University, Guangzhou, China.",
    "entities": [
      {
        "text": "Yat-sen University",
        "label": "ORG"
      },
      {
        "text": "Guangzhou",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "OBJECTIVE: Current literature lacks evidence on the association between the",
    "entities": []
  },
  {
    "text": "triglyceride glucose-weight-adjusted waist index (TyG-WWI) and incident stroke.",
    "entities": [
      {
        "text": "TyG-WWI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Therefore, this study aims to elucidate the relationship between TyG-WWI and",
    "entities": [
      {
        "text": "TyG-WWI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "stroke risk in a nationally representative cohort of middle-aged and elderly",
    "entities": []
  },
  {
    "text": "Chinese adults by: (1) Quantitatively assessing its prospective association with",
    "entities": [
      {
        "text": "Chinese",
        "label": "NORP"
      },
      {
        "text": "1",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "incident stroke, and (2) Investigating potential nonlinear relationships and",
    "entities": [
      {
        "text": "2",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "inflection points.",
    "entities": []
  },
  {
    "text": "METHODS: This national longitudinal study examined data from five waves of the",
    "entities": [
      {
        "text": "five",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "CHARLS (2011-2020). TyG-WWI served as the key exposure variable, while stroke",
    "entities": [
      {
        "text": "CHARLS",
        "label": "ORG"
      },
      {
        "text": "2011-2020",
        "label": "DATE"
      },
      {
        "text": "TyG-WWI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "incidence, as determined by physician diagnosis, was the principal outcome of",
    "entities": []
  },
  {
    "text": "interest. Associations were evaluated using Cox proportional hazards models",
    "entities": [
      {
        "text": "Cox",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "alongside nonlinear analyses, with careful adjustment for a range of covariates.",
    "entities": []
  },
  {
    "text": "To further ensure the reliability of our findings, we performed a series of",
    "entities": []
  },
  {
    "text": "sensitivity and subgroup analyses.",
    "entities": []
  },
  {
    "text": "RESULTS: In this study, we investigated the association between TyG-WWI and",
    "entities": [
      {
        "text": "TyG-WWI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "stroke risk. The results demonstrated a significant positive correlation between",
    "entities": []
  },
  {
    "text": "TyG-WWI quartiles and stroke risk, with HRs of 1.35 (95% CI 1.08-1.69,",
    "entities": [
      {
        "text": "TyG-WWI",
        "label": "ORG"
      },
      {
        "text": "1.35",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "1.08",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "p = 0.0094), 1.38 (95% CI 1.09-1.73, p = 0.0069), and 1.42 (95% CI 1.09-1.85,",
    "entities": [
      {
        "text": "0.0094",
        "label": "CARDINAL"
      },
      {
        "text": "1.38",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "1.09-1.73",
        "label": "PRODUCT"
      },
      {
        "text": "0.0069",
        "label": "CARDINAL"
      },
      {
        "text": "1.42",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "1.09-1.85",
        "label": "PRODUCT"
      }
    ]
  },
  {
    "text": "p = 0.0086) for Q2, Q3, and Q4, respectively, compared to Q1 in Model III (P for",
    "entities": [
      {
        "text": "0.0086",
        "label": "CARDINAL"
      },
      {
        "text": "Q2",
        "label": "CARDINAL"
      },
      {
        "text": "Q3",
        "label": "PRODUCT"
      },
      {
        "text": "Q4",
        "label": "PRODUCT"
      },
      {
        "text": "Q1 in Model III",
        "label": "PRODUCT"
      }
    ]
  },
  {
    "text": "trend = 0.0158). A two-piecewise linear regression model revealed an inflection",
    "entities": [
      {
        "text": "0.0158",
        "label": "CARDINAL"
      },
      {
        "text": "two",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "point of TyG-WWI at 43.32, with a significant association between TyG-WWI and",
    "entities": [
      {
        "text": "TyG-WWI",
        "label": "ORG"
      },
      {
        "text": "43.32",
        "label": "CARDINAL"
      },
      {
        "text": "TyG-WWI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "stroke risk only above this point (HR = 1.03, 95% CI 1.01-1.05, p = 0.0008).",
    "entities": [
      {
        "text": "1.03",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "1.01-1.05",
        "label": "CARDINAL"
      },
      {
        "text": "0.0008",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Stratified analysis indicated a more robust association in non-hypertensive",
    "entities": []
  },
  {
    "text": "individuals (HR = 1.94, 95% CI 1.29-2.91, p = 0.0014 in Q4) and a significant",
    "entities": [
      {
        "text": "1.94",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "1.29-2.91",
        "label": "CARDINAL"
      },
      {
        "text": "0.0014",
        "label": "CARDINAL"
      },
      {
        "text": "Q4",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "interaction for hypertension status (P for interaction = 0.0493).",
    "entities": [
      {
        "text": "0.0493",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "CONCLUSION: In conclusion, our study reveals a significant association between",
    "entities": []
  },
  {
    "text": "TyG-WWI and stroke risk in the middle-aged and elderly population in China, with",
    "entities": [
      {
        "text": "TyG-WWI",
        "label": "ORG"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "stroke risk increasing progressively across higher TyG-WWI quartiles. Notably,",
    "entities": []
  },
  {
    "text": "this association was significantly more pronounced in non-hypertensive",
    "entities": []
  },
  {
    "text": "individuals. Furthermore, an inflection point indicates a stronger association",
    "entities": []
  },
  {
    "text": "beyond this threshold.",
    "entities": []
  },
  {
    "text": "Copyright \u00a9 2025 Ye, He, Wu, Wu and Liang.",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "Wu",
        "label": "PERSON"
      },
      {
        "text": "Wu",
        "label": "PERSON"
      },
      {
        "text": "Liang",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Ablation of Prdm16 and beige fat causes vascular remodeling and elevated blood",
    "entities": []
  },
  {
    "text": "While excess adiposity is a major risk factor for hypertension and",
    "entities": []
  },
  {
    "text": "cardiovascular disease, brown fat is associated with protection from these",
    "entities": []
  },
  {
    "text": "pathologies. Whether brown fat has a causal role in this process and the",
    "entities": []
  },
  {
    "text": "underlying molecular mechanisms remain unknown. Here we investigate the role of",
    "entities": []
  },
  {
    "text": "murine beige fat, as a model of inducible brown fat in humans, in",
    "entities": []
  },
  {
    "text": "adipocyte-vascular crosstalk. Using mice with an adipocyte-specific deletion of",
    "entities": []
  },
  {
    "text": "PRDM16, resulting in a loss of beige adipocyte identity, we discover a dramatic",
    "entities": [
      {
        "text": "PRDM16",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "remodeling of perivascular adipose tissue, increased vascular reactivity and",
    "entities": []
  },
  {
    "text": "elevated blood pressure. We further show that the circulating enzyme Qsox1 is",
    "entities": [
      {
        "text": "Qsox1",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "de-repressed in Prdm16 -deficient adipocytes, and deletion of Qsox1 in PRDM16cKO",
    "entities": [
      {
        "text": "Qsox1",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "mice rescues vascular fibrosis and reactivity. These results demonstrate a key",
    "entities": []
  },
  {
    "text": "new role for beige adipocytes in blood pressure regulation and identify Qsox1 as",
    "entities": [
      {
        "text": "Qsox1",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "an important mediator of adipocyte-vascular crosstalk.",
    "entities": []
  },
  {
    "text": "Flow-sensitive HEG1 controls eNOS activity to prevent endothelial dysfunction,",
    "entities": []
  },
  {
    "text": "hypertension, and atherosclerosis.",
    "entities": []
  },
  {
    "text": "JA, Park C, Kapoor V, Pollock JS, Jo H.",
    "entities": [
      {
        "text": "JA",
        "label": "PERSON"
      },
      {
        "text": "Kapoor V",
        "label": "PERSON"
      },
      {
        "text": "Jo H.\n",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Hypertension (HTN), the chronic elevation of blood pressure, accounts for more",
    "entities": [
      {
        "text": "Hypertension (HTN",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "atherosclerotic cardiovascular disease deaths than any other modifiable risk",
    "entities": []
  },
  {
    "text": "factor. 1 In the arteries, stable blood flow (s-flow) drives healthy,",
    "entities": [
      {
        "text": "1",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "atheroprotective endothelial cell (EC) functions including nitric oxide (NO)",
    "entities": [
      {
        "text": "EC",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "production, barrier function, and anti-inflammatory programs via the action of",
    "entities": []
  },
  {
    "text": "flow-sensitive proteins. We showed that s-flow stimulates Heart-of-Glass 1",
    "entities": []
  },
  {
    "text": "(HEG1) protein expression, localization to cell-cell junctions, and secretion",
    "entities": []
  },
  {
    "text": "from ECs. 2 We found that conditional, endothelial cell-specific knockout of (",
    "entities": [
      {
        "text": "2",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Heg1 ECKO ) exacerbates atherosclerosis 2 , however the mechanism was unknown.",
    "entities": [
      {
        "text": "2",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Here, we report a new role of HEG1 in controlling EC dysfunction, hypertension",
    "entities": [
      {
        "text": "EC",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "and atherosclerosis. We discover a novel mechanism: HEG1 regulates NO",
    "entities": []
  },
  {
    "text": "bioavailability via a flow-dependent HEG1-eNOS interaction (endothelial nitric",
    "entities": []
  },
  {
    "text": "oxide synthase, NOS3). Heg1 ECKO develops spontaneous hypertension and severe",
    "entities": []
  },
  {
    "text": "atherosclerosis, both of which are effectively treated by Angiotensin-Converting",
    "entities": [
      {
        "text": "Angiotensin-Converting\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Enzyme inhibition (ACEi). UK BioBank and Swedish cohort studies reveal that",
    "entities": [
      {
        "text": "UK",
        "label": "GPE"
      },
      {
        "text": "BioBank",
        "label": "ORG"
      },
      {
        "text": "Swedish",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "plasma HEG1 levels are associated with hypertension and cardiovascular disease",
    "entities": []
  },
  {
    "text": "risk. 3,4 Our findings suggest HEG1 may serve as a biomarker to advance",
    "entities": []
  },
  {
    "text": "personalized therapies for EC dysfunction, hypertension, and atherosclerosis.",
    "entities": [
      {
        "text": "EC",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Paracrine Action of Bone Morphogenetic Protein 3 in Pulmonary Arterial",
    "entities": [
      {
        "text": "Paracrine Action of",
        "label": "PERSON"
      },
      {
        "text": "3",
        "label": "CARDINAL"
      },
      {
        "text": "Pulmonary Arterial",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Hypertension.",
    "entities": []
  },
  {
    "text": "BACKGROUND: Despite recent advancements in the management of pulmonary arterial",
    "entities": []
  },
  {
    "text": "hypertension (PAH), the disease remains devastating, with limited survival.",
    "entities": [
      {
        "text": "PAH",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Although the Bone Morphogenetic Protein (BMP) signaling pathway is known to play",
    "entities": [
      {
        "text": "the Bone Morphogenetic Protein",
        "label": "ORG"
      },
      {
        "text": "BMP",
        "label": "PRODUCT"
      }
    ]
  },
  {
    "text": "an important role in PAH, our current understanding of this pathway remains",
    "entities": [
      {
        "text": "PAH",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "METHODS: We assessed BMP3 levels in the lungs of mice, rats, and pigs with",
    "entities": []
  },
  {
    "text": "pulmonary hypertension, and in pulmonary vascular cells from human patients with",
    "entities": [
      {
        "text": "pulmonary",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "PAH. We performed in vitro studies on human pulmonary artery smooth muscle cells",
    "entities": [
      {
        "text": "PAH",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(hPASMCs) and human pulmonary artery endothelial cells (hPAECs) derived from",
    "entities": []
  },
  {
    "text": "healthy donors and from patients with PAH. We generated mice with global or",
    "entities": [
      {
        "text": "PAH",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "SMC-specific deletion of BMP3. Recombinant BMP3 protein and adeno-associated",
    "entities": [
      {
        "text": "SMC",
        "label": "ORG"
      },
      {
        "text": "adeno",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "viruses (AAV) were used to overexpress BMP3 in two different models of PAH in",
    "entities": [
      {
        "text": "AAV",
        "label": "PRODUCT"
      },
      {
        "text": "two",
        "label": "CARDINAL"
      },
      {
        "text": "PAH",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "rodents. Magnetic resonance imaging, cardiac hemodynamics, morphometric, and",
    "entities": []
  },
  {
    "text": "histological measurements were performed to evaluate the effects of BMP3 on",
    "entities": []
  },
  {
    "text": "cardiac function and pulmonary vascular remodeling.",
    "entities": []
  },
  {
    "text": "RESULTS: BMP3 is predominantly expressed in PASMCs and is downregulated in PAH.",
    "entities": [
      {
        "text": "PAH",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "In vitro, conditioned medium from siRNA-BMP3-transfected hPASMCs increased",
    "entities": []
  },
  {
    "text": "hPAECs migration and proliferation, while PASMC-derived BMP3 inhibited",
    "entities": [
      {
        "text": "PASMC",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "PAH-diseased PAEC dysfunction. In both global and SMC-specific BMP3-deficient",
    "entities": [
      {
        "text": "PAH",
        "label": "ORG"
      },
      {
        "text": "SMC",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "mice, exposure to a model of PAH exacerbated cardiac and pulmonary vascular",
    "entities": [
      {
        "text": "PAH",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "remodeling in middle-aged mice. An intraperitoneally injected recombinant BMP3",
    "entities": []
  },
  {
    "text": "prevented and reversed PAH in mice. A lung-targeted overexpression of BMP3, via",
    "entities": [
      {
        "text": "PAH",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "AAV1-BMP3, reversed pulmonary vascular remodeling and inhibited cardiac",
    "entities": [
      {
        "text": "AAV1-BMP3",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "dysfunction in mice and rats. Mechanistically, BMP3 activated the BMP/Smad1,5,8",
    "entities": [
      {
        "text": "BMP",
        "label": "PRODUCT"
      }
    ]
  },
  {
    "text": "pathway, inhibited the TGF-\u03b2/Smad2,3 pathway, and decreased the expression of",
    "entities": []
  },
  {
    "text": "cell cycle genes in hPAECs and in the lungs of BMP3-treated animals with PAH.",
    "entities": [
      {
        "text": "PAH",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "CONCLUSIONS: Our findings provide evidence that BMP3 overexpression attenuates",
    "entities": []
  },
  {
    "text": "pulmonary vascular remodeling and inhibits cardiac dysfunction by restoring the",
    "entities": []
  },
  {
    "text": "balance between the TGF-\u03b2 and BMP pathways through a cell-cell communication",
    "entities": [
      {
        "text": "BMP",
        "label": "PRODUCT"
      }
    ]
  },
  {
    "text": "mechanism, offering a novel therapeutic pathway for PAH.",
    "entities": [
      {
        "text": "PAH",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "CLINICAL PERSPECTIVE: What is New?: BMP3 is downregulated in the lungs of mice,",
    "entities": []
  },
  {
    "text": "rats, and pigs with pulmonary hypertension and in pulmonary artery smooth muscle",
    "entities": []
  },
  {
    "text": "cells of patients with PAH.BMP3 acts as a paracrine factor between pulmonary",
    "entities": []
  },
  {
    "text": "vascular cells.Overexpression of BMP3 decreases pulmonary vascular remodeling",
    "entities": []
  },
  {
    "text": "and reverses cardiac dysfunction in PAH-diseased rodents.BMP3 acts by restoring",
    "entities": [
      {
        "text": "PAH",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "the balance between the TGF-\u03b2/Smad2,3 pathway and the BMP/Smad1,5,8 pathwayWhat",
    "entities": [
      {
        "text": "BMP",
        "label": "PRODUCT"
      }
    ]
  },
  {
    "text": "Are the Clinical Implications?: BMP3 represents a promising disease-modifying",
    "entities": []
  },
  {
    "text": "agent with potential for clinical translation in the treatment of",
    "entities": []
  },
  {
    "text": "PAH.Overexpressing BMP3 with Adeno-Associated Viruses has therapeutic potential",
    "entities": [
      {
        "text": "Adeno-Associated Viruses",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "to treat PAH.",
    "entities": [
      {
        "text": "PAH",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "The 5-HT1A receptor antagonist WAY-100635 maleate reprograms metabolism to",
    "entities": [
      {
        "text": "5",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Metabolic collapse of retinal ganglion cells (RGCs) onsets glaucoma, yet no",
    "entities": []
  },
  {
    "text": "approved drug directly protects these neurons. Through a live-cell mitochondrial",
    "entities": []
  },
  {
    "text": "screen in human stem-cell-derived hRGCs we uncovered WAY-100635 (WAY), a",
    "entities": []
  },
  {
    "text": "clinically tested 5-HT1A antagonist, as a systemic neuroprotectant. WAY triggers",
    "entities": [
      {
        "text": "5",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "a reversible cyclic-AMP surge that activates PGC-1\u03b1-driven reversible",
    "entities": [
      {
        "text": "PGC-1\u03b1",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "mitochondrial biogenesis and suppresses apoptosis. In glaucoma associated OPTN",
    "entities": [
      {
        "text": "OPTN",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "E50K hRGCs, WAY restores mitochondrial fitness, dampens excitotoxicity, and",
    "entities": [
      {
        "text": "E50K hRGCs",
        "label": "ORG"
      },
      {
        "text": "WAY",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "reprograms metabolism toward aerobic glycolysis, while in progenitors WAY boosts",
    "entities": [
      {
        "text": "WAY",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "mitochondrial cristae maturation, oxidative phosphorylation, and cell-cycle exit",
    "entities": []
  },
  {
    "text": "to accelerate RGC specification. Daily intraperitoneal dosing preserves RGC",
    "entities": [
      {
        "text": "RGC",
        "label": "ORG"
      },
      {
        "text": "RGC",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "bodies, neural activity, promotes axon regeneration into the optic nerve and",
    "entities": []
  },
  {
    "text": "vision centers after optic-nerve crush, as well as shows RGC protection and",
    "entities": [
      {
        "text": "RGC",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "maintenance of visual acuity in chronic ocular hypertension glaucoma. As the",
    "entities": []
  },
  {
    "text": "non-invasive neuroprotective therapy with a human safety profile, WAY addresses",
    "entities": [
      {
        "text": "WAY",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "a critical gap in glaucoma care and potentially for other mitochondrial optic",
    "entities": []
  },
  {
    "text": "Effect of Tomato and Cucumber Juice on Blood Pressure in Hypertensive Patients:",
    "entities": []
  },
  {
    "text": "(1)Department of Public Health, Faculty of Health Sciences, Bhakti Kencana",
    "entities": [
      {
        "text": "Public Health, Faculty of Health Sciences",
        "label": "ORG"
      },
      {
        "text": "Bhakti Kencana",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(2)Department of Pharmacy, Binawan University, Jakarta, Indonesia.",
    "entities": [
      {
        "text": "Pharmacy, Binawan University",
        "label": "ORG"
      },
      {
        "text": "Jakarta",
        "label": "GPE"
      },
      {
        "text": "Indonesia",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Department of Midwifery, Hamzar College of Health Sciences, Lombok,",
    "entities": [
      {
        "text": "Midwifery, Hamzar College of Health Sciences",
        "label": "ORG"
      },
      {
        "text": "Lombok",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(4)Department of Physical Education Health and Recreation, Faculty of Sports",
    "entities": [
      {
        "text": "Physical Education Health and Recreation, Faculty of Sports",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(5)Department of Pharmacy, Universitas Darussalam Gontor, Ponorogo, Indonesia.",
    "entities": [
      {
        "text": "Gontor",
        "label": "PERSON"
      },
      {
        "text": "Ponorogo",
        "label": "ORG"
      },
      {
        "text": "Indonesia",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(6)Department of Nursing, Faculty of Nursing, Bhakti Kencana University,",
    "entities": [
      {
        "text": "Nursing, Faculty of Nursing",
        "label": "ORG"
      },
      {
        "text": "Bhakti Kencana University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "BACKGROUND: Hypertension is associated with the improvement of cardiovascular",
    "entities": []
  },
  {
    "text": "disease and all-cause mortality. A healthy diet based on consuming natural foods",
    "entities": []
  },
  {
    "text": "can prevent and control hypertension.",
    "entities": []
  },
  {
    "text": "OBJECTIVE: The aim of this study was to analyze the effectiveness of tomato and",
    "entities": []
  },
  {
    "text": "cucumber juice in reducing the blood pressure of hypertensive patients.",
    "entities": []
  },
  {
    "text": "METHODS: The study used a quasi-experiment pretest-posttest control group",
    "entities": []
  },
  {
    "text": "design. The target population are people with hypertension Stage 1, people",
    "entities": [
      {
        "text": "1",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "living in urban area - Cibiru Health Centre Work Area. Purposive sampling was",
    "entities": [
      {
        "text": "- Cibiru Health Centre Work Area",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "used and the sample size was calculated using the average comparison formula",
    "entities": []
  },
  {
    "text": "with effect size=0.9, \u03b1=0.05, \u03b2 =0.2. Forty-five subjects involved in the study",
    "entities": [
      {
        "text": "0.2",
        "label": "CARDINAL"
      },
      {
        "text": "Forty-five",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "were divided into three groups (15 subjects were given tomato juice, 15 subjects",
    "entities": [
      {
        "text": "three",
        "label": "CARDINAL"
      },
      {
        "text": "15",
        "label": "CARDINAL"
      },
      {
        "text": "15",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "were given cucumber juice, and 15 subjects were given treatment with mineral",
    "entities": [
      {
        "text": "15",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "water (control group)., This research used 100 grams of ripe red tomatoes, 100",
    "entities": [
      {
        "text": "100 grams",
        "label": "QUANTITY"
      },
      {
        "text": "100",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "grams of fresh cucumber, and 200 ml of water. The data collected were patient",
    "entities": [
      {
        "text": "200 ml",
        "label": "QUANTITY"
      }
    ]
  },
  {
    "text": "characteristics and blood pressure. The ANOVA analysis test and the Bonferroni",
    "entities": [
      {
        "text": "ANOVA",
        "label": "ORG"
      },
      {
        "text": "the Bonferroni\n",
        "label": "FAC"
      }
    ]
  },
  {
    "text": "Post Hoc test were used to analyze the data.",
    "entities": []
  },
  {
    "text": "RESULTS: The results of the study showed a difference in blood pressure",
    "entities": []
  },
  {
    "text": "reduction in each group. The decrease in systolic blood pressure in the tomato",
    "entities": []
  },
  {
    "text": "juice group was 7.3\u00b13.1, the cucumber juice group was 4.2\u00b13.3, and the control",
    "entities": [
      {
        "text": "juice group",
        "label": "ORG"
      },
      {
        "text": "4.2\u00b13.3",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "group was -0.0\u00b12.5 (p=0.0001). The decrease in diastolic blood pressure in the",
    "entities": []
  },
  {
    "text": "group given tomato juice was 9.2\u00b13.1, the group given cucumber juice was",
    "entities": [
      {
        "text": "tomato juice",
        "label": "PERSON"
      },
      {
        "text": "9.2\u00b13.1",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "7.6\u00b13.4, and the control group was 0.4\u00b12.1 (p=0.0001).",
    "entities": []
  },
  {
    "text": "CONCLUSION: There is a difference in blood pressure reduction between the group",
    "entities": []
  },
  {
    "text": "given tomato juice and the control group, and there is a difference in blood",
    "entities": []
  },
  {
    "text": "pressure between the group given cucumber juice and the control group.",
    "entities": []
  },
  {
    "text": "Conflict of interest statement: All authors declared no conflicts of interest.",
    "entities": []
  },
  {
    "text": "12. Int J Womens Health. 2025 Jul 11;17:1985-1999. doi: 10.2147/IJWH.S522635.",
    "entities": [
      {
        "text": "12",
        "label": "CARDINAL"
      },
      {
        "text": "Int J Womens Health",
        "label": "ORG"
      },
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "11;17:1985-1999",
        "label": "DATE"
      },
      {
        "text": "10.2147",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Causal Relationship Between Sex Hormone Binding Globulin and Obstetrical",
    "entities": [
      {
        "text": "Causal Relationship Between Sex Hormone Binding Globulin",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Disorders: A Two-Sample Bidirectional Mendelian Randomization Study.",
    "entities": [
      {
        "text": "Two",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "(1)Department of Obstetrics, The First Affiliated Hospital of Chongqing Medical",
    "entities": [
      {
        "text": "Obstetrics",
        "label": "GPE"
      },
      {
        "text": "The First Affiliated Hospital of Chongqing Medical",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "University, Chongqing, People's Republic of China.",
    "entities": [
      {
        "text": "Chongqing",
        "label": "GPE"
      },
      {
        "text": "People's Republic of China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Department of Obstetrics, The Affiliated Hospital of North Sichuan Medical",
    "entities": [
      {
        "text": "Obstetrics",
        "label": "GPE"
      },
      {
        "text": "The Affiliated Hospital of",
        "label": "ORG"
      },
      {
        "text": "North Sichuan Medical",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "College, Nanchong, People's Republic of China.",
    "entities": [
      {
        "text": "Nanchong",
        "label": "GPE"
      },
      {
        "text": "People's Republic of China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(#)Contributed equally",
    "entities": []
  },
  {
    "text": "INTRODUCTION: Obstetrical disorders critically impact maternal and fetal health.",
    "entities": []
  },
  {
    "text": "Sex hormone-binding globulin (SHBG) regulates pregnancy maintenance and",
    "entities": []
  },
  {
    "text": "maternal-infant outcomes through hormonal, metabolic, and inflammatory pathways,",
    "entities": []
  },
  {
    "text": "yet causal relationships with obstetrical disorders remain unclear. This",
    "entities": []
  },
  {
    "text": "Mendelian randomization (MR) study examined SHBG's causal effects on 12",
    "entities": [
      {
        "text": "Mendelian",
        "label": "NORP"
      },
      {
        "text": "SHBG",
        "label": "ORG"
      },
      {
        "text": "12",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "obstetrical conditions.",
    "entities": []
  },
  {
    "text": "METHODS: Using cis-protein quantitative trait loci (cis-pQTLs) of SHBG as",
    "entities": [
      {
        "text": "cis-pQTLs",
        "label": "GPE"
      },
      {
        "text": "SHBG",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "instrumental variables, we conducted MR analyses in FinnGen and UK Biobank",
    "entities": [
      {
        "text": "FinnGen",
        "label": "GPE"
      },
      {
        "text": "UK",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(UKBB), followed by meta-analyses. Inverse variance weighting (IVW) was primary",
    "entities": [
      {
        "text": "UKBB",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "method, with sensitivity analyses ensuring robustness.",
    "entities": []
  },
  {
    "text": "RESULTS: IVW-MR demonstrated reduced risks with elevated SHBG: gestational",
    "entities": []
  },
  {
    "text": "(OR[95%]=0.823[0.728-0.931], P FDR=5.94\u00d710-3), gestational hypertension",
    "entities": [
      {
        "text": "P FDR=5.94\u00d710-3",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(OR[95%]=0.917[0.852-0.987], P FDR=0.041), and early-pregnancy hemorrhage",
    "entities": [
      {
        "text": "P FDR=0.041",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(OR[95%]=0.853[0.794-0.916], P FDR=6.90\u00d710-5). Meta-analysis confirmed SHBG's",
    "entities": [
      {
        "text": "P FDR=6.90\u00d710-5",
        "label": "ORG"
      },
      {
        "text": "SHBG",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "causal role in gestational diabetes (P_combined<0.05). COLOC revealed shared",
    "entities": [
      {
        "text": "COLOC",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "loci between SHBG and five disorders: gestational diabetes, hyperemesis, early",
    "entities": [
      {
        "text": "SHBG",
        "label": "ORG"
      },
      {
        "text": "five",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "hemorrhage, preterm delivery, and postpartum hemorrhage.",
    "entities": []
  },
  {
    "text": "CONCLUSION: SHBG causally lowers risks of gestational diabetes, hypertension,",
    "entities": []
  },
  {
    "text": "hyperemesis, miscarriage, and preterm delivery, highlighting its clinical",
    "entities": []
  },
  {
    "text": "relevance in obstetrical pathophysiology.",
    "entities": []
  },
  {
    "text": "Conflict of interest statement: The authors report no conflicts of interest in",
    "entities": []
  },
  {
    "text": "this work.",
    "entities": []
  },
  {
    "text": "Bilateral Idiopathic Multifocal Retinal Pigment Epithelial Detachments: A Case",
    "entities": [
      {
        "text": "Bilateral Idiopathic Multifocal Retinal Pigment Epithelial Detachments",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Report and Brief Review of the Literature.",
    "entities": []
  },
  {
    "text": "(1)Ophthalmology, St Helens Hospital, Mersey and West Lancashire Teaching",
    "entities": [
      {
        "text": "St Helens Hospital",
        "label": "PERSON"
      },
      {
        "text": "Mersey",
        "label": "GPE"
      },
      {
        "text": "West Lancashire Teaching",
        "label": "LOC"
      }
    ]
  },
  {
    "text": "Retinal pigment epithelial detachments (PEDs) result from a disruption at the",
    "entities": []
  },
  {
    "text": "junction between the basement membrane of the retinal pigment epithelium (RPE)",
    "entities": []
  },
  {
    "text": "and the innermost part of Bruch's membrane. Serous retinal PEDs, whether",
    "entities": [
      {
        "text": "Bruch",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "singular or multiple, are frequently seen across a broad spectrum of ophthalmic",
    "entities": []
  },
  {
    "text": "disorders. Additionally, PEDs have been associated with various systemic",
    "entities": []
  },
  {
    "text": "conditions, including renal, hypertensive, endocrine, and hematologic",
    "entities": []
  },
  {
    "text": "disorders. Idiopathic PEDs, which occur without an associated underlying",
    "entities": []
  },
  {
    "text": "condition, are exceedingly rare, with only a few cases reported in the",
    "entities": []
  },
  {
    "text": "literature. Herein, we report a case of an asymptomatic and otherwise healthy",
    "entities": []
  },
  {
    "text": "individual with multiple idiopathic retinal PEDs, highlighting the importance of",
    "entities": []
  },
  {
    "text": "a comprehensive clinical examination and multimodal ophthalmic imaging.",
    "entities": []
  },
  {
    "text": "Copyright \u00a9 2025, Kalogeropoulos et al.",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "Kalogeropoulos et al.",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: Human subjects: Informed consent for treatment",
    "entities": []
  },
  {
    "text": "and open access publication was obtained or waived by all participants in this",
    "entities": []
  },
  {
    "text": "study. Conflicts of interest: In compliance with the ICMJE uniform disclosure",
    "entities": [
      {
        "text": "ICMJE",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "form, all authors declare the following: Payment/services info: All authors have",
    "entities": []
  },
  {
    "text": "declared that no financial support was received from any organization for the",
    "entities": []
  },
  {
    "text": "submitted work. Financial relationships: All authors have declared that they",
    "entities": []
  },
  {
    "text": "have no financial relationships at present or within the previous three years",
    "entities": [
      {
        "text": "the previous three years",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "with any organizations that might have an interest in the submitted work. Other",
    "entities": []
  },
  {
    "text": "relationships: All authors have declared that there are no other relationships",
    "entities": []
  },
  {
    "text": "or activities that could appear to have influenced the submitted work.",
    "entities": []
  },
  {
    "text": "Monoclonal Gammopathy of Renal Significance in a Patient With Cryoglobulinemia",
    "entities": []
  },
  {
    "text": "and Nephrotic Syndrome: A Case Report.",
    "entities": []
  },
  {
    "text": "(1)College of Medicine, King Saud Bin Abdulaziz University for Health Sciences,",
    "entities": []
  },
  {
    "text": "(2)Department of Pathology and Laboratory Medicine, King Abdulaziz Medical City,",
    "entities": [
      {
        "text": "2)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Pathology and Laboratory Medicine",
        "label": "ORG"
      },
      {
        "text": "King Abdulaziz Medical City",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Ministry of National Guard Health Affairs (MNGHA), Riyadh, SAU.",
    "entities": [
      {
        "text": "Ministry of National Guard Health Affairs",
        "label": "ORG"
      },
      {
        "text": "Riyadh",
        "label": "GPE"
      },
      {
        "text": "SAU",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(3)Department of Medicine/Division of Nephrology, King Abdulaziz Medical City,",
    "entities": [
      {
        "text": "Medicine/Division of Nephrology",
        "label": "ORG"
      },
      {
        "text": "King Abdulaziz Medical City",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "We report a case of monoclonal gammopathy of renal significance (MGRS) in a",
    "entities": []
  },
  {
    "text": "65-year-old female patient who presented to the emergency department with",
    "entities": [
      {
        "text": "65-year-old",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "uncontrolled hypertension, generalized edema, abdominal distension, and frothy",
    "entities": []
  },
  {
    "text": "urine. Apart from recently diagnosed hypertension, she had no significant",
    "entities": []
  },
  {
    "text": "comorbidities. Examination revealed periorbital swelling, bibasal crackles,",
    "entities": []
  },
  {
    "text": "moderate ascites, and bilateral lower limb pitting edema. Laboratory findings",
    "entities": []
  },
  {
    "text": "showed proteinuria, low complement levels, elevated IgM, decreased IgG, and the",
    "entities": [
      {
        "text": "IgG",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "presence of cryoglobulins. Imaging and PET-CT ruled out malignancy. Kidney",
    "entities": [
      {
        "text": "PET-CT",
        "label": "ORG"
      },
      {
        "text": "Kidney\n",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "biopsy revealed membranoproliferative glomerulonephritis with cryoglobulin",
    "entities": []
  },
  {
    "text": "deposition and vasculitis. Bone marrow biopsy confirmed plasma cell dyscrasia",
    "entities": []
  },
  {
    "text": "with kappa light chain restriction. Despite suspicion of Waldenstr\u00f6m",
    "entities": [
      {
        "text": "Waldenstr\u00f6m",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "macroglobulinemia or IgM myeloma, cytogenetics and fluorescence in situ",
    "entities": []
  },
  {
    "text": "hybridization were negative. The patient was treated with rituximab and",
    "entities": []
  },
  {
    "text": "corticosteroids, with complete resolution of ascites, edema, and proteinuria.",
    "entities": []
  },
  {
    "text": "This case highlights an uncommon presentation of IgM kappa-related MGRS with",
    "entities": [
      {
        "text": "IgM",
        "label": "ORDINAL"
      }
    ]
  },
  {
    "text": "type I cryoglobulinemia.",
    "entities": []
  },
  {
    "text": "Catecholamine-Secreting Non-small Cell Lung Cancer Presenting With Hypertensive",
    "entities": [
      {
        "text": "Catecholamine-Secreting Non-small",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Crisis: A Report of a Rare Case.",
    "entities": []
  },
  {
    "text": "(1)Biomedical Sciences, University of South Florida, Tampa, USA.",
    "entities": [
      {
        "text": "Sciences,",
        "label": "ORG"
      },
      {
        "text": "University of South Florida",
        "label": "ORG"
      },
      {
        "text": "Tampa",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Oncology, University of Arizona College of Medicine - Tucson, Tucson, USA.",
    "entities": [
      {
        "text": "University of Arizona College of Medicine - Tucson",
        "label": "ORG"
      },
      {
        "text": "Tucson",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Internal Medicine, Creighton University School of Medicine, Phoenix, USA.",
    "entities": [
      {
        "text": "Creighton University School of Medicine",
        "label": "ORG"
      },
      {
        "text": "Phoenix",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Radiology, Midwestern University Arizona College of Osteopathic Medicine,",
    "entities": [
      {
        "text": "Midwestern University",
        "label": "ORG"
      },
      {
        "text": "Arizona College of Osteopathic Medicine",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(5)Internal Medicine, Chandler Regional Medical Center, Chandler, USA.",
    "entities": [
      {
        "text": "Chandler Regional Medical Center",
        "label": "ORG"
      },
      {
        "text": "Chandler",
        "label": "PERSON"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Ectopic catecholamine production by non-small cell lung cancer (NSCLC) is",
    "entities": [
      {
        "text": "Ectopic",
        "label": "ORG"
      },
      {
        "text": "NSCLC",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "exceptionally rare and, to our knowledge, has not been previously reported in",
    "entities": []
  },
  {
    "text": "the literature. We present the case of a 68-year-old woman with advanced lung",
    "entities": [
      {
        "text": "68-year-old",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "adenocarcinoma who presented in hypertensive crisis due to markedly elevated",
    "entities": []
  },
  {
    "text": "normetanephrine levels. Initial suspicion was for pheochromocytoma, but normal",
    "entities": []
  },
  {
    "text": "chromogranin A levels suggested a paraneoplastic phenomenon. Despite",
    "entities": []
  },
  {
    "text": "alpha-adrenergic blockade, the patient's metastatic disease and refractory",
    "entities": []
  },
  {
    "text": "hypertension contributed to poor treatment tolerance, ultimately necessitating",
    "entities": []
  },
  {
    "text": "transition to hospice care. This case underscores the importance of considering",
    "entities": []
  },
  {
    "text": "atypical endocrine manifestations of NSCLC and highlights the challenges of",
    "entities": [
      {
        "text": "NSCLC",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "managing advanced cancer complicated by paraneoplastic syndromes.",
    "entities": []
  },
  {
    "text": "Copyright \u00a9 2025, Kartoumah et al.",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "al.",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Evaluating the Effects of Stress, Depression, and Anxiety on Hypertension.",
    "entities": [
      {
        "text": "Anxiety on Hypertension",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(1)Community Medicine, Federal Medical Center, Keffi, NGA.",
    "entities": [
      {
        "text": "1)Community",
        "label": "CARDINAL"
      },
      {
        "text": "Federal Medical Center",
        "label": "ORG"
      },
      {
        "text": "Keffi",
        "label": "GPE"
      },
      {
        "text": "NGA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(2)Public Health, Georgia Southern University, Statesboro, USA.",
    "entities": [
      {
        "text": "2)Public Health",
        "label": "ORG"
      },
      {
        "text": "Georgia Southern University",
        "label": "ORG"
      },
      {
        "text": "Statesboro",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Nephrology, Oasis Kidney Care Center, Houston, USA.",
    "entities": [
      {
        "text": "Houston",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Family Medicine, Larkin Community Hospital Palm Springs Campus, Miami, USA.",
    "entities": [
      {
        "text": "Medicine, Larkin Community Hospital Palm Springs Campus",
        "label": "ORG"
      },
      {
        "text": "Miami",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(6)General Medicine, Jiann-Ping Hsu College of Public Health, Georgia Southern",
    "entities": [
      {
        "text": "6)General",
        "label": "CARDINAL"
      },
      {
        "text": "Georgia Southern",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "University, Statesboro, USA.",
    "entities": [
      {
        "text": "Statesboro",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(7)Adult Psychiatry, Cygnet Hospital Harrogate, Harrogate, GBR.",
    "entities": [
      {
        "text": "7)Adult Psychiatry",
        "label": "ORG"
      },
      {
        "text": "Cygnet Hospital Harrogate",
        "label": "ORG"
      },
      {
        "text": "Harrogate",
        "label": "GPE"
      },
      {
        "text": "GBR",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(8)Internal Medicine, Richmond Gabriel University, Kingstown, VCT.",
    "entities": [
      {
        "text": "Richmond Gabriel University",
        "label": "ORG"
      },
      {
        "text": "Kingstown",
        "label": "GPE"
      },
      {
        "text": "VCT",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(9)Family Medicine, Senator's Health Center Family Medicine Collaboration, Glace",
    "entities": [
      {
        "text": "Health Center Family Medicine Collaboration",
        "label": "ORG"
      },
      {
        "text": "Glace",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(10)Family Medicine, Nova Scotia Health Authority, Glace Bay, CAN.",
    "entities": [
      {
        "text": "Glace Bay",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(11)General Medicine, Ternopil National Medical University, Ternopil, UKR.",
    "entities": [
      {
        "text": "Ternopil National Medical University",
        "label": "ORG"
      },
      {
        "text": "Ternopil",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(12)General Medicine, Abia State University, Uturu, NGA.",
    "entities": [
      {
        "text": "Abia State University",
        "label": "ORG"
      },
      {
        "text": "Uturu",
        "label": "ORG"
      },
      {
        "text": "NGA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "INTRODUCTION: Hypertension is a persistent global health issue, with",
    "entities": []
  },
  {
    "text": "psychological factors like stress, anxiety, and depression increasingly studied",
    "entities": []
  },
  {
    "text": "as potential contributors. However, their independent associations with",
    "entities": []
  },
  {
    "text": "hypertension remain unclear.",
    "entities": []
  },
  {
    "text": "OBJECTIVE: To examine the relationship between stress (using self-reported",
    "entities": []
  },
  {
    "text": "irritability as a proxy), anxiety, and depression with both the prevalence and",
    "entities": []
  },
  {
    "text": "severity of hypertension in a nationally representative adult population.",
    "entities": []
  },
  {
    "text": "METHODS: A cross-sectional analysis was conducted using publicly available data",
    "entities": []
  },
  {
    "text": "from the National Health and Nutrition Examination Survey (NHANES), a nationally",
    "entities": [
      {
        "text": "the National Health and Nutrition Examination Survey",
        "label": "ORG"
      },
      {
        "text": "NHANES",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "representative survey conducted by the Centers for Disease Control and",
    "entities": [
      {
        "text": "the Centers for Disease Control",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Prevention (CDC). The study included 18,891 adults aged 18 and older.",
    "entities": [
      {
        "text": "CDC",
        "label": "ORG"
      },
      {
        "text": "18,891",
        "label": "CARDINAL"
      },
      {
        "text": "18 and older",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "Hypertension was defined by self-reported medical diagnosis. Psychological",
    "entities": []
  },
  {
    "text": "variables included depression and anxiety scores, with stress proxied by",
    "entities": []
  },
  {
    "text": "reported irritability. Covariates included age, gender, race/ethnicity, physical",
    "entities": []
  },
  {
    "text": "activity, and BMI. Due to missing data, multiple imputation by chained equations",
    "entities": [
      {
        "text": "BMI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(MICE) was applied. Multivariable logistic regression was used to assess",
    "entities": []
  },
  {
    "text": "associations.",
    "entities": [
      {
        "text": "associations",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "RESULTS: After adjustment, stress was significantly linked to higher odds of",
    "entities": []
  },
  {
    "text": "hypertension (\u03b2 = 0.30, p < 0.03), while anxiety and depression were not. Older",
    "entities": [
      {
        "text": "0.30",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "age, higher body mass index (BMI), and physical inactivity were also significant",
    "entities": [
      {
        "text": "BMI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "risk factors. Non-Hispanic Black and White participants had greater odds of",
    "entities": [
      {
        "text": "Non-Hispanic Black",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "hypertension compared to Mexican Americans.",
    "entities": [
      {
        "text": "Mexican",
        "label": "NORP"
      },
      {
        "text": "Americans",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "CONCLUSION: Stress was independently associated with hypertension, emphasizing",
    "entities": []
  },
  {
    "text": "the relevance of emotional strain in cardiovascular risk. Anxiety and depression",
    "entities": []
  },
  {
    "text": "showed no significant association. Findings support the inclusion of stress",
    "entities": []
  },
  {
    "text": "assessment in hypertension screening, though results are limited by the study's",
    "entities": []
  },
  {
    "text": "cross-sectional design and reliance on imputed data.",
    "entities": []
  },
  {
    "text": "study. Animal subjects: All authors have confirmed that this study did not",
    "entities": []
  },
  {
    "text": "involve animal subjects or tissue. Conflicts of interest: In compliance with the",
    "entities": []
  },
  {
    "text": "ICMJE uniform disclosure form, all authors declare the following:",
    "entities": []
  },
  {
    "text": "Payment/services info: All authors have declared that no financial support was",
    "entities": []
  },
  {
    "text": "received from any organization for the submitted work. Financial relationships:",
    "entities": []
  },
  {
    "text": "All authors have declared that they have no financial relationships at present",
    "entities": []
  },
  {
    "text": "or within the previous three years with any organizations that might have an",
    "entities": [
      {
        "text": "the previous three years",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "interest in the submitted work. Other relationships: All authors have declared",
    "entities": []
  },
  {
    "text": "that there are no other relationships or activities that could appear to have",
    "entities": []
  },
  {
    "text": "influenced the submitted work.",
    "entities": []
  },
  {
    "text": "AI-Derived Splenic Response in Cardiac PET Predicts Mortality: A Multi-Site",
    "entities": [
      {
        "text": "Cardiac PET Predicts Mortality",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Study.",
    "entities": []
  },
  {
    "text": "BACKGROUND: Inadequate pharmacologic stress may limit the diagnostic and",
    "entities": []
  },
  {
    "text": "prognostic accuracy of myocardial perfusion imaging (MPI). The splenic ratio",
    "entities": []
  },
  {
    "text": "(SR), a measure of stress adequacy, has emerged as a potential imaging",
    "entities": []
  },
  {
    "text": "OBJECTIVES: To evaluate the prognostic value of artificial intelligence",
    "entities": [
      {
        "text": "OBJECTIVES",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(AI)-derived SR in a large multicenter 82 Rb-PET cohort undergoing regadenoson",
    "entities": [
      {
        "text": "SR",
        "label": "ORG"
      },
      {
        "text": "82",
        "label": "CARDINAL"
      },
      {
        "text": "Rb-PET",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "stress testing.",
    "entities": []
  },
  {
    "text": "METHODS: We retrospectively analyzed 10,913 patients from three sites in the",
    "entities": [
      {
        "text": "10,913",
        "label": "CARDINAL"
      },
      {
        "text": "three",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "REFINE PET registry with clinically indicated MPI and linked clinical outcomes.",
    "entities": []
  },
  {
    "text": "SR was calculated using fully automated algorithms as the ratio of splenic",
    "entities": [
      {
        "text": "SR",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "uptake at stress versus rest. Patients were stratified by SR into high (\u226590th",
    "entities": [
      {
        "text": "SR",
        "label": "ORG"
      },
      {
        "text": "\u226590th\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "percentile) and low (<90th percentile) groups. The primary outcome was major",
    "entities": []
  },
  {
    "text": "adverse cardiovascular events (MACE). Survival analysis was conducted using",
    "entities": []
  },
  {
    "text": "Kaplan-Meier and Cox proportional hazards models adjusted for clinical and",
    "entities": [
      {
        "text": "Kaplan-Meier",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "imaging covariates, including myocardial flow reserve (MFR \u22652 vs. <2).",
    "entities": [
      {
        "text": "MFR",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "RESULTS: The cohort had a median age of 68 years, with 57% male patients. Common",
    "entities": [
      {
        "text": "age of 68 years",
        "label": "DATE"
      },
      {
        "text": "57%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "risk factors included hypertension (84%), dyslipidemia (76%), diabetes (33%),",
    "entities": [
      {
        "text": "84%",
        "label": "PERCENT"
      },
      {
        "text": "76%",
        "label": "PERCENT"
      },
      {
        "text": "33%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "and prior coronary artery disease (31%). Median follow-up was 4.6 years.",
    "entities": [
      {
        "text": "31%",
        "label": "PERCENT"
      },
      {
        "text": "4.6 years",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "Patients with high SR (n=1,091) had an increased risk of MACE (HR 1.18, 95% CI",
    "entities": [
      {
        "text": "SR",
        "label": "ORG"
      },
      {
        "text": "MACE",
        "label": "PERSON"
      },
      {
        "text": "1.18",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "1.06-1.31, p=0.002). Among patients with preserved MFR (\u22652; n=7,310), high SR",
    "entities": [
      {
        "text": "1.06",
        "label": "CARDINAL"
      },
      {
        "text": "MFR",
        "label": "ORG"
      },
      {
        "text": "n=7,310",
        "label": "GPE"
      },
      {
        "text": "SR",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "remained independently associated with MACE (HR 1.44, 95% CI 1.24-1.67,",
    "entities": [
      {
        "text": "MACE",
        "label": "PERSON"
      },
      {
        "text": "1.44",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "1.24-1.67",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "CONCLUSIONS: Elevated AI-derived SR was independently associated with adverse",
    "entities": [
      {
        "text": "SR",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "cardiovascular outcomes, including among patients with preserved MFR. These",
    "entities": [
      {
        "text": "MFR",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "findings support SR as a novel, automated imaging biomarker for risk",
    "entities": [
      {
        "text": "SR",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "stratification in 82 Rb PET MPI.",
    "entities": [
      {
        "text": "82",
        "label": "CARDINAL"
      },
      {
        "text": "Rb PET MPI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "CONDENSED ABSTRACT: AI-derived splenic ratio (SR), a marker of pharmacologic",
    "entities": [
      {
        "text": "SR",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "stress adequacy, was independently associated with increased cardiovascular risk",
    "entities": []
  },
  {
    "text": "in a large 82 Rb PET cohort, even among patients with preserved myocardial flow",
    "entities": [
      {
        "text": "82",
        "label": "CARDINAL"
      },
      {
        "text": "PET",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "reserve (MFR). High SR identified individuals with elevated MACE risk despite",
    "entities": [
      {
        "text": "MFR",
        "label": "ORG"
      },
      {
        "text": "MACE",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "normal perfusion and flow findings, suggesting unrecognized physiologic",
    "entities": []
  },
  {
    "text": "vulnerability. Incorporating automated SR into PET MPI interpretation may",
    "entities": [
      {
        "text": "SR",
        "label": "ORG"
      },
      {
        "text": "PET",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "enhance risk stratification and identify patients who could benefit from",
    "entities": []
  },
  {
    "text": "intensified preventive care, particularly when traditional imaging markers",
    "entities": []
  },
  {
    "text": "appear reassuring. These findings support SR as a clinically meaningful, easily",
    "entities": [
      {
        "text": "SR",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "integrated biomarker in stress PET imaging.",
    "entities": [
      {
        "text": "PET",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "A Case of Stanford Type A Aortic Dissection Presenting as Syncope and Neurologic",
    "entities": [
      {
        "text": "Stanford Type A Aortic Dissection Presenting as Syncope",
        "label": "ORG"
      },
      {
        "text": "Neurologic",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Deficits Without Pain: Diagnostic Pitfalls and a Therapeutic Dilemma.",
    "entities": []
  },
  {
    "text": "(1)Medicine, NHS Wales, Wales, GBR.",
    "entities": [
      {
        "text": "1)Medicine",
        "label": "CARDINAL"
      },
      {
        "text": "NHS Wales",
        "label": "ORG"
      },
      {
        "text": "Wales",
        "label": "GPE"
      },
      {
        "text": "GBR",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Acute aortic dissection (AAD) is a true medical emergency that classically",
    "entities": []
  },
  {
    "text": "presents with sudden severe tearing chest pain that may radiate to the back or",
    "entities": []
  },
  {
    "text": "with tearing abdominal pain. When it presents atypically without pain,",
    "entities": []
  },
  {
    "text": "diagnostic delays or misdiagnosis are common, often with devastating",
    "entities": []
  },
  {
    "text": "consequences. We report the case of a 59-year-old male with uncontrolled",
    "entities": [
      {
        "text": "59-year-old",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "hypertension who first presented to an outside emergency department (ED) with",
    "entities": [
      {
        "text": "first",
        "label": "ORDINAL"
      }
    ]
  },
  {
    "text": "multiple collapses and was discharged after assessment. He presented 48 hours",
    "entities": [
      {
        "text": "48 hours",
        "label": "TIME"
      }
    ]
  },
  {
    "text": "later to our ED following collapse and loss of consciousness. The patient was in",
    "entities": []
  },
  {
    "text": "shock upon arrival. Transient right upper limb weakness and slurring of speech",
    "entities": []
  },
  {
    "text": "were noted on initial assessment. Acute coronary syndrome (ACS) with cardiogenic",
    "entities": []
  },
  {
    "text": "shock was suspected on the basis of electrocardiographic (ECG) changes and",
    "entities": [
      {
        "text": "ECG",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "raised troponin, and ACS treatment was administered. However, bedside",
    "entities": [
      {
        "text": "ACS",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "echocardiogram performed to assess left ventricular function as part of the ACS",
    "entities": [
      {
        "text": "ACS",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "work-up suggested Stanford type A AAD, which was confirmed by computed tomogram",
    "entities": [
      {
        "text": "Stanford",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(CT) of the aorta. Emergency surgical repair of the aorta was performed after",
    "entities": []
  },
  {
    "text": "transfer to a tertiary hospital, with good postoperative recovery. This case",
    "entities": [
      {
        "text": "tertiary",
        "label": "ORDINAL"
      }
    ]
  },
  {
    "text": "highlights the importance of maintaining a high index of suspicion for aortic",
    "entities": []
  },
  {
    "text": "dissection in patients presenting with syncope and neurological deficits even in",
    "entities": []
  },
  {
    "text": "the absence of classical symptoms. Simulation training specifically tailored to",
    "entities": []
  },
  {
    "text": "scenarios of atypical presentations of AAD may be of benefit to emergency",
    "entities": []
  },
  {
    "text": "clinicians and help reduce the unacceptably high rate of misdiagnosis.",
    "entities": [
      {
        "text": "clinicians",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "Copyright \u00a9 2025, Ismail et al.",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "Ismail et al.",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "eCollection 2025 Aug.",
    "entities": [
      {
        "text": "2025 Aug.",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "Analysis of social determinants of health and extreme climate events:",
    "entities": []
  },
  {
    "text": "Identifying vulnerable populations and health outcomes in Jacksonville.",
    "entities": [
      {
        "text": "Jacksonville",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(1)Division of Nephrology, Hypertension, and Renal Transplantation, Department",
    "entities": [
      {
        "text": "Nephrology, Hypertension",
        "label": "ORG"
      },
      {
        "text": "Renal Transplantation, Department",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "of Medicine, College of Medicine, University of Florida, Gainesville, Florida.",
    "entities": [
      {
        "text": "Medicine, College of Medicine, University of Florida",
        "label": "ORG"
      },
      {
        "text": "Gainesville",
        "label": "GPE"
      },
      {
        "text": "Florida",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Intelligent Clinical Care Center, University of Florida, Gainesville,",
    "entities": [
      {
        "text": "Clinical Care Center,",
        "label": "ORG"
      },
      {
        "text": "University of Florida",
        "label": "ORG"
      },
      {
        "text": "Gainesville",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Department of Environmental Engineering Sciences, University of Florida,",
    "entities": [
      {
        "text": "Environmental Engineering Sciences",
        "label": "ORG"
      },
      {
        "text": "University of Florida",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "BACKGROUND: Heatwaves and hurricanes pose risks to public health, especially for",
    "entities": []
  },
  {
    "text": "METHODS: We assessed the impact of extreme weather events on health outcomes in",
    "entities": []
  },
  {
    "text": "socially vulnerable groups. We analyzed hospital mortality, acute stroke,",
    "entities": []
  },
  {
    "text": "myocardial infarction, and nonelective intensive care unit (ICU) admissions for",
    "entities": [
      {
        "text": "ICU",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "24,814 patients admitted to two hospitals in Jacksonville (2015-2017). We fitted",
    "entities": [
      {
        "text": "24,814",
        "label": "CARDINAL"
      },
      {
        "text": "two",
        "label": "CARDINAL"
      },
      {
        "text": "Jacksonville",
        "label": "GPE"
      },
      {
        "text": "2015-2017",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "modified Poisson regression models to assess differences relative to the",
    "entities": [
      {
        "text": "Poisson",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "heatwave and Hurricane Irma, presenting impacts with relative risks (RR) and 95%",
    "entities": [
      {
        "text": "Hurricane Irma",
        "label": "EVENT"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "confidence intervals (CI).",
    "entities": [
      {
        "text": "CI",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "RESULTS: There was no significant change in the rate of acute stroke or",
    "entities": []
  },
  {
    "text": "myocardial infarction during both the heatwave and Hurricane Irma. The rate of",
    "entities": [
      {
        "text": "Hurricane Irma",
        "label": "EVENT"
      }
    ]
  },
  {
    "text": "nonelective ICU admission showed no significant change during the heatwave and",
    "entities": [
      {
        "text": "ICU",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "immediate posthurricane period (0-14 days after the hurricane) but increased",
    "entities": [
      {
        "text": "0-14 days",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "during the extended posthurricane period (15-74 days after the hurricane) with",
    "entities": [
      {
        "text": "15-74 days",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "an RR of 6.19 (95% CI = 1.25, 30.54) compared with the control period. Extreme",
    "entities": [
      {
        "text": "6.19",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "1.25",
        "label": "CARDINAL"
      },
      {
        "text": "30.54",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "During heatwave and extended posthurricane periods, the rate of acute stroke or",
    "entities": []
  },
  {
    "text": "myocardial infarction increased for elderly patients relative to younger",
    "entities": []
  },
  {
    "text": "patients with RRs of 1.43 (95% CI = 1.05, 1.94) and 1.53 (95% CI = 1.14, 2.07),",
    "entities": [
      {
        "text": "1.43",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "1.05",
        "label": "CARDINAL"
      },
      {
        "text": "1.94",
        "label": "CARDINAL"
      },
      {
        "text": "1.53",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "1.14",
        "label": "CARDINAL"
      },
      {
        "text": "2.07",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "and uninsured or Medicaid-insured patients relative to those with Medicare or",
    "entities": [
      {
        "text": "Medicaid",
        "label": "ORG"
      },
      {
        "text": "Medicare",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "private insurance with RRs of 1.71 (95% CI = 1.26, 2.33) and 1.88 (95% CI =",
    "entities": [
      {
        "text": "1.71",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "1.26",
        "label": "CARDINAL"
      },
      {
        "text": "2.33",
        "label": "CARDINAL"
      },
      {
        "text": "1.88",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "1.38, 2.59). Social vulnerability and air quality further impacted health",
    "entities": [
      {
        "text": "1.38",
        "label": "CARDINAL"
      },
      {
        "text": "2.59",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "outcomes during the extended posthurricane period, with a 0.1-unit increase in",
    "entities": [
      {
        "text": "0.1",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "the Social Vulnerability Index score associated with a 65% decrease in risk of",
    "entities": [
      {
        "text": "65%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "acute stroke or myocardial infarction with RR of 0.35 (95% CI = 0.16, 0.75) and",
    "entities": [
      {
        "text": "0.35",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "0.16",
        "label": "CARDINAL"
      },
      {
        "text": "0.75",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "a 69% decrease in risk of nonelective ICU admissions with RR of 0.31 (95% CI =",
    "entities": [
      {
        "text": "69%",
        "label": "PERCENT"
      },
      {
        "text": "ICU",
        "label": "ORG"
      },
      {
        "text": "RR of 0.31",
        "label": "ORG"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "0.15-0.65), and a 1-unit increase in Air Quality Index value indicated a 2%",
    "entities": [
      {
        "text": "0.15-0.65",
        "label": "CARDINAL"
      },
      {
        "text": "1",
        "label": "CARDINAL"
      },
      {
        "text": "Air Quality",
        "label": "ORG"
      },
      {
        "text": "2%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "increase in risk of acute stroke or myocardial infarction with RR of 1.02 (95%",
    "entities": [
      {
        "text": "RR of 1.02",
        "label": "ORG"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "CI = 1.01, 1.03).",
    "entities": [
      {
        "text": "CI",
        "label": "PERSON"
      },
      {
        "text": "1.01",
        "label": "CARDINAL"
      },
      {
        "text": "1.03",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "CONCLUSIONS: Our findings suggest extreme climate events exacerbate negative",
    "entities": []
  },
  {
    "text": "health outcomes in socioeconomically vulnerable populations, underscoring the",
    "entities": []
  },
  {
    "text": "need for targeted public health interventions, improved healthcare access, and",
    "entities": []
  },
  {
    "text": "Copyright \u00a9 2025 The Authors. Published by Wolters Kluwer Health, Inc. on behalf",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "Wolters Kluwer Health, Inc.",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "of The Environmental Epidemiology. All rights reserved.",
    "entities": [
      {
        "text": "The Environmental Epidemiology",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: The authors declare that they have no conflicts",
    "entities": []
  },
  {
    "text": "of interest with regard to the content of this report.",
    "entities": []
  },
  {
    "text": "Long-Term Consequences of Misdiagnosis of Parathyroid Adenomas in Pediatric",
    "entities": [
      {
        "text": "Long-Term Consequences of Misdiagnosis",
        "label": "ORG"
      },
      {
        "text": "Adenomas",
        "label": "PERSON"
      },
      {
        "text": "Pediatric",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(1)Department of Pediatric and Adolescent Endocrinology, Chair of Pediatrics,",
    "entities": [
      {
        "text": "Pediatric and Adolescent Endocrinology",
        "label": "ORG"
      },
      {
        "text": "Chair of Pediatrics",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Institute of Pediatrics, Jagiellonian University Medical College, Krak\u00f3w,",
    "entities": [
      {
        "text": "Institute of Pediatrics",
        "label": "ORG"
      },
      {
        "text": "Jagiellonian University Medical College",
        "label": "ORG"
      },
      {
        "text": "Krak\u00f3w",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Poland.",
    "entities": [
      {
        "text": "Poland",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Department of Endocrinological Surgery, 3rd Chair of Surgery, Jagiellonian",
    "entities": [
      {
        "text": "3rd Chair of Surgery",
        "label": "ORG"
      },
      {
        "text": "Jagiellonian",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "University Medical College, Krak\u00f3w, Poland.",
    "entities": [
      {
        "text": "University Medical College",
        "label": "ORG"
      },
      {
        "text": "Krak\u00f3w",
        "label": "PERSON"
      },
      {
        "text": "Poland",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Department of Pediatric Surgery, Institute of Pediatrics, Jagiellonian",
    "entities": [
      {
        "text": "Pediatric Surgery",
        "label": "ORG"
      },
      {
        "text": "Institute of Pediatrics",
        "label": "ORG"
      },
      {
        "text": "Jagiellonian",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "Primary hyperparathyroidism (PHPT) is rare in children but exhibits a more",
    "entities": [
      {
        "text": "PHPT",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "dynamic course than in adults, often leading to multiorgan complications if",
    "entities": []
  },
  {
    "text": "diagnosis is delayed. This article aims to highlight diagnostic challenges of",
    "entities": []
  },
  {
    "text": "parathyroid adenomas in children and discuss associated complications from",
    "entities": [
      {
        "text": "parathyroid",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "delayed diagnosis. Three boys, aged 15.5, 10, and 16 years, were retrospectively",
    "entities": [
      {
        "text": "Three",
        "label": "CARDINAL"
      },
      {
        "text": "15.5",
        "label": "DATE"
      },
      {
        "text": "10",
        "label": "DATE"
      },
      {
        "text": "16 years",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "analyzed for hypercalcemia. The diagnosis was based on biochemical and hormonal",
    "entities": []
  },
  {
    "text": "tests, as well as imaging studies (ultrasound, scintigraphy, and densitometry).",
    "entities": []
  },
  {
    "text": "The mean diagnosis delay was 20 months (9-35). All boys experienced appetite",
    "entities": [
      {
        "text": "20 months",
        "label": "DATE"
      },
      {
        "text": "9-35",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "loss and bone symptoms. Patient 1 was initially misdiagnosed with slipped",
    "entities": [
      {
        "text": "1",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "capital femoral epiphysis (SCFE) and underwent orthopedic surgery without",
    "entities": [
      {
        "text": "SCFE",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "recognition of severe hypercalcemia. Patient 2 was misdiagnosed with vasopressin",
    "entities": [
      {
        "text": "2",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "deficiency following a tibia fracture. Patient 3's symptoms were attributed to",
    "entities": [
      {
        "text": "tibia",
        "label": "GPE"
      },
      {
        "text": "3",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "stress. All patients had parathyroid adenomas, but Patients 2 and 3 had an",
    "entities": [
      {
        "text": "2",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "ectopic thymus location. Following adenoma excision, Patients 2 and 3 developed",
    "entities": [
      {
        "text": "ectopic",
        "label": "CARDINAL"
      },
      {
        "text": "2",
        "label": "CARDINAL"
      },
      {
        "text": "3",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "hypocalcemia, the lasting consequences of which included nephrocalcinosis and",
    "entities": []
  },
  {
    "text": "low bone mass; Patient 3 also developed hypertension and depression.",
    "entities": [
      {
        "text": "Patient 3",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Conclusions: (1) any child presenting symptoms such as loss of appetite,",
    "entities": [
      {
        "text": "1",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "abdominal pain, weight loss, depression, or bone abnormalities must urgently",
    "entities": []
  },
  {
    "text": "have serum calcium levels assessed to exclude PHPT. (2) Delayed diagnosis of",
    "entities": [
      {
        "text": "PHPT",
        "label": "ORG"
      },
      {
        "text": "2",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "PHPT in children is dangerous, as it leads to irreversible organ damage,",
    "entities": [
      {
        "text": "PHPT",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "including severe bone loss, nephrocalcinosis, and hypertension. (3)",
    "entities": [
      {
        "text": "3",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Comprehensive hormonal and genetic evaluation prior to surgery is essential,",
    "entities": []
  },
  {
    "text": "along with prompt correction of hypocalcemia to minimize complications and",
    "entities": []
  },
  {
    "text": "improve treatment outcomes. (4) After parathyroid adenoma removal, intensive",
    "entities": [
      {
        "text": "4",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "calcium and vitamin D supplementation is required to prevent hungry bone",
    "entities": []
  },
  {
    "text": "syndrome and support proper bone recovery. (5) Due to the significant risk of",
    "entities": []
  },
  {
    "text": "disease recurrence, children with PHPT require long-term endocrine follow-up and",
    "entities": [
      {
        "text": "PHPT",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "thorough genetic testing, enabling early detection of relapse and timely",
    "entities": []
  },
  {
    "text": "intervention.",
    "entities": []
  },
  {
    "text": "Copyright \u00a9 2025 Dorota Roztoczy\u0144ska et al. Case Reports in Pediatrics published",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "Dorota",
        "label": "PERSON"
      },
      {
        "text": "Roztoczy\u0144ska",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "by John Wiley & Sons Ltd.",
    "entities": [
      {
        "text": "John Wiley & Sons Ltd.",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: The authors declare no conflicts of interest.",
    "entities": []
  },
  {
    "text": "21. Front Public Health. 2025 Jun 30;13:1652830. doi: 10.3389/fpubh.2025.1652830.",
    "entities": [
      {
        "text": "21",
        "label": "CARDINAL"
      },
      {
        "text": "Front Public Health",
        "label": "ORG"
      },
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "30;13:1652830",
        "label": "CARDINAL"
      },
      {
        "text": "10.3389",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Retraction: Prevalence of pulmonary hypertension and its associated factors",
    "entities": []
  },
  {
    "text": "among chronic obstructive pulmonary diseases patients at public hospitals of",
    "entities": []
  },
  {
    "text": "Addis Ababa, Ethiopia, 2024: a facility-based cross-sectional study.",
    "entities": [
      {
        "text": "Addis Ababa",
        "label": "GPE"
      },
      {
        "text": "Ethiopia",
        "label": "GPE"
      },
      {
        "text": "2024",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "Frontiers Editorial Office.",
    "entities": [
      {
        "text": "Frontiers Editorial Office",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Retraction of",
    "entities": []
  },
  {
    "text": "Front Public Health. 2024 Nov 26;12:1456235. doi:",
    "entities": [
      {
        "text": "Front Public Health",
        "label": "ORG"
      },
      {
        "text": "2024 Nov",
        "label": "DATE"
      },
      {
        "text": "26;12:1456235",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "10.3389/fpubh.2024.1456235.",
    "entities": [
      {
        "text": "10.3389",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "[This retracts the article DOI: 10.3389/fpubh.2024.1456235.].",
    "entities": [
      {
        "text": "10.3389",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Copyright \u00a9 2025 Frontiers Editorial Office.",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "DOI: 10.3389/fpubh.2025.1652830",
    "entities": [
      {
        "text": "10.3389",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "22. Tex Heart Inst J. 2025 Jul 9;52(2):e258599. doi: 10.14503/THIJ-25-8599.",
    "entities": [
      {
        "text": "22",
        "label": "CARDINAL"
      },
      {
        "text": "10.14503/THIJ-25-8599",
        "label": "MONEY"
      }
    ]
  },
  {
    "text": "eCollection 2025 Jul-Dec.",
    "entities": []
  },
  {
    "text": "Complex Tricuspid and Pulmonic Carcinoid Heart Disease With Timely Surgical",
    "entities": [
      {
        "text": "Complex Tricuspid",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Hollowed J(1), Woo H(2), Hamburg S(3), Ardehali A(4).",
    "entities": [
      {
        "text": "Hamburg",
        "label": "GPE"
      },
      {
        "text": "Ardehali",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "(1)Division of Cardiology, University of California, Los Angeles, Los Angeles,",
    "entities": [
      {
        "text": "Cardiology, University of California,",
        "label": "ORG"
      },
      {
        "text": "Los Angeles",
        "label": "GPE"
      },
      {
        "text": "Los Angeles",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "California.",
    "entities": [
      {
        "text": "California",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Department of Medicine, University of California, Los Angeles, Los Angeles,",
    "entities": [
      {
        "text": "Medicine, University of California",
        "label": "ORG"
      },
      {
        "text": "Los Angeles",
        "label": "GPE"
      },
      {
        "text": "Los Angeles",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Division of Hematology Oncology, University of California, Los Angeles, Los",
    "entities": [
      {
        "text": "Hematology Oncology",
        "label": "ORG"
      },
      {
        "text": "University of California",
        "label": "ORG"
      },
      {
        "text": "Los Angeles",
        "label": "GPE"
      },
      {
        "text": "Los\n",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Angeles, California.",
    "entities": [
      {
        "text": "Angeles",
        "label": "GPE"
      },
      {
        "text": "California",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Division of Cardiothoracic Surgery, University of California, Los Angeles,",
    "entities": [
      {
        "text": "Cardiothoracic Surgery",
        "label": "ORG"
      },
      {
        "text": "University of California",
        "label": "ORG"
      },
      {
        "text": "Los Angeles",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "A 63-year-old man with a history of hypertension, prediabetes, and sleep apnea",
    "entities": [
      {
        "text": "63-year-old",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "presented with pedal edema, weight loss, and flushing. Laboratory work revealed",
    "entities": []
  },
  {
    "text": "elevated B-type natriuretic peptide and normocytic anemia. Echocardiography",
    "entities": []
  },
  {
    "text": "showed right ventricular enlargement, severe tricuspid valve regurgitation, and",
    "entities": []
  },
  {
    "text": "thickened tricuspid valve leaflets, raising suspicion for carcinoid heart",
    "entities": []
  },
  {
    "text": "disease. Further testing confirmed a neuroendocrine tumor with liver metastasis.",
    "entities": []
  },
  {
    "text": "Despite somatostatin therapy, the patient's symptoms were refractory to",
    "entities": []
  },
  {
    "text": "diuretics. Surgical intervention with tricuspid and pulmonary valve replacement",
    "entities": []
  },
  {
    "text": "was undertaken. Postoperatively, the patient demonstrated substantial",
    "entities": []
  },
  {
    "text": "improvement in functional tolerance and quality of life. This case highlights",
    "entities": []
  },
  {
    "text": "the importance of surgical intervention in advanced carcinoid heart disease.",
    "entities": []
  },
  {
    "text": "\u00a9 2025 The Authors. Published by The Texas Heart Institute\u00ae.",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "The Texas Heart Institute\u00ae",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: Conflict of Interest Disclosure: None.",
    "entities": [
      {
        "text": "Conflict of Interest Disclosure: None",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "embolism combined with shock model possibly by enhancing NO release and",
    "entities": []
  },
  {
    "text": "(1)Department of Cardiology, Wuhan Fourth Hospital, Puai Hospital, Wuhan, China.",
    "entities": [
      {
        "text": "Cardiology",
        "label": "ORG"
      },
      {
        "text": "Wuhan Fourth Hospital",
        "label": "ORG"
      },
      {
        "text": "Puai Hospital",
        "label": "ORG"
      },
      {
        "text": "Wuhan",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Hubei University of Medicine, Shiyan, China.",
    "entities": [
      {
        "text": "University of Medicine, Shiyan",
        "label": "ORG"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Sodium nitroprusside (SNP) is a fast-acting non-endothelium-dependent",
    "entities": [
      {
        "text": "SNP",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "vasodilator, which is commonly used to treat diseases such as hypertensive",
    "entities": []
  },
  {
    "text": "emergencies and acute heart failure. However, there are few experimental studies",
    "entities": []
  },
  {
    "text": "evaluating the effects and mechanism of SNP on acute pulmonary embolism. To",
    "entities": [
      {
        "text": "SNP",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "explore the mechanism of action of SNP in acute pulmonary embolism combined with",
    "entities": [
      {
        "text": "SNP",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "shock, we randomly divided rabbits into sham operation group (S group, n = 8),",
    "entities": [
      {
        "text": "sham operation group",
        "label": "ORG"
      },
      {
        "text": "8)",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "model group (M group, n = 8), and SNP group (SNP group, n = 8). The rabbit model",
    "entities": [
      {
        "text": "8)",
        "label": "DATE"
      },
      {
        "text": "SNP",
        "label": "ORG"
      },
      {
        "text": "SNP",
        "label": "ORG"
      },
      {
        "text": "8)",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "of acute massive pulmonary embolism with circulatory shock was established by",
    "entities": []
  },
  {
    "text": "injecting autologous blood clots into the pulmonary artery. Pulmonary",
    "entities": []
  },
  {
    "text": "angiography showed that the mean pulmonary artery pressure increased",
    "entities": []
  },
  {
    "text": "significantly and the mean arterial pressure decreased significantly in the",
    "entities": []
  },
  {
    "text": "model group, which could be reversed by SNP treatment. In addition, the",
    "entities": [
      {
        "text": "SNP",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "TLR4/NF-\u03baB/HIF-1\u03b1 pathway signaling pathway was activated in the embolic and",
    "entities": [
      {
        "text": "TLR4/NF-\u03baB/HIF-1\u03b1",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "non-embolic areas of the lung tissue in the M group, promoting the release of",
    "entities": []
  },
  {
    "text": "inflammatory factors such as IL-6 and TNF-\u03b1, downregulation of endogenous NO",
    "entities": [
      {
        "text": "IL-6",
        "label": "ORG"
      },
      {
        "text": "TNF",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "expression in the model group. After SNP treatment, the expression of",
    "entities": [
      {
        "text": "SNP",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "TLR4/NF-\u03baB/HIF-1\u03b1 pathway signals in the embolic and non-embolic areas was",
    "entities": [
      {
        "text": "TLR4/NF-\u03baB/HIF-1\u03b1",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "downregulated, the release of inflammatory factors was reduced, the release of",
    "entities": []
  },
  {
    "text": "vascular NO was increased. Our study shows that SNP has a protective effect on",
    "entities": [
      {
        "text": "SNP",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "acute pulmonary embolism combined with shock. Its protective effect may be",
    "entities": []
  },
  {
    "text": "related to inhibiting the TLR4/NF-\u03baB/HIF-1\u03b1 signaling pathway and increasing NO",
    "entities": []
  },
  {
    "text": "release in the embolic and non-embolic areas, thereby dilating pulmonary blood",
    "entities": []
  },
  {
    "text": "vessels, reducing the release of inflammatory factors and partially reversing",
    "entities": []
  },
  {
    "text": "circulatory failure in this model.",
    "entities": []
  },
  {
    "text": "Copyright \u00a9 2025 Zhou, Wang, Yu, Liu, Cao, Li, Gu, Hu and Bai.",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "Zhou",
        "label": "PERSON"
      },
      {
        "text": "Wang",
        "label": "PERSON"
      },
      {
        "text": "Yu",
        "label": "PERSON"
      },
      {
        "text": "Liu",
        "label": "PERSON"
      },
      {
        "text": "Cao",
        "label": "PRODUCT"
      },
      {
        "text": "Li",
        "label": "PERSON"
      },
      {
        "text": "Gu",
        "label": "PERSON"
      },
      {
        "text": "Hu",
        "label": "PERSON"
      },
      {
        "text": "Bai",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Application of SGLT-2 inhibitors in non-diabetic CKD: mechanisms, efficacy, and",
    "entities": []
  },
  {
    "text": "(1)Department of Nephrology, Caidian District People's Hospital, Wuhan, China.",
    "entities": [
      {
        "text": "Nephrology, Caidian District People's Hospital",
        "label": "ORG"
      },
      {
        "text": "Wuhan",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Chronic kidney disease (CKD) represents a major global public health challenge,",
    "entities": []
  },
  {
    "text": "significantly impacting patients' quality of life and placing a heavy burden on",
    "entities": []
  },
  {
    "text": "healthcare systems. While diabetes and hypertension are the primary risk factors",
    "entities": [
      {
        "text": "healthcare",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "for CKD, non-diabetic CKD also constitutes a significant proportion, with its",
    "entities": [
      {
        "text": "CKD",
        "label": "ORG"
      },
      {
        "text": "CKD",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "complex pathological mechanisms necessitating the development of novel",
    "entities": []
  },
  {
    "text": "therapeutic strategies. Sodium-glucose cotransporter 2 (SGLT-2) inhibitors,",
    "entities": [
      {
        "text": "2",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "initially developed for diabetes management, have recently demonstrated",
    "entities": []
  },
  {
    "text": "remarkable renal and cardiovascular protective effects in patients with",
    "entities": []
  },
  {
    "text": "non-diabetic CKD. SGLT-2 inhibitors exert their effects through multiple",
    "entities": [
      {
        "text": "CKD",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "mechanisms, including reactivating the tubulo-glomerular feedback, reducing",
    "entities": []
  },
  {
    "text": "glomerular pressure and filtration rate, decreasing proteinuria, inhibiting",
    "entities": []
  },
  {
    "text": "inflammation and fibrosis, and improving systemic metabolic parameters such as",
    "entities": []
  },
  {
    "text": "lowering blood pressure, uric acid levels, and body weight. These effects not",
    "entities": []
  },
  {
    "text": "only slow the progression of kidney function decline but also significantly",
    "entities": []
  },
  {
    "text": "reduce the risk of end-stage renal disease (ESRD) and cardiovascular events.",
    "entities": [
      {
        "text": "ESRD",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Landmark clinical trials such as DAPA-CKD, CREDENCE, and EMPA-KIDNEY provide",
    "entities": [
      {
        "text": "CREDENCE",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "strong scientific evidence supporting the use of SGLT-2 inhibitors in",
    "entities": []
  },
  {
    "text": "non-diabetic CKD, demonstrating their broad clinical benefits and excellent",
    "entities": [
      {
        "text": "CKD",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "safety profile. Despite potential adverse effects such as urinary tract",
    "entities": []
  },
  {
    "text": "infections, hypotension, and diabetic ketoacidosis, appropriate patient",
    "entities": []
  },
  {
    "text": "selection and personalized treatment strategies can effectively manage these",
    "entities": []
  },
  {
    "text": "risks. The multi-system effects of SGLT-2 inhibitors not only expand their",
    "entities": []
  },
  {
    "text": "clinical indications but also offer new hope for the comprehensive management of",
    "entities": []
  },
  {
    "text": "non-diabetic CKD patients, with significant clinical implications and broad",
    "entities": []
  },
  {
    "text": "Copyright \u00a9 2025 Zhang and Deng.",
    "entities": [
      {
        "text": "2025 Zhang",
        "label": "PERSON"
      },
      {
        "text": "Deng",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "ahead of print.",
    "entities": []
  },
  {
    "text": "Constructing a Preeclampsia Organoid Model to Elucidate the Mechanism of",
    "entities": []
  },
  {
    "text": "(1)Changning Maternity and Infant Health Hospital and School of Life Sciences,",
    "entities": [
      {
        "text": "Infant Health Hospital and School of Life Sciences",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Shanghai Key Laboratory of Regulatory Biology, East China Normal University.",
    "entities": [
      {
        "text": "Shanghai Key Laboratory of Regulatory Biology",
        "label": "ORG"
      },
      {
        "text": "East China Normal University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "BACKGROUND: Preeclampsia is a life-threatening pregnancy disorder characterized",
    "entities": [
      {
        "text": "Preeclampsia",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "by hypertension and multiorgan dysfunction, posing significant risks to both",
    "entities": [
      {
        "text": "multiorgan",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "maternal and fetal health. Although low-dose aspirin is widely recommended for",
    "entities": []
  },
  {
    "text": "preventing preeclampsia, the underlying mechanisms of action are still poorly",
    "entities": [
      {
        "text": "preventing preeclampsia",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "understood, which hinders the optimization of therapeutic strategies.",
    "entities": []
  },
  {
    "text": "METHODS: We developed an in vitro hypoxia-induced preeclampsia model using human",
    "entities": []
  },
  {
    "text": "trophoblast organoids to replicate key pathological features. RNA sequencing",
    "entities": [
      {
        "text": "RNA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "identified dysregulated pathways and molecular targets. Functional assays",
    "entities": []
  },
  {
    "text": "assessed the effects of aspirin on trophoblast proliferation, mitochondrial",
    "entities": []
  },
  {
    "text": "activity, and hormonal regulation, focusing on the PI3K-AKT pathway and CYP",
    "entities": [
      {
        "text": "CYP",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(cytochrome P450) enzymes. We also analyzed the effects of aspirin in the",
    "entities": [
      {
        "text": "P450",
        "label": "PRODUCT"
      }
    ]
  },
  {
    "text": "RESULTS: The hypoxia-induced preeclampsia model successfully mimicked clinical",
    "entities": []
  },
  {
    "text": "(placental growth factor) ratios and oxidative damage. RNA sequencing revealed",
    "entities": [
      {
        "text": "RNA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "significant suppression of the PI3K-AKT-mTOR pathway and dysregulation of CYP",
    "entities": [
      {
        "text": "CYP",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "enzymes. Aspirin treatment restored the sFLT-1/PlGF balance, reactivated the",
    "entities": [
      {
        "text": "sFLT-1",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "PI3K-AKT-mTOR pathway, and improved mitochondrial function, enhancing",
    "entities": []
  },
  {
    "text": "trophoblast proliferation. Furthermore, aspirin regulated CYP expression by",
    "entities": [
      {
        "text": "CYP",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "increasing CYP19A1 and inhibiting CYP1A1, thereby improving placental hormonal",
    "entities": []
  },
  {
    "text": "CONCLUSIONS: This study clarifies aspirin's multitarget mechanisms in",
    "entities": []
  },
  {
    "text": "alleviating preeclampsia, which include restoring the sFLT-1/PlGF balance,",
    "entities": [
      {
        "text": "alleviating preeclampsia",
        "label": "PERSON"
      },
      {
        "text": "sFLT-1",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "activating the PI3K-AKT-mTOR signaling pathway, optimizing mitochondrial",
    "entities": []
  },
  {
    "text": "function, and regulating CYP-mediated hormonal metabolism. These findings",
    "entities": [
      {
        "text": "CYP",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "provide a mechanistic basis for aspirin's clinical effectiveness in preventing",
    "entities": []
  },
  {
    "text": "26. J Matern Fetal Neonatal Med. 2025 Dec;38(1):2531146. doi:",
    "entities": [
      {
        "text": "26",
        "label": "CARDINAL"
      },
      {
        "text": "J Matern Fetal Neonatal Med",
        "label": "ORG"
      },
      {
        "text": "2025",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "The effects of hypertensive disorders of pregnancy on fetal myocardial",
    "entities": []
  },
  {
    "text": "remodelling and cardiac function assessed by two-dimensional speckle tracking",
    "entities": [
      {
        "text": "two",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "(1)Department of Ultrasound Medicine 0f the Fourth Hospital of Shijiazhuang,",
    "entities": [
      {
        "text": "Ultrasound Medicine 0f",
        "label": "ORG"
      },
      {
        "text": "the Fourth Hospital of Shijiazhuang",
        "label": "FAC"
      }
    ]
  },
  {
    "text": "Shijiazhuang Obstetrics and Gynecology Hospital, Hebei Provincial Key Laboratory",
    "entities": [
      {
        "text": "Shijiazhuang Obstetrics and Gynecology Hospital",
        "label": "ORG"
      },
      {
        "text": "Hebei Provincial Key Laboratory",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "of Maternal and Fetal Medicine, China.",
    "entities": [
      {
        "text": "Maternal and Fetal Medicine",
        "label": "ORG"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Department of Cardiology, Geisinger Heart and Vascular Institute and",
    "entities": [
      {
        "text": "Vascular Institute",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Geisinger Commonwealth School of Medicine, Danville, PA, USA.",
    "entities": [
      {
        "text": "Geisinger Commonwealth School of Medicine",
        "label": "ORG"
      },
      {
        "text": "Danville",
        "label": "PERSON"
      },
      {
        "text": "PA",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "OBJECTIVE: To assess the effects of hypertensive disorders of pregnancy on fetal",
    "entities": []
  },
  {
    "text": "myocardial remodeling and cardiac function applying two-dimensional speckle",
    "entities": [
      {
        "text": "two",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "METHODS: This is a case-control study with a 1:1 ratio, including fetuses with",
    "entities": [
      {
        "text": "1:1",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "normal development and those exposed to hypertensive disorders of pregnancy. A",
    "entities": []
  },
  {
    "text": "total of 108 fetuses were included in the study, comprising 54 in the case group",
    "entities": [
      {
        "text": "108",
        "label": "CARDINAL"
      },
      {
        "text": "54",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "and 54 in the control group. A series of parameters, including ventricular size,",
    "entities": [
      {
        "text": "54",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "spherical index, ejection fraction, myocardial strain, fractional change in",
    "entities": []
  },
  {
    "text": "ventricular area, and short axis shortening rate, were measured using Fetal HQ",
    "entities": [
      {
        "text": "Fetal HQ\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "software with two-dimensional speckle tracking imaging. Statistical methods were",
    "entities": [
      {
        "text": "two",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "employed to compare the case and control groups, with the aim of assessing the",
    "entities": []
  },
  {
    "text": "impact of hypertensive disorders of pregnancy on fetal myocardial remodeling and",
    "entities": []
  },
  {
    "text": "RESULTS: (1) The end-diastolic longitudinal diameter and area of the right",
    "entities": [
      {
        "text": "1",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "ventricle in the HDP group were statistically significantly smaller than those",
    "entities": [
      {
        "text": "HDP",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "in the control group (p < 0.05). However, no statistically significant",
    "entities": []
  },
  {
    "text": "differences were observed in the longitudinal and transverse diameters and areas",
    "entities": []
  },
  {
    "text": "of the four-chambered heart, as well as the longitudinal diameter and area of",
    "entities": [
      {
        "text": "four",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "the left ventricle, when comparing the two groups (p > 0.05). (2) In terms of",
    "entities": [
      {
        "text": "two",
        "label": "CARDINAL"
      },
      {
        "text": "0.05",
        "label": "CARDINAL"
      },
      {
        "text": "2",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "fetal cardiac morphology, the right ventricular segments 2-7 SI in the HDP group",
    "entities": [
      {
        "text": "2",
        "label": "CARDINAL"
      },
      {
        "text": "HDP",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "were observed to be smaller than those in the control group, with a",
    "entities": []
  },
  {
    "text": "statistically significant difference (p < 0.05). Conversely, the differences",
    "entities": []
  },
  {
    "text": "between the two groups in right ventricular segment 1, right ventricular",
    "entities": [
      {
        "text": "two",
        "label": "CARDINAL"
      },
      {
        "text": "1",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "segments 8-24 SI, left ventricular segments 24 SI and four-chambered cardiac GSI",
    "entities": [
      {
        "text": "8",
        "label": "CARDINAL"
      },
      {
        "text": "24",
        "label": "CARDINAL"
      },
      {
        "text": "SI",
        "label": "ORG"
      },
      {
        "text": "four",
        "label": "CARDINAL"
      },
      {
        "text": "GSI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "were not statistically significant (p > 0.05). (3) In terms of fetal ventricular",
    "entities": [
      {
        "text": "0.05",
        "label": "CARDINAL"
      },
      {
        "text": "3",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "systolic function, the HDP group exhibited lower left ventricular ejection",
    "entities": [
      {
        "text": "HDP",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "fraction and cardiac output, right ventricular GLS, left and right ventricular",
    "entities": [
      {
        "text": "GLS",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "FAC, left ventricular FS in segments 10-24, and right ventricular FS in segments",
    "entities": [
      {
        "text": "FAC",
        "label": "ORG"
      },
      {
        "text": "FS",
        "label": "ORG"
      },
      {
        "text": "10-24",
        "label": "CARDINAL"
      },
      {
        "text": "FS",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "11-16 than the control group. These differences were statistically significant",
    "entities": [
      {
        "text": "11",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "(p < 0.05). Furthermore, the left ventricular GLS, GCS, and right ventricular",
    "entities": [
      {
        "text": "GLS",
        "label": "ORG"
      },
      {
        "text": "GCS",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "free wall St, left ventricular segments 1-9, and right ventricular segments 1-10",
    "entities": [
      {
        "text": "free wall St",
        "label": "PERSON"
      },
      {
        "text": "1-9",
        "label": "CARDINAL"
      },
      {
        "text": "1-10",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "and 4-chamber GSI were observed to be lower than those of the control group. The",
    "entities": [
      {
        "text": "4",
        "label": "CARDINAL"
      },
      {
        "text": "GSI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "GLS, GCS, and free wall St of the right ventricle, as well as the GLS, GCS, and",
    "entities": [
      {
        "text": "GLS",
        "label": "ORG"
      },
      {
        "text": "GCS",
        "label": "ORG"
      },
      {
        "text": "GLS",
        "label": "ORG"
      },
      {
        "text": "GCS",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "free wall St of the left ventricle (segments 1-9) and the right ventricle",
    "entities": [
      {
        "text": "free wall St",
        "label": "PERSON"
      },
      {
        "text": "1-9",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "(segments 1-10 and 12-24) were also evaluated.",
    "entities": [
      {
        "text": "1-10",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "CONCLUSION: Hypertensive disorders of pregnancy (HDP) have been demonstrated to",
    "entities": [
      {
        "text": "HDP",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "affect fetal myocardial remodeling and contractile function, with a more",
    "entities": []
  },
  {
    "text": "pronounced impact observed on the right ventricle compared to the left",
    "entities": []
  },
  {
    "text": "ventricle. Two-dimensional speckle tracking technology offers the potential to",
    "entities": [
      {
        "text": "Two",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "provide more detailed information for the quantitative assessment of fetal size,",
    "entities": []
  },
  {
    "text": "morphology and cardiac function.",
    "entities": []
  },
  {
    "text": "PMID: 40665473 [Indexed for MEDLINE]",
    "entities": [
      {
        "text": "40665473",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "27. Br J Dermatol. 2025 Jul 16:ljaf213. doi: 10.1093/bjd/ljaf213. Online ahead of",
    "entities": [
      {
        "text": "27",
        "label": "CARDINAL"
      },
      {
        "text": "Br J Dermatol",
        "label": "PERSON"
      },
      {
        "text": "2025",
        "label": "CARDINAL"
      },
      {
        "text": "16",
        "label": "CARDINAL"
      },
      {
        "text": "10.1093",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Prurigo nodularis: disease burden, clinical features and approach to management.",
    "entities": []
  },
  {
    "text": "(1)Department of Dermatology, University of Maryland School of Medicine,",
    "entities": [
      {
        "text": "Dermatology, University of Maryland School of Medicine",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Baltimore, Maryland, USA.",
    "entities": [
      {
        "text": "Baltimore",
        "label": "GPE"
      },
      {
        "text": "Maryland",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Maryland Itch Center, University of Maryland School of Medicine, Baltimore,",
    "entities": [
      {
        "text": "Itch Center",
        "label": "ORG"
      },
      {
        "text": "University of Maryland School of Medicine",
        "label": "ORG"
      },
      {
        "text": "Baltimore",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Maryland, USA.",
    "entities": [
      {
        "text": "Maryland",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Institute of Allergology, Charit\u00e9 - Universit\u00e4tsmedizin Berlin, corporate",
    "entities": []
  },
  {
    "text": "Germany.",
    "entities": [
      {
        "text": "Germany",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Fraunhofer Institute for Translational Medicine and Pharmacology ITMP,",
    "entities": [
      {
        "text": "Institute for Translational Medicine and Pharmacology ITMP",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Immunology and Allergology Berlin, Berlin, Germany.",
    "entities": [
      {
        "text": "Allergology Berlin",
        "label": "GPE"
      },
      {
        "text": "Berlin",
        "label": "GPE"
      },
      {
        "text": "Germany",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(5)Department of Dermatology, French Expert Itch Center, University Hospital,",
    "entities": [
      {
        "text": "5)Department",
        "label": "CARDINAL"
      },
      {
        "text": "French",
        "label": "NORP"
      },
      {
        "text": "Itch Center",
        "label": "ORG"
      },
      {
        "text": "University Hospital",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(6)Department of Dermatology, University of Pennsylvania Perelman School of",
    "entities": [
      {
        "text": "Dermatology, University of Pennsylvania Perelman School",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(7)Regeneron Pharmaceuticals Inc., Tarrytown, New York, USA.",
    "entities": [
      {
        "text": "7)Regeneron Pharmaceuticals Inc.",
        "label": "ORG"
      },
      {
        "text": "Tarrytown",
        "label": "GPE"
      },
      {
        "text": "New York",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(8)Sanofi, Reading, UK.",
    "entities": [
      {
        "text": "Reading",
        "label": "GPE"
      },
      {
        "text": "UK",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Prurigo nodularis (PN) is a distinct, chronic inflammatory skin disease",
    "entities": []
  },
  {
    "text": "characterised by intensely pruritic, fibrotic nodular lesions. Despite continued",
    "entities": []
  },
  {
    "text": "progress in the field, lack of clarity regarding the definition of PN as a",
    "entities": []
  },
  {
    "text": "disease, clinical presentation and therapeutic options results in delayed",
    "entities": []
  },
  {
    "text": "diagnosis and management. PN can arise following other diseases, but once",
    "entities": []
  },
  {
    "text": "established, it is an independent disease. Here, we summarise the current",
    "entities": []
  },
  {
    "text": "knowledge of epidemiology, clinical characteristics, disease burden and",
    "entities": []
  },
  {
    "text": "management approaches that may help healthcare providers recognise PN as a",
    "entities": []
  },
  {
    "text": "primary diagnosis independent of triggers or associated comorbidities. PN is",
    "entities": []
  },
  {
    "text": "more common among patients aged 50-60 years, and some evidence suggests it is",
    "entities": [
      {
        "text": "50-60 years",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "more frequent among Black populations than White and Asian populations. A subset",
    "entities": [
      {
        "text": "Asian",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "of PN patients have an atopic background and can present with comorbid atopic",
    "entities": []
  },
  {
    "text": "dermatitis; however, PN can also exist without atopic comorbidities. Other",
    "entities": []
  },
  {
    "text": "comorbidities typically include diabetes, obesity, thyroid disease, kidney",
    "entities": []
  },
  {
    "text": "disease, chronic liver disease, hypertension, HIV infection, skin infections,",
    "entities": []
  },
  {
    "text": "malignancies and mental health disorders. Multiple intensely pruritic lesions",
    "entities": []
  },
  {
    "text": "induce chronic scratching, which leads to inflammation, hyperkeratotic nodules",
    "entities": []
  },
  {
    "text": "and perpetuation of a vicious itch-scratch cycle. PN is associated with a high",
    "entities": []
  },
  {
    "text": "disease burden and negative effect on quality of life; patients often report",
    "entities": []
  },
  {
    "text": "intense and relentless itching, poor sleep, absence from work, anxiety and",
    "entities": []
  },
  {
    "text": "depression. Early diagnosis of PN and identification of comorbidities are",
    "entities": []
  },
  {
    "text": "important to facilitate better disease management. By increasing their awareness",
    "entities": []
  },
  {
    "text": "of PN epidemiology, disease burden, clinical presentation and management,",
    "entities": []
  },
  {
    "text": "physicians may begin to identify the disease as a distinct condition independent",
    "entities": []
  },
  {
    "text": "of its triggers or associated comorbidities and provide patients with",
    "entities": []
  },
  {
    "text": "appropriate care earlier in their treatment journeys.",
    "entities": []
  },
  {
    "text": "\u00a9 The Author(s) 2025. Published by Oxford University Press on behalf of British",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "Oxford University Press",
        "label": "ORG"
      },
      {
        "text": "British",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "Association of Dermatologists. All rights reserved. For commercial re-use,",
    "entities": [
      {
        "text": "Association of Dermatologists",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "please contact reprints@oup.com for reprints and translation rights for",
    "entities": []
  },
  {
    "text": "reprints. All other permissions can be obtained through our RightsLink service",
    "entities": []
  },
  {
    "text": "via the Permissions link on the article page on our site\u2014for further information",
    "entities": [
      {
        "text": "Permissions",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "please contact journals.permissions@oup.com.",
    "entities": [
      {
        "text": "journals.permissions@oup.com",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Burden level and quality of life of caregivers of hemodialysis patient's in",
    "entities": []
  },
  {
    "text": "central India: a mixed-method cross-sectional study.",
    "entities": [
      {
        "text": "India",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Ramasamy S(1)(2), Rathore V(3), Agrawal V(4), Galhotra A(5).",
    "entities": [
      {
        "text": "Agrawal",
        "label": "EVENT"
      },
      {
        "text": "Galhotra A(5",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(1)School of Public Health (at time of study), All India Institute of Medical",
    "entities": [
      {
        "text": "1)School of Public Health",
        "label": "ORG"
      },
      {
        "text": "All India Institute of Medical",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Sciences, Raipur, Chhattisgarh, India.",
    "entities": [
      {
        "text": "Raipur",
        "label": "GPE"
      },
      {
        "text": "Chhattisgarh",
        "label": "GPE"
      },
      {
        "text": "India",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Vedanta Medical Research Foundation (BALCO Medical Centre), Raipur,",
    "entities": [
      {
        "text": "2)Vedanta Medical Research Foundation",
        "label": "ORG"
      },
      {
        "text": "BALCO Medical Centre",
        "label": "ORG"
      },
      {
        "text": "Raipur",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(3)Department of Nephrology, All India Institute of Medical Sciences, Raipur,",
    "entities": [
      {
        "text": "Nephrology",
        "label": "ORG"
      },
      {
        "text": "All India Institute of Medical Sciences",
        "label": "ORG"
      },
      {
        "text": "Raipur",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(4)Department of Nephrology, Dau Kalyan Singh Post Graduate Institute and",
    "entities": [
      {
        "text": "Nephrology",
        "label": "ORG"
      },
      {
        "text": "Dau Kalyan Singh Post Graduate Institute",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Research center, Raipur, Chhattisgarh, India.",
    "entities": [
      {
        "text": "Raipur",
        "label": "PERSON"
      },
      {
        "text": "Chhattisgarh",
        "label": "GPE"
      },
      {
        "text": "India",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(5)Department of Community & Family Medicine, All India Institute of Medical",
    "entities": [
      {
        "text": "Community & Family Medicine",
        "label": "ORG"
      },
      {
        "text": "All India Institute of Medical",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Sciences, Raipur, Chhattisgarh, India. abhiruchigalhotra@aiimsraipur.edu.in.",
    "entities": [
      {
        "text": "Raipur",
        "label": "GPE"
      },
      {
        "text": "Chhattisgarh",
        "label": "GPE"
      },
      {
        "text": "India",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "PURPOSE: Caregivers of hemodialysis patients are at high risk of developing",
    "entities": [
      {
        "text": "PURPOSE",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "reduced quality of life (QoL) and increased caregiver burden.",
    "entities": [
      {
        "text": "QoL",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "AIM: This study aims to explore the level of caregiver burden and quality of",
    "entities": [
      {
        "text": "AIM",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "life in caregivers of hemodialysis patients in central India.",
    "entities": [
      {
        "text": "India",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "METHODS: This cross-sectional mixed-method study was undertaken among caregivers",
    "entities": []
  },
  {
    "text": "of stable hemodialysis patients attending a tertiary care hospital in central",
    "entities": [
      {
        "text": "tertiary",
        "label": "ORDINAL"
      }
    ]
  },
  {
    "text": "India. The Zarit Burden Interview (ZBI) and WHOQoL BREF questionnaire measured",
    "entities": [
      {
        "text": "India",
        "label": "GPE"
      },
      {
        "text": "The Zarit Burden Interview",
        "label": "ORG"
      },
      {
        "text": "BREF",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "caregiver burden and QoL. The qualitative data was gathered through in-depth",
    "entities": []
  },
  {
    "text": "interviews using a semi-structured open-ended questionnaire that delved into",
    "entities": []
  },
  {
    "text": "their personal experiences with caregiving. The transcripts of these interviews",
    "entities": []
  },
  {
    "text": "were analysed using applied thematic analysis, allowing for the identification",
    "entities": []
  },
  {
    "text": "and exploration of recurring themes and patterns within the data.",
    "entities": []
  },
  {
    "text": "RESULTS: A total of 105 caregivers took part in this study, with a mean age of",
    "entities": [
      {
        "text": "105",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "40.04 \u00b1 12.96 years. 56 (53.3%) caregivers were female. Most (48.6%, n = 51)",
    "entities": [
      {
        "text": "40.04",
        "label": "CARDINAL"
      },
      {
        "text": "12.96 years",
        "label": "DATE"
      },
      {
        "text": "56",
        "label": "CARDINAL"
      },
      {
        "text": "53.3%",
        "label": "PERCENT"
      },
      {
        "text": "48.6%",
        "label": "PERCENT"
      },
      {
        "text": "51",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "were spouses/partners. Ten caregivers (9.5%) had to change their occupations due",
    "entities": [
      {
        "text": "Ten",
        "label": "CARDINAL"
      },
      {
        "text": "9.5%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "to caregiving responsibilities. 14 (23.33%) had comorbidities (diabetes,",
    "entities": [
      {
        "text": "14",
        "label": "CARDINAL"
      },
      {
        "text": "23.33%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "hypertension, asthma, and arthritis) themselves. The mean caregiver burden level",
    "entities": []
  },
  {
    "text": "(ZBI) was 18.55 \u00b1 7.58. Most (59.0%) experienced mild to moderate burden, while",
    "entities": [
      {
        "text": "ZBI",
        "label": "ORG"
      },
      {
        "text": "18.55",
        "label": "CARDINAL"
      },
      {
        "text": "59.0%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "28.6% reported a high burden. The WHOQoL BREF mean score of various domains of",
    "entities": [
      {
        "text": "28.6%",
        "label": "PERCENT"
      },
      {
        "text": "BREF",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "physical health, psychological, social relationship and environmental was",
    "entities": []
  },
  {
    "text": "35.70 \u00b1 12.14, 44.20 \u00b1 13.28, 44.28 \u00b1 15.10 and 40.07 \u00b1 13.36 respectively. The",
    "entities": [
      {
        "text": "35.70",
        "label": "CARDINAL"
      },
      {
        "text": "12.14",
        "label": "DATE"
      },
      {
        "text": "44.20",
        "label": "CARDINAL"
      },
      {
        "text": "13.28",
        "label": "CARDINAL"
      },
      {
        "text": "44.28",
        "label": "CARDINAL"
      },
      {
        "text": "15.10",
        "label": "CARDINAL"
      },
      {
        "text": "40.07",
        "label": "CARDINAL"
      },
      {
        "text": "13.36",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "thematic analysis revealed, difficulty in continuing education and employment,",
    "entities": []
  },
  {
    "text": "changing jobs, the need to travel long distances to reach dialysis facilities",
    "entities": []
  },
  {
    "text": "and hardship due to COVID-19 pandemic as recurring challenges among caregivers.",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "CONCLUSION: Caregivers of Hemodialysis patients had significant caregiver burden",
    "entities": []
  },
  {
    "text": "and poor QoL. Regular assessment and special attention are needed for these",
    "entities": []
  },
  {
    "text": "\u00a9 2025. The Author(s).",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "DOI: 10.1186/s13104-025-07374-1",
    "entities": [
      {
        "text": "10.1186",
        "label": "CARDINAL"
      },
      {
        "text": "025",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "PMID: 40665407 [Indexed for MEDLINE]",
    "entities": [
      {
        "text": "40665407",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: Declarations. Ethical approval and consent to",
    "entities": []
  },
  {
    "text": "participate: This study was approved by the Institutional Ethical Committee with",
    "entities": [
      {
        "text": "the Institutional Ethical Committee",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "IEC Proposal No: AIIMSRPR/IEC/2021/1041 from the All India Institute of Medical",
    "entities": [
      {
        "text": "the All India Institute of Medical",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Sciences, Raipur, Chhattisgarh, India. All participants signed an informed",
    "entities": [
      {
        "text": "Raipur",
        "label": "GPE"
      },
      {
        "text": "Chhattisgarh",
        "label": "GPE"
      },
      {
        "text": "India",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "written consent before participation and informed consent was obtained from",
    "entities": []
  },
  {
    "text": "parents and/or legal guardians of minor/illiterate study participants. The study",
    "entities": []
  },
  {
    "text": "was conducted under the principles of the Helsinki Declaration. Consent for",
    "entities": [
      {
        "text": "the Helsinki Declaration",
        "label": "LAW"
      }
    ]
  },
  {
    "text": "publication: Not applicable. Competing interests: The authors declare no",
    "entities": []
  },
  {
    "text": "competing interests.",
    "entities": []
  },
  {
    "text": "29. J Med Case Rep. 2025 Jul 15;19(1):345. doi: 10.1186/s13256-025-05397-7.",
    "entities": [
      {
        "text": "29",
        "label": "CARDINAL"
      },
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "15;19(1):345",
        "label": "CARDINAL"
      },
      {
        "text": "10.1186",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Massive peritoneal effusion following hip arthroscopy: a case report and review",
    "entities": []
  },
  {
    "text": "of the literature.",
    "entities": []
  },
  {
    "text": "(1)Center for Joint Surgery, Intelligent Manufacturing and Rehabilitation",
    "entities": [
      {
        "text": "1)Center",
        "label": "CARDINAL"
      },
      {
        "text": "Rehabilitation",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Engineering Center, The First Affiliated Hospital of Army Medical University,",
    "entities": [
      {
        "text": "The First Affiliated Hospital of Army Medical University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(2)Chongqing Municipal Science and Technology Bureau Key Laboratory of Precision",
    "entities": []
  },
  {
    "text": "Medicine in Joint Surgery, Chongqing, 400038, China.",
    "entities": [
      {
        "text": "Chongqing",
        "label": "GPE"
      },
      {
        "text": "400038",
        "label": "DATE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Chongqing Municipal Education Commission Key Laboratory of Joint Biology,",
    "entities": [
      {
        "text": "Municipal Education Commission Key Laboratory",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(4)Center for Joint Surgery, Intelligent Manufacturing and Rehabilitation",
    "entities": [
      {
        "text": "Rehabilitation",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(5)Chongqing Municipal Science and Technology Bureau Key Laboratory of Precision",
    "entities": [
      {
        "text": "Municipal Science and Technology Bureau Key Laboratory",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Medicine in Joint Surgery, Chongqing, 400038, China. cgx7676@tmmu.edu.cn.",
    "entities": [
      {
        "text": "Chongqing",
        "label": "GPE"
      },
      {
        "text": "400038",
        "label": "DATE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(6)Chongqing Municipal Education Commission Key Laboratory of Joint Biology,",
    "entities": [
      {
        "text": "Municipal Education Commission Key Laboratory",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "BACKGROUND: Peritoneal effusion is a rare but potentially life-threatening",
    "entities": []
  },
  {
    "text": "complication. This article aims to report two cases of massive peritoneal",
    "entities": [
      {
        "text": "two",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "effusion following hip arthroscopy, both of whom had favorable outcomes.",
    "entities": []
  },
  {
    "text": "CASE PRESENTATION: Two patients of Han Chinese ethnicity underwent hip",
    "entities": [
      {
        "text": "Two",
        "label": "CARDINAL"
      },
      {
        "text": "Han",
        "label": "NORP"
      },
      {
        "text": "Chinese",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "arthroscopy under epidural anesthesia. Case 1 was a 49-year-old female who had a",
    "entities": [
      {
        "text": "anesthesia",
        "label": "GPE"
      },
      {
        "text": "49-year-old",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "right acetabular labral tear and cyst, while Case 2 was a 69-year-old female who",
    "entities": [
      {
        "text": "Case 2",
        "label": "PERSON"
      },
      {
        "text": "69-year-old",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "had left hip femoroacetabular impingement. Both surgeries used standard",
    "entities": []
  },
  {
    "text": "anterolateral and anterior approaches with 18 L and 24 L of irrigation fluid at",
    "entities": [
      {
        "text": "18",
        "label": "CARDINAL"
      },
      {
        "text": "24",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "100 mmHg pressure, respectively. During surgery, both patients developed severe",
    "entities": [
      {
        "text": "100",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "abdominal distension; Case 2 also experienced transient hemodynamic instability.",
    "entities": [
      {
        "text": "Case 2",
        "label": "PRODUCT"
      }
    ]
  },
  {
    "text": "Imaging results confirmed extensive fluid accumulation in the abdominal and",
    "entities": []
  },
  {
    "text": "pelvic cavities. Both patients were treated with diuretics (furosemide),",
    "entities": []
  },
  {
    "text": "gastrointestinal motility regulators (trimebutine maleate), and intermittent",
    "entities": []
  },
  {
    "text": "enemas. Case 1 urinated approximately 3000 mL, and Case 2 urinated 1500 mL.",
    "entities": [
      {
        "text": "enemas",
        "label": "PERSON"
      },
      {
        "text": "Case 2",
        "label": "PERSON"
      },
      {
        "text": "1500",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "Follow-up imaging results showed significant reduction in fluid accumulation,",
    "entities": []
  },
  {
    "text": "and both were discharged without further complications.",
    "entities": []
  },
  {
    "text": "CONCLUSION: Large peritoneal effusion after hip arthroscopy is a rare but",
    "entities": []
  },
  {
    "text": "serious complication that can lead to intra-abdominal hypertension. Surgeons",
    "entities": []
  },
  {
    "text": "should be careful, especially in patients with prior abdominal surgeries or",
    "entities": []
  },
  {
    "text": "prolonged procedures near the iliopsoas tendon sheath, and take preventive",
    "entities": []
  },
  {
    "text": "measures such as minimizing perfusion pressure and monitoring vital signs.",
    "entities": []
  },
  {
    "text": "DOI: 10.1186/s13256-025-05397-7",
    "entities": [
      {
        "text": "10.1186",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "PMID: 40665404 [Indexed for MEDLINE]",
    "entities": [
      {
        "text": "40665404",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: Declarations. Ethics approval and consent to",
    "entities": []
  },
  {
    "text": "participate: All protocols in this study were approved by the ethics committee",
    "entities": []
  },
  {
    "text": "of the Southwest Hospital, Army Medical University, Chongqing, China. Consent",
    "entities": [
      {
        "text": "the Southwest Hospital",
        "label": "ORG"
      },
      {
        "text": "Army Medical University",
        "label": "ORG"
      },
      {
        "text": "Chongqing",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "for publication: Written informed consent was obtained from the patient for",
    "entities": []
  },
  {
    "text": "publication of this case report and any accompanying images. A copy of the",
    "entities": []
  },
  {
    "text": "written consent is available for review by the Editor-in-Chief of this journal.",
    "entities": []
  },
  {
    "text": "Competing interests: The authors declare no competing interests.",
    "entities": []
  },
  {
    "text": "Utility of patient-reported outcomes for pulmonary symptoms and sleep",
    "entities": []
  },
  {
    "text": "disturbance and impairment in children with systemic juvenile idiopathic",
    "entities": []
  },
  {
    "text": "arthritis.",
    "entities": []
  },
  {
    "text": "(1)Division of Rheumatology, TriHealth Hospital System, Cincinnati, OH, USA.",
    "entities": [
      {
        "text": "TriHealth Hospital System",
        "label": "ORG"
      },
      {
        "text": "Cincinnati",
        "label": "GPE"
      },
      {
        "text": "OH",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Division of Rheumatology, 3333 Burnet Ave, MLC 4010, Cincinnati, OH, 45208,",
    "entities": [
      {
        "text": "Burnet Ave",
        "label": "PERSON"
      },
      {
        "text": "4010",
        "label": "DATE"
      },
      {
        "text": "Cincinnati",
        "label": "GPE"
      },
      {
        "text": "OH",
        "label": "GPE"
      },
      {
        "text": "45208",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "(3)Department of Pediatrics, University of Cincinnati College of Medicine,",
    "entities": [
      {
        "text": "Pediatrics, University of Cincinnati College of Medicine",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(4)Pulmonary Medicine, Cincinnati Children's Hospital Medical Center, 3333",
    "entities": [
      {
        "text": "4)Pulmonary Medicine",
        "label": "ORG"
      },
      {
        "text": "Cincinnati Children's",
        "label": "ORG"
      },
      {
        "text": "Hospital Medical Center",
        "label": "ORG"
      },
      {
        "text": "3333",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "Burnet Ave, MLC 4010, Cincinnati, OH, 45208, USA. Christopher.towe@cchmc.org.",
    "entities": [
      {
        "text": "4010",
        "label": "DATE"
      },
      {
        "text": "Cincinnati",
        "label": "GPE"
      },
      {
        "text": "OH",
        "label": "GPE"
      },
      {
        "text": "45208",
        "label": "DATE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(5)Department of Pediatrics, University of Cincinnati College of Medicine,",
    "entities": [
      {
        "text": "Pediatrics, University of Cincinnati College of Medicine",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(6)Division of Rheumatology, 3333 Burnet Ave, MLC 4010, Cincinnati, OH, 45208,",
    "entities": [
      {
        "text": "Burnet Ave",
        "label": "PERSON"
      },
      {
        "text": "4010",
        "label": "DATE"
      },
      {
        "text": "Cincinnati",
        "label": "GPE"
      },
      {
        "text": "OH",
        "label": "GPE"
      },
      {
        "text": "45208",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "(7)Department of Pediatrics, University of Cincinnati College of Medicine,",
    "entities": [
      {
        "text": "Pediatrics, University of Cincinnati College of Medicine",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "BACKGROUND: Patient-reported outcomes (PROs) are critical assessment tools for",
    "entities": []
  },
  {
    "text": "clinical practice, observational studies, and interventional trials. While",
    "entities": []
  },
  {
    "text": "families of children with systemic juvenile idiopathic arthritis (SJIA) and",
    "entities": [
      {
        "text": "SJIA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "SJIA-associated lung disease (SJIA-LD) report significant limitations in their",
    "entities": []
  },
  {
    "text": "quality of life, existing PROs for juvenile idiopathic arthritis may not",
    "entities": []
  },
  {
    "text": "properly measure the full impact of these disorders. Our objective was to",
    "entities": []
  },
  {
    "text": "utilize a newly developed lung symptom survey as well as existing, validated",
    "entities": []
  },
  {
    "text": "Patient-Reported Outcomes Measurement Information System (PROMIS) measures in",
    "entities": []
  },
  {
    "text": "children with SJIA with and without LD.",
    "entities": [
      {
        "text": "SJIA",
        "label": "ORG"
      },
      {
        "text": "LD",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "METHODS: Participants were parents/guardians of SJIA patients \u2264 18 years and",
    "entities": [
      {
        "text": "SJIA",
        "label": "ORG"
      },
      {
        "text": "\u2264 18 years",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "were invited to participate using the Cincinnati Children's Hospital Medical",
    "entities": [
      {
        "text": "the Cincinnati Children's Hospital Medical",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Center (CCHMC) JIA Registry, and memberships in the Systemic JIA Foundation, and",
    "entities": [
      {
        "text": "JIA Registry",
        "label": "ORG"
      },
      {
        "text": "the Systemic JIA Foundation",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "SJIA Facebook Group. Participants provided proxy-reports for their child using",
    "entities": [
      {
        "text": "SJIA Facebook Group",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "several PRO questionnaires [CCHMC Lung Symptom Survey; PROMIS Asthma Impact,",
    "entities": [
      {
        "text": "PRO",
        "label": "ORG"
      },
      {
        "text": "Lung Symptom Survey",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Sleep Disturbance, Sleep Impairment Forms] and selected demographic and SJIA",
    "entities": [
      {
        "text": "SJIA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "specific information.",
    "entities": []
  },
  {
    "text": "RESULTS: There were 139 responses, of which 40.3% (n = 57) reported some lung",
    "entities": [
      {
        "text": "139",
        "label": "CARDINAL"
      },
      {
        "text": "40.3%",
        "label": "PERCENT"
      },
      {
        "text": "57",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "disease including 12.9% (n = 20) with interstitial lung disease (ILD), pulmonary",
    "entities": [
      {
        "text": "12.9%",
        "label": "PERCENT"
      },
      {
        "text": "20",
        "label": "CARDINAL"
      },
      {
        "text": "ILD",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "alveolar proteinosis (PAP) and/or pulmonary artery hypertension (PAH). All SJIA",
    "entities": [
      {
        "text": "PAH",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "patients with any lung disease and those with ILD/PAP/PAH had significantly",
    "entities": [
      {
        "text": "ILD/PAP/PAH",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "higher total questionnaire scores than patients without lung disease on the",
    "entities": []
  },
  {
    "text": "CCHMC Lung Symptoms Survey. Both the full survey and individual questions showed",
    "entities": [
      {
        "text": "CCHMC Lung Symptoms Survey",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "good ability to distinguish patients with ILD/PAP/PAH from those without (area",
    "entities": [
      {
        "text": "ILD/PAP/PAH",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "under the curve (AUC) > 0.7). The majority of patients reported some level of",
    "entities": [
      {
        "text": "0.7",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "regardless of presence or absence of lung disease, including moderate to severe",
    "entities": []
  },
  {
    "text": "sleep impairment and/or disturbance in 48% of SJIA patients.",
    "entities": [
      {
        "text": "48%",
        "label": "PERCENT"
      },
      {
        "text": "SJIA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "CONCLUSIONS: Children with SJIA and lung problems had higher scores on the CCHMC",
    "entities": [
      {
        "text": "SJIA",
        "label": "ORG"
      },
      {
        "text": "CCHMC",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Lung Symptom Survey; however, these measures did not discriminate between",
    "entities": [
      {
        "text": "Lung Symptom Survey",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "SJIA-LD and other pulmonary conditions such as asthma. Based on PROMIS measures,",
    "entities": [
      {
        "text": "SJIA-LD",
        "label": "ORG"
      },
      {
        "text": "PROMIS",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "a majority of children with SJIA had sleep disturbance and impairment,",
    "entities": [
      {
        "text": "SJIA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "regardless of steroid use or presence of lung disease.",
    "entities": []
  },
  {
    "text": "PMID: 40665383 [Indexed for MEDLINE]",
    "entities": []
  },
  {
    "text": "participate: This study was reviewed and approved by the Cincinnati Children\u2019s",
    "entities": [
      {
        "text": "the Cincinnati Children\u2019s",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Hospital Medical Center Institutional Review Board (2019 \u2212 0888) with a waiver",
    "entities": [
      {
        "text": "Hospital Medical Center Institutional Review Board",
        "label": "ORG"
      },
      {
        "text": "2019 \u2212",
        "label": "DATE"
      },
      {
        "text": "0888",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "of consent. Competing interests: Dr. Schulert has received consulting fees from",
    "entities": [
      {
        "text": "Schulert",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Novartis and Boehringer Ingelheim and research support from IpiNovyx. Dr. Grom",
    "entities": [
      {
        "text": "Boehringer Ingelheim",
        "label": "ORG"
      },
      {
        "text": "IpiNovyx",
        "label": "ORG"
      },
      {
        "text": "Grom\n",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "has received consulting fees from Novartis and SOBI. All author authors report",
    "entities": [
      {
        "text": "Novartis",
        "label": "ORG"
      },
      {
        "text": "SOBI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "no competing interests.",
    "entities": []
  },
  {
    "text": "The accuracy of a new noninvasive approach using physical examination combined",
    "entities": []
  },
  {
    "text": "with ultrasonography to detect intraabdominal hypertension.",
    "entities": []
  },
  {
    "text": "(1)Department of Anesthesiology, Faculty of Medicine, Chulalongkorn University,",
    "entities": [
      {
        "text": "Anesthesiology, Faculty of Medicine, Chulalongkorn University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok, Thailand.",
    "entities": [
      {
        "text": "King Chulalongkorn Memorial Hospital",
        "label": "ORG"
      },
      {
        "text": "Thai Red Cross Society",
        "label": "ORG"
      },
      {
        "text": "Bangkok",
        "label": "GPE"
      },
      {
        "text": "Thailand",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Department of Surgery, Faculty of Medicine, Thammasat University, Thammasat",
    "entities": [
      {
        "text": "Surgery, Faculty of Medicine, Thammasat University",
        "label": "ORG"
      },
      {
        "text": "Thammasat",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "University Hospital, Pathum Thani, Thailand. nut_jiew@hotmail.com.",
    "entities": [
      {
        "text": "University Hospital",
        "label": "ORG"
      },
      {
        "text": "Pathum Thani",
        "label": "PERSON"
      },
      {
        "text": "Thailand",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Department of Anesthesiology, Faculty of Medicine, Chulalongkorn University,",
    "entities": [
      {
        "text": "Anesthesiology, Faculty of Medicine, Chulalongkorn University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(4)Department of Anesthesiology, Faculty of Medicine, Chulalongkorn University,",
    "entities": [
      {
        "text": "Anesthesiology, Faculty of Medicine, Chulalongkorn University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Intra-abdominal hypertension (IAH) is common in critically ill patients and",
    "entities": [
      {
        "text": "Intra",
        "label": "NORP"
      },
      {
        "text": "IAH",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "associated with increased morbidity and mortality. While intravesical manometry",
    "entities": []
  },
  {
    "text": "is the gold standard for measuring intra-abdominal pressure (IAP), its",
    "entities": [
      {
        "text": "IAP",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "applicability may be limited in some clinical settings. This study evaluated the",
    "entities": []
  },
  {
    "text": "accuracy of a noninvasive bedside method combining physical examination and",
    "entities": []
  },
  {
    "text": "ultrasonography to assess the ratio of the maximal anteroposterior to transverse",
    "entities": []
  },
  {
    "text": "abdominal diameter (AP-T ratio) for detecting IAH. This cross-sectional",
    "entities": [
      {
        "text": "AP",
        "label": "ORG"
      },
      {
        "text": "IAH",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "diagnostic study was conducted in the surgical ICU of a tertiary care hospital.",
    "entities": [
      {
        "text": "ICU",
        "label": "ORG"
      },
      {
        "text": "tertiary",
        "label": "ORDINAL"
      }
    ]
  },
  {
    "text": "Intravesical pressure was measured as the reference standard. The AP-T ratio was",
    "entities": [
      {
        "text": "AP",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "assessed at the L2 level by two blinded investigators. Among 67 patients, 18",
    "entities": [
      {
        "text": "L2",
        "label": "CARDINAL"
      },
      {
        "text": "two",
        "label": "CARDINAL"
      },
      {
        "text": "67",
        "label": "CARDINAL"
      },
      {
        "text": "18",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "were diagnosed with IAH. The AP-T ratio showed a strong correlation with IAP",
    "entities": [
      {
        "text": "IAH",
        "label": "ORG"
      },
      {
        "text": "AP",
        "label": "ORG"
      },
      {
        "text": "IAP",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(r = 0.70, P < 0.001). An AP-T ratio \u2265 0.56 demonstrated 83% sensitivity, 84%",
    "entities": [
      {
        "text": "0.70",
        "label": "CARDINAL"
      },
      {
        "text": "P < 0.001",
        "label": "ORG"
      },
      {
        "text": "AP",
        "label": "ORG"
      },
      {
        "text": "\u2265 0.56",
        "label": "PERSON"
      },
      {
        "text": "83%",
        "label": "PERCENT"
      },
      {
        "text": "84%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "specificity, and an AUROC of 0.84 for detecting IAH. After adjusting for BMI,",
    "entities": [
      {
        "text": "0.84",
        "label": "CARDINAL"
      },
      {
        "text": "IAH",
        "label": "ORG"
      },
      {
        "text": "BMI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "the association remained significant. Diagnostic performance was highest in",
    "entities": []
  },
  {
    "text": "patients with normal BMI. The AP-T ratio was predominantly influenced by the",
    "entities": [
      {
        "text": "BMI",
        "label": "ORG"
      },
      {
        "text": "AP",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "anteroposterior diameter. This simple, noninvasive technique may serve as a",
    "entities": []
  },
  {
    "text": "practical alternative when standard IAP measurements are not feasible. Further",
    "entities": [
      {
        "text": "IAP",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "validation in patients with severe IAH or abdominal compartment syndrome is",
    "entities": [
      {
        "text": "IAH",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "warranted.Thai Clinical Trials Registry reference number TCTR20220831002.",
    "entities": [
      {
        "text": "Thai Clinical Trials Registry",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "DOI: 10.1038/s41598-025-10888-0",
    "entities": [
      {
        "text": "10.1038",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "PMID: 40665132 [Indexed for MEDLINE]",
    "entities": [
      {
        "text": "40665132",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: Declarations. Competing interests: The authors",
    "entities": []
  },
  {
    "text": "declare no competing interests. Ethics approval and consent to participate: The",
    "entities": []
  },
  {
    "text": "study protocol was approved by the Institutional Review Board of the Faculty of",
    "entities": [
      {
        "text": "the Institutional Review Board",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Medicine, Chulalongkorn University (COA 1379/2022). The participant enrollment",
    "entities": [
      {
        "text": "Medicine, Chulalongkorn University",
        "label": "ORG"
      },
      {
        "text": "1379/2022",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "began after ethics approval and trial registration. Written informed consent was",
    "entities": []
  },
  {
    "text": "obtained in all participants. Consent for publication: Consent for publication",
    "entities": []
  },
  {
    "text": "is obtained.",
    "entities": []
  },
  {
    "text": "Maternal adherence to the EAT-Lancet diet recommendations among pregnant women",
    "entities": [
      {
        "text": "EAT",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "in Ireland and associations with offspring birth outcomes and childhood",
    "entities": [
      {
        "text": "Ireland",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "adiposity.",
    "entities": []
  },
  {
    "text": "Pen G(1), Douglass A(1), Murrin CM(1), Kelleher CC(1), Aubert AM(#)(1), Phillips",
    "entities": [
      {
        "text": "Murrin CM(1",
        "label": "PERSON"
      },
      {
        "text": "Kelleher CC(1",
        "label": "PERSON"
      },
      {
        "text": "Aubert",
        "label": "PERSON"
      },
      {
        "text": "Phillips",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "CM(#)(2).",
    "entities": []
  },
  {
    "text": "(1)School of Public Health, Physiotherapy, and Sports Science, University",
    "entities": [
      {
        "text": "1)School of Public Health",
        "label": "ORG"
      },
      {
        "text": "Physiotherapy",
        "label": "GPE"
      },
      {
        "text": "Sports Science",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "College Dublin, Room F13, Woodview House, Belfield, Dublin 4, Ireland.",
    "entities": [
      {
        "text": "Woodview House",
        "label": "ORG"
      },
      {
        "text": "Belfield",
        "label": "GPE"
      },
      {
        "text": "Dublin 4",
        "label": "PERSON"
      },
      {
        "text": "Ireland",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)School of Public Health, Physiotherapy, and Sports Science, University",
    "entities": [
      {
        "text": "Physiotherapy",
        "label": "GPE"
      },
      {
        "text": "Sports Science",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "BACKGROUND AND AIMS: Pregnancy is a critical period during which maternal diet",
    "entities": []
  },
  {
    "text": "may impact offspring growth and future health. The EAT-Lancet commission",
    "entities": [
      {
        "text": "EAT",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "promotes a plant-based diet pattern for meeting environmental and health",
    "entities": []
  },
  {
    "text": "challenges. EAT-Lancet diet scores have been developed however, thus far they",
    "entities": [
      {
        "text": "EAT",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "have not been examined in the context of maternal-child health. We investigated",
    "entities": []
  },
  {
    "text": "adherence to EAT-Lancet diet recommendations during pregnancy and associations",
    "entities": [
      {
        "text": "EAT",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "with offspring birth outcomes and childhood adiposity. The hypothesis tested was",
    "entities": []
  },
  {
    "text": "that greater adherence is not related to adverse outcomes.",
    "entities": []
  },
  {
    "text": "METHODS: This study included mother-child pairs (n = 1,052) from the Lifeways",
    "entities": [
      {
        "text": "1,052",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Cross-generational cohort, in Ireland. Maternal EAT-Lancet diet score was",
    "entities": [
      {
        "text": "Ireland",
        "label": "GPE"
      },
      {
        "text": "EAT",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "derived from an early pregnancy validated food frequency questionnaire.",
    "entities": []
  },
  {
    "text": "Correlation analysis examined relationships with other diet scores (Healthy",
    "entities": []
  },
  {
    "text": "Eating Index (HEI-2015), Dietary Approach to Stop Hypertension (DASH) score, and",
    "entities": [
      {
        "text": "Dietary Approach",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "energy adjusted-Dietary Inflammatory Index (E-DII). Logistic and linear",
    "entities": []
  },
  {
    "text": "regression analyses examined associations with offspring birth outcomes and",
    "entities": []
  },
  {
    "text": "childhood adiposity and weight status at age 5 and 9 years, with adjustment for",
    "entities": [
      {
        "text": "age 5 and 9 years",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "energy intake and potential confounders.",
    "entities": []
  },
  {
    "text": "RESULTS: The EAT-Lancet diet score (mean \u00b1 SD 21.0 \u00b1 4.1) was moderately",
    "entities": [
      {
        "text": "EAT",
        "label": "ORG"
      },
      {
        "text": "21.0",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "positively correlated with HEI-2015 and DASH scores (\u03c1 > 0.5) and negatively",
    "entities": [
      {
        "text": "HEI-2015",
        "label": "GPE"
      },
      {
        "text": "0.5",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "correlated with dietary inflammation (E-DII (\u03c1 < - 0.5, all p-value < 0.001)).",
    "entities": []
  },
  {
    "text": "Greater adherence to the EAT-Lancet diet recommendations was associated with",
    "entities": [
      {
        "text": "EAT",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "higher intake of most micronutrients (except for retinol, riboflavin, vitamin",
    "entities": []
  },
  {
    "text": "B12 and calcium which were significantly lower). In energy-adjusted models,",
    "entities": [
      {
        "text": "B12",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "maternal EAT-Lancet diet score was positively associated with offspring birth",
    "entities": [
      {
        "text": "EAT",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "weight (\u03b2 8.77, 95% CI 0.35-17.19, p = 0.04), length (\u03b2 0.06, 95% CI 0.01-0.1,",
    "entities": [
      {
        "text": "8.77",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "0.35-17.19",
        "label": "CARDINAL"
      },
      {
        "text": "0.04",
        "label": "CARDINAL"
      },
      {
        "text": "0.06",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "0.01-0.1",
        "label": "PRODUCT"
      }
    ]
  },
  {
    "text": "p = 0.01), head circumference (\u03b2 0.04, 95% CI 0.01-0.07, p = 0.01) and lower",
    "entities": [
      {
        "text": "0.01",
        "label": "CARDINAL"
      },
      {
        "text": "0.04",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "0.01",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "likelihood of having a low birth weight (Odds ratio 0.91, 95% CI 0.85-0.99,",
    "entities": [
      {
        "text": "0.91",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "0.85-0.99",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "p = 0.01). These associations did not withstand adjustment for additional",
    "entities": [
      {
        "text": "0.01",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "confounders.",
    "entities": []
  },
  {
    "text": "CONCLUSIONS: Adherence to EAT-Lancet diet recommendations during pregnancy was",
    "entities": [
      {
        "text": "EAT",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "not associated with adverse short or long-term offspring outcomes. Further",
    "entities": []
  },
  {
    "text": "examination in other cohorts with more diverse diets, and with additional health",
    "entities": []
  },
  {
    "text": "outcomes, is warranted.",
    "entities": []
  },
  {
    "text": "DOI: 10.1007/s00394-025-03756-0",
    "entities": [
      {
        "text": "10.1007",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "PMID: 40665062 [Indexed for MEDLINE]",
    "entities": [
      {
        "text": "40665062",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: Declarations. Conflict of interest: We do not",
    "entities": []
  },
  {
    "text": "have any conflicts of interest to disclose.",
    "entities": []
  },
  {
    "text": "33. Nat Med. 2025 Jul 15. doi: 10.1038/s41591-025-03835-z. Online ahead of print.",
    "entities": [
      {
        "text": "33",
        "label": "CARDINAL"
      },
      {
        "text": "Nat Med",
        "label": "PERSON"
      },
      {
        "text": "2025",
        "label": "CARDINAL"
      },
      {
        "text": "15",
        "label": "CARDINAL"
      },
      {
        "text": "10.1038",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "APOE \u03b54 carriers share immune-related proteomic changes across neurodegenerative",
    "entities": [
      {
        "text": "APOE",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "HM(7)(8)(9), Thompson TG(10), Rothstein JD(11)(12), Krish V(13), Imam FB(13);",
    "entities": [
      {
        "text": "Thompson",
        "label": "PERSON"
      },
      {
        "text": "Rothstein JD(11)(12",
        "label": "PERSON"
      },
      {
        "text": "Krish V(13",
        "label": "ORG"
      },
      {
        "text": "Imam",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Global Neurodegeneration Proteomics Consortium (GNPC); Burns JM(7)(8), Swerdlow",
    "entities": [
      {
        "text": "Global Neurodegeneration Proteomics Consortium",
        "label": "ORG"
      },
      {
        "text": "GNPC",
        "label": "ORG"
      },
      {
        "text": "Burns JM(7)(8",
        "label": "PERSON"
      },
      {
        "text": "Swerdlow",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "RH(7)(8)(9)(14), Slawson C(7)(9)(15), Finney CA(16)(17).",
    "entities": [
      {
        "text": "Slawson C(7)(9)(15",
        "label": "PERSON"
      },
      {
        "text": "Finney CA(16)(17",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(1)Neurodegeneration and Disease Modelling Research Group, Westmead Institute",
    "entities": [
      {
        "text": "Disease Modelling Research Group",
        "label": "ORG"
      },
      {
        "text": "Westmead Institute",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "for Medical Research, The University of Sydney, Westmead, New South Wales,",
    "entities": [
      {
        "text": "Medical Research",
        "label": "ORG"
      },
      {
        "text": "The University of Sydney, Westmead",
        "label": "ORG"
      },
      {
        "text": "New South Wales",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)School of Medical Sciences, Faculty of Medicine and Health, The University of",
    "entities": [
      {
        "text": "Medical Sciences",
        "label": "ORG"
      },
      {
        "text": "Faculty of Medicine and Health",
        "label": "ORG"
      },
      {
        "text": "The University of\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Sydney, Sydney, New South Wales, Australia. artur.shvetcov@wimr.org.au.",
    "entities": [
      {
        "text": "Sydney",
        "label": "GPE"
      },
      {
        "text": "Sydney",
        "label": "GPE"
      },
      {
        "text": "New South Wales",
        "label": "GPE"
      },
      {
        "text": "Australia",
        "label": "GPE"
      },
      {
        "text": "artur.shvetcov@wimr.org.au",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(3)Department of Neurology, Emory University, Atlanta, GA, USA.",
    "entities": [
      {
        "text": "Neurology, Emory University",
        "label": "ORG"
      },
      {
        "text": "Atlanta",
        "label": "GPE"
      },
      {
        "text": "GA",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Goizueta Alzheimer's Disease Research Centre, Emory University, Atlanta, GA,",
    "entities": [
      {
        "text": "Disease Research Centre",
        "label": "ORG"
      },
      {
        "text": "Emory University",
        "label": "ORG"
      },
      {
        "text": "Atlanta",
        "label": "GPE"
      },
      {
        "text": "GA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(5)Department of Psychiatry, University of Oxford, Oxford, UK.",
    "entities": [
      {
        "text": "5)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Psychiatry",
        "label": "ORG"
      },
      {
        "text": "University of Oxford",
        "label": "ORG"
      },
      {
        "text": "Oxford",
        "label": "GPE"
      },
      {
        "text": "UK",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(6)Laboratory of Behavioral Neuroscience, National Institute on Aging,",
    "entities": [
      {
        "text": "Behavioral Neuroscience",
        "label": "ORG"
      },
      {
        "text": "National Institute on Aging",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Intramural Research Program, Baltimore, MD, USA.",
    "entities": [
      {
        "text": "Intramural Research Program",
        "label": "ORG"
      },
      {
        "text": "Baltimore",
        "label": "GPE"
      },
      {
        "text": "MD",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(7)University of Kansas Alzheimer's Disease Research Centre, University of",
    "entities": [
      {
        "text": "Kansas Alzheimer's Disease Research Centre",
        "label": "ORG"
      },
      {
        "text": "University of\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Kansas Medical Center, Kansas City, KS, USA.",
    "entities": [
      {
        "text": "Kansas Medical Center",
        "label": "ORG"
      },
      {
        "text": "Kansas City",
        "label": "GPE"
      },
      {
        "text": "KS",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(8)Department of Neurology, University of Kansas School of Medicine, Kansas",
    "entities": [
      {
        "text": "Neurology, University of Kansas School of Medicine",
        "label": "ORG"
      },
      {
        "text": "Kansas",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "City, KS, USA.",
    "entities": [
      {
        "text": "KS",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(9)Department of Biochemistry and Molecular Biology, University of Kansas",
    "entities": [
      {
        "text": "Biochemistry and Molecular Biology",
        "label": "ORG"
      },
      {
        "text": "University of Kansas",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Medical Center, Kansas City, KS, USA.",
    "entities": [
      {
        "text": "Medical Center",
        "label": "ORG"
      },
      {
        "text": "Kansas City",
        "label": "GPE"
      },
      {
        "text": "KS",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(10)OnPoint Scientific, Inc., San Diego, CA, USA.",
    "entities": [
      {
        "text": "10)OnPoint",
        "label": "CARDINAL"
      },
      {
        "text": "San Diego",
        "label": "GPE"
      },
      {
        "text": "CA",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(11)Brain Science Institute, Johns Hopkins University School of Medicine,",
    "entities": [
      {
        "text": "11)Brain",
        "label": "CARDINAL"
      },
      {
        "text": "Science Institute",
        "label": "ORG"
      },
      {
        "text": "Johns Hopkins University School of Medicine",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(12)Department of Neurology, Johns Hopkins University School of Medicine,",
    "entities": [
      {
        "text": "Johns Hopkins University School of Medicine",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(13)Gates Ventures, Seattle, WA, USA.",
    "entities": [
      {
        "text": "13)Gates",
        "label": "CARDINAL"
      },
      {
        "text": "Ventures",
        "label": "GPE"
      },
      {
        "text": "Seattle",
        "label": "GPE"
      },
      {
        "text": "WA",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(14)Department of Cell Biology and Physiology, University of Kansas Medical",
    "entities": [
      {
        "text": "Cell Biology and Physiology, University of Kansas Medical",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Center, Kansas City, KS, USA.",
    "entities": [
      {
        "text": "Center",
        "label": "GPE"
      },
      {
        "text": "Kansas City",
        "label": "GPE"
      },
      {
        "text": "KS",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(15)University of Kansas Cancer Center, University of Kansas Medical Center,",
    "entities": [
      {
        "text": "15)University",
        "label": "CARDINAL"
      },
      {
        "text": "Kansas Cancer Center,",
        "label": "ORG"
      },
      {
        "text": "University of Kansas Medical Center",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(16)Neurodegeneration and Disease Modelling Research Group, Westmead Institute",
    "entities": [
      {
        "text": "16)Neurodegeneration",
        "label": "CARDINAL"
      },
      {
        "text": "Disease Modelling Research Group",
        "label": "ORG"
      },
      {
        "text": "Westmead Institute",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(17)School of Medical Sciences, Faculty of Medicine and Health, The University",
    "entities": [
      {
        "text": "17)School",
        "label": "CARDINAL"
      },
      {
        "text": "Medical Sciences",
        "label": "ORG"
      },
      {
        "text": "Faculty of Medicine and Health",
        "label": "ORG"
      },
      {
        "text": "The University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "of Sydney, Sydney, New South Wales, Australia. caitlin.finney@wimr.org.au.",
    "entities": [
      {
        "text": "Sydney",
        "label": "GPE"
      },
      {
        "text": "Sydney",
        "label": "GPE"
      },
      {
        "text": "New South Wales",
        "label": "GPE"
      },
      {
        "text": "Australia",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "The APOE \u03b54 genetic variant is the strongest genetic risk factor for late-onset",
    "entities": [
      {
        "text": "APOE",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Alzheimer's disease (AD) and is increasingly being implicated in other",
    "entities": []
  },
  {
    "text": "neurodegenerative diseases. Using the Global Neurodegeneration Proteomics",
    "entities": [
      {
        "text": "the Global Neurodegeneration Proteomics",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Consortium SomaScan dataset covering 1,346 cerebrospinal fluid (CSF) and 9,924",
    "entities": [
      {
        "text": "1,346 cerebrospinal fluid",
        "label": "QUANTITY"
      },
      {
        "text": "CSF",
        "label": "ORG"
      },
      {
        "text": "9,924",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "plasma samples, we used machine learning-based proteome profiling to identify an",
    "entities": [
      {
        "text": "plasma samples",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "APOE \u03b54 proteomic signature shared across individuals with AD, frontotemporal",
    "entities": [
      {
        "text": "APOE",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "amyotrophic lateral sclerosis (ALS) and nonimpaired controls. This signature was",
    "entities": [
      {
        "text": "ALS",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "enriched in pro-inflammatory immune and infection pathways as well as immune",
    "entities": []
  },
  {
    "text": "cells, including monocytes, T cells and natural killer cells. Analysis of the",
    "entities": []
  },
  {
    "text": "dorsolateral prefrontal cortex proteome for 262 donors from the Accelerating",
    "entities": [
      {
        "text": "262",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Medicines Partnership for AD UPenn Proteomics Study revealed a consistent APOE",
    "entities": []
  },
  {
    "text": "\u03b54 phenotype, independent of neurodegenerative pathology, including amyloid-\u03b2",
    "entities": [
      {
        "text": "\u03b54 phenotype",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "tau and gliosis for all diseases, as well as TDP-43 in ALS and FTD cases, and",
    "entities": [
      {
        "text": "ALS",
        "label": "ORG"
      },
      {
        "text": "FTD",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "\u03b1-synuclein in PD and PDD cases. While systemic proteomic changes were",
    "entities": [
      {
        "text": "PD",
        "label": "GPE"
      },
      {
        "text": "PDD",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "consistent across APOE \u03b54 carriers, their relationship with clinical and",
    "entities": [
      {
        "text": "APOE",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "lifestyle factors, such as hypertension and smoking, varied by disease. These",
    "entities": []
  },
  {
    "text": "findings suggest APOE \u03b54 confers a systemic biological vulnerability that is",
    "entities": [
      {
        "text": "APOE",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "necessary but not sufficient for neurodegeneration, emphasizing the need to",
    "entities": []
  },
  {
    "text": "consider gene-environment interactions. Overall, our study reveals a conserved",
    "entities": []
  },
  {
    "text": "APOE \u03b54-associated pro-inflammatory immune signature persistent across the",
    "entities": [
      {
        "text": "APOE",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "brain, CSF and plasma irrespective of neurodegenerative disease, highlighting a",
    "entities": [
      {
        "text": "CSF",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "This work reframes APOE \u03b54 as a pleiotropic immune modulator rather than an",
    "entities": [
      {
        "text": "APOE",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "AD-specific risk gene, providing a foundation for precision biomarker",
    "entities": [
      {
        "text": "AD",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "development and early intervention strategies across neurodegenerative diseases.",
    "entities": []
  },
  {
    "text": "Conflict of interest statement: Competing interests: The authors declare no",
    "entities": []
  },
  {
    "text": "10.1007/s00590-025-04446-7.",
    "entities": [
      {
        "text": "10.1007",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Editorial on sartans and skeletal muscle regeneration: rethinking fibrosis as a",
    "entities": []
  },
  {
    "text": "modifiable target in traumatic injury.",
    "entities": []
  },
  {
    "text": "(1)Department of Trauma and Reconstructive Surgery, University Hospital in",
    "entities": [
      {
        "text": "Trauma",
        "label": "NORP"
      },
      {
        "text": "University Hospital",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(2)Department of Life Sciences, Health, and Health Professions, Link Campus",
    "entities": [
      {
        "text": "Life Sciences",
        "label": "ORG"
      },
      {
        "text": "Health Professions",
        "label": "ORG"
      },
      {
        "text": "Link Campus",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "University, Rome, Italy. Filippo.Migliorini@uk-halle.de.",
    "entities": [
      {
        "text": "University",
        "label": "ORG"
      },
      {
        "text": "Rome",
        "label": "GPE"
      },
      {
        "text": "Italy",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Department of Orthopaedic and Trauma Surgery, Academic Hospital of Bolzano",
    "entities": [
      {
        "text": "Orthopaedic",
        "label": "PERSON"
      },
      {
        "text": "Trauma Surgery",
        "label": "PERSON"
      },
      {
        "text": "Academic Hospital of Bolzano",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(4)Department of Orthopaedics and Joint Replacement Surgery, Indraprastha Apollo",
    "entities": [
      {
        "text": "Orthopaedics and Joint Replacement Surgery",
        "label": "ORG"
      },
      {
        "text": "Indraprastha Apollo",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Hospitals, New Delhi, India.",
    "entities": [
      {
        "text": "Hospitals",
        "label": "ORG"
      },
      {
        "text": "New Delhi",
        "label": "GPE"
      },
      {
        "text": "India",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Traumatic muscle injuries are common yet often lead to incomplete recovery,",
    "entities": []
  },
  {
    "text": "despite the high regenerative potential of skeletal muscle. A major obstacle is",
    "entities": []
  },
  {
    "text": "fibrosis, which replaces functional tissue with disorganised extracellular",
    "entities": []
  },
  {
    "text": "matrix, impairing contractility and healing. Central to this maladaptive",
    "entities": []
  },
  {
    "text": "response is the TGF-\u03b21 pathway, a conserved fibrogenic signal also implicated in",
    "entities": []
  },
  {
    "text": "cardiac, hepatic, and renal fibrosis. This has prompted interest in repurposing",
    "entities": [
      {
        "text": "cardiac, hepatic",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "antifibrotic agents, particularly angiotensin II receptor blockers (ARBs), or",
    "entities": []
  },
  {
    "text": "sartans. These drugs, widely used for hypertension, inhibit TGF-\u03b21 activation",
    "entities": []
  },
  {
    "text": "via AT1R antagonism. Preclinical studies in murine models have shown that",
    "entities": [
      {
        "text": "AT1R",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "sartans reduce collagen deposition, promote muscle regeneration, and improve",
    "entities": [
      {
        "text": "sartans",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "functional outcomes after injury. Some also activate additional regenerative",
    "entities": [
      {
        "text": "functional outcomes after injury",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "pathways, such as PPAR-\u03b3. Although no clinical trials have evaluated ARBs for",
    "entities": []
  },
  {
    "text": "muscle injuries, preliminary data from orthopaedic settings suggest potential",
    "entities": []
  },
  {
    "text": "benefits. Given their safety, availability, and biological plausibility, sartans",
    "entities": []
  },
  {
    "text": "represent a promising avenue for therapeutic modulation of fibrosis in muscle",
    "entities": []
  },
  {
    "text": "trauma. Future research should clarify optimal timing, dosing, and patient",
    "entities": []
  },
  {
    "text": "selection to translate these findings into clinical practice.",
    "entities": []
  },
  {
    "text": "DOI: 10.1007/s00590-025-04446-7",
    "entities": [
      {
        "text": "10.1007",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "PMID: 40664986 [Indexed for MEDLINE]",
    "entities": [
      {
        "text": "40664986",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: Declarations. Conflict of interest: The authors",
    "entities": []
  },
  {
    "text": "declare no competing interests. Registration and protocol: The present review",
    "entities": []
  },
  {
    "text": "was not registered.",
    "entities": []
  },
  {
    "text": "Prevalence and risk factors of hypertensive retinopathy in South Korea based on",
    "entities": [
      {
        "text": "South Korea",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "national health survey data.",
    "entities": [
      {
        "text": "national health survey data",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Park SH(1), Nam D(2), Choi JY(3), Yoo TK(4).",
    "entities": [
      {
        "text": "Nam D(2",
        "label": "PERSON"
      },
      {
        "text": "Choi JY(3",
        "label": "PERSON"
      },
      {
        "text": "Yoo TK(4",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(1)Department of Ophthalmology, Hangil Eye Hospital, 35 Bupyeong-daero,",
    "entities": [
      {
        "text": "Ophthalmology, Hangil Eye Hospital",
        "label": "ORG"
      },
      {
        "text": "35",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Bupyeong-gu, Incheon, 21388, Republic of Korea.",
    "entities": [
      {
        "text": "Incheon",
        "label": "ORG"
      },
      {
        "text": "21388",
        "label": "DATE"
      },
      {
        "text": "Republic of Korea",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Department of Internal Medicine, Graduate School, College of Medicine, Yonsei",
    "entities": [
      {
        "text": "Internal Medicine",
        "label": "ORG"
      },
      {
        "text": "Graduate School, College of Medicine",
        "label": "ORG"
      },
      {
        "text": "Yonsei",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "University, Seoul, South Korea.",
    "entities": [
      {
        "text": "Seoul",
        "label": "GPE"
      },
      {
        "text": "South Korea",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Department of Biomedical Engineering, Yonsei University, Wonju, South Korea.",
    "entities": [
      {
        "text": "Biomedical Engineering",
        "label": "ORG"
      },
      {
        "text": "Yonsei University",
        "label": "ORG"
      },
      {
        "text": "Wonju",
        "label": "GPE"
      },
      {
        "text": "South Korea",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Department of Ophthalmology, Hangil Eye Hospital, 35 Bupyeong-daero,",
    "entities": [
      {
        "text": "Ophthalmology, Hangil Eye Hospital",
        "label": "ORG"
      },
      {
        "text": "35",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Bupyeong-gu, Incheon, 21388, Republic of Korea. fawoo2@yonsei.ac.kr.",
    "entities": [
      {
        "text": "Incheon",
        "label": "ORG"
      },
      {
        "text": "21388",
        "label": "DATE"
      },
      {
        "text": "Republic of Korea",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "This study investigated the prevalence and risk factors of moderate to severe",
    "entities": []
  },
  {
    "text": "hypertensive retinopathy among non-diabetic South Korean adults using data from",
    "entities": [
      {
        "text": "South Korean",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "the Korea National Health and Nutrition Examination Survey (KNHANES) 2008-2011.",
    "entities": [
      {
        "text": "the Korea National Health and Nutrition Examination Survey",
        "label": "ORG"
      },
      {
        "text": "KNHANES",
        "label": "ORG"
      },
      {
        "text": "2008-2011",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "Hypertensive retinopathy was defined through standardized retinal image grading.",
    "entities": []
  },
  {
    "text": "A multivariable logistic regression model was developed using weighted analysis",
    "entities": []
  },
  {
    "text": "and predictor selection based on pathophysiological relevance and",
    "entities": []
  },
  {
    "text": "multicollinearity diagnostics. Final model features included age, systolic blood",
    "entities": []
  },
  {
    "text": "pressure, HbA1c, total cholesterol, creatinine, and hemoglobin. Among 5,075",
    "entities": [
      {
        "text": "5,075",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "participants, the weighted prevalence of moderate to severe hypertensive",
    "entities": []
  },
  {
    "text": "retinopathy was 0.8%. The prevalence rate increased with higher systolic blood",
    "entities": [
      {
        "text": "0.8%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "pressure levels. The model demonstrated moderate discrimination, with an average",
    "entities": []
  },
  {
    "text": "area under the receiver operating characteristic curve (AUC) of 0.721 in 5-fold",
    "entities": [
      {
        "text": "0.721",
        "label": "CARDINAL"
      },
      {
        "text": "5-fold",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "cross-validation and 0.679 in external validation using the KNHANES 2012",
    "entities": [
      {
        "text": "0.679",
        "label": "CARDINAL"
      },
      {
        "text": "KNHANES",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "dataset. External validation was performed using averaged predictions from the",
    "entities": []
  },
  {
    "text": "five internally validated models. The relatively low prevalence of hypertensive",
    "entities": [
      {
        "text": "five",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "retinopathy compared to Western populations may reflect differences in",
    "entities": []
  },
  {
    "text": "hypertension control, lifestyle, or genetic susceptibility. Future research",
    "entities": []
  },
  {
    "text": "should explore retinal image analysis and longitudinal datasets to enhance early",
    "entities": []
  },
  {
    "text": "detection and clarify the systemic implications of hypertensive retinopathy.",
    "entities": []
  },
  {
    "text": "DOI: 10.1038/s41598-025-11017-7",
    "entities": [
      {
        "text": "10.1038",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "PMID: 40664953 [Indexed for MEDLINE]",
    "entities": [
      {
        "text": "40664953",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: Declarations. Competing interests: T K Yoo is an",
    "entities": [
      {
        "text": "T K Yoo",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "advisory board member of MediWhale and has received consultant fees as part of",
    "entities": [
      {
        "text": "MediWhale",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "the standard compensation package. The remaining authors declare no conflicts of",
    "entities": []
  },
  {
    "text": "interest. Ethics approval and consent to participate: This study was conducted",
    "entities": []
  },
  {
    "text": "using anonymized data from the publicly available KNHANES dataset, which was",
    "entities": [
      {
        "text": "KNHANES",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "approved by the Institutional Review Board (IRB) of the Korea Centers for",
    "entities": [
      {
        "text": "the Institutional Review Board",
        "label": "ORG"
      },
      {
        "text": "IRB",
        "label": "ORG"
      },
      {
        "text": "the Korea Centers",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Disease Control and Prevention (IRB numbers: 2008-04EXP-01-C, 2009-01CON-03\u20132 C,",
    "entities": [
      {
        "text": "Disease Control and Prevention",
        "label": "ORG"
      },
      {
        "text": "IRB",
        "label": "ORG"
      },
      {
        "text": "2008",
        "label": "DATE"
      },
      {
        "text": "2009",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "2010-02CON-21-C, 2011-02-CON-06-C, and 2012-01-EXP-01\u20132 C). Written informed",
    "entities": [
      {
        "text": "2010",
        "label": "DATE"
      },
      {
        "text": "2011-02",
        "label": "DATE"
      },
      {
        "text": "2012-01",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "consent was obtained from all participants prior to their inclusion in the",
    "entities": []
  },
  {
    "text": "survey. As the study exclusively utilized publicly available data, additional",
    "entities": []
  },
  {
    "text": "IRB approval was not required. The study complied with the principles outlined",
    "entities": [
      {
        "text": "IRB",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "in the Declaration of Helsinki, ensuring ethical standards were maintained",
    "entities": [
      {
        "text": "the Declaration of Helsinki",
        "label": "WORK_OF_ART"
      }
    ]
  },
  {
    "text": "throughout. Consent for publication: Not applicable, as this study does not",
    "entities": []
  },
  {
    "text": "consent for publication.",
    "entities": []
  },
  {
    "text": "36. Eur Radiol. 2025 Jul 15. doi: 10.1007/s00330-025-11799-4. Online ahead of",
    "entities": [
      {
        "text": "36",
        "label": "CARDINAL"
      },
      {
        "text": "2025",
        "label": "CARDINAL"
      },
      {
        "text": "15",
        "label": "CARDINAL"
      },
      {
        "text": "10.1007",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Splanchnic hemodynamic parameters measured with 4D flow MRI can diagnose severe",
    "entities": []
  },
  {
    "text": "G(3)(4), Kennedy P(3)(4), Sharma H(3), Hectors SJ(3)(4), Thung S(6), Jin N(7),",
    "entities": [
      {
        "text": "Kennedy",
        "label": "PERSON"
      },
      {
        "text": "Sharma",
        "label": "NORP"
      },
      {
        "text": "Thung",
        "label": "GPE"
      },
      {
        "text": "Jin N(7",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(1)Department of Diagnostic, Molecular and Interventional Radiology, Icahn",
    "entities": [
      {
        "text": "Diagnostic, Molecular and Interventional Radiology",
        "label": "ORG"
      },
      {
        "text": "Icahn",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "School of Medicine at Mount Sinai, New York, NY, USA.",
    "entities": [
      {
        "text": "School of Medicine",
        "label": "ORG"
      },
      {
        "text": "Mount Sinai",
        "label": "FAC"
      },
      {
        "text": "New York",
        "label": "GPE"
      },
      {
        "text": "NY",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)BioMedical Engineering and Imaging Institute, Icahn School of Medicine at",
    "entities": [
      {
        "text": "Imaging Institute",
        "label": "ORG"
      },
      {
        "text": "Icahn School of Medicine",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Mount Sinai, New York, NY, USA. octavia.bane@mountsinai.org.",
    "entities": [
      {
        "text": "Mount Sinai",
        "label": "GPE"
      },
      {
        "text": "New York",
        "label": "GPE"
      },
      {
        "text": "NY",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Department of Diagnostic, Molecular and Interventional Radiology, Icahn",
    "entities": [
      {
        "text": "Diagnostic, Molecular and Interventional Radiology",
        "label": "ORG"
      },
      {
        "text": "Icahn",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "(4)BioMedical Engineering and Imaging Institute, Icahn School of Medicine at",
    "entities": [
      {
        "text": "Imaging Institute",
        "label": "ORG"
      },
      {
        "text": "Icahn School of Medicine",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Mount Sinai, New York, NY, USA.",
    "entities": [
      {
        "text": "Mount Sinai",
        "label": "GPE"
      },
      {
        "text": "New York",
        "label": "GPE"
      },
      {
        "text": "NY",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(5)Department of Radiology, University Hospital Zurich, Zurich, Switzerland.",
    "entities": [
      {
        "text": "Radiology, University Hospital Zurich",
        "label": "ORG"
      },
      {
        "text": "Zurich",
        "label": "GPE"
      },
      {
        "text": "Switzerland",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(6)Department of Pathology, Icahn School of Medicine at Mount Sinai, New York,",
    "entities": [
      {
        "text": "Pathology",
        "label": "ORG"
      },
      {
        "text": "Icahn School of Medicine",
        "label": "ORG"
      },
      {
        "text": "Mount Sinai",
        "label": "FAC"
      },
      {
        "text": "New York",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(7)Siemens Healthineers, Solon, OH, USA.",
    "entities": [
      {
        "text": "Healthineers",
        "label": "ORG"
      },
      {
        "text": "Solon",
        "label": "ORG"
      },
      {
        "text": "OH",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(8)Department of Biomedical Engineering, McCormick School of Engineering,",
    "entities": [
      {
        "text": "Biomedical Engineering",
        "label": "ORG"
      },
      {
        "text": "McCormick School of Engineering",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Northwestern University, Evanston, IL, USA.",
    "entities": [
      {
        "text": "Northwestern University",
        "label": "ORG"
      },
      {
        "text": "Evanston",
        "label": "ORG"
      },
      {
        "text": "IL",
        "label": "ORG"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(9)Department of Radiology, Feinberg School of Medicine, Northwestern",
    "entities": [
      {
        "text": "Radiology, Feinberg School of Medicine",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "University, Chicago, IL, USA.",
    "entities": [
      {
        "text": "Chicago",
        "label": "GPE"
      },
      {
        "text": "IL",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(10)Department of Radiology, University of Wisconsin Madison, Madison, WI, USA.",
    "entities": [
      {
        "text": "10)Department of Radiology, University of Wisconsin Madison",
        "label": "MONEY"
      },
      {
        "text": "Madison",
        "label": "PERSON"
      },
      {
        "text": "WI",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(11)Recanati-Miller Transplantation Institute, Icahn School of Medicine at Mount",
    "entities": [
      {
        "text": "11)Recanati",
        "label": "CARDINAL"
      },
      {
        "text": "Icahn School of Medicine",
        "label": "ORG"
      },
      {
        "text": "Mount\n",
        "label": "LOC"
      }
    ]
  },
  {
    "text": "Sinai, New York, NY, USA.",
    "entities": [
      {
        "text": "New York",
        "label": "GPE"
      },
      {
        "text": "NY",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "OBJECTIVES: To assess the diagnostic performance of splanchnic hemodynamic",
    "entities": [
      {
        "text": "OBJECTIVES",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "parameters measured with 4D flow MRI for diagnosis of severe portal hypertension",
    "entities": []
  },
  {
    "text": "(PH; hepatic venous pressure gradient (HVPG) \u2265 12 mmHg), and prediction of liver",
    "entities": [
      {
        "text": "HVPG",
        "label": "ORG"
      },
      {
        "text": "\u2265",
        "label": "PERSON"
      },
      {
        "text": "12",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "decompensation in patients with chronic liver disease.",
    "entities": []
  },
  {
    "text": "MATERIALS AND METHODS: Our single-center prospective study (2018-2022) enrolled",
    "entities": [
      {
        "text": "2018-2022",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "patients undergoing transjugular liver biopsy with wedge HVPG measurement for",
    "entities": []
  },
  {
    "text": "abdominal 4D flow MRI (MRI-HVPG interval = 28 \u00b1 18 (1-78) days). 4D flow MRI was",
    "entities": [
      {
        "text": "28",
        "label": "CARDINAL"
      },
      {
        "text": "1-78) days",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "acquired at 1.5 T, 10 min. after injection of gadoxetic acid, with a prototype",
    "entities": [
      {
        "text": "1.5",
        "label": "CARDINAL"
      },
      {
        "text": "10",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "manually segmented the portal, superior mesenteric, splenic and middle hepatic",
    "entities": [
      {
        "text": "middle hepatic",
        "label": "LOC"
      }
    ]
  },
  {
    "text": "Time-averaged vessel cross-section area, through-plane time-averaged velocity",
    "entities": []
  },
  {
    "text": "and flow, and peak velocity were compared between patients with/without severe",
    "entities": []
  },
  {
    "text": "PH, and with/without future liver decompensation by Mann-Whitney U test and ROC",
    "entities": [
      {
        "text": "Mann-Whitney U",
        "label": "ORG"
      },
      {
        "text": "ROC",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "RESULTS: 50 patients (M/F: 26/24, age = 52 \u00b1 15 years) were included, of which",
    "entities": [
      {
        "text": "50",
        "label": "CARDINAL"
      },
      {
        "text": "26/24",
        "label": "CARDINAL"
      },
      {
        "text": "52",
        "label": "DATE"
      },
      {
        "text": "15 years",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "47 had clinical follow-up 1084 \u00b1 618 days after MRI. Twenty-three of 50 (46%)",
    "entities": [
      {
        "text": "47",
        "label": "CARDINAL"
      },
      {
        "text": "1084",
        "label": "DATE"
      },
      {
        "text": "618 days",
        "label": "DATE"
      },
      {
        "text": "Twenty-three",
        "label": "CARDINAL"
      },
      {
        "text": "46%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "patients had PH, 8/50 (16%) had severe PH, and 12/47 (26%) had decompensation.",
    "entities": [
      {
        "text": "16%",
        "label": "PERCENT"
      },
      {
        "text": "12/47",
        "label": "CARDINAL"
      },
      {
        "text": "26%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "Celiac trunk peak velocity [AUC (95% CI) = 0.90 (0.80-0.99)] and superior",
    "entities": [
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "0.90",
        "label": "CARDINAL"
      },
      {
        "text": "0.80-0.99",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "mesenteric vein area [AUC (95% CI) = 0.88 (0.77-0.99)] identified severe PH with",
    "entities": [
      {
        "text": "AUC",
        "label": "ORG"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "0.88",
        "label": "CARDINAL"
      },
      {
        "text": "0.77",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "the highest diagnostic performance. A logistic regression model combining celiac",
    "entities": []
  },
  {
    "text": "trunk peak velocity and superior mesenteric vein flow identified severe PH with",
    "entities": []
  },
  {
    "text": "AUC (95% CI) = 0.95 (0.88-1.00), sensitivity = 100%, specificity = 89%. Hepatic",
    "entities": [
      {
        "text": "AUC",
        "label": "ORG"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "0.95",
        "label": "CARDINAL"
      },
      {
        "text": "0.88-1.00",
        "label": "DATE"
      },
      {
        "text": "100%",
        "label": "PERCENT"
      },
      {
        "text": "89%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "[AUC (95% CI) = 0.74 (0.57-0.92)] and splenic artery [AUC (95% CI) = 0.74",
    "entities": [
      {
        "text": "AUC",
        "label": "ORG"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "0.74",
        "label": "CARDINAL"
      },
      {
        "text": "0.57",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "0.74",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "mesenteric vein [AUC (95% CI) = 0.72 (0.55-0.89)] flow predicted liver",
    "entities": [
      {
        "text": "mesenteric vein",
        "label": "PERSON"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "0.72",
        "label": "CARDINAL"
      },
      {
        "text": "0.55-0.89",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "decompensation with good diagnostic performance.",
    "entities": []
  },
  {
    "text": "CONCLUSION: Splanchnic 4D flow MRI measurements have excellent performance for",
    "entities": []
  },
  {
    "text": "diagnosing severe PH and good performance for predicting liver decompensation.",
    "entities": []
  },
  {
    "text": "KEY POINTS: Question Noninvasive detection of severe portal hypertension",
    "entities": [
      {
        "text": "Question Noninvasive",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(hepatic venous pressure gradient \u2265 12 mmHg) is important to prevent bleeding,",
    "entities": [
      {
        "text": "\u2265",
        "label": "PERSON"
      },
      {
        "text": "12",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "decompensation, and death in patients with chronic liver disease. Findings",
    "entities": []
  },
  {
    "text": "Splanchnic hemodynamic measurements by 4D flow MRI can identify patients with",
    "entities": []
  },
  {
    "text": "severe portal hypertension and predict liver decompensation with excellent/good",
    "entities": []
  },
  {
    "text": "diagnostic performance. Clinical relevance 4D flow MRI can potentially be",
    "entities": []
  },
  {
    "text": "integrated into the clinical MRI protocols of patients with liver cirrhosis.",
    "entities": []
  },
  {
    "text": "\u00a9 2025. The Author(s), under exclusive licence to European Society of Radiology.",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "European Society of Radiology",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "DOI: 10.1007/s00330-025-11799-4",
    "entities": [
      {
        "text": "10.1007",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: Compliance with ethical standards. Guarantor:",
    "entities": []
  },
  {
    "text": "The scientific guarantor of this publication is Bachir Taouli. Conflict of",
    "entities": [
      {
        "text": "Bachir Taouli",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "interest: The authors of this manuscript declare relationships with the",
    "entities": []
  },
  {
    "text": "following companies: P.K. is an employee of Boston Scientific, and S.J.H. is an",
    "entities": [
      {
        "text": "P.K.",
        "label": "ORG"
      },
      {
        "text": "Boston Scientific",
        "label": "ORG"
      },
      {
        "text": "S.J.H.",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "employee of Regeneron Pharmaceuticals, which are not sponsors of this project.",
    "entities": [
      {
        "text": "Regeneron Pharmaceuticals",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "N.J. is an employee of Siemens Healthineers, which supported this project with a",
    "entities": [
      {
        "text": "N.J.",
        "label": "GPE"
      },
      {
        "text": "Siemens Healthineers",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "prototype pulse sequence and data analysis software. B.T. received material",
    "entities": [
      {
        "text": "B.T.",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "support for this research from Siemens, in the form of a research 4D flow MRI",
    "entities": [
      {
        "text": "Siemens",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "pulse sequence and data analysis software. O.B., A.G., D.S., S.P., G.A., H.S.,",
    "entities": [
      {
        "text": "O.B.",
        "label": "GPE"
      },
      {
        "text": "A.G.",
        "label": "GPE"
      },
      {
        "text": "D.S.",
        "label": "GPE"
      },
      {
        "text": "S.P.",
        "label": "GPE"
      },
      {
        "text": "G.A.",
        "label": "GPE"
      },
      {
        "text": "H.S.",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "A.F., M.M., S.T., T.D.S. and S.R. declare no relationships with any companies,",
    "entities": [
      {
        "text": "A.F.",
        "label": "GPE"
      },
      {
        "text": "M.M.",
        "label": "GPE"
      },
      {
        "text": "S.T.",
        "label": "GPE"
      },
      {
        "text": "T.D.S.",
        "label": "GPE"
      },
      {
        "text": "S.R.",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "whose products or services may be related to the subject matter of the article.",
    "entities": []
  },
  {
    "text": "Statistics and biometry: No complex statistical methods were necessary for this",
    "entities": []
  },
  {
    "text": "paper. Informed consent: Written informed consent was obtained from all subjects",
    "entities": []
  },
  {
    "text": "(patients) in this study. Ethical approval: Institutional Review Board approval",
    "entities": [
      {
        "text": "Institutional Review Board",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "was obtained from the Icahn School of Medicine at Mount Sinai Institutional",
    "entities": [
      {
        "text": "the Icahn School of Medicine",
        "label": "ORG"
      },
      {
        "text": "Mount Sinai Institutional",
        "label": "FAC"
      }
    ]
  },
  {
    "text": "Review Board. Study subjects or cohorts overlap: All patients in our cohort",
    "entities": [
      {
        "text": "Review Board",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "underwent multiparametric MRI (diffusion-weighted, DCE-MRI, T1, T1\u03c1, MR",
    "entities": [
      {
        "text": "DCE-MRI",
        "label": "ORG"
      },
      {
        "text": "T1",
        "label": "NORP"
      },
      {
        "text": "T1\u03c1",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "elastography and 4D flow). In the interest of clarity and brevity, we decided to",
    "entities": []
  },
  {
    "text": "present the data acquired with different MRI methods (e.g., 4D flow, T1 and T1\u03c1",
    "entities": [
      {
        "text": "T1",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "relaxometry, and elastography) separately. Some study subjects or cohorts have",
    "entities": []
  },
  {
    "text": "been previously reported in a published study on T1 and T1\u03c1 mapping in portal",
    "entities": [
      {
        "text": "T1",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "hypertension (Hectors et al [19]), native and contrast-enhanced T1 (Altinmakas",
    "entities": [
      {
        "text": "19",
        "label": "CARDINAL"
      },
      {
        "text": "T1",
        "label": "PRODUCT"
      },
      {
        "text": "Altinmakas",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "et al [18]), DCE-MRI (Hectors et al [17]) and MR elastography (Kennedy et al",
    "entities": [
      {
        "text": "18",
        "label": "CARDINAL"
      },
      {
        "text": "DCE-MRI",
        "label": "ORG"
      },
      {
        "text": "17",
        "label": "CARDINAL"
      },
      {
        "text": "Kennedy",
        "label": "PERSON"
      },
      {
        "text": "al\n",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "[16]). A subset of 10 patients was also included in a technical paper comparing",
    "entities": [
      {
        "text": "16",
        "label": "CARDINAL"
      },
      {
        "text": "10",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "two 4D flow methods (Bane et al [20]). We have presented preliminary results of",
    "entities": [
      {
        "text": "two",
        "label": "CARDINAL"
      },
      {
        "text": "Bane",
        "label": "PERSON"
      },
      {
        "text": "20",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "this study in oral presentations at the annual meetings of the Society of",
    "entities": [
      {
        "text": "annual",
        "label": "DATE"
      },
      {
        "text": "the Society of\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Abdominal Radiology (2024, 2020), the Society of Advanced Body Imaging (2023),",
    "entities": [
      {
        "text": "2024, 2020",
        "label": "DATE"
      },
      {
        "text": "the Society of Advanced Body Imaging",
        "label": "ORG"
      },
      {
        "text": "2023",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "and the International Society of Magnetic Resonance in Medicine (2020).",
    "entities": [
      {
        "text": "the International Society of Magnetic Resonance in Medicine",
        "label": "ORG"
      },
      {
        "text": "2020",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "Methodology: Prospective Cross-sectional study/observational Performed at one",
    "entities": [
      {
        "text": "Prospective Cross",
        "label": "ORG"
      },
      {
        "text": "Performed",
        "label": "ORG"
      },
      {
        "text": "one",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "institution",
    "entities": []
  },
  {
    "text": "Risk factors, clinical presentation, stroke subtype and short-term outcome",
    "entities": []
  },
  {
    "text": "following acute stroke in a multi-ethnic population: a 10-year study from Qatar.",
    "entities": [
      {
        "text": "10-year",
        "label": "DATE"
      },
      {
        "text": "Qatar",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(1)Department of Neurology, Stroke Program, University of Alberta, 11350 83 Ave,",
    "entities": [
      {
        "text": "Neurology",
        "label": "ORG"
      },
      {
        "text": "Stroke Program",
        "label": "ORG"
      },
      {
        "text": "University of Alberta",
        "label": "ORG"
      },
      {
        "text": "11350 83",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "(2)Department of Neurology, Stroke Program, University of Alberta, 11350 83 Ave,",
    "entities": [
      {
        "text": "Neurology",
        "label": "ORG"
      },
      {
        "text": "Stroke Program",
        "label": "ORG"
      },
      {
        "text": "University of Alberta",
        "label": "ORG"
      },
      {
        "text": "11350 83",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "(3)Department of Neuroscience, Hamad Medical Corporation, Doha, Qatar.",
    "entities": [
      {
        "text": "Neuroscience",
        "label": "ORG"
      },
      {
        "text": "Hamad Medical Corporation",
        "label": "ORG"
      },
      {
        "text": "Doha",
        "label": "GPE"
      },
      {
        "text": "Qatar",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "BACKGROUND: Stroke remains a leading global cause of disability and mortality",
    "entities": []
  },
  {
    "text": "with over 100 million patients affected worldwide. Its incidence has risen in",
    "entities": [
      {
        "text": "over 100 million",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "recent decades, especially in low- and middle-income countries (LMICs), due to",
    "entities": [
      {
        "text": "recent decades",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "limited education, healthcare, and effective prevention measures. This study",
    "entities": [
      {
        "text": "healthcare",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "investigates the association between ethnicity and outcomes of stroke in Qatar,",
    "entities": [
      {
        "text": "Qatar",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "a country with a heterogeneous population.",
    "entities": []
  },
  {
    "text": "METHODS: Data from 18,174 stroke patients admitted to Hamad General Hospital",
    "entities": [
      {
        "text": "18,174",
        "label": "CARDINAL"
      },
      {
        "text": "Hamad General Hospital",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "from 2014 to 2024 were analyzed. We assessed patient characteristics, stroke",
    "entities": [
      {
        "text": "2014 to 2024",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "types, comorbidities, and outcomes using the NIH Stroke Scale and modified",
    "entities": [
      {
        "text": "NIH",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "RESULTS: There were significant ethnic differences in stroke presentation and",
    "entities": []
  },
  {
    "text": "outcomes. Middle Easterns were older (59.7 \u00b1 14.2) than South East Asian",
    "entities": [
      {
        "text": "59.7",
        "label": "CARDINAL"
      },
      {
        "text": "14.2",
        "label": "CARDINAL"
      },
      {
        "text": "South East",
        "label": "LOC"
      },
      {
        "text": "Asian",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "(50.1 \u00b1 11.7) and Far Eastern (47.5 \u00b1 9.85) patients; p < 0.001. Middle Eastern",
    "entities": [
      {
        "text": "50.1 \u00b1",
        "label": "QUANTITY"
      },
      {
        "text": "Far Eastern",
        "label": "ORG"
      },
      {
        "text": "47.5",
        "label": "CARDINAL"
      },
      {
        "text": "9.85",
        "label": "CARDINAL"
      },
      {
        "text": "p < 0.001",
        "label": "ORG"
      },
      {
        "text": "Middle Eastern",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "patients had a higher prevalence of stroke risk factors (diabetes, hypertension,",
    "entities": []
  },
  {
    "text": "obesity) and stroke mimics (39.8%) than Southeast Asian (21.7%) and Far Eastern",
    "entities": [
      {
        "text": "39.8%",
        "label": "PERCENT"
      },
      {
        "text": "Southeast Asian",
        "label": "NORP"
      },
      {
        "text": "21.7%",
        "label": "PERCENT"
      },
      {
        "text": "Far Eastern",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "(27.7%) patients (p < 0.0001). Far Eastern patients demonstrated a higher",
    "entities": [
      {
        "text": "27.7%",
        "label": "PERCENT"
      },
      {
        "text": "Far Eastern",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "incidence (17.6%) of intracerebral hemorrhage compared to Middle Easterns (6.2%)",
    "entities": [
      {
        "text": "17.6%",
        "label": "PERCENT"
      },
      {
        "text": "Middle Easterns",
        "label": "PERSON"
      },
      {
        "text": "6.2%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "and East Asians (10.6%); p < 0.0001. However, ischemic stroke was more common",
    "entities": [
      {
        "text": "East Asians",
        "label": "NORP"
      },
      {
        "text": "10.6%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "among Southeast Asians (58.6%) than Middle Eastern (43.8%) and Far Eastern",
    "entities": [
      {
        "text": "Southeast Asians",
        "label": "NORP"
      },
      {
        "text": "58.6%",
        "label": "PERCENT"
      },
      {
        "text": "Middle Eastern",
        "label": "NORP"
      },
      {
        "text": "43.8%",
        "label": "PERCENT"
      },
      {
        "text": "Far Eastern",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "(44.4%) patients; p < 0.0001. Lastly, there were significant differences in",
    "entities": [
      {
        "text": "44.4%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "outcomes as measured by mortality and the mRS.",
    "entities": []
  },
  {
    "text": "CONCLUSION: There are significant ethnic differences in stroke presentation,",
    "entities": []
  },
  {
    "text": "management, and outcomes in Qatar, some of which may reflect underlying",
    "entities": [
      {
        "text": "Qatar",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "disparities driven by social and structural inequities. While genetic",
    "entities": []
  },
  {
    "text": "differences play a role, early management of vascular risk factors is a crucial,",
    "entities": []
  },
  {
    "text": "preventable measure to reduce stroke burden in LMICs and improve health",
    "entities": []
  },
  {
    "text": "\u00a9 2025. Springer-Verlag GmbH Germany, part of Springer Nature.",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "Springer-Verlag GmbH Germany",
        "label": "ORG"
      },
      {
        "text": "Springer Nature",
        "label": "WORK_OF_ART"
      }
    ]
  },
  {
    "text": "PMID: 40664805 [Indexed for MEDLINE]",
    "entities": []
  },
  {
    "text": "Conflict of interest statement: Declarations. Conflict of interest: On behalf of",
    "entities": []
  },
  {
    "text": "all authors, the corresponding author states that there is no conflict of",
    "entities": []
  },
  {
    "text": "interest. Ethical standards: For this type of study formal consent is not",
    "entities": []
  },
  {
    "text": "required.",
    "entities": []
  },
  {
    "text": "Linear inverse association between prognostic nutritional index and colorectal",
    "entities": [
      {
        "text": "Linear",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "cancer risk based on NHANES data.",
    "entities": [
      {
        "text": "NHANES",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(1)Department of General Surgery, The Affiliated Wuxi No.2 People's Hospital of",
    "entities": [
      {
        "text": "Surgery",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Nanjing Medical University, Wuxi, China.",
    "entities": [
      {
        "text": "Nanjing Medical University",
        "label": "ORG"
      },
      {
        "text": "Wuxi",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Department of General Surgery, Institute of General Surgical Research, School",
    "entities": [
      {
        "text": "2)Department",
        "label": "CARDINAL"
      },
      {
        "text": "General Surgery, Institute of General Surgical Research",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "of Medicine, Jiangnan University Medical Center, Jiangnan University, Wuxi,",
    "entities": [
      {
        "text": "Medicine, Jiangnan University Medical Center, Jiangnan University",
        "label": "ORG"
      },
      {
        "text": "Wuxi",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Department of General Surgery, The Affiliated Wuxi No.2 People's Hospital of",
    "entities": [
      {
        "text": "Surgery",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Nanjing Medical University, Wuxi, China. xjz_wuxi@alumni.sjtu.edu.cn.",
    "entities": [
      {
        "text": "Nanjing Medical University",
        "label": "ORG"
      },
      {
        "text": "Wuxi",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Department of General Surgery, Institute of General Surgical Research, School",
    "entities": [
      {
        "text": "General Surgery, Institute of General Surgical Research",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Despite the Prognostic Nutritional Index (PNI) serving as a crucial prognostic",
    "entities": [
      {
        "text": "the Prognostic Nutritional Index (",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "marker for predicting survival outcomes in cancer patients, its association with",
    "entities": []
  },
  {
    "text": "the risk of Colorectal Cancer (CRC) is not well comprehended. We hypothesized",
    "entities": [
      {
        "text": "Colorectal Cancer",
        "label": "ORG"
      },
      {
        "text": "CRC",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "that lower PNI levels are associated with a higher risk of CRC. The datasets",
    "entities": [
      {
        "text": "CRC",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "from the National Health and Nutrition Examination Survey (NHANES) spanning from",
    "entities": [
      {
        "text": "the National Health and Nutrition Examination Survey",
        "label": "ORG"
      },
      {
        "text": "NHANES",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "2007 to 2016 were employed in this study, incorporating data on demographics,",
    "entities": [
      {
        "text": "2007 to 2016",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "laboratory tests, and questionnaires. Participants aged \u2265 20 years were",
    "entities": [
      {
        "text": "\u2265",
        "label": "PERSON"
      },
      {
        "text": "20 years",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "included, while those with missing tumor history or incomplete laboratory data",
    "entities": []
  },
  {
    "text": "for PNI calculation (serum albumin or lymphocyte count) were excluded. A total",
    "entities": []
  },
  {
    "text": "of 26,229 participants who met the inclusion criteria were evaluated, of which",
    "entities": [
      {
        "text": "26,229",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "176 had a history of CRC. The PNI was calculated as 0.005 \u00d7 absolute lymphocyte",
    "entities": [
      {
        "text": "176",
        "label": "CARDINAL"
      },
      {
        "text": "CRC",
        "label": "ORG"
      },
      {
        "text": "PNI",
        "label": "ORG"
      },
      {
        "text": "0.005",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "count + 10 \u00d7 serum albumin, and categorized into quartiles. CRC status was",
    "entities": [
      {
        "text": "+ 10 \u00d7",
        "label": "FAC"
      },
      {
        "text": "CRC",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "determined via self-reported medical history. To investigate the linear",
    "entities": []
  },
  {
    "text": "relationship between PNI and CRC, multivariable logistic regression models,",
    "entities": [
      {
        "text": "PNI",
        "label": "ORG"
      },
      {
        "text": "CRC",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "restricted cubic spline analysis, and subgroup analyses were used. Covariates",
    "entities": []
  },
  {
    "text": "were adjusted using multiple imputation, and all analyses were conducted using",
    "entities": []
  },
  {
    "text": "DecisionLinnc v1.0. Statistical significance was set at P < 0.05. The average",
    "entities": [
      {
        "text": "DecisionLinnc",
        "label": "ORG"
      },
      {
        "text": "P < 0.05",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "PNI score was 42.55 \u00b1 3.42. Fully adjusted multivariable logistic regression",
    "entities": [
      {
        "text": "42.55",
        "label": "CARDINAL"
      },
      {
        "text": "3.42",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "models identified a significant inverse relationship between higher PNI scores",
    "entities": [
      {
        "text": "PNI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "and lower odds of CRC. Specifically, each one-unit increase in PNI was",
    "entities": [
      {
        "text": "CRC",
        "label": "ORG"
      },
      {
        "text": "one",
        "label": "CARDINAL"
      },
      {
        "text": "PNI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "associated with a 6.43% reduction in the odds of CRC [OR: 0.9357; 95% CI:",
    "entities": [
      {
        "text": "6.43%",
        "label": "PERCENT"
      },
      {
        "text": "CRC",
        "label": "ORG"
      },
      {
        "text": "0.9357",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "0.8942, 0.9807; p = 0.005]. Restricted cubic spline analysis further validated a",
    "entities": [
      {
        "text": "0.8942",
        "label": "CARDINAL"
      },
      {
        "text": "0.9807",
        "label": "CARDINAL"
      },
      {
        "text": "0.005",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "linear association between PNI and CRC risk. Subgroup analyses demonstrated that",
    "entities": [
      {
        "text": "linear",
        "label": "ORG"
      },
      {
        "text": "PNI",
        "label": "ORG"
      },
      {
        "text": "CRC",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "the association remained consistent across factors including gender, age,",
    "entities": []
  },
  {
    "text": "marital status, education level, BMI, alcohol consumption, smoking habits,",
    "entities": [
      {
        "text": "BMI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "history of hypertension, hyperlipidemia, and diabetes. Males exhibited a more",
    "entities": [
      {
        "text": "Males",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "pronounced inverse correlation between PNI and CRC risk. Higher PNI scores are",
    "entities": [
      {
        "text": "PNI",
        "label": "ORG"
      },
      {
        "text": "CRC",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "independently associated with reduced odds of CRC. PNI may serve as a valuable",
    "entities": [
      {
        "text": "CRC",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "enhance large-scale screening strategies.",
    "entities": []
  },
  {
    "text": "DOI: 10.1038/s41598-025-10574-1",
    "entities": [
      {
        "text": "10.1038",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "PMID: 40664778 [Indexed for MEDLINE]",
    "entities": [
      {
        "text": "40664778",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Conducting the National Health and Morbidity Survey 2023 in Malaysia with focus",
    "entities": [
      {
        "text": "the National Health and Morbidity Survey 2023",
        "label": "ORG"
      },
      {
        "text": "Malaysia",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "on methodology and main findings on non-communicable diseases.",
    "entities": []
  },
  {
    "text": "Mat Rifin H(1), Mohd Yusoff MF(2), Abd Hamid HA(2).",
    "entities": [
      {
        "text": "Mohd Yusoff MF(2",
        "label": "PERSON"
      },
      {
        "text": "Abd Hamid HA(2",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(1)Institute for Public Health, National Institutes of Health, Ministry of",
    "entities": [
      {
        "text": "National Institutes of Health",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(2)Institute for Public Health, National Institutes of Health, Ministry of",
    "entities": [
      {
        "text": "National Institutes of Health",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "The National Health and Morbidity Survey (NHMS), which focuses on",
    "entities": [
      {
        "text": "The National Health and Morbidity Survey (NHMS",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "non-communicable diseases (NCDs), their risk factors and healthcare demand, is a",
    "entities": []
  },
  {
    "text": "cross-sectional, nationwide, population-based survey conducted every four-year",
    "entities": [
      {
        "text": "four-year",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "cycle since 2011. NHMS 2023 was the 7th cycle of NCDs, their risk factors and",
    "entities": [
      {
        "text": "2011",
        "label": "DATE"
      },
      {
        "text": "NHMS 2023",
        "label": "DATE"
      },
      {
        "text": "7th",
        "label": "ORDINAL"
      }
    ]
  },
  {
    "text": "healthcare demand, which aimed to monitor trends in diseases and healthcare",
    "entities": [
      {
        "text": "healthcare",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "utilisation. This article outlines the methodology, sociodemographic",
    "entities": []
  },
  {
    "text": "characteristics, and overall findings from the population surveyed in 2023",
    "entities": [
      {
        "text": "2023",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "regarding NCDs, their risk factors, and various health-related topics. This",
    "entities": []
  },
  {
    "text": "survey utilised a two-stage stratified random sampling design and encompassed",
    "entities": [
      {
        "text": "two",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "fifteen main scopes, with sample sizes calculated to meet the specific",
    "entities": [
      {
        "text": "fifteen",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "requirements of each scope. Conducted from July to September 2023, it involved",
    "entities": [
      {
        "text": "July to September 2023",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "the random selection of 499 enumeration blocks(EBs) by the Department of",
    "entities": [
      {
        "text": "499",
        "label": "CARDINAL"
      },
      {
        "text": "the Department of\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Statistics Malaysia (DOSM) across all states and federal territories in",
    "entities": [
      {
        "text": "DOSM",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Malaysia. The step resulted in the selection of 5,988 living quarters (LQs).",
    "entities": [
      {
        "text": "Malaysia",
        "label": "GPE"
      },
      {
        "text": "5,988",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Data collection methods included validated questionnaires administered through",
    "entities": []
  },
  {
    "text": "face-to-face interviews and self-administered questionnaires, alongside clinical",
    "entities": []
  },
  {
    "text": "assessments and blood investigations using calibrated devices. To ensure the",
    "entities": []
  },
  {
    "text": "high quality of the collected data, we implemented stringent quality control",
    "entities": []
  },
  {
    "text": "measures. Furthermore, we applied complex sampling analyses to ensure that the",
    "entities": []
  },
  {
    "text": "findings accurately represented the population in Malaysia. The survey received",
    "entities": [
      {
        "text": "Malaysia",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "responses from 13,616 individuals out of the 5,006 LQs that were successfully",
    "entities": [
      {
        "text": "13,616",
        "label": "CARDINAL"
      },
      {
        "text": "5,006",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "visited, resulting in an overall response rate of the survey of 83.2%, which",
    "entities": [
      {
        "text": "83.2%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "includes individuals aged 5 years and above. A substantial segment of the",
    "entities": [
      {
        "text": "5 years",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "population lived in urban regions, comprising 77.6% of the total. About half of",
    "entities": [
      {
        "text": "77.6%",
        "label": "PERCENT"
      },
      {
        "text": "About half",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "the population consisted of males (51.9%), Malay (54.6%), and individuals who",
    "entities": [
      {
        "text": "51.9%",
        "label": "PERCENT"
      },
      {
        "text": "Malay",
        "label": "PERSON"
      },
      {
        "text": "54.6%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "had attained secondary education (54.2%). Additionally, 20.0% of the population",
    "entities": [
      {
        "text": "54.2%",
        "label": "PERCENT"
      },
      {
        "text": "20.0%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "were within the age range of 30 to 39 years. The weighted prevalence of diabetes",
    "entities": [
      {
        "text": "30 to 39 years",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "was 15.6%, hypertension 29.2%, hypercholesterolaemia 33.3%, overweight and",
    "entities": [
      {
        "text": "15.6%",
        "label": "PERCENT"
      },
      {
        "text": "29.2%",
        "label": "PERCENT"
      },
      {
        "text": "33.3%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "obesity 54.4%. Depression among adults was 4.6%, while mental health problems",
    "entities": [
      {
        "text": "54.4%",
        "label": "PERCENT"
      },
      {
        "text": "4.6%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "among children were reported at 16.5%. The current tobacco smokers prevalence",
    "entities": [
      {
        "text": "16.5%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "was 19.0%, and 29.9% of adults in Malaysia were physically inactive. The known",
    "entities": [
      {
        "text": "19.0%",
        "label": "PERCENT"
      },
      {
        "text": "29.9%",
        "label": "PERCENT"
      },
      {
        "text": "Malaysia",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "asthma prevalence among adults was 6.2%, while the current asthma among children",
    "entities": [
      {
        "text": "6.2%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "was 3.4%. Additionally, 37.7% of adults experienced sleep insufficiency. The",
    "entities": [
      {
        "text": "3.4%",
        "label": "PERCENT"
      },
      {
        "text": "37.7%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "results indicate that the higher proportion of diabetes, hypertension, and",
    "entities": []
  },
  {
    "text": "hypercholesterolaemia, particularly among the young age group, and the high",
    "entities": []
  },
  {
    "text": "prevalence of overweight and obesity, as well as mental health problems, are",
    "entities": []
  },
  {
    "text": "making the healthcare system deal with more non-communicable diseases,",
    "entities": []
  },
  {
    "text": "complications, and problems. The methodology of this survey is robust for a",
    "entities": []
  },
  {
    "text": "population-based study. We took comprehensive steps to ensure the validity and",
    "entities": []
  },
  {
    "text": "reliability of the findings. The findings indicate an urgent need for targeted",
    "entities": []
  },
  {
    "text": "public health interventions to address the escalating health issues. By focusing",
    "entities": []
  },
  {
    "text": "on prevention and early intervention strategies, we can mitigate the impact of",
    "entities": []
  },
  {
    "text": "NCDs on the healthcare system and improve overall population health.",
    "entities": []
  },
  {
    "text": "DOI: 10.1038/s41598-025-08311-9",
    "entities": [
      {
        "text": "10.1038",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "PMID: 40664716 [Indexed for MEDLINE]",
    "entities": []
  },
  {
    "text": "participate: All respondents provided written informed consent prior to",
    "entities": []
  },
  {
    "text": "interviews. The survey protocol was approved by the Medical Research and Ethics",
    "entities": [
      {
        "text": "the Medical Research and Ethics",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Committee (MREC), Ministry of Health Malaysia (22-00545-XAC (2)). All methods",
    "entities": [
      {
        "text": "Ministry of Health Malaysia",
        "label": "ORG"
      },
      {
        "text": "22-00545-XAC",
        "label": "DATE"
      },
      {
        "text": "2",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "adhered to the principles of the Declaration of Helsinki and the Malaysian Good",
    "entities": [
      {
        "text": "the Declaration of Helsinki",
        "label": "WORK_OF_ART"
      },
      {
        "text": "Malaysian",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "Clinical Practice Guidelines. Competing interests: The authors declare no",
    "entities": [
      {
        "text": "Clinical Practice Guidelines",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "10.1016/j.acra.2025.06.046. Online ahead of print.",
    "entities": [
      {
        "text": "10.1016",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Ultrasound-Guided Radiofrequency Ablation for Unilateral Isolated",
    "entities": [
      {
        "text": "Ultrasound-Guided Radiofrequency Ablation for Unilateral Isolated\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Aldosterone-Producing Adenoma: A Two-centre Retrospective Study.",
    "entities": [
      {
        "text": "Aldosterone-Producing Adenoma",
        "label": "ORG"
      },
      {
        "text": "Two",
        "label": "CARDINAL"
      },
      {
        "text": "Retrospective Study",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(1)Shengli Clinical Medical College of Fujian Medical University, Fujian Medical",
    "entities": [
      {
        "text": "Clinical Medical College of Fujian Medical University",
        "label": "ORG"
      },
      {
        "text": "Fujian Medical",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "University, Fuzhou 350001, China (L.T., J.Y., X.L., T.H., S.W.); Department of",
    "entities": [
      {
        "text": "Fuzhou",
        "label": "GPE"
      },
      {
        "text": "350001",
        "label": "DATE"
      },
      {
        "text": "China",
        "label": "GPE"
      },
      {
        "text": "L.T.",
        "label": "GPE"
      },
      {
        "text": "J.Y.",
        "label": "GPE"
      },
      {
        "text": "X.L.",
        "label": "GPE"
      },
      {
        "text": "T.H.",
        "label": "GPE"
      },
      {
        "text": "Department of\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Ultrasonography, Fujian Provincial Hospital, Fuzhou University Affiliated",
    "entities": [
      {
        "text": "Fujian Provincial Hospital",
        "label": "ORG"
      },
      {
        "text": "Fuzhou University Affiliated",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(2)Department of Ultrasound, The Third Affiliated Hospital of Sun Yat-sen",
    "entities": [
      {
        "text": "The Third Affiliated Hospital of Sun Yat-sen",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "University, 600 Tianhe Road, Guangzhou City, Guangdong Province, 510630, China",
    "entities": [
      {
        "text": "600",
        "label": "CARDINAL"
      },
      {
        "text": "Guangzhou City",
        "label": "GPE"
      },
      {
        "text": "Guangdong Province",
        "label": "GPE"
      },
      {
        "text": "510630",
        "label": "DATE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Department of Ultrasound, The Second Affiliated Hospital of Fujian Medical",
    "entities": [
      {
        "text": "Ultrasound",
        "label": "GPE"
      },
      {
        "text": "The Second Affiliated Hospital of Fujian Medical",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "University, Quanzhou, 362000 China (D.W.).",
    "entities": [
      {
        "text": "Quanzhou",
        "label": "GPE"
      },
      {
        "text": "362000",
        "label": "CARDINAL"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Shengli Clinical Medical College of Fujian Medical University, Fujian Medical",
    "entities": [
      {
        "text": "Clinical Medical College of Fujian Medical University",
        "label": "ORG"
      },
      {
        "text": "Fujian Medical",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "OBJECTIVE: This study aimed to evaluate the safety and efficacy of percutaneous",
    "entities": []
  },
  {
    "text": "ultrasound-guided radiofrequency (US-guided RFA) as a potential treatment for",
    "entities": [
      {
        "text": "US",
        "label": "GPE"
      },
      {
        "text": "RFA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "unilateral isolated Aldosterone-producing adenomas (APA). MATERIALS AND METHODS:",
    "entities": [
      {
        "text": "APA",
        "label": "ORG"
      },
      {
        "text": "MATERIALS",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Clinical data from patients with APA who underwent US-guided RFA between January",
    "entities": [
      {
        "text": "APA",
        "label": "ORG"
      },
      {
        "text": "US",
        "label": "GPE"
      },
      {
        "text": "RFA",
        "label": "ORG"
      },
      {
        "text": "between January\n",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "2020 and June 2024 at the Fuzhou University Affiliated Provincial Hospital and",
    "entities": [
      {
        "text": "2020 and June 2024",
        "label": "DATE"
      },
      {
        "text": "the Fuzhou University Affiliated Provincial Hospital",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "the Third Affiliated Hospital of Sun Yat-sen University were retrospectively",
    "entities": [
      {
        "text": "the Third Affiliated Hospital of Sun Yat-sen University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "analysed. Technical success (complete tumor ablation and normalization of the",
    "entities": []
  },
  {
    "text": "serum aldosterone-renin ratio [ARR] at 3-6 months post-RFA), blood pressure",
    "entities": [
      {
        "text": "3-6 months",
        "label": "DATE"
      },
      {
        "text": "post-RFA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "control, complication rates, and RFA-related parameters were assessed.",
    "entities": []
  },
  {
    "text": "Repeated-measures ANOVA was used to compare tumor volume changes before ablation",
    "entities": [
      {
        "text": "ANOVA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "and at each follow-up.",
    "entities": []
  },
  {
    "text": "RESULTS: A total of 36 patients (Median age, 49.5\u00b15.3 years; 13 men, 23 women)",
    "entities": [
      {
        "text": "36",
        "label": "CARDINAL"
      },
      {
        "text": "49.5\u00b15.3 years",
        "label": "DATE"
      },
      {
        "text": "13",
        "label": "CARDINAL"
      },
      {
        "text": "23",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "were evaluated. All patients achieved successful single-session ablation, with",
    "entities": []
  },
  {
    "text": "complete biochemical remission of primary aldosteronism (36/36). The",
    "entities": [
      {
        "text": "36/36",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "hypertension control rate was 66.7% (24/36). The complication rate was 13.89%",
    "entities": [
      {
        "text": "66.7%",
        "label": "PERCENT"
      },
      {
        "text": "24/36",
        "label": "CARDINAL"
      },
      {
        "text": "13.89%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "(five patients), primarily fever caused by postoperative infection. A transient",
    "entities": [
      {
        "text": "five",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "significant increase in blood pressure occurred in 10 patients (27.8%). No",
    "entities": [
      {
        "text": "10",
        "label": "CARDINAL"
      },
      {
        "text": "27.8%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "short-term recurrence was observed.",
    "entities": []
  },
  {
    "text": "CONCLUSION: This two-centre study provides evidence that US-guided RFA is an",
    "entities": [
      {
        "text": "two",
        "label": "CARDINAL"
      },
      {
        "text": "US",
        "label": "GPE"
      },
      {
        "text": "RFA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "effective and safe treatment option in selected patients with unilateral",
    "entities": []
  },
  {
    "text": "isolated APA.",
    "entities": [
      {
        "text": "APA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Copyright \u00a9 2025 The Association of University Radiologists. Published by",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "The Association of University Radiologists",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Elsevier Inc. All rights reserved.",
    "entities": [
      {
        "text": "Elsevier Inc.",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: Declaration of Competing Interest The authors",
    "entities": []
  },
  {
    "text": "declare that they have no known competing financial interests or personal",
    "entities": []
  },
  {
    "text": "relationships that could have appeared to influence the work reported in this",
    "entities": []
  },
  {
    "text": "Online ahead of print.",
    "entities": []
  },
  {
    "text": "Genetic Insights Into Nephrolithiasis and Renal Cancer Predisposition: Precision",
    "entities": []
  },
  {
    "text": "Medicine in Genes, Diagnosis, and Therapy.",
    "entities": [
      {
        "text": "Therapy",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(1)Department of Urology, Case Western Reserve University/University Hospitals,",
    "entities": [
      {
        "text": "Urology, Case Western Reserve University/University Hospitals",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Cleveland, OH; Department of Genetics and Genome Sciences, Case Western Reserve",
    "entities": [
      {
        "text": "Cleveland",
        "label": "GPE"
      },
      {
        "text": "Department of Genetics and Genome Sciences",
        "label": "ORG"
      },
      {
        "text": "Case Western Reserve",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "University/University Hospitals, Cleveland, OH. Electronic address:",
    "entities": [
      {
        "text": "University/University Hospitals",
        "label": "ORG"
      },
      {
        "text": "Cleveland",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Department of Urology, Case Western Reserve University/University Hospitals,",
    "entities": [
      {
        "text": "Urology, Case Western Reserve University/University Hospitals",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "University/University Hospitals, Cleveland, OH.",
    "entities": [
      {
        "text": "University/University Hospitals",
        "label": "ORG"
      },
      {
        "text": "Cleveland",
        "label": "GPE"
      },
      {
        "text": "OH",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Department of Urology, Case Western Reserve University/University Hospitals,",
    "entities": [
      {
        "text": "Urology, Case Western Reserve University/University Hospitals",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "University/University Hospitals, Cleveland, OH; Division of Urology, Taipei Tzu",
    "entities": [
      {
        "text": "University/University Hospitals",
        "label": "ORG"
      },
      {
        "text": "Cleveland",
        "label": "GPE"
      },
      {
        "text": "Division of Urology",
        "label": "ORG"
      },
      {
        "text": "Taipei Tzu",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Chi Hospital, New Taipei City, Taiwan.",
    "entities": [
      {
        "text": "Chi Hospital",
        "label": "ORG"
      },
      {
        "text": "New Taipei City",
        "label": "GPE"
      },
      {
        "text": "Taiwan",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Division of Nephrology, Department of Pediatrics, Boston Childrens'",
    "entities": [
      {
        "text": "Nephrology, Department of Pediatrics",
        "label": "ORG"
      },
      {
        "text": "Boston Childrens'",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Hospital/Harvard Medical School, Boston, MA.",
    "entities": [
      {
        "text": "Hospital/Harvard Medical School",
        "label": "ORG"
      },
      {
        "text": "Boston",
        "label": "GPE"
      },
      {
        "text": "MA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(5)Division of Urology, Taipei Tzu Chi Hospital, New Taipei City, Taiwan.",
    "entities": [
      {
        "text": "Urology",
        "label": "GPE"
      },
      {
        "text": "Taipei",
        "label": "GPE"
      },
      {
        "text": "New Taipei City",
        "label": "GPE"
      },
      {
        "text": "Taiwan",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(6)Department of Urology, Case Western Reserve University/University Hospitals,",
    "entities": [
      {
        "text": "Urology, Case Western Reserve University/University Hospitals",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Cleveland, OH.",
    "entities": [
      {
        "text": "Cleveland",
        "label": "GPE"
      },
      {
        "text": "OH",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(7)Department of Urology, University of California San Francisco, San Francisco,",
    "entities": [
      {
        "text": "Urology, University of California San Francisco",
        "label": "ORG"
      },
      {
        "text": "San Francisco",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(8)Department of Physiology and Biomedical Engineering, Mayo Clinic College of",
    "entities": [
      {
        "text": "Physiology and Biomedical Engineering",
        "label": "ORG"
      },
      {
        "text": "Mayo Clinic College",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Medicine, Rochester, MN; Division of Nephrology and Hypertension, Mayo Clinic",
    "entities": [
      {
        "text": "Rochester",
        "label": "GPE"
      },
      {
        "text": "MN",
        "label": "ORG"
      },
      {
        "text": "Division of Nephrology and Hypertension",
        "label": "ORG"
      },
      {
        "text": "Mayo Clinic",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "College of Medicine, Rochester, MN.",
    "entities": [
      {
        "text": "College of Medicine",
        "label": "ORG"
      },
      {
        "text": "Rochester",
        "label": "GPE"
      },
      {
        "text": "MN",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "This article explores the role of genetics in kidney stones and kidney cancer",
    "entities": []
  },
  {
    "text": "predisposition, focusing on monogenic genetic causes that can be identified",
    "entities": []
  },
  {
    "text": "through genetic testing. We provide a comprehensive review of monogenic causes",
    "entities": []
  },
  {
    "text": "of kidney stones and kidney cancer as well as the current treatment options. A",
    "entities": []
  },
  {
    "text": "curated list of 64 monogenic causes of kidney stones, including 11 provisional",
    "entities": [
      {
        "text": "64",
        "label": "CARDINAL"
      },
      {
        "text": "11",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "genes, and 50 genes for kidney cancer predisposition, also including 11",
    "entities": [
      {
        "text": "50",
        "label": "CARDINAL"
      },
      {
        "text": "11",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "provisional genes, is presented. Selected genes are discussed in detail,",
    "entities": []
  },
  {
    "text": "highlighting their clinical presentations, underlying genetic mechanisms, and",
    "entities": []
  },
  {
    "text": "available treatment options. These include gene-specific therapies, such as",
    "entities": []
  },
  {
    "text": "drugs targeting AGXT for primary hyperoxaluria type 1 and VHL for renal cell",
    "entities": [
      {
        "text": "AGXT",
        "label": "ORG"
      },
      {
        "text": "1",
        "label": "CARDINAL"
      },
      {
        "text": "VHL",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "carcinoma, alongside nonspecific treatments for conditions such as Bartter",
    "entities": [
      {
        "text": "carcinoma",
        "label": "ORG"
      },
      {
        "text": "Bartter",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "syndrome and Lynch syndrome. As gene discovery continues to progress, it holds",
    "entities": [
      {
        "text": "Lynch",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "the potential to inform future preventive guidelines, novel therapeutic",
    "entities": []
  },
  {
    "text": "approaches, and precision medicine strategies, ultimately advancing the field of",
    "entities": []
  },
  {
    "text": "nephrology and improving patient outcomes. Semin Nephrol 36:x-xx \u00a9 20XX Elsevier",
    "entities": [
      {
        "text": "Semin Nephrol",
        "label": "PERSON"
      },
      {
        "text": "36",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Inc. All rights reserved.",
    "entities": []
  },
  {
    "text": "Copyright \u00a9 2025. Published by Elsevier Inc.",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "Elsevier Inc.",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Value of the 6 min walk test in detecting cardiopulmonary involvement in",
    "entities": [
      {
        "text": "6",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "patients with systemic sclerosis.",
    "entities": []
  },
  {
    "text": "Ahmed S(1), Liem SIE(2), Ciaffi J(3)(4), Hoekstra EM(5), Schouffoer AA(6),",
    "entities": [
      {
        "text": "Ahmed S(1)",
        "label": "PERSON"
      },
      {
        "text": "Liem SIE(2",
        "label": "PERSON"
      },
      {
        "text": "Ciaffi",
        "label": "PRODUCT"
      },
      {
        "text": "Hoekstra EM(5",
        "label": "LAW"
      },
      {
        "text": "Schouffoer AA(6",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(1)Department of Rheumatology, Leiden University Medical Center, Leiden, The",
    "entities": [
      {
        "text": "Rheumatology",
        "label": "GPE"
      },
      {
        "text": "Leiden University Medical Center",
        "label": "ORG"
      },
      {
        "text": "Leiden",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Department of Rheumatology, Leiden University Medical Center, Leiden, The",
    "entities": [
      {
        "text": "Rheumatology",
        "label": "GPE"
      },
      {
        "text": "Leiden University Medical Center",
        "label": "ORG"
      },
      {
        "text": "Leiden",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Italy.",
    "entities": [
      {
        "text": "Italy",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(5)Rheumatology, Leiden University Medical Center, Leiden, The Netherlands.",
    "entities": [
      {
        "text": "Leiden University Medical Center",
        "label": "ORG"
      },
      {
        "text": "Leiden",
        "label": "GPE"
      },
      {
        "text": "The Netherlands",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(6)Rheumatology, Haga Hospital, the Hague, The Netherlands.",
    "entities": [
      {
        "text": "Haga Hospital",
        "label": "ORG"
      },
      {
        "text": "the Hague",
        "label": "GPE"
      },
      {
        "text": "The Netherlands",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(7)Physical Therapy, Leiden University Medical Center, Leiden, The Netherlands.",
    "entities": [
      {
        "text": "Therapy",
        "label": "PERSON"
      },
      {
        "text": "Leiden University Medical Center",
        "label": "ORG"
      },
      {
        "text": "Leiden",
        "label": "GPE"
      },
      {
        "text": "The Netherlands",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(8)Pulmonology, Leiden University Medical Center, Leiden, The Netherlands.",
    "entities": [
      {
        "text": "Leiden University Medical Center",
        "label": "ORG"
      },
      {
        "text": "Leiden",
        "label": "GPE"
      },
      {
        "text": "The Netherlands",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(9)Department of Rheumatology, University of Zurich, Zurich, Switzerland.",
    "entities": [
      {
        "text": "Rheumatology, University of Zurich",
        "label": "ORG"
      },
      {
        "text": "Zurich",
        "label": "GPE"
      },
      {
        "text": "Switzerland",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(11)Department of Rheumatology, University of Zurich, University Hospital",
    "entities": [
      {
        "text": "11)Department of Rheumatology, University of Zurich",
        "label": "ORG"
      },
      {
        "text": "University Hospital",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(12)Cardiology, Leiden University Medical Center, Leiden, Zuid-Holland, The",
    "entities": [
      {
        "text": "12)Cardiology",
        "label": "CARDINAL"
      },
      {
        "text": "Leiden University Medical Center",
        "label": "ORG"
      },
      {
        "text": "Leiden",
        "label": "GPE"
      },
      {
        "text": "Zuid-Holland",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(13)Rheumatology C01-51, LUMC, Leiden, The Netherlands.",
    "entities": [
      {
        "text": "C01-51",
        "label": "PRODUCT"
      },
      {
        "text": "LUMC",
        "label": "ORG"
      },
      {
        "text": "Leiden",
        "label": "GPE"
      },
      {
        "text": "The Netherlands",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "OBJECTIVES: Cardiopulmonary involvement (CPI) is a major cause of morbidity and",
    "entities": []
  },
  {
    "text": "mortality in systemic sclerosis (SSc). The 6 min walk test (6MWT) is widely used",
    "entities": [
      {
        "text": "6",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "to assess functional capacity, but its ability to detect incident CPI remains",
    "entities": []
  },
  {
    "text": "uncertain. This study aimed to evaluate the determinants and trajectory of 6MWT",
    "entities": []
  },
  {
    "text": "parameters over time and its diagnostic utility in identifying incident CPI in",
    "entities": []
  },
  {
    "text": "METHODS: Two large prospective SSc cohorts were analysed. Multivariable",
    "entities": [
      {
        "text": "Two",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "regression identified factors associated with baseline 6MWT parameters.",
    "entities": []
  },
  {
    "text": "Longitudinal changes were assessed using linear mixed models, and diagnostic",
    "entities": [
      {
        "text": "linear",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "accuracy for incident CPI was evaluated using predefined thresholds for a",
    "entities": []
  },
  {
    "text": "decline in 6 min walking distance (6MWD) (\u226533 m) and oxygen desaturation (<95%).",
    "entities": [
      {
        "text": "6",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "RESULTS: Patients with CPI walked 89 m less than those without (95% CI -116 to",
    "entities": [
      {
        "text": "89",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "61) and exercise-induced desaturation was more frequent in CPI (OR 17.0, 95% CI",
    "entities": [
      {
        "text": "61",
        "label": "CARDINAL"
      },
      {
        "text": "17.0",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "8.7 to 33). Over time, 6MWD increased slightly by 3.0 m per year (95% CI 1.7 to",
    "entities": [
      {
        "text": "8.7 to 33",
        "label": "CARDINAL"
      },
      {
        "text": "6MWD",
        "label": "PERSON"
      },
      {
        "text": "3.0",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "1.7",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "4.3). Linear mixed model analysis showed an independent association of 6MWD",
    "entities": [
      {
        "text": "4.3",
        "label": "CARDINAL"
      },
      {
        "text": "Linear",
        "label": "ORG"
      },
      {
        "text": "6MWD",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "(-33 m, 95% CI -45 to 21) and occurrence of exercise-induced desaturation (OR",
    "entities": [
      {
        "text": "-33 m",
        "label": "PERSON"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "21",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "15, 95% CI 8.5 to 30) in patients with CPI. A \u226533 m decline in 6MWD had 34.7%",
    "entities": [
      {
        "text": "15",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "8.5 to 30",
        "label": "CARDINAL"
      },
      {
        "text": "6MWD",
        "label": "PRODUCT"
      },
      {
        "text": "34.7%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "sensitivity and 79% specificity for detecting incident CPI, while new",
    "entities": [
      {
        "text": "79%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "desaturation had 10.6% sensitivity and 92.6% specificity.",
    "entities": [
      {
        "text": "10.6%",
        "label": "PERCENT"
      },
      {
        "text": "92.6%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "CONCLUSION: 6MWT parameters are associated with CPI in SSc. A stable 6MWD and",
    "entities": [
      {
        "text": "6MWD",
        "label": "PRODUCT"
      }
    ]
  },
  {
    "text": "absence of desaturation may help rule out CPI, but their low sensitivity",
    "entities": []
  },
  {
    "text": "suggests that 6MWT alone is insufficient for screening and should be",
    "entities": [
      {
        "text": "6MWT",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "complemented by additional diagnostic modalities.",
    "entities": []
  },
  {
    "text": "\u00a9 Author(s) (or their employer(s)) 2025. Re-use permitted under CC BY-NC. No",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "CC BY-NC",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "commercial re-use. See rights and permissions. Published by BMJ Group.",
    "entities": [
      {
        "text": "BMJ Group",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "PMID: 40664469 [Indexed for MEDLINE]",
    "entities": []
  },
  {
    "text": "Conflict of interest statement: Competing interests: SA: received an ASPIRE",
    "entities": [
      {
        "text": "ASPIRE",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "grant from Pfizer and speaker fees from Benecke. CB: consulting for Boehringer",
    "entities": [
      {
        "text": "Pfizer",
        "label": "ORG"
      },
      {
        "text": "Benecke",
        "label": "PERSON"
      },
      {
        "text": "Boehringer\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Ingelheim. Research grants from Foundation for Research in Rheumatology",
    "entities": [
      {
        "text": "Ingelheim",
        "label": "ORG"
      },
      {
        "text": "Foundation for Research in Rheumatology",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Trials and Research Group (EUSTAR), Foundation for Research in Rheumatology",
    "entities": [
      {
        "text": "Trials and Research Group",
        "label": "ORG"
      },
      {
        "text": "Foundation for Research in Rheumatology",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(FOREUM), Scleroderma Clinical Trials Consortium (SCTC), Scleroderma Research",
    "entities": [
      {
        "text": "FOREUM",
        "label": "ORG"
      },
      {
        "text": "Scleroderma Clinical Trials Consortium",
        "label": "ORG"
      },
      {
        "text": "SCTC",
        "label": "ORG"
      },
      {
        "text": "Scleroderma Research",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Foundation (SRF), Novartis Foundation for Bio-medical Research, EMDO Foundation.",
    "entities": [
      {
        "text": "SRF",
        "label": "ORG"
      },
      {
        "text": "Novartis Foundation for",
        "label": "ORG"
      },
      {
        "text": "Research, EMDO Foundation",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Educational grants from AbbVie and Wellcome Trust. Congress participation",
    "entities": [
      {
        "text": "AbbVie",
        "label": "ORG"
      },
      {
        "text": "Wellcome Trust",
        "label": "ORG"
      },
      {
        "text": "Congress",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "support from Boehringer Ingelheim.JDV-B: received grant/research support to her",
    "entities": [
      {
        "text": "Boehringer Ingelheim",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "institution from ReumaNederland (Dutch Patient Society for Rheumatology),",
    "entities": [
      {
        "text": "ReumaNederland",
        "label": "ORG"
      },
      {
        "text": "Dutch",
        "label": "NORP"
      },
      {
        "text": "Society for Rheumatology",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Patient Society), ARCH (Autoimmune Research and Collaboration Hub; Dutch",
    "entities": [
      {
        "text": "ARCH",
        "label": "PERSON"
      },
      {
        "text": "Autoimmune Research and Collaboration Hub",
        "label": "ORG"
      },
      {
        "text": "Dutch",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "interdisciplinary society for patients and caregivers), Roche, Galapagos,",
    "entities": [
      {
        "text": "Roche",
        "label": "ORG"
      },
      {
        "text": "Galapagos",
        "label": "LOC"
      }
    ]
  },
  {
    "text": "Ingelheim, Jansen-Cilag and AbbVie; speaker fees from Dutch Society of",
    "entities": [
      {
        "text": "Ingelheim",
        "label": "ORG"
      },
      {
        "text": "Jansen-Cilag",
        "label": "PERSON"
      },
      {
        "text": "AbbVie",
        "label": "PRODUCT"
      },
      {
        "text": "Dutch Society",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Rheumatology, Boehringer Ingelheim and Janssen-Cilag ; all payments are made to",
    "entities": [
      {
        "text": "Boehringer Ingelheim",
        "label": "ORG"
      },
      {
        "text": "Janssen-Cilag",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "her institution.",
    "entities": []
  },
  {
    "text": "of print.",
    "entities": []
  },
  {
    "text": "Assessment of lipid parameters and its association with risk of stage 1",
    "entities": [
      {
        "text": "1",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "hypertension: a cohort study in middle-aged and elderly Chinese.",
    "entities": [
      {
        "text": "Chinese",
        "label": "LANGUAGE"
      }
    ]
  },
  {
    "text": "(1)Department of Endocrinology, Sun Yat-sen Memorial Hospital, Sun Yat-sen",
    "entities": [
      {
        "text": "Sun Yat-sen Memorial Hospital",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "University, Guangzhou 510120, People's Republic of China.",
    "entities": [
      {
        "text": "Guangzhou 510120",
        "label": "DATE"
      },
      {
        "text": "People's Republic of China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Baiyun Branch of Nanfang Hospital, Southern Medical University, Guangzhou",
    "entities": [
      {
        "text": "2)Baiyun",
        "label": "CARDINAL"
      },
      {
        "text": "Nanfang Hospital",
        "label": "ORG"
      },
      {
        "text": "Southern Medical University",
        "label": "ORG"
      },
      {
        "text": "Guangzhou",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "510599, People's Republic of China.",
    "entities": [
      {
        "text": "510599",
        "label": "DATE"
      },
      {
        "text": "People's Republic of China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "BACKGROUND: There is a correlation between dyslipidemia and elevated blood",
    "entities": []
  },
  {
    "text": "pressure, but the relationship between different lipid parameters and elevated",
    "entities": []
  },
  {
    "text": "blood pressure is inconsistent. Therefore, understanding the impact of",
    "entities": []
  },
  {
    "text": "dyslipidemia on blood pressure is significant for the prevention and control of",
    "entities": []
  },
  {
    "text": "ASCVD. Our study is aimed at assessing longitudinally the correlation between",
    "entities": []
  },
  {
    "text": "lipid parameters and the incidence of stage 1 hypertension in a large Chinese",
    "entities": [
      {
        "text": "1",
        "label": "CARDINAL"
      },
      {
        "text": "Chinese",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "community population.",
    "entities": []
  },
  {
    "text": "METHODS: This community-based cohort study conducted from 2011 to 2014-2016",
    "entities": [
      {
        "text": "2011 to",
        "label": "DATE"
      },
      {
        "text": "2014-2016",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "included 2,843 eligible individuals aged 40 years or older. The diagnosis of",
    "entities": [
      {
        "text": "2,843",
        "label": "CARDINAL"
      },
      {
        "text": "40 years or older",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "stage 1 hypertension was systolic blood pressure (SBP) 130~139 mmHg and/or",
    "entities": [
      {
        "text": "1",
        "label": "CARDINAL"
      },
      {
        "text": "SBP",
        "label": "ORG"
      },
      {
        "text": "130~139",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "diastolic blood pressure (DBP) 80~89 mmHg. We collect data through standardized",
    "entities": [
      {
        "text": "DBP",
        "label": "ORG"
      },
      {
        "text": "80~89",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "questionnaires and clinical and biochemical measurements conducted in unified",
    "entities": []
  },
  {
    "text": "institutions. The relationship between lipid parameters and risk of stage 1",
    "entities": [
      {
        "text": "1",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "hypertension were estimated using multiple Cox regression analysis.",
    "entities": []
  },
  {
    "text": "RESULTS: During the follow-up period, 388 subjects (13.7%) developed stage 1",
    "entities": [
      {
        "text": "388",
        "label": "CARDINAL"
      },
      {
        "text": "13.7%",
        "label": "PERCENT"
      },
      {
        "text": "1",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "hypertension. Incidence of stage 1 hypertension gradually increased with the",
    "entities": [
      {
        "text": "1",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "quartiles of triglycerides (TG) and the ratio of TG to high-density lipoprotein",
    "entities": [
      {
        "text": "TG",
        "label": "ORG"
      },
      {
        "text": "TG",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "cholesterol (TG/HDL-C, all P < 0.0001). Multiple Cox regression analyses",
    "entities": [
      {
        "text": "TG/HDL-C",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "indicated that, compared to the quartile 1 of TG/HDL-C, quartile 4 was",
    "entities": [
      {
        "text": "1",
        "label": "CARDINAL"
      },
      {
        "text": "TG/HDL-C",
        "label": "ORG"
      },
      {
        "text": "4",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "associated with higher risk of incident stage 1 hypertension (model 1: HR =",
    "entities": [
      {
        "text": "1",
        "label": "CARDINAL"
      },
      {
        "text": "1",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "1.48, 95% CI 1.05-2.09).",
    "entities": [
      {
        "text": "1.48",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "1.05-2.09",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "CONCLUSIONS: Our study findings suggest that TG/HDL-C is independently",
    "entities": [
      {
        "text": "TG/HDL-C",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "associated with the incidence of stage 1 hypertension in the Chinese middle-aged",
    "entities": [
      {
        "text": "1",
        "label": "CARDINAL"
      },
      {
        "text": "Chinese",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "and elderly population.",
    "entities": []
  },
  {
    "text": "Sex differences in onset and prevalence of 108 diseases and multimorbidity",
    "entities": [
      {
        "text": "108",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "across lifespan in Yichang, China: quantitative analysis of real-world linked",
    "entities": [
      {
        "text": "Yichang",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "electronic health records.",
    "entities": []
  },
  {
    "text": "(1)School of Population Medicine and Public Health, Chinese Academy of Medical",
    "entities": [
      {
        "text": "Population Medicine and Public Health",
        "label": "ORG"
      },
      {
        "text": "Chinese Academy of Medical",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Sciences & Peking Union Medical College, Beijing, Beijing, China.",
    "entities": [
      {
        "text": "Sciences & Peking Union Medical College",
        "label": "ORG"
      },
      {
        "text": "Beijing",
        "label": "GPE"
      },
      {
        "text": "Beijing",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Yichang City Centre for Disease Control and Prevention, Yichang, Hubei,",
    "entities": [
      {
        "text": "Yichang",
        "label": "GPE"
      },
      {
        "text": "Hubei",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Department of Pulmonary and Critical Care Medicine, Beijing Hospital,",
    "entities": [
      {
        "text": "Pulmonary and Critical Care Medicine",
        "label": "ORG"
      },
      {
        "text": "Beijing Hospital",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(4)Department of Epidemiology and Biostatistics, Chinese Academy of Medical",
    "entities": [
      {
        "text": "Epidemiology and Biostatistics",
        "label": "ORG"
      },
      {
        "text": "Chinese Academy of Medical",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Sciences and Peking Union Medical College Institute of Basic Medical Sciences,",
    "entities": [
      {
        "text": "Peking Union Medical College Institute of Basic Medical Sciences",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(5)Liver Cancer Institute, Fudan University Zhongshan Hospital, Shanghai,",
    "entities": [
      {
        "text": "Cancer Institute",
        "label": "ORG"
      },
      {
        "text": "Fudan University Zhongshan Hospital",
        "label": "ORG"
      },
      {
        "text": "Shanghai",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(6)School of Medicine and Dentistry, Griffith University - Nathan Campus,",
    "entities": [
      {
        "text": "Medicine and Dentistry",
        "label": "ORG"
      },
      {
        "text": "Griffith University - Nathan Campus",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Brisbane, Queensland, Australia.",
    "entities": [
      {
        "text": "Brisbane",
        "label": "GPE"
      },
      {
        "text": "Queensland",
        "label": "GPE"
      },
      {
        "text": "Australia",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(7)School of Medicine and Dentistry, Griffith University - Gold Coast Campus,",
    "entities": [
      {
        "text": "7)School of Medicine and Dentistry",
        "label": "ORG"
      },
      {
        "text": "Griffith University - Gold Coast Campus",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Southport, Queensland, Australia.",
    "entities": [
      {
        "text": "Southport",
        "label": "GPE"
      },
      {
        "text": "Queensland",
        "label": "GPE"
      },
      {
        "text": "Australia",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(8)The National Center for Chronic and Non-communicable Disease Control and",
    "entities": [
      {
        "text": "National Center for Chronic",
        "label": "ORG"
      },
      {
        "text": "Disease Control",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Prevention, Chinese Center for Disease Control and Prevention, Beijing, Beijing,",
    "entities": [
      {
        "text": "Beijing",
        "label": "GPE"
      },
      {
        "text": "Beijing",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(9)School of Population Medicine and Public Health, Chinese Academy of Medical",
    "entities": [
      {
        "text": "Population Medicine and Public Health",
        "label": "ORG"
      },
      {
        "text": "Chinese Academy of Medical",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Sciences & Peking Union Medical College, Beijing, Beijing, China",
    "entities": [
      {
        "text": "Sciences & Peking Union Medical College",
        "label": "ORG"
      },
      {
        "text": "Beijing",
        "label": "GPE"
      },
      {
        "text": "Beijing",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(10)State Key Laboratory of Respiratory Health and Multimorbidity, Chinese",
    "entities": [
      {
        "text": "10)State",
        "label": "CARDINAL"
      },
      {
        "text": "Key Laboratory of Respiratory Health and Multimorbidity",
        "label": "ORG"
      },
      {
        "text": "Chinese",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "Academy of Medical Sciences and Peking Union Medical College, Beijing, Beijing,",
    "entities": [
      {
        "text": "Academy of Medical Sciences",
        "label": "ORG"
      },
      {
        "text": "Peking Union Medical College",
        "label": "ORG"
      },
      {
        "text": "Beijing",
        "label": "GPE"
      },
      {
        "text": "Beijing",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(11)Department of Pulmonary and Critical Care Medicine, Center of Respiratory",
    "entities": [
      {
        "text": "11)Department",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Medicine, China-Japan Friendship Hospital, Beijing, Beijing, China.",
    "entities": [
      {
        "text": "China",
        "label": "GPE"
      },
      {
        "text": "Beijing",
        "label": "GPE"
      },
      {
        "text": "Beijing",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(12)National Clinical Research Center for Respiratory Diseases, Beijing,",
    "entities": [
      {
        "text": "12)National Clinical Research Center for Respiratory Diseases",
        "label": "ORG"
      },
      {
        "text": "Beijing",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "OBJECTIVE: The magnitude and persistence of diseases and multimorbidity between",
    "entities": []
  },
  {
    "text": "females and males are different. This study comprehensively quantified sex",
    "entities": []
  },
  {
    "text": "differences in the onset and progression of 108 major physical and mental",
    "entities": [
      {
        "text": "108",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "diseases to multimorbidity through adulthood in Chinese population.",
    "entities": [
      {
        "text": "Chinese",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "DESIGN: Quantitative analysis of real-world linked electronic health records.",
    "entities": []
  },
  {
    "text": "SETTING: Linked health records from 160 health facilities across primary,",
    "entities": [
      {
        "text": "160",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "secondary and tertiary healthcare, comprising routinely collected electronic",
    "entities": [
      {
        "text": "tertiary",
        "label": "ORDINAL"
      }
    ]
  },
  {
    "text": "health records from the whole urban residents of Yichang, China between 1",
    "entities": [
      {
        "text": "Yichang",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      },
      {
        "text": "1",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "January 2016 and 31 December 2019.",
    "entities": [
      {
        "text": "January 2016",
        "label": "DATE"
      },
      {
        "text": "31 December 2019",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "PARTICIPANTS: 684 455 urban residents aged 20 years and above with documented",
    "entities": [
      {
        "text": "684 455",
        "label": "CARDINAL"
      },
      {
        "text": "20 years",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "health records during the study period.",
    "entities": []
  },
  {
    "text": "MAIN OUTCOMES MEASURES: The cumulative incidence, relative risks (RR) and 95%",
    "entities": [
      {
        "text": "MAIN",
        "label": "ORG"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "CIs, period prevalence, median age at disease diagnosis and the prevalence of",
    "entities": [
      {
        "text": "CIs",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "multimorbidity of 108 major physical and mental diseases were computed. All",
    "entities": [
      {
        "text": "108",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "analyses were stratified by sex and age groups.",
    "entities": []
  },
  {
    "text": "RESULTS: The analysis included 684 455 individuals (54.8% females, mean age:",
    "entities": [
      {
        "text": "684 455",
        "label": "CARDINAL"
      },
      {
        "text": "54.8%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "46.9), among whom 46.3% had multimorbidity, with a higher prevalence in females",
    "entities": [
      {
        "text": "46.9",
        "label": "CARDINAL"
      },
      {
        "text": "46.3%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "(47.6%) than males (44.9%). The chronological disease map revealed stark",
    "entities": [
      {
        "text": "47.6%",
        "label": "PERCENT"
      },
      {
        "text": "44.9%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "differences between females and males, with notable lower risk of obstructive",
    "entities": []
  },
  {
    "text": "sleep apnoea-hypopnoea syndrome (OSAHS, RR: 0.03, 95% CI: 0.01 to 0.11) for",
    "entities": [
      {
        "text": "0.03",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "0.01",
        "label": "CARDINAL"
      },
      {
        "text": "0.11",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "young adults, oesophageal cancer (RR: 0.02, 95% CI: 0.0 to 0.17) for mid-age",
    "entities": [
      {
        "text": "0.02",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "0.0",
        "label": "CARDINAL"
      },
      {
        "text": "0.17",
        "label": "CARDINAL"
      },
      {
        "text": "mid-age",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "adults and remarkable higher risk of lupus (RR: 8.8, 95% CI: 2.7 to 29.0) for",
    "entities": [
      {
        "text": "8.8,",
        "label": "PERCENT"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "2.7",
        "label": "CARDINAL"
      },
      {
        "text": "29.0",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "older adults of females. Males exhibited an incidence surge in hypertension,",
    "entities": [
      {
        "text": "Males",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "diabetes, coronary disease and chronic obstructive pulmonary disease a decade",
    "entities": [
      {
        "text": "a decade",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "earlier than females, while females had a life-long higher prevalence in",
    "entities": []
  },
  {
    "text": "immune-mediated diseases and urinary disorders. For the new incident diseases,",
    "entities": []
  },
  {
    "text": "the manifestation of eating disorders, anaemia and urinary incontinence was",
    "entities": []
  },
  {
    "text": "recorded 20 years earlier in females; whereas, males were diagnosed with",
    "entities": [
      {
        "text": "20 years earlier",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "hyperuricaemia, OSAHS and schizophrenia at younger ages.",
    "entities": [
      {
        "text": "OSAHS",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "CONCLUSIONS: The significant variations in disease nature and trajectory between",
    "entities": []
  },
  {
    "text": "sexes underscore the urgent needs for tailored prevention strategies and",
    "entities": []
  },
  {
    "text": "appropriate health resources allocation. Sex differences in disease profile",
    "entities": []
  },
  {
    "text": "should be considered to delay disease and multimorbidity progression, ultimately",
    "entities": []
  },
  {
    "text": "promoting health equity.",
    "entities": []
  },
  {
    "text": "PMID: 40664420 [Indexed for MEDLINE]",
    "entities": [
      {
        "text": "40664420",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: Competing interests: None declared.",
    "entities": []
  },
  {
    "text": "Time of onset of pre-eclampsia as a determinant of risk of cardiovascular",
    "entities": [
      {
        "text": "pre-eclampsia",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "disease and renal impairment at six weeks post partum: a cohort study in Lagos,",
    "entities": [
      {
        "text": "six weeks",
        "label": "DATE"
      },
      {
        "text": "Lagos",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(1)Department of Obstetrics and Gynaecology, Lagos University Teaching Hospital,",
    "entities": [
      {
        "text": "Obstetrics and Gynaecology",
        "label": "ORG"
      },
      {
        "text": "Lagos University Teaching Hospital",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(2)Department of Obstetrics and Gynaecology, University of Lagos College of",
    "entities": [
      {
        "text": "Obstetrics and Gynaecology",
        "label": "ORG"
      },
      {
        "text": "University of Lagos College",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(3)Department of Obstetrics and Gynaecology, Lagos University Teaching Hospital,",
    "entities": [
      {
        "text": "Obstetrics and Gynaecology",
        "label": "ORG"
      },
      {
        "text": "Lagos University Teaching Hospital",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(4)Department of Global Public Health, Karolinska Institute, Solna, Sweden.",
    "entities": [
      {
        "text": "Global Public Health",
        "label": "ORG"
      },
      {
        "text": "Karolinska Institute",
        "label": "PERSON"
      },
      {
        "text": "Solna",
        "label": "GPE"
      },
      {
        "text": "Sweden",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(5)Centre for Clinical Trials, Research and Implementation Science, University",
    "entities": [
      {
        "text": "5)Centre",
        "label": "CARDINAL"
      },
      {
        "text": "Clinical Trials, Research and Implementation Science, University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "of Lagos College of Medicine, Idi-Araba, Lagos, Nigeria.",
    "entities": [
      {
        "text": "Lagos College of Medicine",
        "label": "ORG"
      },
      {
        "text": "Lagos",
        "label": "GPE"
      },
      {
        "text": "Nigeria",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(6)Department of Chemical Pathology, University of Lagos, Akoka, Nigeria.",
    "entities": [
      {
        "text": "Chemical Pathology",
        "label": "ORG"
      },
      {
        "text": "University of Lagos",
        "label": "ORG"
      },
      {
        "text": "Akoka",
        "label": "GPE"
      },
      {
        "text": "Nigeria",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "and mortality. It also causes changes in the cardiovascular, endothelial and",
    "entities": []
  },
  {
    "text": "metabolic systems, from which women may not fully recover after delivery. This",
    "entities": [
      {
        "text": "metabolic systems",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "study examined the association between the time of onset of pre-eclampsia and",
    "entities": [
      {
        "text": "pre-eclampsia",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "the risk for cardiovascular disease (using glucose tolerance, lipid profile and",
    "entities": []
  },
  {
    "text": "blood pressure) and renal function at 6 weeks post partum.",
    "entities": [
      {
        "text": "6 weeks",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "STUDY DESIGN: A prospective cohort study.",
    "entities": []
  },
  {
    "text": "SETTING: Lagos University Teaching Hospital, Idi-Araba, Mother and Child Centre,",
    "entities": [
      {
        "text": "Lagos University Teaching Hospital",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Gbaja, Surulere and Lagos Island Maternity Hospital, Lagos, Nigeria.",
    "entities": [
      {
        "text": "Gbaja, Surulere and Lagos Island Maternity Hospital",
        "label": "ORG"
      },
      {
        "text": "Lagos",
        "label": "GPE"
      },
      {
        "text": "Nigeria",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "PARTICIPANTS: 44 women with pre-eclampsia were studied and data on their",
    "entities": [
      {
        "text": "44",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "sociodemographic characteristics, gestational age at diagnosis and blood",
    "entities": []
  },
  {
    "text": "pressure were collected on admission. They were followed up through delivery",
    "entities": []
  },
  {
    "text": "till 6 weeks post partum, when blood pressure check, 75 g oral glucose tolerance",
    "entities": [
      {
        "text": "6 weeks",
        "label": "DATE"
      },
      {
        "text": "75",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "test, fasting lipid profile and serum creatinine were done.",
    "entities": []
  },
  {
    "text": "OUTCOME MEASURES: The exposure was pre-eclampsia. The outcomes were",
    "entities": [
      {
        "text": "pre-eclampsia",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "intolerance and dyslipidaemia, and renal function at 6 weeks post partum in",
    "entities": [
      {
        "text": "6 weeks",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "women who had pre-eclampsia.",
    "entities": [
      {
        "text": "pre-eclampsia",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "STATISTICAL ANALYSIS: Data were analysed using Stata V.16.1. Mann Whitney-U test",
    "entities": [
      {
        "text": "Stata",
        "label": "PERSON"
      },
      {
        "text": "Mann Whitney-U",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "was used to compare medians and Fisher's exact test was used to compare the",
    "entities": [
      {
        "text": "Fisher",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "RESULTS: Of the women studied, 13 (29.5%) had early onset pre-eclampsia and 31",
    "entities": [
      {
        "text": "13",
        "label": "CARDINAL"
      },
      {
        "text": "29.5%",
        "label": "PERCENT"
      },
      {
        "text": "pre-eclampsia",
        "label": "DATE"
      },
      {
        "text": "31",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "(70.5%) had late onset pre-eclampsia. Mean gestational age at diagnosis was",
    "entities": [
      {
        "text": "70.5%",
        "label": "PERCENT"
      },
      {
        "text": "pre-eclampsia",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "30.8\u00b11.57 weeks in women with early-onset pre-eclampsia and 35.6\u00b11.26 weeks in",
    "entities": [
      {
        "text": "30.8\u00b11.57 weeks",
        "label": "DATE"
      },
      {
        "text": "pre-eclampsia",
        "label": "DATE"
      },
      {
        "text": "35.6\u00b11.26 weeks",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "women with late-onset pre-eclampsia (p<0.001). There was no significant",
    "entities": [
      {
        "text": "pre-eclampsia",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "difference in terms of disease severity in women who had early-onset compared",
    "entities": []
  },
  {
    "text": "with late-onset disease. Of the cardiovascular risk markers assessed at 6 weeks",
    "entities": [
      {
        "text": "6 weeks",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "post partum, only serum triglyceride was found to be statistically higher in",
    "entities": []
  },
  {
    "text": "women with early onset compared with late onset pre-eclampsia, median values of",
    "entities": [
      {
        "text": "pre-eclampsia",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "(18.2%) of the pre-eclamptic women became normotensive at the end of puerperium.",
    "entities": [
      {
        "text": "18.2%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "CONCLUSION: The prevalence of persistent hypertension at 6 weeks post partum is",
    "entities": [
      {
        "text": "6 weeks",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "high in women with pre-eclampsia. Serum triglyceride concentration was",
    "entities": [
      {
        "text": "pre-eclampsia",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "significantly higher in early onset compared with late onset pre-eclampsia;",
    "entities": [
      {
        "text": "pre-eclampsia",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "subsequent studies powered to determine the full cardiovascular risk and how",
    "entities": []
  },
  {
    "text": "long to follow postnatal women up will be beneficial.",
    "entities": []
  },
  {
    "text": "\u00a9 Author(s) (or their employer(s)) 2025. Re-use permitted under CC BY. Published",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "CC BY",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "by BMJ Group.",
    "entities": [
      {
        "text": "BMJ Group",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "PMID: 40664417 [Indexed for MEDLINE]",
    "entities": [
      {
        "text": "40664417",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "The electrophysiological effects of angiotensin 1-7 on hypertrophic myocardium",
    "entities": []
  },
  {
    "text": "in spontaneously hypertensive rats.",
    "entities": []
  },
  {
    "text": "(1)School of Laboratory Medicine, Ningxia Medical University, Yinchuan 750004,",
    "entities": [
      {
        "text": "1)School of Laboratory Medicine",
        "label": "ORG"
      },
      {
        "text": "Ningxia Medical University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(2)Heart Center, the General Hospital of Ningxia Medical University, Yinchuan",
    "entities": [
      {
        "text": "2)Heart",
        "label": "CARDINAL"
      },
      {
        "text": "the General Hospital of Ningxia Medical University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(3)Department of Cardiology, the Cardiovascular and Cerebrovascular Disease",
    "entities": [
      {
        "text": "Cardiology",
        "label": "ORG"
      },
      {
        "text": "Cardiovascular",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Hospital of Ningxia Medical University, Yinchuan 750004, PR China.",
    "entities": [
      {
        "text": "Ningxia Medical University",
        "label": "ORG"
      },
      {
        "text": "PR China",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(4)Department of pathology, Ningxia Medical University, Yinchuan 750004, PR",
    "entities": [
      {
        "text": "4)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Ningxia Medical University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "China. Electronic address: 1711141269@qq.com.",
    "entities": [
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "This study aimed to explore the effects of Angiotensin 1-7 (Ang1-7) on",
    "entities": [
      {
        "text": "Angiotensin 1-7",
        "label": "FAC"
      }
    ]
  },
  {
    "text": "electrophysiological remodeling of hypertensive hypertrophic myocardium in",
    "entities": []
  },
  {
    "text": "spontaneously hypertensive rats (SHR). Thirty male SHR rats were equally divided",
    "entities": [
      {
        "text": "Thirty",
        "label": "CARDINAL"
      },
      {
        "text": "SHR",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "into three groups: SHR control group (SHRC) treated with saline; Ang1-7 group",
    "entities": [
      {
        "text": "three",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "(SHR-A) treated with Ang1-7[25 \u03bcg\u00b7(kg min)-1] and Ang1-7 blocker group (SHRB)",
    "entities": []
  },
  {
    "text": "treated with A779 [72 \u03bcg\u00b7(kg min)-1]. Wistar-Kyoto (WKY) rats (n = 10) were used",
    "entities": [
      {
        "text": "A779",
        "label": "ORG"
      },
      {
        "text": "72",
        "label": "CARDINAL"
      },
      {
        "text": "Wistar-Kyoto",
        "label": "ORG"
      },
      {
        "text": "10",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "as a normotensive group. The treatment period was 5 weeks. Systolic blood",
    "entities": [
      {
        "text": "5 weeks",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "pressure (SBP) and diastolic blood pressure (DBP) were measured.",
    "entities": [
      {
        "text": "SBP",
        "label": "ORG"
      },
      {
        "text": "DBP",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Echocardiography was used to evaluate cardiac function. The ventricular myocytes",
    "entities": []
  },
  {
    "text": "were isolated for evaluation of electrophysiological remodeling of myocardium",
    "entities": []
  },
  {
    "text": "using microelectrode and patch clamp techniques. When compared with those in WKY",
    "entities": []
  },
  {
    "text": "rats before treatment, systolic and diastolic pressures were significantly",
    "entities": []
  },
  {
    "text": "higher in SHR (P < 0.01 and P < 0.001 respectively), left ventricular",
    "entities": [
      {
        "text": "SHR",
        "label": "ORG"
      },
      {
        "text": "0.01",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "end-diastolic diameter (LVEDd) was significantly lower (P < 0.05), while",
    "entities": []
  },
  {
    "text": "diastolic interventricular septum thickness (IVSd), diastolic left ventricular",
    "entities": []
  },
  {
    "text": "posterior wall thickness (LVPWd) were significantly greater in SHR (P < 0.01).",
    "entities": [
      {
        "text": "SHR",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "After 5 weeks of treatment, compared with SHR-C group, SBP, DBP, IVSd, LVPWd in",
    "entities": [
      {
        "text": "5 weeks",
        "label": "DATE"
      },
      {
        "text": "SBP",
        "label": "ORG"
      },
      {
        "text": "DBP",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "SHR-A group were lower significantly (P < 0.05), while SBP in SHR-B group was",
    "entities": [
      {
        "text": "SBP",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "significantly higher (P < 0.05). Compared with WKY group, the resting potential",
    "entities": []
  },
  {
    "text": "(RP), action potential amplitude (APA) and transient sodium current (INa-T) in",
    "entities": [
      {
        "text": "APA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "SHR group were significantly lower (P < 0.05), and the action potential duration",
    "entities": [
      {
        "text": "SHR",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(APD20, APD50 and APD90) in SHR group was greater (P < 0.05). After Ang1-7",
    "entities": [
      {
        "text": "SHR",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "intervention, RP, APA and INa-T were significantly greater in SHR-A than those",
    "entities": [
      {
        "text": "RP",
        "label": "ORG"
      },
      {
        "text": "APA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "in SHR-C (P < 0.05), and APD in SHR-A significantly lower than that in SHR-C",
    "entities": [
      {
        "text": "APD",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(P < 0.05). Taken together, these results demonstrated that Ang1-7 can not only",
    "entities": []
  },
  {
    "text": "decrease the blood pressure, but reverse the myocardial hypertrophy and",
    "entities": []
  },
  {
    "text": "electrophysiological remodeling as well in SHR rats.",
    "entities": [
      {
        "text": "SHR",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Copyright \u00a9 2025 The Author(s). Published by Elsevier Inc. All rights reserved.",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "Elsevier Inc.",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: Declaration of competing interest The authors",
    "entities": []
  },
  {
    "text": "declare the following financial interests/personal relationships which may be",
    "entities": []
  },
  {
    "text": "considered as potential competing interests: Xin Yu reports financial support",
    "entities": [
      {
        "text": "Xin Yu",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "was provided by National Natural Science Foundation of China (No. 81660056) and",
    "entities": [
      {
        "text": "National Natural Science Foundation of China",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Ningxia Natural Science Foundation (No. 2022AAC03193). If there are other",
    "entities": [
      {
        "text": "Ningxia Natural Science Foundation",
        "label": "ORG"
      },
      {
        "text": "2022AAC03193",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "authors, they declare that they have no known competing financial interests or",
    "entities": []
  },
  {
    "text": "personal relationships that could have appeared to influence the work reported",
    "entities": []
  },
  {
    "text": "in this paper.",
    "entities": []
  },
  {
    "text": "The comparison of two volumetric microsampling devices (qDBS and VAMS) for",
    "entities": [
      {
        "text": "two",
        "label": "CARDINAL"
      },
      {
        "text": "VAMS",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "determining ganciclovir levels in capillary blood using the LC-MS/MS technique",
    "entities": [
      {
        "text": "LC-MS/MS",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(1)Department of Drug Chemistry, Pharmaceutical and Biomedical Analysis, Faculty",
    "entities": [
      {
        "text": "Drug Chemistry",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "of Pharmacy, Medical University of Warsaw, 02-097 Warsaw, Poland. Electronic",
    "entities": [
      {
        "text": "Pharmacy, Medical University of Warsaw",
        "label": "ORG"
      },
      {
        "text": "02",
        "label": "CARDINAL"
      },
      {
        "text": "Warsaw",
        "label": "GPE"
      },
      {
        "text": "Poland",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Department of Drug Chemistry, Pharmaceutical and Biomedical Analysis, Faculty",
    "entities": [
      {
        "text": "Drug Chemistry",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(3)Therapeutic Drug Monitoring, Clinical Pharmacokinetics and Toxicology",
    "entities": [
      {
        "text": "Drug Monitoring, Clinical Pharmacokinetics and Toxicology",
        "label": "WORK_OF_ART"
      }
    ]
  },
  {
    "text": "Laboratory Unit, Department of Clinical Biochemistry, The Children's Memorial",
    "entities": [
      {
        "text": "Laboratory Unit",
        "label": "ORG"
      },
      {
        "text": "Department of Clinical Biochemistry",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Health Institute, 04-730 Warsaw, Poland. Electronic address:",
    "entities": [
      {
        "text": "Health Institute",
        "label": "ORG"
      },
      {
        "text": "04",
        "label": "CARDINAL"
      },
      {
        "text": "Warsaw",
        "label": "GPE"
      },
      {
        "text": "Poland",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Therapeutic Drug Monitoring, Clinical Pharmacokinetics and Toxicology",
    "entities": [
      {
        "text": "Drug Monitoring, Clinical Pharmacokinetics and Toxicology",
        "label": "WORK_OF_ART"
      }
    ]
  },
  {
    "text": "Health Institute, 04-730 Warsaw, Poland. Electronic address: a.czeczek@ipczd.pl.",
    "entities": [
      {
        "text": "Health Institute",
        "label": "ORG"
      },
      {
        "text": "04",
        "label": "CARDINAL"
      },
      {
        "text": "Warsaw",
        "label": "GPE"
      },
      {
        "text": "Poland",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(5)Department of Nephrology, Kidney Transplantation and Arterial Hypertension,",
    "entities": [
      {
        "text": "Nephrology",
        "label": "ORG"
      },
      {
        "text": "Kidney Transplantation",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "The Children's Memorial Health Institute, Dzieci Polskich 20, 04-730 Warsaw,",
    "entities": [
      {
        "text": "The Children's Memorial Health Institute",
        "label": "ORG"
      },
      {
        "text": "Dzieci Polskich",
        "label": "ORG"
      },
      {
        "text": "20",
        "label": "CARDINAL"
      },
      {
        "text": "04",
        "label": "CARDINAL"
      },
      {
        "text": "Warsaw",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Poland. Electronic address: j.rubik@ipczd.pl.",
    "entities": [
      {
        "text": "Poland",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(Val)Ganciclovir (VGCV) is utilised for the prevention and treatment of",
    "entities": [
      {
        "text": "VGCV",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "cytomegalovirus (CMV) infections in pediatric patients who have undergone renal",
    "entities": [
      {
        "text": "CMV",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "transplants. Due to toxic side effects, therapeutic drug monitoring (TDM) is",
    "entities": [
      {
        "text": "TDM",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "recommended, especially in vulnerable populations. Microsampling offers",
    "entities": []
  },
  {
    "text": "collecting small volumes of body fluids (<50\u00b5L), making it ideal for TDM",
    "entities": [
      {
        "text": "TDM",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "service. This study aimed to develop and clinically validate two microsampling",
    "entities": [
      {
        "text": "two",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "techniques - MitraTM and Capitainer\u00ae- employing volumetric absorptive",
    "entities": [
      {
        "text": "Capitainer",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "microsampling (VAMS) and quantitative dried blood spot (qDBS) methods,",
    "entities": [
      {
        "text": "VAMS",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "respectively. Additionally, reference methods for analysing GCV in whole blood",
    "entities": []
  },
  {
    "text": "and plasma were validated. The LC-MS/MS multi-matrix method for quantifying GCV",
    "entities": [
      {
        "text": "LC-MS",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "was validated using a calibration range of 0.01-25 mg/L in accordance with ICH",
    "entities": [
      {
        "text": "0.01-25",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "M10 and Food and Drug Administration guidelines. The calculated accuracies and",
    "entities": [
      {
        "text": "M10",
        "label": "ORG"
      },
      {
        "text": "Food and Drug Administration",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "precisions for all tested matrices were within 15%. No significant matrix and",
    "entities": [
      {
        "text": "15%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "carryover effects were observed. Clinical validation demonstrated the efficacy",
    "entities": []
  },
  {
    "text": "of the examined microsampling devices in practice, highlighting the feasibility",
    "entities": []
  },
  {
    "text": "of home-based self-sampling. The developed methodologies were utilised to assess",
    "entities": []
  },
  {
    "text": "receiving VGCV treatment within a preemptive or prophylactic CMV protocol. The",
    "entities": [
      {
        "text": "VGCV",
        "label": "ORG"
      },
      {
        "text": "CMV",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "results were clinically evaluated through regression and bias estimation",
    "entities": []
  },
  {
    "text": "analyses, confirming a high level of correlation between GCV levels in the",
    "entities": []
  },
  {
    "text": "tested matrices. In conclusion, the newly developed, straightforward, and robust",
    "entities": []
  },
  {
    "text": "multi-matrix LC-MS/MS method has been effectively validated and integrated into",
    "entities": [
      {
        "text": "LC-MS",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "clinical practice. For the first time in the literature, we demonstrated the",
    "entities": [
      {
        "text": "first",
        "label": "ORDINAL"
      }
    ]
  },
  {
    "text": "analytical and clinical feasibility of tested microsampling devices for routine",
    "entities": []
  },
  {
    "text": "Copyright \u00a9 2025. Published by Elsevier B.V.",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "Elsevier B.V.",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "DNA methylation levels are independently associated with prevalence of",
    "entities": []
  },
  {
    "text": "(1)Genetic Dyslipidemias Clinic of the Montreal Clinical Research Institute,",
    "entities": [
      {
        "text": "Dyslipidemias Clinic of the Montreal Clinical Research Institute",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Montr\u00e9al, Qu\u00e9bec, Canada; Department of Pediatrics, Division of Medical",
    "entities": [
      {
        "text": "Montr\u00e9al",
        "label": "GPE"
      },
      {
        "text": "Qu\u00e9bec",
        "label": "GPE"
      },
      {
        "text": "Canada",
        "label": "GPE"
      },
      {
        "text": "Department of Pediatrics",
        "label": "ORG"
      },
      {
        "text": "Division of Medical",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Genetics, Universit\u00e9 de Sherbrooke, Sherbrooke, Quebec, Canada; Centre de",
    "entities": [
      {
        "text": "Genetics",
        "label": "ORG"
      },
      {
        "text": "Universit\u00e9 de Sherbrooke",
        "label": "ORG"
      },
      {
        "text": "Sherbrooke, Quebec",
        "label": "GPE"
      },
      {
        "text": "Canada",
        "label": "GPE"
      },
      {
        "text": "Centre de\n",
        "label": "FAC"
      }
    ]
  },
  {
    "text": "Sherbrooke, Sherbrooke, Qu\u00e9bec, Canada.",
    "entities": [
      {
        "text": "Sherbrooke, Qu\u00e9bec,",
        "label": "ORG"
      },
      {
        "text": "Canada",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Genetic Dyslipidemias Clinic of the Montreal Clinical Research Institute,",
    "entities": []
  },
  {
    "text": "(3)Department of Biochemistry and Functional Genomics, Faculty of Medicine and",
    "entities": [
      {
        "text": "Biochemistry and Functional Genomics, Faculty of Medicine",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Health Sciences, Universit\u00e9 de Sherbrooke, Sherbrooke, Qu\u00e9bec, Canada.",
    "entities": [
      {
        "text": "Health Sciences",
        "label": "ORG"
      },
      {
        "text": "Universit\u00e9 de Sherbrooke",
        "label": "ORG"
      },
      {
        "text": "Sherbrooke, Qu\u00e9bec,",
        "label": "ORG"
      },
      {
        "text": "Canada",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Department of Biochemistry and Functional Genomics, Faculty of Medicine and",
    "entities": [
      {
        "text": "Biochemistry and Functional Genomics, Faculty of Medicine",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Universit\u00e9 de Sherbrooke, Sherbrooke, Qu\u00e9bec, Canada; Department of Biochemistry",
    "entities": [
      {
        "text": "Universit\u00e9 de Sherbrooke",
        "label": "PERSON"
      },
      {
        "text": "Sherbrooke, Qu\u00e9bec,",
        "label": "ORG"
      },
      {
        "text": "Canada",
        "label": "GPE"
      },
      {
        "text": "Department of Biochemistry",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "and Functional Genomics, Faculty of Medicine and Health Sciences, Universit\u00e9 de",
    "entities": [
      {
        "text": "Functional Genomics, Faculty of Medicine and Health Sciences",
        "label": "ORG"
      },
      {
        "text": "Universit\u00e9 de\n",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Sherbrooke, Sherbrooke, Qu\u00e9bec, Canada; Centre de recherche et d'innovation,",
    "entities": [
      {
        "text": "Sherbrooke, Qu\u00e9bec,",
        "label": "ORG"
      },
      {
        "text": "Canada",
        "label": "GPE"
      },
      {
        "text": "Centre de recherche et d'innovation",
        "label": "FAC"
      }
    ]
  },
  {
    "text": "Saguenay-Lac-Saint-Jean, Saguenay, Qu\u00e9bec, Canada; Clinical Department of",
    "entities": [
      {
        "text": "Saguenay-Lac-Saint-Jean",
        "label": "GPE"
      },
      {
        "text": "Saguenay",
        "label": "GPE"
      },
      {
        "text": "Qu\u00e9bec",
        "label": "GPE"
      },
      {
        "text": "Canada",
        "label": "GPE"
      },
      {
        "text": "Clinical Department",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(6)Genetic Dyslipidemias Clinic of the Montreal Clinical Research Institute,",
    "entities": []
  },
  {
    "text": "(7)Genetic Dyslipidemias Clinic of the Montreal Clinical Research Institute,",
    "entities": []
  },
  {
    "text": "Montr\u00e9al, Qu\u00e9bec, Canada; Department of Medicine, Divisions of Experimental",
    "entities": [
      {
        "text": "Montr\u00e9al",
        "label": "GPE"
      },
      {
        "text": "Qu\u00e9bec",
        "label": "GPE"
      },
      {
        "text": "Canada",
        "label": "GPE"
      },
      {
        "text": "Department of Medicine, Divisions of Experimental",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Medicine and Medical Biochemistry, McGill University, Montr\u00e9al, Qu\u00e9bec, Canada.",
    "entities": [
      {
        "text": "McGill University",
        "label": "ORG"
      },
      {
        "text": "Montr\u00e9al",
        "label": "GPE"
      },
      {
        "text": "Qu\u00e9bec",
        "label": "GPE"
      },
      {
        "text": "Canada",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "BACKGROUND: Multifactorial chylomicronemia syndrome (MCS) is a form of severe",
    "entities": []
  },
  {
    "text": "hypertriglyceridemia (sHTG) associated with increased risk of acute pancreatitis",
    "entities": []
  },
  {
    "text": "and atherosclerotic cardiovascular disease (ASCVD). We recently reported",
    "entities": []
  },
  {
    "text": "suggestive evidence that DNA methylation (DNAm) contribute to the sHTG phenotype",
    "entities": []
  },
  {
    "text": "in MCS. While few predictors of acute pancreatitis were previously identified in",
    "entities": []
  },
  {
    "text": "MCS, predictors of ASCVD in MCS remain mostly unknown.",
    "entities": [
      {
        "text": "ASCVD",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "OBJECTIVE: To study the factors associated with previous history of ASCVD in MCS",
    "entities": []
  },
  {
    "text": "METHODS: A total of 114 patients with MCS were included in this retrospective",
    "entities": [
      {
        "text": "114",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "study. Prevalence of ASCVD was determined at the baseline visit and defined as",
    "entities": []
  },
  {
    "text": "any atherosclerotic event: angina, myocardial infarction, coronary angioplasty,",
    "entities": [
      {
        "text": "coronary angioplasty",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "coronary bypass surgery, claudication, peripheral angioplasty, peripheral",
    "entities": []
  },
  {
    "text": "arterial surgery, transient ischemic attack, stroke, carotid endarterectomy, and",
    "entities": []
  },
  {
    "text": "artery stenosis (>50 %). DNAm level at ABCG1 (cg06500161), CPT1A (cg00574958),",
    "entities": [
      {
        "text": "50 %",
        "label": "PERCENT"
      },
      {
        "text": "ABCG1 (cg06500161",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "and SREBF1 (cg11024682) candidate gene loci was quantified using pyrosequencing",
    "entities": [
      {
        "text": "SREBF1",
        "label": "PERSON"
      },
      {
        "text": "gene loci",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "of bisulfite-treated DNA.",
    "entities": []
  },
  {
    "text": "RESULTS: Univariate analysis showed that age, ABCG1 and SREBF1 DNAm level, and",
    "entities": [
      {
        "text": "ABCG1",
        "label": "PERSON"
      },
      {
        "text": "SREBF1",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "the presence of obesity, hypertension, diabetes, and maximal TG",
    "entities": []
  },
  {
    "text": "level > 40 mmol/L were associated with previous history of ASCVD. Multivariate",
    "entities": [
      {
        "text": "40",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "analysis showed that age (OR 1.11 [1.04-1.18], p = 0.0006), SREBF1 DNAm levels",
    "entities": [
      {
        "text": "1.11",
        "label": "CARDINAL"
      },
      {
        "text": "1.04",
        "label": "CARDINAL"
      },
      {
        "text": "0.0006",
        "label": "CARDINAL"
      },
      {
        "text": "SREBF1",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(OR 1.12 [1.03-1.24], p = 0.01), the presence of a maximal TG level > 40 mmol/L",
    "entities": [
      {
        "text": "1.12",
        "label": "CARDINAL"
      },
      {
        "text": "1.03-1.24",
        "label": "CARDINAL"
      },
      {
        "text": "0.01",
        "label": "CARDINAL"
      },
      {
        "text": "40",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "(OR 0.13 [0.02-0.90], p = 0.04), and obesity (OR 3.32 [1.00-11.19, p = 0.05]",
    "entities": [
      {
        "text": "0.13",
        "label": "CARDINAL"
      },
      {
        "text": "0.02",
        "label": "CARDINAL"
      },
      {
        "text": "0.04",
        "label": "CARDINAL"
      },
      {
        "text": "3.32",
        "label": "CARDINAL"
      },
      {
        "text": "1.00",
        "label": "CARDINAL"
      },
      {
        "text": "0.05",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "were independently associated with history of ASCVD and explained 44.8 % of the",
    "entities": [
      {
        "text": "44.8 %",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "variability in the prevalence of ASCVD (p < 0.0001).",
    "entities": [
      {
        "text": "ASCVD",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "CONCLUSION: This study shows that SREBF1 DNAm levels are independently",
    "entities": [
      {
        "text": "SREBF1",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "associated with prevalence of ASCVD in MCS patients. It suggests that further",
    "entities": []
  },
  {
    "text": "studies of epivariations may contribute to better understand the clinical",
    "entities": []
  },
  {
    "text": "considered as potential competing interests: AB received research grants from",
    "entities": []
  },
  {
    "text": "Akcea, Amgen, Astra Zeneca, Fondation Leducq, Fondation Yvan Morin, Merck",
    "entities": [
      {
        "text": "Akcea",
        "label": "ORG"
      },
      {
        "text": "Amgen",
        "label": "ORG"
      },
      {
        "text": "Astra Zeneca",
        "label": "PERSON"
      },
      {
        "text": "Fondation Leducq",
        "label": "PERSON"
      },
      {
        "text": "Yvan Morin",
        "label": "PERSON"
      },
      {
        "text": "Merck",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Frosst, and Sanofi. He has participated in clinical research protocols from",
    "entities": [
      {
        "text": "Frosst",
        "label": "ORG"
      },
      {
        "text": "Sanofi",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Acasti Pharma Inc., Akcea, Amgen, Arrowhead Pharmaceuticals, Astra Zeneca, Ionis",
    "entities": [
      {
        "text": "Acasti Pharma Inc.",
        "label": "ORG"
      },
      {
        "text": "Akcea",
        "label": "ORG"
      },
      {
        "text": "Amgen",
        "label": "ORG"
      },
      {
        "text": "Arrowhead Pharmaceuticals",
        "label": "ORG"
      },
      {
        "text": "Astra Zeneca",
        "label": "PERSON"
      },
      {
        "text": "Ionis",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "Pharmaceuticals, Inc., ISIS Pharmaceuticals, The Medicines Company, Merck",
    "entities": [
      {
        "text": "Pharmaceuticals, Inc.",
        "label": "ORG"
      },
      {
        "text": "ISIS Pharmaceuticals",
        "label": "ORG"
      },
      {
        "text": "The Medicines Company",
        "label": "ORG"
      },
      {
        "text": "Merck",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Frosst, Novartis, Pfizer, Regeneron Pharmaceuticals Inc., and Sanofi. He has",
    "entities": [
      {
        "text": "Frosst",
        "label": "ORG"
      },
      {
        "text": "Novartis",
        "label": "ORG"
      },
      {
        "text": "Pfizer",
        "label": "ORG"
      },
      {
        "text": "Regeneron Pharmaceuticals Inc.",
        "label": "ORG"
      },
      {
        "text": "Sanofi",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "served on advisory boards and received honoraria for symposia from Akcea, Amgen,",
    "entities": [
      {
        "text": "symposia",
        "label": "GPE"
      },
      {
        "text": "Akcea",
        "label": "GPE"
      },
      {
        "text": "Amgen",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "and Sanofi. SBreceived research grants from Akcea, Fondation Leducq, and",
    "entities": [
      {
        "text": "Sanofi",
        "label": "ORG"
      },
      {
        "text": "Akcea",
        "label": "ORG"
      },
      {
        "text": "Fondation Leducq",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Fondation Yvan Morin. She has participated in clinical research protocols from",
    "entities": [
      {
        "text": "Yvan Morin",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Akcea, Amgen, Ionis Pharmaceuticals, Inc., The Medicines Company, Novartis,",
    "entities": [
      {
        "text": "Akcea",
        "label": "ORG"
      },
      {
        "text": "Amgen",
        "label": "ORG"
      },
      {
        "text": "Ionis Pharmaceuticals, Inc.",
        "label": "ORG"
      },
      {
        "text": "The Medicines Company",
        "label": "ORG"
      },
      {
        "text": "Novartis",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Pfizer, and Sanofi. She has served on advisory boards for Akcea, Amgen, HLS",
    "entities": [
      {
        "text": "Pfizer",
        "label": "ORG"
      },
      {
        "text": "Sanofi",
        "label": "ORG"
      },
      {
        "text": "Akcea",
        "label": "ORG"
      },
      {
        "text": "Amgen",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Therapeutics, Novartis, Novo Nordisk, and Sanofi, and received honoraria for",
    "entities": [
      {
        "text": "Novartis",
        "label": "GPE"
      },
      {
        "text": "Novo Nordisk",
        "label": "PERSON"
      },
      {
        "text": "Sanofi",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "symposia from Akcea, Amgen, Novo Nordisk, and Sanofi. SPG has served on advisory",
    "entities": [
      {
        "text": "symposia",
        "label": "GPE"
      },
      {
        "text": "Akcea",
        "label": "GPE"
      },
      {
        "text": "Amgen",
        "label": "ORG"
      },
      {
        "text": "Novo Nordisk",
        "label": "PERSON"
      },
      {
        "text": "Sanofi",
        "label": "ORG"
      },
      {
        "text": "SPG",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "boards for Ultragenyx. MP, LB, LG, VD and AT have nothing to declare.",
    "entities": [
      {
        "text": "Ultragenyx",
        "label": "GPE"
      },
      {
        "text": "LB",
        "label": "ORG"
      },
      {
        "text": "LG",
        "label": "GPE"
      },
      {
        "text": "VD",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "10.1016/j.jelectrocard.2025.154059. Online ahead of print.",
    "entities": [
      {
        "text": "10.1016",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "QT dispersion and T wave peak-to-end in pediatric patients with sickle cell",
    "entities": [
      {
        "text": "QT",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Eldash HH(1), Mostafa R(1), Borayek HA(2).",
    "entities": [
      {
        "text": "Mostafa R(1",
        "label": "PERSON"
      },
      {
        "text": "Borayek HA(2",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(1)Department of Pediatrics, Faculty of Medicine, Fayoum University, Fayoum,",
    "entities": [
      {
        "text": "Pediatrics, Faculty of Medicine",
        "label": "ORG"
      },
      {
        "text": "Fayoum University",
        "label": "ORG"
      },
      {
        "text": "Fayoum",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(2)Department of Pediatrics, Faculty of Medicine, Fayoum University, Fayoum,",
    "entities": [
      {
        "text": "Pediatrics, Faculty of Medicine",
        "label": "ORG"
      },
      {
        "text": "Fayoum University",
        "label": "ORG"
      },
      {
        "text": "Fayoum",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "AIM: The aim of the study was to detect cardiac repolarization changes and the",
    "entities": [
      {
        "text": "AIM",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "risk of arrhythmias in children with sickle cell disease (SCD) and sickle",
    "entities": [
      {
        "text": "SCD",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "thalassemia using echocardiography and electrocardiography (ECG).",
    "entities": [
      {
        "text": "ECG",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "METHODS: This is an observational case-control study that compared 20 patients",
    "entities": [
      {
        "text": "20",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "with SCD and 20 patients with sickle thalassemia who regularly follow in the",
    "entities": [
      {
        "text": "SCD",
        "label": "ORG"
      },
      {
        "text": "20",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "outpatient hematology clinic of Fayoum University Hospital with 40 healthy",
    "entities": [
      {
        "text": "Fayoum University Hospital",
        "label": "ORG"
      },
      {
        "text": "40",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "controls with history of non-hematological or cardiac illness who attended the",
    "entities": []
  },
  {
    "text": "general outpatient clinic from November 2022 to July 2023. All patients were",
    "entities": [
      {
        "text": "November 2022 to July 2023",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "evaluated clinically and by routine echocardiography, tissue Doppler imaging",
    "entities": [
      {
        "text": "Doppler",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(TDI), and long-strip ECG.",
    "entities": [
      {
        "text": "TDI",
        "label": "ORG"
      },
      {
        "text": "ECG",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "RESULTS: The QT, QT corrected (QTc), and QT dispersion (QTd) intervals were",
    "entities": [
      {
        "text": "QT",
        "label": "GPE"
      },
      {
        "text": "QT",
        "label": "PERSON"
      },
      {
        "text": "QT",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "significantly higher in the case groups (all p = 0.001). There was a",
    "entities": [
      {
        "text": "0.001",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "significantly higher T-wave peak-to-end interval (Tp-e) among sickle patients in",
    "entities": []
  },
  {
    "text": "comparison to controls. There was a statistically significant higher level of",
    "entities": []
  },
  {
    "text": "Tei index and velocity of the e' wave among each case group in comparison to the",
    "entities": [
      {
        "text": "Tei",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "control group (p < 0.05). As regards QTc and QTd intervals, there was a",
    "entities": [
      {
        "text": "control group",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "statistically significant positive correlation with each of estimated pulmonary",
    "entities": []
  },
  {
    "text": "artery pressure (ESPAP), isovolumetric contraction time (IVCT), Tei index, and",
    "entities": [
      {
        "text": "Tei",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "velocity of the s' wave among study groups.",
    "entities": []
  },
  {
    "text": "CONCLUSIONS: The risk of malignant arrhythmia and sudden cardiac death may occur",
    "entities": []
  },
  {
    "text": "in children with SCD and sickle thalassemia. They had longer QTc, QTd, and Tp-e",
    "entities": [
      {
        "text": "SCD",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "intervals than healthy individuals. Prolonged QTc was significantly associated",
    "entities": []
  },
  {
    "text": "with increased left ventricular dimensions, pulmonary hypertension, and global",
    "entities": []
  },
  {
    "text": "myocardial dysfunction.",
    "entities": []
  },
  {
    "text": "Conflict of interest statement: Declaration of competing interest None.",
    "entities": []
  },
  {
    "text": "Characterization and functional analysis of BRCA1 and BRCA2 variants in a cohort",
    "entities": [
      {
        "text": "BRCA1",
        "label": "GPE"
      },
      {
        "text": "BRCA2",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "of 100 unselected patients undergoing germline screening.",
    "entities": [
      {
        "text": "100",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "(1)Department of Laboratory Medicine, the Third Affiliated Hospital of Zhengzhou",
    "entities": [
      {
        "text": "Laboratory Medicine",
        "label": "ORG"
      },
      {
        "text": "the Third Affiliated Hospital",
        "label": "ORG"
      },
      {
        "text": "Zhengzhou",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "University, Zhengzhou, Henan, , 450052, China; Zhengzhou Key Laboratory for In",
    "entities": [
      {
        "text": "Zhengzhou",
        "label": "GPE"
      },
      {
        "text": "Henan",
        "label": "GPE"
      },
      {
        "text": "450052",
        "label": "DATE"
      },
      {
        "text": "China",
        "label": "GPE"
      },
      {
        "text": "Zhengzhou Key Laboratory",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Vitro Diagnosis of Hypertensive Disorders of Pregnancy, Zhengzhou, Henan,",
    "entities": [
      {
        "text": "Zhengzhou",
        "label": "GPE"
      },
      {
        "text": "Henan",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "450052, China; Tianjian Laboratory of Advanced Biomedical Sciences, Institute of",
    "entities": [
      {
        "text": "450052",
        "label": "DATE"
      },
      {
        "text": "China",
        "label": "GPE"
      },
      {
        "text": "Tianjian Laboratory of Advanced Biomedical Sciences",
        "label": "ORG"
      },
      {
        "text": "Institute of\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Advanced Biomedical Sciences, Zhengzhou University, Zhengzhou, Henan, , 450000,",
    "entities": [
      {
        "text": "Advanced Biomedical Sciences",
        "label": "ORG"
      },
      {
        "text": "Zhengzhou University",
        "label": "ORG"
      },
      {
        "text": "Zhengzhou",
        "label": "GPE"
      },
      {
        "text": "Henan",
        "label": "GPE"
      },
      {
        "text": "450000",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "China. Electronic address: qianqianshi@zzu.edu.cn.",
    "entities": [
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Department of Laboratory Medicine, the Third Affiliated Hospital of Zhengzhou",
    "entities": [
      {
        "text": "Laboratory Medicine",
        "label": "ORG"
      },
      {
        "text": "the Third Affiliated Hospital",
        "label": "ORG"
      },
      {
        "text": "Zhengzhou",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Department of Breast Surgery, the Third Affiliated Hospital of Zhengzhou",
    "entities": [
      {
        "text": "Breast Surgery",
        "label": "PERSON"
      },
      {
        "text": "the Third Affiliated Hospital",
        "label": "ORG"
      },
      {
        "text": "Zhengzhou",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "University, Zhengzhou, Henan, 450052, China.",
    "entities": [
      {
        "text": "Zhengzhou",
        "label": "GPE"
      },
      {
        "text": "Henan",
        "label": "GPE"
      },
      {
        "text": "450052",
        "label": "DATE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Department of Laboratory Medicine, the Third Affiliated Hospital of Zhengzhou",
    "entities": [
      {
        "text": "Laboratory Medicine",
        "label": "ORG"
      },
      {
        "text": "the Third Affiliated Hospital",
        "label": "ORG"
      },
      {
        "text": "Zhengzhou",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(5)Tianjian Laboratory of Advanced Biomedical Sciences, Institute of Advanced",
    "entities": [
      {
        "text": "5)Tianjian Laboratory of Advanced Biomedical Sciences",
        "label": "ORG"
      },
      {
        "text": "Institute of Advanced",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Biomedical Sciences, Zhengzhou University, Zhengzhou, Henan, , 450000, China;",
    "entities": [
      {
        "text": "Biomedical Sciences",
        "label": "ORG"
      },
      {
        "text": "Zhengzhou University",
        "label": "ORG"
      },
      {
        "text": "Zhengzhou",
        "label": "GPE"
      },
      {
        "text": "Henan",
        "label": "GPE"
      },
      {
        "text": "450000",
        "label": "DATE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Department of Breast Surgery, the Third Affiliated Hospital of Zhengzhou",
    "entities": [
      {
        "text": "the Third Affiliated Hospital",
        "label": "ORG"
      },
      {
        "text": "Zhengzhou",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "University, Zhengzhou, Henan, 450052, China. Electronic address:",
    "entities": [
      {
        "text": "Zhengzhou",
        "label": "GPE"
      },
      {
        "text": "Henan",
        "label": "GPE"
      },
      {
        "text": "450052",
        "label": "DATE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(6)Tianjian Laboratory of Advanced Biomedical Sciences, Institute of Advanced",
    "entities": [
      {
        "text": "6)Tianjian",
        "label": "CARDINAL"
      },
      {
        "text": "Laboratory of Advanced Biomedical Sciences",
        "label": "ORG"
      },
      {
        "text": "Institute of Advanced",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Biomedical Sciences, Zhengzhou University, Zhengzhou, Henan, , 450000, China.",
    "entities": [
      {
        "text": "Biomedical Sciences",
        "label": "ORG"
      },
      {
        "text": "Zhengzhou University",
        "label": "ORG"
      },
      {
        "text": "Zhengzhou",
        "label": "GPE"
      },
      {
        "text": "Henan",
        "label": "GPE"
      },
      {
        "text": "450000",
        "label": "DATE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(7)Department of Laboratory Medicine, the Third Affiliated Hospital of Zhengzhou",
    "entities": [
      {
        "text": "Laboratory Medicine",
        "label": "ORG"
      },
      {
        "text": "the Third Affiliated Hospital",
        "label": "ORG"
      },
      {
        "text": "Zhengzhou",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Germline loss-of-function mutations in BRCA1 and BRCA2 (BRCA) genes are",
    "entities": [
      {
        "text": "Germline",
        "label": "ORG"
      },
      {
        "text": "BRCA1",
        "label": "GPE"
      },
      {
        "text": "BRCA2",
        "label": "PERSON"
      },
      {
        "text": "BRCA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "well-established as causative factors for hereditary breast and ovarian cancer",
    "entities": []
  },
  {
    "text": "(HBOC), conferring an approximately tenfold increased lifetime risk. The",
    "entities": []
  },
  {
    "text": "identification of BRCA mutations is essential for risk assessment and management",
    "entities": [
      {
        "text": "BRCA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "in high-risk individuals and cancer patients. In this study, we utilized",
    "entities": []
  },
  {
    "text": "next-generation sequencing (NGS) to comprehensively analyze the entire coding",
    "entities": [
      {
        "text": "NGS",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "regions of BRCA genes in a cohort of 100 unselected patients undergoing germline",
    "entities": [
      {
        "text": "BRCA",
        "label": "ORG"
      },
      {
        "text": "100",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "screening (average age \u226445 years and/or family history of related cancers). A",
    "entities": []
  },
  {
    "text": "total of twenty-two variants were identified, including thirteen pathogenic or",
    "entities": [
      {
        "text": "twenty-two",
        "label": "CARDINAL"
      },
      {
        "text": "thirteen",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "likely pathogenic variants (PVs/LPVs) and nine variants of uncertain",
    "entities": [
      {
        "text": "nine",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "significance (VUSs). Notably, six novel variants (two in BRCA1 and four in",
    "entities": [
      {
        "text": "six",
        "label": "CARDINAL"
      },
      {
        "text": "two",
        "label": "CARDINAL"
      },
      {
        "text": "BRCA1",
        "label": "GPE"
      },
      {
        "text": "four",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "BRCA2) were discovered. Molecular subtyping revealed that breast cancer (BC)",
    "entities": [
      {
        "text": "BRCA2",
        "label": "ORG"
      },
      {
        "text": "BC",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "patients with BRCA variants were predominantly human epidermal growth factor",
    "entities": [
      {
        "text": "BRCA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "receptor-2 (HER2)-negative. Using in silico prediction tools, nine VUSs were",
    "entities": [
      {
        "text": "nine",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "reclassified, with functional impairment confirmed for the BRCA2 p.W2619C and",
    "entities": [
      {
        "text": "BRCA2",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "BRCA2 p.N1023_I1024del variants. Functional assays demonstrated that the BRCA2",
    "entities": [
      {
        "text": "BRCA2",
        "label": "ORG"
      },
      {
        "text": "N1023_I1024del",
        "label": "ORG"
      },
      {
        "text": "BRCA2",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "p.W2619C variant significantly enhanced cell proliferation, migration, and",
    "entities": [
      {
        "text": "p.W2619C",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "invasion. Moreover, cells harboring the BRCA2 p.W2619C mutation exhibited",
    "entities": [
      {
        "text": "BRCA2",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "increased sensitivity to Olaparib, suggesting potential therapeutic benefit from",
    "entities": [
      {
        "text": "Olaparib",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "PARP inhibitors for patients with this variant. Our study identified six novel",
    "entities": [
      {
        "text": "six",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "BRCA mutations and functionally validated the pathogenicity of the BRCA2",
    "entities": [
      {
        "text": "BRCA",
        "label": "ORG"
      },
      {
        "text": "BRCA2",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "p.W2619C variant, thereby advancing the understanding of BRCA-related cancer",
    "entities": [
      {
        "text": "p.W2619C variant",
        "label": "PERSON"
      },
      {
        "text": "BRCA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "risk and supporting enhanced genetic counseling and testing strategies for",
    "entities": []
  },
  {
    "text": "at-risk populations.",
    "entities": []
  },
  {
    "text": "Cross-sectional imaging of congenital and acquired hepatic vascular",
    "entities": []
  },
  {
    "text": "abnormalities.",
    "entities": []
  },
  {
    "text": "Via Pergolesi 33, 20900 Monza, MB, Italy. Electronic address:",
    "entities": [
      {
        "text": "Via Pergolesi",
        "label": "PERSON"
      },
      {
        "text": "33",
        "label": "CARDINAL"
      },
      {
        "text": "MB",
        "label": "GPE"
      },
      {
        "text": "Italy",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Section of Radiology - Department of Biomedicine, Neuroscience and Advanced",
    "entities": [
      {
        "text": "Radiology - Department of Biomedicine,",
        "label": "ORG"
      },
      {
        "text": "Advanced",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(3)Department of Surgical Sciences, University of Turin, Turin 10126, Italy.",
    "entities": [
      {
        "text": "Surgical Sciences",
        "label": "ORG"
      },
      {
        "text": "University of Turin",
        "label": "ORG"
      },
      {
        "text": "Italy",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "70021, Italy.",
    "entities": [
      {
        "text": "70021",
        "label": "DATE"
      },
      {
        "text": "Italy",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Via Pergolesi 33, 20900 Monza, MB, Italy; School of Medicine, University of",
    "entities": [
      {
        "text": "Via Pergolesi",
        "label": "PERSON"
      },
      {
        "text": "33",
        "label": "CARDINAL"
      },
      {
        "text": "MB",
        "label": "GPE"
      },
      {
        "text": "Italy",
        "label": "GPE"
      },
      {
        "text": "School of Medicine, University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "70021, Italy; Department of Medicine and Surgery, LUM University, Casamassima,",
    "entities": [
      {
        "text": "70021",
        "label": "DATE"
      },
      {
        "text": "Italy",
        "label": "GPE"
      },
      {
        "text": "Department of Medicine and Surgery",
        "label": "ORG"
      },
      {
        "text": "LUM University",
        "label": "ORG"
      },
      {
        "text": "Casamassima",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Bari, Italy. Electronic address: riccardoin@hotmail.it.",
    "entities": [
      {
        "text": "Bari",
        "label": "PERSON"
      },
      {
        "text": "Italy",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Cross-sectional imaging plays a crucial role in the diagnosis and management of",
    "entities": []
  },
  {
    "text": "both congenital and acquired hepatic vascular abnormalities. Congenital vascular",
    "entities": []
  },
  {
    "text": "anomalies, such as arteriovenous malformations, portal vein and hepatic vein",
    "entities": []
  },
  {
    "text": "anomalies, often present with nonspecific symptoms and require precise imaging",
    "entities": []
  },
  {
    "text": "for accurate assessment. Acquired hepatic vascular conditions, including",
    "entities": []
  },
  {
    "text": "cirrhosis-related vascular changes, portal hypertension, and vascular lesions,",
    "entities": []
  },
  {
    "text": "can lead to clinical complications and may necessitate timely intervention.",
    "entities": []
  },
  {
    "text": "Cross-sectional imaging techniques like computed tomography (CT) and magnetic",
    "entities": []
  },
  {
    "text": "resonance (MR) imaging offer detailed visualization of these abnormalities,",
    "entities": []
  },
  {
    "text": "aiding in the detection, characterization, and monitoring of disease",
    "entities": []
  },
  {
    "text": "progression. The integration of dynamic contrast-enhanced imaging techniques",
    "entities": []
  },
  {
    "text": "further enhances the ability to evaluate blood flow, vessel architecture, and",
    "entities": []
  },
  {
    "text": "the impact of vascular abnormalities on liver function. Early and accurate",
    "entities": []
  },
  {
    "text": "detection of both congenital and acquired hepatic vascular abnormalities through",
    "entities": []
  },
  {
    "text": "cross-sectional imaging is vital for optimizing patient outcomes, guiding",
    "entities": []
  },
  {
    "text": "therapeutic strategies, and preventing further complications.",
    "entities": []
  },
  {
    "text": "Copyright \u00a9 2025 Elsevier B.V. All rights reserved.",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "Understanding how patient education affects the process of treatment",
    "entities": []
  },
  {
    "text": "decision-making: Cultural model change in kidney disease therapy.",
    "entities": []
  },
  {
    "text": "Campbell-Montalvo R(1), Ftouni D(2), Shell P(3), Subhash S(3), Pearce K(3),",
    "entities": [
      {
        "text": "Campbell-Montalvo R(1",
        "label": "ORG"
      },
      {
        "text": "Ftouni D(2",
        "label": "PERSON"
      },
      {
        "text": "Shell",
        "label": "ORG"
      },
      {
        "text": "Pearce K(3",
        "label": "PRODUCT"
      }
    ]
  },
  {
    "text": "(1)Research Service, James A. Haley Veterans' Hospital, Tampa, USA; Department",
    "entities": [
      {
        "text": "1)Research Service",
        "label": "ORG"
      },
      {
        "text": "James A. Haley Veterans' Hospital",
        "label": "PERSON"
      },
      {
        "text": "Tampa",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      },
      {
        "text": "Department",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "of Emergency Medicine, Morsani College of Medicine, University of South Florida,",
    "entities": [
      {
        "text": "Emergency Medicine",
        "label": "ORG"
      },
      {
        "text": "Morsani College of Medicine, University of South Florida",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(2)North Florida South Georgia Veteran Healthcare System, Gainesville, USA;",
    "entities": [
      {
        "text": "2)North",
        "label": "CARDINAL"
      },
      {
        "text": "Florida",
        "label": "GPE"
      },
      {
        "text": "Georgia Veteran Healthcare System",
        "label": "ORG"
      },
      {
        "text": "Gainesville",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Social and Behavioral Sciences, University of Florida, Gainesville, USA.",
    "entities": [
      {
        "text": "Social and Behavioral Sciences",
        "label": "ORG"
      },
      {
        "text": "University of Florida",
        "label": "ORG"
      },
      {
        "text": "Gainesville",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)North Florida South Georgia Veteran Healthcare System, Gainesville, USA.",
    "entities": [
      {
        "text": "Florida",
        "label": "GPE"
      },
      {
        "text": "Georgia Veteran Healthcare System",
        "label": "ORG"
      },
      {
        "text": "Gainesville",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)North Florida South Georgia Veteran Healthcare System, Gainesville, USA;",
    "entities": [
      {
        "text": "Florida",
        "label": "GPE"
      },
      {
        "text": "Gainesville",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Division of Nephrology, Hypertension, and Transplantation, Department of",
    "entities": [
      {
        "text": "Division of Nephrology",
        "label": "ORG"
      },
      {
        "text": "Transplantation, Department",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Medicine, University of Florida, Gainesville, USA.",
    "entities": [
      {
        "text": "Medicine, University of Florida",
        "label": "ORG"
      },
      {
        "text": "Gainesville",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "OBJECTIVE: Chronic kidney disease affects 1 in 7 people in the US, and 1 in 6 US",
    "entities": [
      {
        "text": "1",
        "label": "CARDINAL"
      },
      {
        "text": "7",
        "label": "CARDINAL"
      },
      {
        "text": "US",
        "label": "GPE"
      },
      {
        "text": "1",
        "label": "CARDINAL"
      },
      {
        "text": "6",
        "label": "CARDINAL"
      },
      {
        "text": "US",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Veterans. Treatment for kidney failure includes home dialysis, which, despite",
    "entities": [
      {
        "text": "Veterans",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "its benefits, is infrequently used. A major barrier to using home dialysis is",
    "entities": []
  },
  {
    "text": "receiving adequate education about it. This research investigates how patient",
    "entities": []
  },
  {
    "text": "education affects treatment choices of Veterans with kidney disease.",
    "entities": [
      {
        "text": "Veterans",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "METHODS: As part of a randomized control trial, we interviewed 42 US Veterans",
    "entities": [
      {
        "text": "42",
        "label": "CARDINAL"
      },
      {
        "text": "US",
        "label": "GPE"
      },
      {
        "text": "Veterans",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "with advanced chronic kidney disease. An interview based on the Theoretical",
    "entities": []
  },
  {
    "text": "Domains Framework elicited on the impact of study education on decision-making.",
    "entities": [
      {
        "text": "Domains Framework",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Reflexive thematic analysis attuned to cultural model theory-the beliefs which",
    "entities": []
  },
  {
    "text": "motivate behavior held by groups-was used for analysis.",
    "entities": []
  },
  {
    "text": "RESULTS: There were four themes in the data: 1) Pre-education, patients had a",
    "entities": [
      {
        "text": "four",
        "label": "CARDINAL"
      },
      {
        "text": "1",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "lack of knowledge of kidney disease and treatment. 2) After education, patients",
    "entities": [
      {
        "text": "2",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "reacted with surprise and then coping actions. 3) Patients experienced positive",
    "entities": [
      {
        "text": "3",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "emotions and beliefs from education and coping. 4) Patients dealt with diagnosis",
    "entities": [
      {
        "text": "4",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "and engaged in treatment decision-making. Ten cognitive, emotional, and",
    "entities": [
      {
        "text": "Ten",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "behavioral subthemes were seen. Themes were found in the interviews of 76 % of",
    "entities": [
      {
        "text": "76 %",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "participants receiving comprehensive patient education, but only 27 % of those",
    "entities": [
      {
        "text": "only 27 %",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "receiving enhanced usual care.",
    "entities": []
  },
  {
    "text": "CONCLUSION: We provide a mechanistic understanding of the process through which",
    "entities": []
  },
  {
    "text": "education affects cultural models to support patients' decision-making by",
    "entities": []
  },
  {
    "text": "preparing and equipping them to confront the future. We note that cultural model",
    "entities": []
  },
  {
    "text": "changes occur across longitudinal stages, which are recursive with one another",
    "entities": []
  },
  {
    "text": "and dynamic based on the individual case.",
    "entities": []
  },
  {
    "text": "PRACTICE IMPLICATIONS: Because optimal dialysis outcomes require time to plan,",
    "entities": []
  },
  {
    "text": "create, and heal from dialysis access surgery, practitioners should provide",
    "entities": []
  },
  {
    "text": "patient education 6 months prior to estimated start to account for time needed",
    "entities": [
      {
        "text": "6 months",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "for cultural model change. Helping patients know what to expect in terms of",
    "entities": []
  },
  {
    "text": "their own changing understanding may further support.",
    "entities": []
  },
  {
    "text": "Published by Elsevier B.V.",
    "entities": [
      {
        "text": "Elsevier B.V.",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: Declaration of Competing Interest AMS reports",
    "entities": []
  },
  {
    "text": "additional ongoing research support from the US Department of Veterans Affairs,",
    "entities": [
      {
        "text": "the US Department of Veterans Affairs",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Clinical Science Research and Development award I01CX001661, consultancy",
    "entities": [
      {
        "text": "Clinical Science Research and Development award I01CX001661",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "agreements with Chemocentryx Inc, and an advisory or leadership role for the VHA",
    "entities": [
      {
        "text": "Chemocentryx Inc",
        "label": "ORG"
      },
      {
        "text": "VHA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "National Peritoneal Dialysis Workgroup. The other authors declare that they have",
    "entities": [
      {
        "text": "National Peritoneal Dialysis Workgroup",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "53. Clin J Am Soc Nephrol. 2025 Jul 15. doi: 10.2215/CJN.0000000775. Online ahead",
    "entities": [
      {
        "text": "53",
        "label": "CARDINAL"
      },
      {
        "text": "2025",
        "label": "CARDINAL"
      },
      {
        "text": "15",
        "label": "CARDINAL"
      },
      {
        "text": "10.2215",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Fall Risk in Maintenance Hemodialysis Patients: A Secondary Analysis of the HOPE",
    "entities": [
      {
        "text": "HOPE",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(1)Division of Nephrology, Department of Medicine, New York University Grossman",
    "entities": [
      {
        "text": "Nephrology, Department of Medicine",
        "label": "ORG"
      },
      {
        "text": "New York University",
        "label": "ORG"
      },
      {
        "text": "Grossman",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "School of Medicine, New York, NY.",
    "entities": [
      {
        "text": "School of Medicine",
        "label": "ORG"
      },
      {
        "text": "New York",
        "label": "GPE"
      },
      {
        "text": "NY",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(2)Divisions of Nephrology, Geriatrics, and Palliative Medicine, West Virginia",
    "entities": [
      {
        "text": "Nephrology",
        "label": "GPE"
      },
      {
        "text": "Geriatrics",
        "label": "GPE"
      },
      {
        "text": "Palliative Medicine",
        "label": "ORG"
      },
      {
        "text": "West Virginia",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "University School of Medicine, Morgantown, West Virginia.",
    "entities": [
      {
        "text": "University School of Medicine, Morgantown",
        "label": "ORG"
      },
      {
        "text": "West Virginia",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Divisions of Geriatrics and Palliative Medicine, West Virginia University",
    "entities": [
      {
        "text": "3)Divisions",
        "label": "CARDINAL"
      },
      {
        "text": "Geriatrics and Palliative Medicine",
        "label": "ORG"
      },
      {
        "text": "West Virginia University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "School of Medicine, Morgantown, West Virginia.",
    "entities": [
      {
        "text": "School of Medicine",
        "label": "ORG"
      },
      {
        "text": "Morgantown",
        "label": "GPE"
      },
      {
        "text": "West Virginia",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Division of Biostatistics, Department of Population Health, New York",
    "entities": [
      {
        "text": "Biostatistics, Department of Population Health",
        "label": "ORG"
      },
      {
        "text": "New York",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "University Grossman School of Medicine.",
    "entities": [
      {
        "text": "University Grossman School of Medicine",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(5)Renal, Electrolyte and Hypertension Division, Department of Medicine,",
    "entities": [
      {
        "text": "Electrolyte and Hypertension Division",
        "label": "ORG"
      },
      {
        "text": "Department of Medicine",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "University of Pennsylvania Perelman School of Medicine.",
    "entities": [
      {
        "text": "University of Pennsylvania Perelman School of Medicine",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(6)Department of Biostatistics, Epidemiology and Informatics, University of",
    "entities": [
      {
        "text": "Biostatistics, Epidemiology and Informatics, University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Pennsylvania Perelman School of Medicine.",
    "entities": [
      {
        "text": "Pennsylvania Perelman School of Medicine",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(7)Center for Clinical Epidemiology and Biostatistics, Perelman School of",
    "entities": [
      {
        "text": "Clinical Epidemiology and Biostatistics",
        "label": "ORG"
      },
      {
        "text": "Perelman School of\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Medicine, University of Pennsylvania, Philadelphia, PA.",
    "entities": [
      {
        "text": "Medicine, University of Pennsylvania",
        "label": "ORG"
      },
      {
        "text": "Philadelphia",
        "label": "GPE"
      },
      {
        "text": "PA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(8)Department of Biostatistics, Yale School of Public Health, New Haven, CT.",
    "entities": [
      {
        "text": "Biostatistics, Yale School of Public Health",
        "label": "ORG"
      },
      {
        "text": "New Haven",
        "label": "GPE"
      },
      {
        "text": "CT",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(9)Division of Nephrology, Department of Medicine, Massachusetts General",
    "entities": [
      {
        "text": "Nephrology, Department of Medicine",
        "label": "ORG"
      },
      {
        "text": "Massachusetts",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Hospital and Harvard Medical School, Boston, MA.",
    "entities": [
      {
        "text": "Harvard Medical School",
        "label": "ORG"
      },
      {
        "text": "Boston",
        "label": "GPE"
      },
      {
        "text": "MA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(10)National Institutes of Diabetes Digestive and Kidney Diseases, National",
    "entities": [
      {
        "text": "10)National",
        "label": "CARDINAL"
      },
      {
        "text": "Kidney Diseases",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Institutes of Health, Bethesda, Md.",
    "entities": [
      {
        "text": "Institutes of Health",
        "label": "ORG"
      },
      {
        "text": "Bethesda",
        "label": "GPE"
      },
      {
        "text": "Md.",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(11)Department of Biobehavioral Nursing Science, University of Illinois Chicago",
    "entities": [
      {
        "text": "11)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Biobehavioral Nursing Science, University of Illinois Chicago",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "College of Nursing, Chicago, IL.",
    "entities": [
      {
        "text": "Nursing",
        "label": "GPE"
      },
      {
        "text": "Chicago",
        "label": "GPE"
      },
      {
        "text": "IL",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(12)Division of Nephrology, Department. of Medicine, Duke University School of",
    "entities": [
      {
        "text": "12)Division of Nephrology",
        "label": "MONEY"
      },
      {
        "text": "Medicine, Duke University School of\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Medicine, Durham, NC.",
    "entities": [
      {
        "text": "Durham",
        "label": "GPE"
      },
      {
        "text": "NC",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(13)The Berman Center, Hennepin Healthcare Research Institute, Minneapolis, MN.",
    "entities": [
      {
        "text": "13)The Berman Center",
        "label": "ORG"
      },
      {
        "text": "Hennepin Healthcare Research Institute",
        "label": "ORG"
      },
      {
        "text": "Minneapolis",
        "label": "GPE"
      },
      {
        "text": "MN",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(14)Division of Geriatric Medicine and Palliative Care, Department of Medicine,",
    "entities": [
      {
        "text": "14)Division",
        "label": "CARDINAL"
      },
      {
        "text": "Geriatric Medicine and Palliative Care,",
        "label": "ORG"
      },
      {
        "text": "Department of Medicine",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "New York University Grossman School of Medicine.",
    "entities": [
      {
        "text": "New York University Grossman School of Medicine",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(15)Division of Nephrology, Department of Medicine, Tufts Medical Center,",
    "entities": [
      {
        "text": "Department of Medicine",
        "label": "ORG"
      },
      {
        "text": "Tufts Medical Center",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Boston, MA.",
    "entities": [
      {
        "text": "Boston",
        "label": "GPE"
      },
      {
        "text": "MA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(16)Kidney Research Institute, Division of Nephrology, Department of Medicine,",
    "entities": [
      {
        "text": "16)Kidney Research Institute",
        "label": "ORG"
      },
      {
        "text": "Division of Nephrology, Department of Medicine",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "University of Washington School of Medicine, Seattle, WA.",
    "entities": [
      {
        "text": "University of Washington School of Medicine",
        "label": "ORG"
      },
      {
        "text": "Seattle",
        "label": "GPE"
      },
      {
        "text": "WA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "BACKGROUND: Falls are thought to be common in patients undergoing maintenance",
    "entities": []
  },
  {
    "text": "hemodialysis, but little is known about their frequency or outcomes. In this",
    "entities": []
  },
  {
    "text": "prospective study, we sought to increase our knowledge regarding the incidence,",
    "entities": []
  },
  {
    "text": "timing, circumstances, and outcomes of falls in this population.",
    "entities": []
  },
  {
    "text": "METHODS: Between January 2021 and April 2023, adults undergoing maintenance",
    "entities": [
      {
        "text": "Between January 2021",
        "label": "DATE"
      },
      {
        "text": "April 2023",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "hemodialysis from 103 U.S. dialysis facilities were enrolled in the HOPE",
    "entities": [
      {
        "text": "103",
        "label": "CARDINAL"
      },
      {
        "text": "U.S.",
        "label": "GPE"
      },
      {
        "text": "HOPE",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Consortium trial, which randomized participants with moderate or severe chronic",
    "entities": []
  },
  {
    "text": "pain to a pain coping skills cognitive behavioral therapy intervention or usual",
    "entities": []
  },
  {
    "text": "care. Occurrence of falls was a pre-specified trial outcome. The research team",
    "entities": []
  },
  {
    "text": "inquired about falls at each four-week follow-up visit during the 36-week study.",
    "entities": [
      {
        "text": "four-week",
        "label": "DATE"
      },
      {
        "text": "36-week",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "Multivariable regression was used to explore associations of demographic and",
    "entities": []
  },
  {
    "text": "clinical characteristics, including patient-reported symptoms, with fall risk.",
    "entities": []
  },
  {
    "text": "cumulative follow-up period of 429 participant-years for an overall rate of 0.68",
    "entities": [
      {
        "text": "429",
        "label": "CARDINAL"
      },
      {
        "text": "0.68",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "falls per participant-year (95% CI: 0.61, 0.76). Accidents were the most",
    "entities": [
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "0.61",
        "label": "CARDINAL"
      },
      {
        "text": "0.76",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "frequent cause of falls (38%). It was rare for falls to be related to the",
    "entities": [
      {
        "text": "38%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "hemodialysis treatment or to occur in the hemodialysis unit. Of the 293 falls,",
    "entities": [
      {
        "text": "293",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "36 (12%) were evaluated in the emergency department without subsequent",
    "entities": [
      {
        "text": "36",
        "label": "CARDINAL"
      },
      {
        "text": "12%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "hospitalization, 41 (14%) resulted in a hospital admission, and 19 (7%) led to a",
    "entities": [
      {
        "text": "41",
        "label": "CARDINAL"
      },
      {
        "text": "14%",
        "label": "PERCENT"
      },
      {
        "text": "19",
        "label": "CARDINAL"
      },
      {
        "text": "7%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "fracture. In multivariable analyses, neither demographic characteristics",
    "entities": []
  },
  {
    "text": "severity of pain symptoms or medication use such as opioids at enrollment was",
    "entities": []
  },
  {
    "text": "associated with the fall risk.",
    "entities": []
  },
  {
    "text": "CONCLUSIONS: Falls were common in this cohort of maintenance hemodialysis",
    "entities": []
  },
  {
    "text": "patients with chronic pain, occurring in 28% of individuals during a planned",
    "entities": [
      {
        "text": "28%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "follow-up of 36 weeks. Falls rarely occurred in the dialysis unit, with the vast",
    "entities": [
      {
        "text": "36 weeks",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "majority occurring at participants' homes and due to accidental causes. There",
    "entities": []
  },
  {
    "text": "was no significant association between patient-reported symptoms or medication",
    "entities": []
  },
  {
    "text": "use and the risk of subsequent falls.",
    "entities": []
  },
  {
    "text": "Copyright \u00a9 2025 by the American Society of Nephrology.",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "the American Society of Nephrology",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Therapeutic Plasma Exchange and Changes in Calcium, Phosphate, Parathyroid",
    "entities": [
      {
        "text": "Therapeutic Plasma Exchange",
        "label": "ORG"
      },
      {
        "text": "Phosphate",
        "label": "ORG"
      },
      {
        "text": "Parathyroid",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Hormone, and Fibroblast Growth Factor-23.",
    "entities": []
  },
  {
    "text": "Jin SS(1), Dugar A(2), Hoofnagle AN(3), Sanchez AP(4), Ward DM(4), Ix JH(4)(5),",
    "entities": [
      {
        "text": "Jin SS(1",
        "label": "PERSON"
      },
      {
        "text": "Dugar A(2",
        "label": "PERSON"
      },
      {
        "text": "Hoofnagle AN(3",
        "label": "PERSON"
      },
      {
        "text": "Sanchez",
        "label": "GPE"
      },
      {
        "text": "Ward DM(4",
        "label": "PERSON"
      },
      {
        "text": "Ix JH(4)(5",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(1)School of Medicine, University of California San Diego, San Diego, CA.",
    "entities": [
      {
        "text": "1)School of Medicine, University of California San Diego",
        "label": "ORG"
      },
      {
        "text": "San Diego",
        "label": "GPE"
      },
      {
        "text": "CA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(2)Department of Neurology, Icahn School of Medicine at Mount Sinai, New York,",
    "entities": [
      {
        "text": "Neurology",
        "label": "ORG"
      },
      {
        "text": "Icahn School of Medicine",
        "label": "ORG"
      },
      {
        "text": "Mount Sinai",
        "label": "FAC"
      },
      {
        "text": "New York",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Departments of Laboratory Medicine and Pathology and Medicine and the Kidney",
    "entities": [
      {
        "text": "3)Departments",
        "label": "CARDINAL"
      },
      {
        "text": "Laboratory Medicine",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Research Institute, University of Washington, Seattle, WA.",
    "entities": [
      {
        "text": "Research Institute",
        "label": "ORG"
      },
      {
        "text": "University of Washington",
        "label": "ORG"
      },
      {
        "text": "Seattle",
        "label": "GPE"
      },
      {
        "text": "WA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Division of Nephrology-Hypertension, University of California, San Diego, San",
    "entities": [
      {
        "text": "Nephrology-Hypertension",
        "label": "ORG"
      },
      {
        "text": "University of California",
        "label": "ORG"
      },
      {
        "text": "San Diego",
        "label": "GPE"
      },
      {
        "text": "San\n",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(5)Nephrology Section, Veterans Affairs San Diego Healthcare System, San Diego,",
    "entities": [
      {
        "text": "Veterans Affairs",
        "label": "ORG"
      },
      {
        "text": "San Diego Healthcare System",
        "label": "ORG"
      },
      {
        "text": "San Diego",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "CONTEXT: Therapeutic plasma exchange (TPE) removes plasma proteins and other",
    "entities": [
      {
        "text": "TPE",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "unwanted substances, causing non-specific alterations of plasma components. A",
    "entities": []
  },
  {
    "text": "previous study showed \u223c70% reduction in vitamin D metabolites following a single",
    "entities": []
  },
  {
    "text": "TPE treatment, prompting further investigation into TPE's effects on vitamin D",
    "entities": [
      {
        "text": "TPE",
        "label": "ORG"
      },
      {
        "text": "TPE",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "regulators and metabolites: calcium, phosphate, parathyroid hormone (PTH), and",
    "entities": [
      {
        "text": "PTH",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "fibroblast growth factor 23 (FGF-23).",
    "entities": [
      {
        "text": "23",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "OBJECTIVE: This study examined changes in plasma and effluent levels of total",
    "entities": []
  },
  {
    "text": "calcium, phosphate, PTH, and FGF-23 in persons undergoing TPE.",
    "entities": [
      {
        "text": "PTH",
        "label": "ORG"
      },
      {
        "text": "TPE",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "METHODS: Measurements were taken immediately before, immediately after, and at",
    "entities": []
  },
  {
    "text": "follow-up. Paired t-tests compared the percent changes in metabolites from pre-",
    "entities": []
  },
  {
    "text": "to post-TPE.",
    "entities": [
      {
        "text": "post-TPE",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "RESULTS: Study participants (N=42) had a mean age of 55 \u00b1 16 years, 28 (67%)",
    "entities": [
      {
        "text": "N=42",
        "label": "GPE"
      },
      {
        "text": "16 years",
        "label": "DATE"
      },
      {
        "text": "28",
        "label": "DATE"
      },
      {
        "text": "67%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "were female and 32 (76%) were white. TPE led to acute changes in calcium [-9%,",
    "entities": [
      {
        "text": "32",
        "label": "DATE"
      },
      {
        "text": "76%",
        "label": "PERCENT"
      },
      {
        "text": "TPE",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(95% CI -11%, -8%)], phosphate [-14%, (-18%, -11%)], and FGF-23 [-12%, (-18%,",
    "entities": [
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "-11%",
        "label": "PERCENT"
      },
      {
        "text": "-14%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "-6%)] concentrations. In contrast, PTH levels increased [91% (63%, 119%)] from",
    "entities": [
      {
        "text": "-6%",
        "label": "PERCENT"
      },
      {
        "text": "PTH",
        "label": "ORG"
      },
      {
        "text": "91%",
        "label": "PERCENT"
      },
      {
        "text": "63%",
        "label": "PERCENT"
      },
      {
        "text": "119%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "baseline to post-TPE. While most metabolites returned to baseline by the",
    "entities": [
      {
        "text": "post-TPE",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "follow-up visit (median 4 [IQR 3,7] days), nearly 25% of patients experienced",
    "entities": [
      {
        "text": "4",
        "label": "CARDINAL"
      },
      {
        "text": "IQR",
        "label": "ORG"
      },
      {
        "text": "nearly 25%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "persistent asymptomatic hypocalcemia. This persistent calcium deficit was not",
    "entities": []
  },
  {
    "text": "fully corrected by continuous IV calcium gluconate infusions administered during",
    "entities": [
      {
        "text": "IV",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "the study, nor by the endogenously increased PTH levels.",
    "entities": [
      {
        "text": "PTH",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "CONCLUSIONS: These findings underscore the need for improved care protocols and",
    "entities": []
  },
  {
    "text": "vigilant monitoring of mineral metabolism TPE patients, especially those",
    "entities": [
      {
        "text": "TPE",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "receiving long-term treatment. Further research is warranted to understand the",
    "entities": []
  },
  {
    "text": "enduring effects of TPE on mineral metabolism and develop strategies to prevent",
    "entities": [
      {
        "text": "TPE",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "complications.",
    "entities": []
  },
  {
    "text": "\u00a9 The Author(s) 2025. Published by Oxford University Press on behalf of the",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "Oxford University Press",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Endocrine Society.",
    "entities": [
      {
        "text": "Endocrine Society",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "55. J Endourol. 2025 Jul 15. doi: 10.1177/08927790251360011. Online ahead of",
    "entities": [
      {
        "text": "55",
        "label": "CARDINAL"
      },
      {
        "text": "J Endourol",
        "label": "PRODUCT"
      },
      {
        "text": "2025",
        "label": "CARDINAL"
      },
      {
        "text": "15",
        "label": "CARDINAL"
      },
      {
        "text": "10.1177/08927790251360011",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Factors Influencing Oxalate Synthesis in Healthy Volunteers.",
    "entities": [
      {
        "text": "Healthy Volunteers",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Fargue S(1), Knight J(1), Maalouf NM(2), Oster RA(3), Crivelli JJ(1), Assimos",
    "entities": [
      {
        "text": "Knight J(1",
        "label": "PERSON"
      },
      {
        "text": "Maalouf NM(2",
        "label": "PERSON"
      },
      {
        "text": "Oster RA(3",
        "label": "PERSON"
      },
      {
        "text": "Crivelli JJ(1",
        "label": "PERSON"
      },
      {
        "text": "Assimos",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(1)Department of Urology, University of Alabama at Birmingham, Birmingham,",
    "entities": [
      {
        "text": "Urology, University of Alabama at Birmingham",
        "label": "ORG"
      },
      {
        "text": "Birmingham",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Charles and Jane Pak Center of Mineral Metabolism and Clinical Research and",
    "entities": [
      {
        "text": "Jane Pak",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Department of Internal Medicine, University of Texas Southwestern Medical",
    "entities": [
      {
        "text": "Department of Internal Medicine, University of Texas Southwestern Medical",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Center, Dallas, Texas, USA.",
    "entities": [
      {
        "text": "Dallas",
        "label": "GPE"
      },
      {
        "text": "Texas",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Department of Medicine, Division of General Internal Medicine and Population",
    "entities": [
      {
        "text": "Medicine, Division of General Internal Medicine and Population\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Science, University of Alabama at Birmingham, Birmingham, Alabama, USA.",
    "entities": [
      {
        "text": "Science, University of Alabama at Birmingham,",
        "label": "ORG"
      },
      {
        "text": "Birmingham",
        "label": "GPE"
      },
      {
        "text": "Alabama",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Introduction: Urine oxalate excretion influences the risk of calcium oxalate",
    "entities": []
  },
  {
    "text": "kidney stone formation and has been reported to positively correlate with body",
    "entities": []
  },
  {
    "text": "mass index (BMI) and body weight. The two major sources of urine oxalate are",
    "entities": [
      {
        "text": "BMI",
        "label": "ORG"
      },
      {
        "text": "two",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "dietary oxalate absorption and endogenous oxalate synthesis (EOS). In this",
    "entities": [
      {
        "text": "EOS",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "study, we investigated the association between EOS, as estimated by oxalate",
    "entities": [
      {
        "text": "EOS",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "content of 24-hour urine collected while consuming an ultra-low oxalate diet,",
    "entities": [
      {
        "text": "24-hour",
        "label": "TIME"
      }
    ]
  },
  {
    "text": "and measures of body size and composition. Methods: An analysis of prospectively",
    "entities": []
  },
  {
    "text": "performed studies conducted on adults consuming ultra-low oxalate diets between",
    "entities": []
  },
  {
    "text": "January 2018 and January 2025 at the University of Alabama at Birmingham was",
    "entities": [
      {
        "text": "January 2018",
        "label": "DATE"
      },
      {
        "text": "January 2025",
        "label": "DATE"
      },
      {
        "text": "the University of Alabama at Birmingham",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "undertaken. All participants (n = 88) were healthy and had no history of kidney",
    "entities": [
      {
        "text": "88",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "stone disease, hypertension, or diabetes. Participants underwent anthropomorphic",
    "entities": []
  },
  {
    "text": "measurements, and body composition was measured by bioelectrical impedance",
    "entities": []
  },
  {
    "text": "analysis. Urinary oxalate was measured by ion chromatography coupled to mass",
    "entities": []
  },
  {
    "text": "spectrometry. Results: Total urinary oxalate was positively correlated with body",
    "entities": []
  },
  {
    "text": "weight, BMI, lean body muscle mass, appendicular lean muscle mass, waist-to-hip",
    "entities": [
      {
        "text": "BMI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "ratio, and urinary creatinine excretion. There was no significant correlation",
    "entities": []
  },
  {
    "text": "between urinary oxalate excretion and body fat or age. Urinary oxalate excretion",
    "entities": []
  },
  {
    "text": "was different in males and females, even after adjusting for measures of lean",
    "entities": []
  },
  {
    "text": "body composition. Discussion: This analysis of low oxalate controlled diet",
    "entities": []
  },
  {
    "text": "studies in healthy participants suggests lean body mass, not body fat, is the",
    "entities": []
  },
  {
    "text": "major driver of EOS. This study also highlights that oxalate synthesis in lean",
    "entities": [
      {
        "text": "EOS",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "body compartments is different in males and females.",
    "entities": []
  },
  {
    "text": "[Article in English]",
    "entities": [
      {
        "text": "English",
        "label": "LANGUAGE"
      }
    ]
  },
  {
    "text": "Cantrell's pentalogy is a rare syndrome associated with a midline embryological",
    "entities": [
      {
        "text": "Cantrell",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "defect involving a series of malformations: anomalies of the lower sternum,",
    "entities": []
  },
  {
    "text": "anterior diaphragm, heart, and anterior abdominal wall. It can be classified as",
    "entities": []
  },
  {
    "text": "complete, probable or partial, but the most important thing is to describe and",
    "entities": []
  },
  {
    "text": "understand the anomalies involved. We describe a case of a late diagnosis of",
    "entities": []
  },
  {
    "text": "Cantrell's pentalogy at 35 weeks and 5 days of pregnancy in a woman from the",
    "entities": [
      {
        "text": "Cantrell",
        "label": "PERSON"
      },
      {
        "text": "35 weeks",
        "label": "DATE"
      },
      {
        "text": "5 days",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "interior of Par\u00e1 state, an Amazon Brazilian region. Fetal echocardiography",
    "entities": [
      {
        "text": "Par\u00e1",
        "label": "ORG"
      },
      {
        "text": "Amazon Brazilian",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "confirmed the diagnosis of Cantrell's pentalogy with tetralogy of Fallot and",
    "entities": [
      {
        "text": "Cantrell",
        "label": "PERSON"
      },
      {
        "text": "Fallot",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "ultrasound examination showing a bilateral clubfoot. Cesarean section was",
    "entities": []
  },
  {
    "text": "performed at 36 weeks because of pre-eclampsia superimposed on chronic arterial",
    "entities": [
      {
        "text": "36 weeks",
        "label": "DATE"
      },
      {
        "text": "pre-eclampsia",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "hypertension with signs of severity. The male newborn was delivered weighting",
    "entities": []
  },
  {
    "text": "2,320 grams. Postnatal echocardiography confirmed the diagnosis of Cantrell's",
    "entities": [
      {
        "text": "2,320 grams",
        "label": "QUANTITY"
      },
      {
        "text": "Cantrell",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "pentalogy and karyotype was normal (46, XY). Infant was discharged at 47 days of",
    "entities": [
      {
        "text": "46",
        "label": "DATE"
      },
      {
        "text": "XY",
        "label": "ORG"
      },
      {
        "text": "Infant",
        "label": "PERSON"
      },
      {
        "text": "47 days",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "age with good weight gain, artificial breastfeeding, and outpatient follow-up by",
    "entities": []
  },
  {
    "text": "the cardiology and cardiac surgery specialists.",
    "entities": []
  },
  {
    "text": "PMID: 40663450 [Indexed for MEDLINE]",
    "entities": [
      {
        "text": "40663450",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "The association between 1st trimester serum kisspeptin level and antenatal",
    "entities": [
      {
        "text": "between 1st",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "OBJECTIVE: We aimed to evaluate the usefulness of serum kisspeptin (KP),",
    "entities": [
      {
        "text": "serum kisspeptin",
        "label": "PERSON"
      },
      {
        "text": "KP",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "measured in the 1st trimester (11-14 weeks), as a new biomarker that can predict",
    "entities": [
      {
        "text": "1st",
        "label": "ORDINAL"
      },
      {
        "text": "11-14 weeks",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "MATERIALS AND METHODS: A prospective case-control study of prospectively",
    "entities": []
  },
  {
    "text": "collected data. Blood samples of all patients (N = 124) were preserved at -70 \u00b0C",
    "entities": [
      {
        "text": "124",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "for the assessment of serum KP-10 and KP-54 levels. The KP levels were analyzed",
    "entities": [
      {
        "text": "KP-10",
        "label": "PRODUCT"
      },
      {
        "text": "KP-54",
        "label": "PRODUCT"
      },
      {
        "text": "KP",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "for comparison among women who experienced complications including fetal growth",
    "entities": []
  },
  {
    "text": "retardation (FGR), pregnancy-induced hypertension (PIH), preterm delivery,",
    "entities": [
      {
        "text": "FGR",
        "label": "ORG"
      },
      {
        "text": "PIH",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "gestational diabetes, and fetal death. The control group consisted of matching",
    "entities": []
  },
  {
    "text": "subjects who completed their pregnancies without problems. The predictive effect",
    "entities": []
  },
  {
    "text": "of serum KP on adverse pregnancy outcomes was investigated.",
    "entities": []
  },
  {
    "text": "RESULTS: Among all adverse pregnancy outcomes, the KP-10 level was significantly",
    "entities": [
      {
        "text": "KP-10",
        "label": "PRODUCT"
      }
    ]
  },
  {
    "text": "higher in patients who developed FGR (P = 0.025). In the patient cohort affected",
    "entities": [
      {
        "text": "FGR",
        "label": "ORG"
      },
      {
        "text": "0.025",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "by PIH, either accompanied by preeclampsia or standalone, there was a trend",
    "entities": [
      {
        "text": "PIH",
        "label": "ORG"
      },
      {
        "text": "preeclampsia",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "towards higher KP-10 levels (P = 0.059), although statistical significance was",
    "entities": [
      {
        "text": "KP-10",
        "label": "PRODUCT"
      },
      {
        "text": "0.059",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "not achieved. However, regarding KP-10, the calculated cut-off value and the",
    "entities": [
      {
        "text": "KP-10",
        "label": "PRODUCT"
      }
    ]
  },
  {
    "text": "area under the curve (AUC) for predicting the onset of FGR were statistically",
    "entities": [
      {
        "text": "FGR",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "significant (AUC: 0.684; P = 0.006). The model established with KP-10, PIH, and",
    "entities": [
      {
        "text": "0.684",
        "label": "CARDINAL"
      },
      {
        "text": "0.006",
        "label": "CARDINAL"
      },
      {
        "text": "KP-10",
        "label": "GPE"
      },
      {
        "text": "PIH",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "pregnancy associated plasma protein-A (PAPP-A) was found to be significant in",
    "entities": []
  },
  {
    "text": "predicting the development of FGR (P = 0.006; NPV: 98%; PPV: 21.4%; OR: 0.10;",
    "entities": [
      {
        "text": "FGR",
        "label": "ORG"
      },
      {
        "text": "0.006",
        "label": "CARDINAL"
      },
      {
        "text": "NPV",
        "label": "ORG"
      },
      {
        "text": "98%",
        "label": "PERCENT"
      },
      {
        "text": "PPV",
        "label": "ORG"
      },
      {
        "text": "21.4%",
        "label": "PERCENT"
      },
      {
        "text": "0.10",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "95% CI 0.016-0.611).",
    "entities": [
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "0.016-0.611",
        "label": "PRODUCT"
      }
    ]
  },
  {
    "text": "CONCLUSIONS: First trimester maternal serum KP levels may have the potential to",
    "entities": [
      {
        "text": "First",
        "label": "ORDINAL"
      },
      {
        "text": "KP",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "be used as a 1st trimester biomarker that can predict the development of FGR.",
    "entities": [
      {
        "text": "1st",
        "label": "ORDINAL"
      },
      {
        "text": "FGR",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "PMID: 40663448 [Indexed for MEDLINE]",
    "entities": [
      {
        "text": "40663448",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "Analysing risk factors for foetal growth outcomes - the influence of maternal",
    "entities": []
  },
  {
    "text": "conditions and congenital cytomegalovirus infection.",
    "entities": []
  },
  {
    "text": "OBJECTIVE: This study aimed to analyse the risk factors differentiating small",
    "entities": []
  },
  {
    "text": "for gestational age (SGA) and appropriate for gestational age (AGA) neonates.",
    "entities": [
      {
        "text": "AGA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "MATERIALS AND METHODS: A retrospective-prospective cohort study was conducted",
    "entities": []
  },
  {
    "text": "from 2019 to 2024 at the 2nd Department of Obstetrics and Gynaecology,",
    "entities": [
      {
        "text": "2019 to 2024",
        "label": "DATE"
      },
      {
        "text": "2nd",
        "label": "ORDINAL"
      },
      {
        "text": "Department of Obstetrics and Gynaecology",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "University Hospital Bratislava. The study involved 174 term neonates from",
    "entities": [
      {
        "text": "University Hospital Bratislava",
        "label": "ORG"
      },
      {
        "text": "174",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "singleton pregnancies, including 125 SGA and 49 AGA infants. Various maternal,",
    "entities": [
      {
        "text": "125",
        "label": "CARDINAL"
      },
      {
        "text": "49",
        "label": "CARDINAL"
      },
      {
        "text": "AGA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "foetal, and placental risk factors were analysed, with a particular focus on",
    "entities": []
  },
  {
    "text": "congenital cytomegalovirus infection (cCMV).",
    "entities": []
  },
  {
    "text": "RESULTS: Neonates' birth weights ranged from 1,480 to 4,470 grams. Of the risk",
    "entities": [
      {
        "text": "1,480",
        "label": "CARDINAL"
      },
      {
        "text": "4,470 grams",
        "label": "QUANTITY"
      }
    ]
  },
  {
    "text": "factors assessed, only maternal COVID-19 infection during pregnancy was",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "significantly associated with AGA outcomes (P = 0.009). No significant",
    "entities": [
      {
        "text": "AGA",
        "label": "ORG"
      },
      {
        "text": "0.009",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "associations were found between common risk factors (e. g. hypertension,",
    "entities": [
      {
        "text": "associations",
        "label": "ORG"
      },
      {
        "text": "e. g. hypertension",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "diabetes mellitus) and foetal growth restriction. Congenital CMV infection was",
    "entities": [
      {
        "text": "CMV",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "not significantly associated with SGA. Logistic regression analysis confirmed",
    "entities": [
      {
        "text": "SGA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "the association of COVID-19 infection with foetal weight, while no significant",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "effect was observed for CMV.",
    "entities": [
      {
        "text": "CMV",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "CONCLUSION: Maternal COVID-19 infection was associated with AGA outcomes,",
    "entities": [
      {
        "text": "AGA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "potentially due to enhanced medical surveillance and immune responses. However,",
    "entities": []
  },
  {
    "text": "the study's small sample size limits the interpretation of these findings, and",
    "entities": []
  },
  {
    "text": "further research is required to fully understand the impacts of COVID-19 on",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "pregnancy. No significant association between congenital CMV infection and",
    "entities": [
      {
        "text": "CMV",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "foetal growth restriction was found in this cohort, which was most likely due to",
    "entities": []
  },
  {
    "text": "the low prevalence of cCMV. Moreover, documented risk factors for foetal growth",
    "entities": []
  },
  {
    "text": "restriction, including hypertension and diabetes mellitus, were not",
    "entities": []
  },
  {
    "text": "statistically significant in our study population.",
    "entities": []
  },
  {
    "text": "PMID: 40663445 [Indexed for MEDLINE]",
    "entities": []
  },
  {
    "text": "59. J Clin Invest. 2025 Jul 15:e182702. doi: 10.1172/JCI182702. Online ahead of",
    "entities": [
      {
        "text": "59",
        "label": "CARDINAL"
      },
      {
        "text": "Clin Invest",
        "label": "PERSON"
      },
      {
        "text": "2025",
        "label": "CARDINAL"
      },
      {
        "text": "15",
        "label": "CARDINAL"
      },
      {
        "text": "10.1172/JCI182702",
        "label": "MONEY"
      }
    ]
  },
  {
    "text": "Efficacy and safety of a therapeutic humanized FSH-blocking antibody in obesity",
    "entities": [
      {
        "text": "FSH",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "and Alzheimer's disease models.",
    "entities": []
  },
  {
    "text": "(1)Mount Sinai Center for Translational Medicine, Icahn School of Medicine at",
    "entities": [
      {
        "text": "1)Mount",
        "label": "TIME"
      },
      {
        "text": "Sinai Center for Translational Medicine",
        "label": "ORG"
      },
      {
        "text": "Icahn School of Medicine",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Mount Sinai, New York, United States of America.",
    "entities": [
      {
        "text": "Mount Sinai",
        "label": "GPE"
      },
      {
        "text": "New York",
        "label": "GPE"
      },
      {
        "text": "United States of America",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Greehey Children's Cancer Research Institute, University of Texas Health",
    "entities": [
      {
        "text": "Cancer Research Institute",
        "label": "ORG"
      },
      {
        "text": "University of Texas Health",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Science Center at San Antonio, San Antonio, United States of America.",
    "entities": [
      {
        "text": "San Antonio",
        "label": "GPE"
      },
      {
        "text": "San Antonio",
        "label": "GPE"
      },
      {
        "text": "United States of America",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Northeastern Collaborative Access Team, Department of Chemistry and Chemica,",
    "entities": [
      {
        "text": "Collaborative Access Team,",
        "label": "ORG"
      },
      {
        "text": "Department of Chemistry",
        "label": "ORG"
      },
      {
        "text": "Chemica",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Cornell University, Ithaca, United States of America.",
    "entities": [
      {
        "text": "Cornell University",
        "label": "ORG"
      },
      {
        "text": "Ithaca",
        "label": "GPE"
      },
      {
        "text": "United States of America",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(5)Department of Pathology-Comparative Medicine, Wake Forest University School",
    "entities": [
      {
        "text": "5)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Pathology-Comparative Medicine",
        "label": "ORG"
      },
      {
        "text": "Wake Forest University School",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "of Medicine, Winston-Salem, United States of America.",
    "entities": [
      {
        "text": "Winston-Salem",
        "label": "GPE"
      },
      {
        "text": "United States of America",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(6)Division of Endocrinology, Diabetes and Hypertension, Brigham and Women's",
    "entities": []
  },
  {
    "text": "Hospital, Harvard Medical School, Boston, United States of America.",
    "entities": [
      {
        "text": "Harvard Medical School",
        "label": "ORG"
      },
      {
        "text": "Boston",
        "label": "GPE"
      },
      {
        "text": "United States of America",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(7)Institute of Systems, Molecular and Integrative Biology, University of",
    "entities": [
      {
        "text": "Integrative Biology, University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Liverpool, Liverpool, United Kingdom.",
    "entities": [
      {
        "text": "Liverpool",
        "label": "GPE"
      },
      {
        "text": "Liverpool",
        "label": "GPE"
      },
      {
        "text": "United Kingdom",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(8)School of Pharmacy, University College, London, United Kingdom.",
    "entities": [
      {
        "text": "Pharmacy, University College",
        "label": "ORG"
      },
      {
        "text": "London",
        "label": "GPE"
      },
      {
        "text": "United Kingdom",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(9)5MaineHealth Institute for Research, Scarborough, United States of America.",
    "entities": [
      {
        "text": "Institute for Research",
        "label": "ORG"
      },
      {
        "text": "Scarborough",
        "label": "GPE"
      },
      {
        "text": "United States of America",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "There is growing evidence for direct actions of follicle-stimulating hormone",
    "entities": []
  },
  {
    "text": "(FSH) on tissues other than the ovaries and testes. Blocking FSH action, either",
    "entities": [
      {
        "text": "FSH",
        "label": "ORG"
      },
      {
        "text": "FSH",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "genetically or pharmacologically, protects against bone loss, fat gain, and",
    "entities": []
  },
  {
    "text": "memory loss in mice. We thus developed a humanized FSH-blocking",
    "entities": [
      {
        "text": "FSH",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "antibody--MS-Hu6--as a lead therapeutic for three diseases of public health",
    "entities": [
      {
        "text": "three",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "magnitude--osteoporosis, obesity and Alzheimer's disease (AD) that track",
    "entities": []
  },
  {
    "text": "together in post-menopausal women. Here, we report the crystal structure of",
    "entities": [
      {
        "text": "crystal",
        "label": "LOC"
      }
    ]
  },
  {
    "text": "MS-Hu6 and its interaction with FSH in atomistic detail. Using our",
    "entities": [
      {
        "text": "FSH",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Good-Laboratory-Practice-Compliant platform (21CFR58), we formulated MS-Hu6 and",
    "entities": [
      {
        "text": "Good-Laboratory-Practice-Compliant",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "the murine equivalent Hf2 at an ultra-high concentration; both formulated",
    "entities": []
  },
  {
    "text": "antibodies displayed enhanced thermal and colloidal stability. A single",
    "entities": []
  },
  {
    "text": "injection of 89Zr-labelled MS-Hu6 revealed a beta-phase t\u00bd of 89 and 131 hours",
    "entities": [
      {
        "text": "89 and 131 hours",
        "label": "TIME"
      }
    ]
  },
  {
    "text": "for female and male mice, respectively, with retention in regions of interest.",
    "entities": []
  },
  {
    "text": "Female mice injected subcutaneously with Hf2 displayed a dose-dependent",
    "entities": []
  },
  {
    "text": "reduction in body weight and body fat. Hf2 also rescued recognition memory and",
    "entities": []
  },
  {
    "text": "spatial learning loss in a context- and time-dependent manner in AD-prone 3xTg",
    "entities": [
      {
        "text": "AD-prone 3xTg",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "and APP/PS1 mice. MS-Hu6 injected into African green monkeys (8 mg/kg)",
    "entities": [
      {
        "text": "APP",
        "label": "ORG"
      },
      {
        "text": "African",
        "label": "NORP"
      },
      {
        "text": "8 mg/kg",
        "label": "QUANTITY"
      }
    ]
  },
  {
    "text": "intravenously, and then subcutaneously at monthly intervals, was safe, and",
    "entities": [
      {
        "text": "monthly",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "without effects on vitals, blood chemistries or blood counts. There was a",
    "entities": []
  },
  {
    "text": "notable ~4% weight loss in all four monkeys after the first injection, which",
    "entities": [
      {
        "text": "~4",
        "label": "GPE"
      },
      {
        "text": "four",
        "label": "CARDINAL"
      },
      {
        "text": "first",
        "label": "ORDINAL"
      }
    ]
  },
  {
    "text": "continued in two of four monkeys. We thus provide IND-enabling data towards an",
    "entities": [
      {
        "text": "two",
        "label": "CARDINAL"
      },
      {
        "text": "four",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "upcoming first-in-human study.",
    "entities": [
      {
        "text": "first",
        "label": "ORDINAL"
      }
    ]
  },
  {
    "text": "60. Clin J Am Soc Nephrol. 2025 Jul 15. doi: 10.2215/CJN.0000000793. Online ahead",
    "entities": [
      {
        "text": "60",
        "label": "CARDINAL"
      },
      {
        "text": "2025",
        "label": "CARDINAL"
      },
      {
        "text": "15",
        "label": "CARDINAL"
      },
      {
        "text": "10.2215",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Genetic Risk for Hypertension Increases the Effect of Salt Intake on the Risk of",
    "entities": [
      {
        "text": "Genetic Risk for Hypertension Increases the Effect of Salt Intake",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Incident Chronic Kidney Disease.",
    "entities": [
      {
        "text": "Kidney Disease",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(1)Division of Nephrology, Department of Internal Medicine, Korea University",
    "entities": [
      {
        "text": "Nephrology, Department of Internal Medicine",
        "label": "ORG"
      },
      {
        "text": "Korea University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "College of Medicine, Seoul, Republic of Korea.",
    "entities": [
      {
        "text": "College of Medicine",
        "label": "ORG"
      },
      {
        "text": "Seoul",
        "label": "GPE"
      },
      {
        "text": "Republic of Korea",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Department of Internal Medicine, Institute of Kidney Disease Research,",
    "entities": [
      {
        "text": "Internal Medicine, Institute of Kidney Disease Research",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "College of Medicine, Yonsei University, Seoul, Republic of Korea.",
    "entities": [
      {
        "text": "College of Medicine",
        "label": "ORG"
      },
      {
        "text": "Yonsei University",
        "label": "ORG"
      },
      {
        "text": "Seoul",
        "label": "GPE"
      },
      {
        "text": "Republic of Korea",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Division of Nephrology, International Saint Mary's Hospital, Catholic",
    "entities": [
      {
        "text": "Nephrology",
        "label": "GPE"
      },
      {
        "text": "Catholic",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "Kwandong University, Incheon, Republic of Korea.",
    "entities": [
      {
        "text": "Kwandong University",
        "label": "ORG"
      },
      {
        "text": "Incheon",
        "label": "GPE"
      },
      {
        "text": "Republic of Korea",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "BACKGROUND: Although excessive salt intake increases the risk of adverse health",
    "entities": []
  },
  {
    "text": "outcomes, its effects may vary among individuals, supporting the concept of salt",
    "entities": []
  },
  {
    "text": "sensitivity. This study aimed to investigate whether genetic factors,",
    "entities": []
  },
  {
    "text": "represented by the polygenic risk score for hypertension (PRS-hypertension),",
    "entities": []
  },
  {
    "text": "could act as determinants of salt sensitivity and modify the impact of salt",
    "entities": []
  },
  {
    "text": "intake on incident chronic kidney disease (CKD).",
    "entities": []
  },
  {
    "text": "METHODS: Data from UK Biobank were used, including participants of White British",
    "entities": [
      {
        "text": "UK",
        "label": "GPE"
      },
      {
        "text": "Biobank",
        "label": "ORG"
      },
      {
        "text": "White British",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "ancestry without preexisting CKD or hypertension. The primary exposures were the",
    "entities": [
      {
        "text": "CKD",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "self-reported frequency of adding salt to food and the PRS-hypertension tertile",
    "entities": []
  },
  {
    "text": "group. The primary outcome was the development of CKD, analyzed using",
    "entities": [
      {
        "text": "CKD",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "RESULTS: Among 258,555 participants (mean age 55.3 \u00b1 8.1 years, 44% men), 8,686",
    "entities": [
      {
        "text": "258,555",
        "label": "CARDINAL"
      },
      {
        "text": "age 55.3",
        "label": "DATE"
      },
      {
        "text": "8.1 years",
        "label": "DATE"
      },
      {
        "text": "44%",
        "label": "PERCENT"
      },
      {
        "text": "8,686",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "(3%) cases of incident CKD were observed during median follow-up of 13.7 years.",
    "entities": [
      {
        "text": "3%",
        "label": "PERCENT"
      },
      {
        "text": "13.7 years",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "A significant interaction was observed between PRS-hypertension and frequency of",
    "entities": []
  },
  {
    "text": "adding salt with respect to CKD risk (P for multiplicative interaction = 0.001).",
    "entities": [
      {
        "text": "0.001",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "In the high PRS-hypertension group, compared to those who rarely/never added",
    "entities": []
  },
  {
    "text": "salt to food, the adjusted hazard ratio was 1.11 (95% confidence interval [CI],",
    "entities": [
      {
        "text": "1.11",
        "label": "DATE"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "1.02 to 1.21) for those who sometimes added salt, and 1.23 (95% CI, 1.14 to",
    "entities": [
      {
        "text": "1.02",
        "label": "CARDINAL"
      },
      {
        "text": "1.23",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "1.14",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "1.36) for those who usually/always added salt. Additionally, there were",
    "entities": [
      {
        "text": "1.36",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "significant additive interactions between high PRS-hypertension and",
    "entities": []
  },
  {
    "text": "usually/always adding salt on the risk of incident CKD compared with those with",
    "entities": [
      {
        "text": "CKD",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "low PRS-hypertension and who rarely/never added salt (relative excess risk due",
    "entities": [
      {
        "text": "PRS",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "to interaction=0.19; 95% CI: 0.03 to 0.34; attributable proportion=0.15; 95% CI:",
    "entities": [
      {
        "text": "interaction=0.19",
        "label": "GPE"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "0.03",
        "label": "CARDINAL"
      },
      {
        "text": "0.34",
        "label": "CARDINAL"
      },
      {
        "text": "proportion=0.15",
        "label": "ORG"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "0.04 to 0.27).",
    "entities": [
      {
        "text": "0.04",
        "label": "CARDINAL"
      },
      {
        "text": "0.27",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "CONCLUSION: PRS-hypertension modified the association between frequency of",
    "entities": []
  },
  {
    "text": "adding salt and incident CKD. These findings suggest that the effects of high",
    "entities": []
  },
  {
    "text": "sodium intake on kidney function may be influenced by genetic factors.",
    "entities": []
  },
  {
    "text": "PMID: 4066340561. J Am Soc Nephrol. 2025 Jul 15. doi: 10.1681/ASN.0000000797. Online ahead of",
    "entities": [
      {
        "text": "4066340561",
        "label": "DATE"
      },
      {
        "text": "2025",
        "label": "CARDINAL"
      },
      {
        "text": "15",
        "label": "CARDINAL"
      },
      {
        "text": "10.1681",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Measurement, Estimation, and Correlates of the Glomerular Filtration Rate before",
    "entities": [
      {
        "text": "Correlates",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "and after Bariatric Surgery.",
    "entities": [
      {
        "text": "Bariatric Surgery",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Friedman AN(1), Chang AR(2), Chuah LL(3), Favre GA(4), Grangeon-Chapon C(5),",
    "entities": [
      {
        "text": "Friedman AN(1",
        "label": "ORG"
      },
      {
        "text": "Chang AR(2",
        "label": "PERSON"
      },
      {
        "text": "Chuah LL(3",
        "label": "PERSON"
      },
      {
        "text": "Favre GA(4",
        "label": "PERSON"
      },
      {
        "text": "Grangeon-Chapon C(5",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(1)Department of Medicine, Indiana University School of Medicine, Indianapolis,",
    "entities": [
      {
        "text": "Medicine, Indiana University School of Medicine",
        "label": "ORG"
      },
      {
        "text": "Indianapolis",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "IN, USA.",
    "entities": [
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Departments of Nephrology and Population Health Sciences, Geisinger,",
    "entities": [
      {
        "text": "Nephrology and Population Health Sciences",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(3)Department of Endocrinology, King's College Hospital NHS Foundation Trust,",
    "entities": [
      {
        "text": "King's College Hospital NHS Foundation Trust",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "London, United Kingdom.",
    "entities": [
      {
        "text": "London",
        "label": "GPE"
      },
      {
        "text": "United Kingdom",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Nephrology-Dialysis-Transplantation Department, Pasteur Hospital, Universit\u00e9",
    "entities": [
      {
        "text": "4)Nephrology-Dialysis-Transplantation Department",
        "label": "ORG"
      },
      {
        "text": "Pasteur Hospital",
        "label": "ORG"
      },
      {
        "text": "Universit\u00e9\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(5)University C\u00f4te d'Azur, Archet Hospital, University Hospital of Nice,",
    "entities": [
      {
        "text": "Archet Hospital",
        "label": "ORG"
      },
      {
        "text": "University Hospital of Nice",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Department of Nuclear Medicine, Nice, France.",
    "entities": [
      {
        "text": "Department of Nuclear Medicine,",
        "label": "ORG"
      },
      {
        "text": "Nice",
        "label": "GPE"
      },
      {
        "text": "France",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(6)Department of Biostatistics and Health Data Science, Indiana University",
    "entities": [
      {
        "text": "Biostatistics and Health Data Science",
        "label": "ORG"
      },
      {
        "text": "Indiana University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "School of Medicine, Indianapolis, IN, USA.",
    "entities": [
      {
        "text": "School of Medicine",
        "label": "ORG"
      },
      {
        "text": "Indianapolis",
        "label": "GPE"
      },
      {
        "text": "IN",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(7)Richard M. Fairbanks School of Public Health, Indiana University,",
    "entities": [
      {
        "text": "Indiana University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(8)Diabetes Complications Research Centre, University College Dublin, Ireland.",
    "entities": [
      {
        "text": "Complications Research Centre",
        "label": "ORG"
      },
      {
        "text": "University College Dublin",
        "label": "ORG"
      },
      {
        "text": "Ireland",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(9)Division of Nephrology and Hypertension, Department of Internal Medicine,",
    "entities": [
      {
        "text": "Nephrology and Hypertension, Department of Internal Medicine",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Mayo Clinic, Rochester, Minnesota, USA.",
    "entities": [
      {
        "text": "Mayo Clinic",
        "label": "ORG"
      },
      {
        "text": "Rochester",
        "label": "GPE"
      },
      {
        "text": "Minnesota",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(10)Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester,",
    "entities": [
      {
        "text": "10)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Laboratory Medicine",
        "label": "ORG"
      },
      {
        "text": "Mayo Clinic",
        "label": "ORG"
      },
      {
        "text": "Rochester",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(11)Department of Nephrology, Hospital 12 de Octubre, 28041 Madrid, Spain.",
    "entities": [
      {
        "text": "11)Department of Nephrology",
        "label": "MONEY"
      },
      {
        "text": "28041",
        "label": "DATE"
      },
      {
        "text": "Madrid",
        "label": "GPE"
      },
      {
        "text": "Spain",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(12)Research Institute of University Hospital 12 de Octubre (imas12), Department",
    "entities": [
      {
        "text": "12)Research Institute of University Hospital",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "of Medicine, Complutense University of Madrid, 28041 Madrid, Spain.",
    "entities": [
      {
        "text": "Medicine,",
        "label": "ORG"
      },
      {
        "text": "Complutense University of Madrid",
        "label": "ORG"
      },
      {
        "text": "28041",
        "label": "DATE"
      },
      {
        "text": "Madrid",
        "label": "GPE"
      },
      {
        "text": "Spain",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(13)Faculty of Medicine, Instituto de Tecnolog\u00edas Biom\u00e9dicas, University of La",
    "entities": [
      {
        "text": "13)Faculty",
        "label": "CARDINAL"
      },
      {
        "text": "University of La",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(14)Maccabi Healthcare Services, Ramat Hasharon Medical Center, Israel.",
    "entities": [
      {
        "text": "14)Maccabi",
        "label": "CARDINAL"
      },
      {
        "text": "Healthcare Services",
        "label": "ORG"
      },
      {
        "text": "Ramat Hasharon Medical Center",
        "label": "ORG"
      },
      {
        "text": "Israel",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "BACKGROUND: Important questions remain about how bariatric (i.e. weight loss)",
    "entities": []
  },
  {
    "text": "surgery affects measured glomerular filtration rate (mGFR) and estimated GFR",
    "entities": [
      {
        "text": "GFR",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(eGFR) as well as what factors influence change in mGFR post-surgery.",
    "entities": []
  },
  {
    "text": "METHODS: Data were pooled from all seven available studies (dates: 2004-2018)",
    "entities": [
      {
        "text": "seven",
        "label": "CARDINAL"
      },
      {
        "text": "2004-2018",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "measuring GFR pre- and post-bariatric surgery using gold standard methods.",
    "entities": [
      {
        "text": "GFR",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Change in post-surgery mGFR, factors that influence change in mGFR, and effects",
    "entities": []
  },
  {
    "text": "on five GFR-estimating equations were analyzed using standard statistical",
    "entities": [
      {
        "text": "five",
        "label": "CARDINAL"
      },
      {
        "text": "GFR",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "RESULTS: The cohort included 105 individuals from the US and Europe. 68% were",
    "entities": [
      {
        "text": "105",
        "label": "CARDINAL"
      },
      {
        "text": "US",
        "label": "GPE"
      },
      {
        "text": "Europe",
        "label": "LOC"
      },
      {
        "text": "68%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "female, 97% white, mean age was 50 years (range: 24-70), and mean BMI 46\u00b18",
    "entities": [
      {
        "text": "97%",
        "label": "PERCENT"
      },
      {
        "text": "50 years",
        "label": "DATE"
      },
      {
        "text": "24-70",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "kg/m2. Mean pre-surgery mGFR of 107 ml/min (range: 31-215) fell to 92 ml/min",
    "entities": [
      {
        "text": "kg/m2",
        "label": "PERSON"
      },
      {
        "text": "107 ml/min",
        "label": "QUANTITY"
      },
      {
        "text": "31-215",
        "label": "CARDINAL"
      },
      {
        "text": "92 ml/min",
        "label": "QUANTITY"
      }
    ]
  },
  {
    "text": "(-14%, 95% CI: -21, -10) post-surgery, with a strong linear relationship",
    "entities": [
      {
        "text": "-14%",
        "label": "PERCENT"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "existing between pre-surgery mGFR and % change in GFR (r=-0.51; -0.64, -0.35).",
    "entities": [
      {
        "text": "GFR",
        "label": "ORG"
      },
      {
        "text": "-0.64",
        "label": "GPE"
      },
      {
        "text": "-0.35",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Individuals with pre-surgery mGFR \u226590, 60-<90, and <60 ml/min had -25 (-32,",
    "entities": [
      {
        "text": "60 ml/min",
        "label": "QUANTITY"
      }
    ]
  },
  {
    "text": "-19), 1 (-11, 13P=0.82), and 7 (0, 14) ml/min mean postoperative changes in",
    "entities": [
      {
        "text": "-11",
        "label": "NORP"
      },
      {
        "text": "13P=0.82",
        "label": "DATE"
      },
      {
        "text": "7",
        "label": "CARDINAL"
      },
      {
        "text": "0",
        "label": "DATE"
      },
      {
        "text": "14",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "mGFR. Change in weight was significantly correlated with change in mGFR (r=0.22;",
    "entities": []
  },
  {
    "text": "0.03, 0.40). After adjusting for sex, changes in mGFR post-surgery were",
    "entities": [
      {
        "text": "0.03",
        "label": "CARDINAL"
      },
      {
        "text": "0.40",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "associated with higher pre-surgical age (-0.6 ml/min per year; -1.1, -0.2), mGFR",
    "entities": []
  },
  {
    "text": "(-0.5 ml/min per 1 ml/min; -0.6, -0.4) and change in systolic blood pressure",
    "entities": [
      {
        "text": "1 ml/min",
        "label": "QUANTITY"
      }
    ]
  },
  {
    "text": "(-0.3 ml/min per 1 mmHg; -0.6, 0.0). All GFR-estimating equations significantly",
    "entities": [
      {
        "text": "1",
        "label": "CARDINAL"
      },
      {
        "text": "0.0",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "underestimated post-surgical GFR reductions in people with preserved kidney",
    "entities": []
  },
  {
    "text": "function and had improved bias, precision and accuracy when de-indexed and",
    "entities": []
  },
  {
    "text": "applied to individuals with mGFR<90 ml/min.",
    "entities": []
  },
  {
    "text": "CONCLUSIONS: In individuals with obesity undergoing bariatric surgery the",
    "entities": []
  },
  {
    "text": "magnitude of post-surgical decline in mGFR is directly associated with",
    "entities": []
  },
  {
    "text": "pre-surgery GFR and only weakly correlated with weight loss. Additionally,",
    "entities": []
  },
  {
    "text": "GFR-estimating equations' performance improved when de-indexed and used in",
    "entities": []
  },
  {
    "text": "people with reduced kidney function, with the combined creatinine/cystatin C",
    "entities": []
  },
  {
    "text": "equations having the best overall performance.",
    "entities": []
  },
  {
    "text": "62. J Occup Environ Med. 2025 Jul 15. doi: 10.1097/JOM.0000000000003505. Online",
    "entities": [
      {
        "text": "62",
        "label": "CARDINAL"
      },
      {
        "text": "Occup Environ Med",
        "label": "ORG"
      },
      {
        "text": "2025",
        "label": "CARDINAL"
      },
      {
        "text": "10.1097",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Association of Physical Health Indices with Antidepressant and/or Anxiolytic Use",
    "entities": [
      {
        "text": "Association of Physical Health Indices",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "DeVaughn A(1), Go LHT, Bonney T(1), Cohen RA, Shannon B(1), Friedman LS(1),",
    "entities": [
      {
        "text": "Bonney T(1",
        "label": "PERSON"
      },
      {
        "text": "Cohen RA",
        "label": "PERSON"
      },
      {
        "text": "Friedman LS(1",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(1)Department of Environmental and Occupational Health Sciences, School of",
    "entities": [
      {
        "text": "Environmental and Occupational Health Sciences",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Public Health, University of Illinois Chicago, Chicago, Illinois (AD, LHTG, TB,",
    "entities": [
      {
        "text": "Public Health",
        "label": "ORG"
      },
      {
        "text": "University of Illinois Chicago",
        "label": "ORG"
      },
      {
        "text": "Chicago",
        "label": "GPE"
      },
      {
        "text": "Illinois",
        "label": "GPE"
      },
      {
        "text": "LHTG",
        "label": "ORG"
      },
      {
        "text": "TB",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "OBJECTIVE: Most health research on coal miners has focused primarily on",
    "entities": []
  },
  {
    "text": "cardio-respiratory health and injuries, despite the presence of significant risk",
    "entities": []
  },
  {
    "text": "factors for poor mental health in the industry, including illness and pain,",
    "entities": []
  },
  {
    "text": "traumatic experiences, and socio-economic stressors.",
    "entities": []
  },
  {
    "text": "METHODS: Clinical and occupational data from coal miners examined in a West",
    "entities": [
      {
        "text": "West",
        "label": "LOC"
      }
    ]
  },
  {
    "text": "Virginia clinic between 2004-2015 was used to examine associations between",
    "entities": [
      {
        "text": "Virginia",
        "label": "GPE"
      },
      {
        "text": "between 2004-2015",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "physical indicators of health and antidepressant/anxiolytic medication use",
    "entities": []
  },
  {
    "text": "(proxy for depression/anxiety) through multivariable models.",
    "entities": []
  },
  {
    "text": "RESULTS: Antidepressant/anxiolytic use was prevalent (33%) in this population.",
    "entities": [
      {
        "text": "33%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "Lung function impairment, hypertension, cardiovascular disease, chronic pain,",
    "entities": [
      {
        "text": "Lung",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "and trauma significantly increased the odds of antidepressant/anxiolytic",
    "entities": []
  },
  {
    "text": "CONCLUSIONS: This study reveals a high burden of depression and/or anxiety among",
    "entities": []
  },
  {
    "text": "U.S. coal miners and underscores the importance of evaluating this workforce for",
    "entities": [
      {
        "text": "U.S.",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "their mental health, which has largely been ignored to date.",
    "entities": []
  },
  {
    "text": "Copyright \u00a9 2025 American College of Occupational and Environmental Medicine.",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "American College of Occupational and Environmental Medicine",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "63. Reproduction. 2025 Jul 15:REP-24-0182. doi: 10.1530/REP-24-0182. Online ahead",
    "entities": [
      {
        "text": "63",
        "label": "CARDINAL"
      },
      {
        "text": "Reproduction",
        "label": "TIME"
      },
      {
        "text": "2025",
        "label": "CARDINAL"
      },
      {
        "text": "15",
        "label": "CARDINAL"
      },
      {
        "text": "10.1530",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Epicatechin inhibits inflammatory injury in preeclampsia extravillous",
    "entities": [
      {
        "text": "Epicatechin inhibits inflammatory injury",
        "label": "ORG"
      },
      {
        "text": "preeclampsia",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "trophoblasts.",
    "entities": []
  },
  {
    "text": "(1)Hainan Provincial Key Laboratory for human reproductive medicine and Genetic",
    "entities": [
      {
        "text": "Provincial Key Laboratory",
        "label": "ORG"
      },
      {
        "text": "Genetic",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "Research, Hainan Provincial Clinical Research Center for Thalassemia, Department",
    "entities": [
      {
        "text": "Hainan Provincial Clinical Research Center",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "of Reproductive Medicine, The First Affiliated Hospital of Hainan Medical",
    "entities": [
      {
        "text": "Reproductive Medicine",
        "label": "ORG"
      },
      {
        "text": "The First Affiliated Hospital",
        "label": "ORG"
      },
      {
        "text": "Hainan Medical",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "University, Hainan Medical University, Haikou, Hainan 571199, China.",
    "entities": [
      {
        "text": "Hainan Medical University",
        "label": "ORG"
      },
      {
        "text": "Haikou",
        "label": "GPE"
      },
      {
        "text": "Hainan 571199",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Key Laboratory of Reproductive Health Diseases Research and",
    "entities": [
      {
        "text": "2)Key Laboratory of Reproductive Health Diseases Research",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Translation(Hainan Medical University), Ministry of Education, Haikou, Hainan",
    "entities": [
      {
        "text": "Translation(Hainan Medical University",
        "label": "ORG"
      },
      {
        "text": "Ministry of Education",
        "label": "ORG"
      },
      {
        "text": "Haikou",
        "label": "GPE"
      },
      {
        "text": "Hainan",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Haikou Key Laboratory for Preservation of Human Genetic Resource, The First",
    "entities": [
      {
        "text": "3)Haikou Key Laboratory for Preservation of Human Genetic Resource",
        "label": "ORG"
      },
      {
        "text": "First",
        "label": "ORDINAL"
      }
    ]
  },
  {
    "text": "Affiliated Hospital of Hainan Medical University, Hainan Medical University,",
    "entities": [
      {
        "text": "Affiliated Hospital",
        "label": "ORG"
      },
      {
        "text": "Hainan Medical University",
        "label": "ORG"
      },
      {
        "text": "Hainan Medical University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(4)Department of Obstetrics and Gynecology, Reproductive Medicine, Nanfang",
    "entities": [
      {
        "text": "Obstetrics and Gynecology",
        "label": "ORG"
      },
      {
        "text": "Reproductive Medicine",
        "label": "ORG"
      },
      {
        "text": "Nanfang",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Hospital, Southern Medical University, Guangzhou, Guangdong 510515, China.",
    "entities": [
      {
        "text": "Southern Medical University",
        "label": "ORG"
      },
      {
        "text": "Guangzhou",
        "label": "GPE"
      },
      {
        "text": "Guangdong 510515",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(5)Key Laboratory of Natural Products Research and Development from Li Folk",
    "entities": [
      {
        "text": "5)Key Laboratory of Natural Products Research and Development",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Medicine of Hainan Province, Institute of Tropical Bioscience and Biotechnology,",
    "entities": [
      {
        "text": "Hainan Province",
        "label": "GPE"
      },
      {
        "text": "Institute of Tropical Bioscience",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Chinese Academy of Tropical Agricultural Sciences, Haikou, Hainan 570216, China.",
    "entities": [
      {
        "text": "Chinese Academy of Tropical Agricultural Sciences",
        "label": "ORG"
      },
      {
        "text": "Haikou",
        "label": "GPE"
      },
      {
        "text": "Hainan 570216",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "IN BRIEF: Preeclampsia is a severe pregnancy-related complication that can",
    "entities": [
      {
        "text": "BRIEF",
        "label": "ORG"
      },
      {
        "text": "Preeclampsia",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "result in adverse maternal and fetal outcomes. Current therapeutic options for",
    "entities": []
  },
  {
    "text": "preeclampsia remain limited. This study demonstrates that epicatechin can",
    "entities": [
      {
        "text": "preeclampsia remain limited",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "inhibit pyroptosis in extravillous trophoblasts and block the activation of the",
    "entities": []
  },
  {
    "text": "NF-\u03baB signaling pathway, thereby offering a novel therapeutic approach for the",
    "entities": [
      {
        "text": "NF-\u03baB",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "management of preeclampsia.",
    "entities": [
      {
        "text": "preeclampsia",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "ABSTRACT: Preeclampsia (PE) is characterized as new-onset hypertension and",
    "entities": [
      {
        "text": "Preeclampsia",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "proteinuria after 20 weeks of gestation, and affects 5%-7% pregnant women",
    "entities": [
      {
        "text": "20 weeks",
        "label": "DATE"
      },
      {
        "text": "5%-7%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "globally. PE is associated with a systemic inflammatory status that is overly",
    "entities": [
      {
        "text": "PE",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "activated and contributes to dysregulated extravillous trophoblasts (EVTs)",
    "entities": []
  },
  {
    "text": "invasion and impaired spiral vessel remodeling. Recent studies showed that",
    "entities": []
  },
  {
    "text": "inhibition of systematic inflammatory response significantly ameliorates the",
    "entities": []
  },
  {
    "text": "PE-like symptoms, suggesting that anti-inflammation could be a potential PE",
    "entities": []
  },
  {
    "text": "treatment. However, few effective therapeutic strategies have been shown to",
    "entities": []
  },
  {
    "text": "control systemic inflammation in PE patients. In the current study, we",
    "entities": [
      {
        "text": "PE",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "investigated the protective effects of epicatechin (EC), one small molecule",
    "entities": [
      {
        "text": "EC",
        "label": "ORG"
      },
      {
        "text": "one",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "compound that exhibits excellent anti-inflammatory activity, on HTR8/SVneo cells",
    "entities": []
  },
  {
    "text": "and EVTs stimulated with lipopolysaccharide (LPS). Our results revealed that EC",
    "entities": [
      {
        "text": "LPS",
        "label": "ORG"
      },
      {
        "text": "EC",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "pretreatment significantly improved cellular viability and attenuated the",
    "entities": []
  },
  {
    "text": "inflammatory response of EVTs in response to LPS stimulation. Mechanistically,",
    "entities": [
      {
        "text": "LPS",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "we found that EC significantly blocked the activation of the LPS-induced",
    "entities": [
      {
        "text": "EC",
        "label": "ORG"
      },
      {
        "text": "LPS",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "pyroptosis pathway of classical pyrin domain protein 3, cleaved caspase 1 and",
    "entities": [
      {
        "text": "3",
        "label": "CARDINAL"
      },
      {
        "text": "1",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "cleaved gasdermin D (NLRP3/Caspase-1/GSDMD) in LPS-treated EVTs and inhibited",
    "entities": [
      {
        "text": "NLRP3",
        "label": "ORG"
      },
      {
        "text": "LPS",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "interleukin-1\u03b2 (IL-1\u03b2) expression (a hallmark of pyroptosis) by suppressing the",
    "entities": [
      {
        "text": "IL-1\u03b2",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "nuclear factor-\u03baB (NF-\u03baB) signaling. Our study demonstrates the protective",
    "entities": [
      {
        "text": "NF-\u03baB",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "effects of EC on LPS-stimulated and provide the direct evidence in vitro that EC",
    "entities": [
      {
        "text": "EC",
        "label": "ORG"
      },
      {
        "text": "LPS",
        "label": "ORG"
      },
      {
        "text": "EC",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "may be a promising compound that mitigates the PE-associated systemic",
    "entities": []
  },
  {
    "text": "inflammation.",
    "entities": []
  },
  {
    "text": "64. J Proteome Res. 2025 Jul 15. doi: 10.1021/acs.jproteome.5c00094. Online ahead",
    "entities": [
      {
        "text": "64",
        "label": "CARDINAL"
      },
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "10.1021",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Plasma Metabolomics and Machine Learning Reveals Metabolic Alterations and",
    "entities": [
      {
        "text": "Plasma Metabolomics",
        "label": "ORG"
      },
      {
        "text": "Machine Learning Reveals Metabolic Alterations",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Diagnostic Biomarkers for Deep Venous Thrombosis in Hypertensive Patients after",
    "entities": [
      {
        "text": "Diagnostic Biomarkers for Deep Venous Thrombosis",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(1)Key Laboratory of Biomedical Information Engineering of Ministry of",
    "entities": [
      {
        "text": "Laboratory of Biomedical Information Engineering of Ministry",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Education, Key Laboratory of Biology Multi-omics and Diseases in Shaanxi",
    "entities": [
      {
        "text": "Key Laboratory",
        "label": "ORG"
      },
      {
        "text": "Diseases",
        "label": "PERSON"
      },
      {
        "text": "Shaanxi",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Province Higher Education Institutions, Biomedical Informatics & Genomics",
    "entities": [
      {
        "text": "Province Higher Education Institutions, Biomedical Informatics & Genomics",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Center, School of Life Science and Technology, Xi'an Jiaotong University, Xi'an,",
    "entities": [
      {
        "text": "Center, School of Life Science and Technology",
        "label": "ORG"
      },
      {
        "text": "Xi'an Jiaotong University",
        "label": "ORG"
      },
      {
        "text": "Xi'an",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Department of Biochemistry and Molecular Biology, Federal University",
    "entities": [
      {
        "text": "Biochemistry and Molecular Biology",
        "label": "ORG"
      },
      {
        "text": "Federal University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(3)Department of Trauma Surgery, Honghui Hospital, Xi'an Jiaotong University,",
    "entities": [
      {
        "text": "Trauma Surgery",
        "label": "PERSON"
      },
      {
        "text": "Honghui Hospital",
        "label": "ORG"
      },
      {
        "text": "Xi'an Jiaotong University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "We aimed to explore the metabolic dysregulations and diagnostic biomarkers for",
    "entities": []
  },
  {
    "text": "post-traumatic deep venous thrombosis (pt-DVT) in hypertensive (HPT) patients",
    "entities": []
  },
  {
    "text": "after fracture. An untargeted ultraperformance liquid chromatography-mass",
    "entities": []
  },
  {
    "text": "spectrometry-based metabolomics approach was employed to perform a comprehensive",
    "entities": []
  },
  {
    "text": "metabolic analysis of plasma samples of 80 patients with post-traumatic deep",
    "entities": [
      {
        "text": "80",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "venous thrombosis and hypertension (pt-DVT&HPT) and 117 patients with",
    "entities": [
      {
        "text": "117",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "hypertension only (HPT). Thirty-seven (37) differential metabolites were",
    "entities": [
      {
        "text": "Thirty-seven",
        "label": "CARDINAL"
      },
      {
        "text": "37",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "identified between pt-DVT&HPT and HPT patients. Purine metabolism, citric acid",
    "entities": []
  },
  {
    "text": "cycle, sphingolipid metabolism, histidine metabolism, aminoacyl-tRNA",
    "entities": []
  },
  {
    "text": "biosynthesis, valine, leucine, and isoleucine degradation were the most",
    "entities": []
  },
  {
    "text": "significantly altered metabolic pathways in pt-DVT in HPT patients.",
    "entities": []
  },
  {
    "text": "Metabolite-protein interaction network analysis unveils ten (10) proteins/genes",
    "entities": [
      {
        "text": "ten",
        "label": "CARDINAL"
      },
      {
        "text": "10",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "that could serve as therapeutic targets. Multivariate methods with Unbiased",
    "entities": []
  },
  {
    "text": "Variable selection in the R package (MUVR) algorithm identified four metabolites",
    "entities": [
      {
        "text": "four",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "as novel biomarkers for pt-DVT&HPT, and receiver operating characteristics (ROC)",
    "entities": [
      {
        "text": "ROC",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "analysis showed that a predictive model based on the four biomarkers",
    "entities": [
      {
        "text": "four",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "(l-carnitine, lactic acid, adenine, and l-acetylcarnitine) exhibited better",
    "entities": []
  },
  {
    "text": "predictive capability for pt-DVT than the D-Dimer. The integration of these",
    "entities": []
  },
  {
    "text": "diagnostic biomarkers and D-Dimer increased its diagnostic potential. The",
    "entities": []
  },
  {
    "text": "generalization ability of this biomarker panel was validated in an independent",
    "entities": []
  },
  {
    "text": "cohort. This study contributed to our understanding of metabolic alterations",
    "entities": []
  },
  {
    "text": "associated with pt-DVT and paved the way for early diagnosis of pt-DVT in HPT",
    "entities": []
  },
  {
    "text": "65. J Nephrol. 2025 Jul 15. doi: 10.1007/s40620-025-02334-1. Online ahead of",
    "entities": [
      {
        "text": "65",
        "label": "CARDINAL"
      },
      {
        "text": "2025",
        "label": "CARDINAL"
      },
      {
        "text": "15",
        "label": "CARDINAL"
      },
      {
        "text": "10.1007",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Potentially reversible severe cardiac involvement in thrombotic",
    "entities": []
  },
  {
    "text": "microangiopathies with malignant hypertension.",
    "entities": []
  },
  {
    "text": "(1)Nephrology, Dialysis and Transplantation Unit, Careggi University Hospital,",
    "entities": [
      {
        "text": "Dialysis and Transplantation Unit",
        "label": "ORG"
      },
      {
        "text": "Careggi University Hospital",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "3, 50134, Florence, Italy. silvia.menale@unifi.it.",
    "entities": [
      {
        "text": "3, 50134",
        "label": "DATE"
      },
      {
        "text": "Florence",
        "label": "GPE"
      },
      {
        "text": "Italy",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Division of Cardiovascular and Perioperative Medicine, Cardiothoracovascular",
    "entities": [
      {
        "text": "Cardiovascular",
        "label": "ORG"
      },
      {
        "text": "Cardiothoracovascular",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "(4)Department of Biomedical Experimental and Clinical Sciences \"Mario Serio\",",
    "entities": [
      {
        "text": "Biomedical Experimental",
        "label": "ORG"
      },
      {
        "text": "Clinical Sciences",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "University of Florence, 50121, Florence, Italy.",
    "entities": [
      {
        "text": "University of Florence",
        "label": "ORG"
      },
      {
        "text": "50121",
        "label": "DATE"
      },
      {
        "text": "Florence",
        "label": "GPE"
      },
      {
        "text": "Italy",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(5)Division of General Cardiology, Careggi University Hospital, Largo Brambilla,",
    "entities": [
      {
        "text": "General Cardiology",
        "label": "ORG"
      },
      {
        "text": "Careggi University Hospital",
        "label": "ORG"
      },
      {
        "text": "Largo Brambilla",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "3, 50134, Florence, Italy.",
    "entities": [
      {
        "text": "3, 50134",
        "label": "DATE"
      },
      {
        "text": "Florence",
        "label": "GPE"
      },
      {
        "text": "Italy",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(6)Division of Cardiovascular and Perioperative Medicine, Cardiothoracovascular",
    "entities": [
      {
        "text": "Cardiothoracovascular",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "BACKGROUND: Thrombotic microangiopathy (TMA) represents a pathological response",
    "entities": [
      {
        "text": "TMA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "to endothelial damage, caused by genetic or acquired factors. It includes",
    "entities": []
  },
  {
    "text": "conditions like thrombotic thrombocytopenic purpura, atypical hemolytic uremic",
    "entities": []
  },
  {
    "text": "syndrome (aHUS), and secondary TMAs. Malignant hypertension can both result from",
    "entities": []
  },
  {
    "text": "and trigger TMA. This study aims to identify risk factors for severe cardiac",
    "entities": [
      {
        "text": "TMA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "involvement, defined as a left ventricular ejection fraction \u2264 50%, in patients",
    "entities": [
      {
        "text": "50%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "with concomitant TMA and malignant hypertension, and to investigate the",
    "entities": [
      {
        "text": "TMA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "evolution of cardiac anomalies post-TMA remission.",
    "entities": []
  },
  {
    "text": "METHODS: We retrospectively collected data of 33 patients with TMA and malignant",
    "entities": [
      {
        "text": "33",
        "label": "CARDINAL"
      },
      {
        "text": "TMA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "hypertension, admitted to our hospital between January 2014 and December 2023.",
    "entities": [
      {
        "text": "between January 2014",
        "label": "DATE"
      },
      {
        "text": "December 2023",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "Patients were followed up to monitor kidney function, blood pressure, and",
    "entities": []
  },
  {
    "text": "hematological parameters, and those with severe cardiac involvement at admission",
    "entities": []
  },
  {
    "text": "underwent repeated echocardiograms. Genetic testing for complement factors was",
    "entities": []
  },
  {
    "text": "performed to identify aHUS cases.",
    "entities": []
  },
  {
    "text": "RESULTS: Severe cardiac involvement was diagnosed in 9 patients, all of whom",
    "entities": [
      {
        "text": "9",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "exhibited left ventricular hypertrophy and varying degrees of diastolic",
    "entities": []
  },
  {
    "text": "dysfunction and valve regurgitation. Patients with severe cardiac involvement",
    "entities": []
  },
  {
    "text": "had significantly higher interventricular septal and posterior wall thickness at",
    "entities": []
  },
  {
    "text": "admission. Over a mean follow up of 42 months, all patients with severe cardiac",
    "entities": [
      {
        "text": "42 months",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "involvement showed recovery of left ventricular systolic function. Patients with",
    "entities": []
  },
  {
    "text": "severe cardiac involvement had a higher incidence of respiratory failure [5/9",
    "entities": [
      {
        "text": "5/9",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "(56%) vs 2/24 (8%) patients, p = 0.003] and kidney failure [7/9 (78%) vs 8/24",
    "entities": [
      {
        "text": "56%",
        "label": "PERCENT"
      },
      {
        "text": "2/24",
        "label": "CARDINAL"
      },
      {
        "text": "8%",
        "label": "PERCENT"
      },
      {
        "text": "0.003",
        "label": "CARDINAL"
      },
      {
        "text": "7/9",
        "label": "CARDINAL"
      },
      {
        "text": "78%",
        "label": "PERCENT"
      },
      {
        "text": "8/24",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "CONCLUSIONS: Severe cardiac involvement in TMA associated with malignant",
    "entities": [
      {
        "text": "TMA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "hypertension is common but largely reversible. Early identification and tailored",
    "entities": []
  },
  {
    "text": "treatment can lead to improved outcomes. This study highlights the importance of",
    "entities": []
  },
  {
    "text": "comprehensive cardiac assessment in managing TMA patients with malignant",
    "entities": [
      {
        "text": "TMA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "hypertension.",
    "entities": []
  },
  {
    "text": "\u00a9 2025. The Author(s) under exclusive licence to Italian Society of Nephrology.",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "Italian Society of Nephrology",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "DOI: 10.1007/s40620-025-02334-1",
    "entities": [
      {
        "text": "10.1007",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: Declarations. Conflict of interest: None.",
    "entities": []
  },
  {
    "text": "Ethical approval: Approval was obtained from the local ethics committee.",
    "entities": []
  },
  {
    "text": "Informed consent to participate: At admission, the patient signed a generic",
    "entities": []
  },
  {
    "text": "informed consent form for the treatment of personal data and publication.",
    "entities": []
  },
  {
    "text": "66. High Blood Press Cardiovasc Prev. 2025 Jul 15. doi:",
    "entities": [
      {
        "text": "66",
        "label": "CARDINAL"
      },
      {
        "text": "High Blood Press Cardiovasc Prev",
        "label": "ORG"
      },
      {
        "text": "15",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "10.1007/s40292-025-00727-8. Online ahead of print.",
    "entities": [
      {
        "text": "10.1007",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Association Between Elevated Lipoprotein(a) and Diastolic Dysfunction: A",
    "entities": [
      {
        "text": "Lipoprotein(a",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Retrospective Cohort Study.",
    "entities": []
  },
  {
    "text": "Sheashaa H(#)(1), Awad K(#)(1), Mohammed A(2), Farina JM(1), Abbas MT(1), Pietri",
    "entities": [
      {
        "text": "Mohammed A(2",
        "label": "PERSON"
      },
      {
        "text": "Farina JM(1",
        "label": "PERSON"
      },
      {
        "text": "Abbas MT(1",
        "label": "PERSON"
      },
      {
        "text": "Pietri",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(1)Department of Cardiovascular Medicine, Mayo Clinic, 5777 E Mayo Blvd,",
    "entities": [
      {
        "text": "Cardiovascular Medicine",
        "label": "ORG"
      },
      {
        "text": "Mayo Clinic",
        "label": "ORG"
      },
      {
        "text": "5777",
        "label": "CARDINAL"
      },
      {
        "text": "Mayo Blvd",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(2)Mayo Clinic Alix School of Medicine Phoenix, Phoenix, AZ, USA.",
    "entities": [
      {
        "text": "Clinic Alix School of Medicine Phoenix",
        "label": "ORG"
      },
      {
        "text": "Phoenix",
        "label": "GPE"
      },
      {
        "text": "AZ",
        "label": "ORG"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Department of Cardiovascular Medicine, Mayo Clinic, 5777 E Mayo Blvd,",
    "entities": [
      {
        "text": "Cardiovascular Medicine",
        "label": "ORG"
      },
      {
        "text": "Mayo Clinic",
        "label": "ORG"
      },
      {
        "text": "5777",
        "label": "CARDINAL"
      },
      {
        "text": "Mayo Blvd",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Phoenix, AZ, 85054, USA. Arsanjani.Reza@mayo.edu.",
    "entities": [
      {
        "text": "Phoenix",
        "label": "GPE"
      },
      {
        "text": "AZ",
        "label": "ORG"
      },
      {
        "text": "85054",
        "label": "DATE"
      },
      {
        "text": "USA",
        "label": "GPE"
      },
      {
        "text": "Arsanjani.Reza@mayo.edu",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "INTRODUCTION: Lipoprotein(a) [Lp(a)] has been linked to myocardial fibrosis and",
    "entities": [
      {
        "text": "Lipoprotein(a",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "endothelial dysfunction, proposed mechanisms for diastolic dysfunction (DD).",
    "entities": []
  },
  {
    "text": "This study assessed the association between elevated Lp(a) (\u2265 50 mg/dL) and DD",
    "entities": [
      {
        "text": "\u2265",
        "label": "PERSON"
      },
      {
        "text": "50",
        "label": "MONEY"
      },
      {
        "text": "DD",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "in patients with preserved ejection fraction (EF).",
    "entities": []
  },
  {
    "text": "AIM: We analyzed 1492 adults (median age59) with an Lp(a) measurement and",
    "entities": [
      {
        "text": "AIM",
        "label": "ORG"
      },
      {
        "text": "1492",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "METHODS: Diastolicdysfunction required \u2265 3 abnormal echo parameters, as per",
    "entities": [
      {
        "text": "\u2265",
        "label": "PERSON"
      },
      {
        "text": "3",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "recent guidelines. Logisticregression adjusting for potential confounders was",
    "entities": []
  },
  {
    "text": "RESULTS: Seventy-sevenpatients (5.1%) had DD. Lp(a) \u2265 50 mg/dL was not",
    "entities": [
      {
        "text": "Seventy",
        "label": "CARDINAL"
      },
      {
        "text": "5.1%",
        "label": "PERCENT"
      },
      {
        "text": "DD",
        "label": "GPE"
      },
      {
        "text": "\u2265",
        "label": "PERSON"
      },
      {
        "text": "50",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "associated with DD [adjusted oddsratio (aOR): 0.89, 95% confidence interval",
    "entities": [
      {
        "text": "DD",
        "label": "GPE"
      },
      {
        "text": "0.89",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "(CI): 0.49-1.54]. However, age (aOR:1.03, p = 0.026), hypertension (aOR: 1.83, p",
    "entities": [
      {
        "text": "CI",
        "label": "PERSON"
      },
      {
        "text": "0.49",
        "label": "CARDINAL"
      },
      {
        "text": "0.026",
        "label": "CARDINAL"
      },
      {
        "text": "1.83",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "diseases (aOR: 1.90, p = 0.043) were associated withDD, while statin therapy was",
    "entities": [
      {
        "text": "1.90",
        "label": "CARDINAL"
      },
      {
        "text": "0.043",
        "label": "CARDINAL"
      },
      {
        "text": "statin",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "associated with reduced risk (aOR: 0.51, p = 0.016).",
    "entities": [
      {
        "text": "0.51",
        "label": "CARDINAL"
      },
      {
        "text": "0.016",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "CONCLUSIONS: In the setting of preserved EF, Lp(a) was not associated with",
    "entities": []
  },
  {
    "text": "DD,emphasizing management of traditional CV risks.",
    "entities": [
      {
        "text": "CV",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "DOI: 10.1007/s40292-025-00727-8",
    "entities": [
      {
        "text": "10.1007",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "have no competing interests to declare that are relevant to the content of this",
    "entities": []
  },
  {
    "text": "article. Ethical approval: The study was approved by the Mayo Clinic",
    "entities": [
      {
        "text": "the Mayo Clinic",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Institutional Review Board, with informed consent waived due to its",
    "entities": [
      {
        "text": "Institutional Review Board",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "67. High Blood Press Cardiovasc Prev. 2025 Jul 15. doi:",
    "entities": [
      {
        "text": "67",
        "label": "CARDINAL"
      },
      {
        "text": "High Blood Press Cardiovasc Prev",
        "label": "ORG"
      },
      {
        "text": "15",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "10.1007/s40292-025-00731-y. Online ahead of print.",
    "entities": [
      {
        "text": "10.1007",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Impact of the Teach-Back Method on Patients Engagement with Digital Technology",
    "entities": [
      {
        "text": "the Teach-Back Method on Patients Engagement",
        "label": "ORG"
      },
      {
        "text": "Digital Technology",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "in Hypertension Management: A Longitudinal Study.",
    "entities": [
      {
        "text": "Hypertension Management",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(1)Center for Nursing Research and Innovation, Faculty of Medicine and Surgery,",
    "entities": [
      {
        "text": "Nursing Research and Innovation, Faculty of Medicine and Surgery",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Vita-Salute San Raffaele University, Milan, Italy.",
    "entities": [
      {
        "text": "Vita-Salute San Raffaele University",
        "label": "ORG"
      },
      {
        "text": "Milan",
        "label": "GPE"
      },
      {
        "text": "Italy",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Center for Nursing Research and Innovation, Faculty of Medicine and Surgery,",
    "entities": [
      {
        "text": "2)Center",
        "label": "CARDINAL"
      },
      {
        "text": "Nursing Research and Innovation, Faculty of Medicine and Surgery",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Vita-Salute San Raffaele University, Milan, Italy. marcomini.ilaria@unisr.it.",
    "entities": [
      {
        "text": "Vita-Salute San Raffaele University",
        "label": "ORG"
      },
      {
        "text": "Milan",
        "label": "GPE"
      },
      {
        "text": "Italy",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Department of Electronics Information and Bioengineering, Politecnico di",
    "entities": [
      {
        "text": "Electronics Information and Bioengineering",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(5)Department of Medicine and Surgery, University of Milano-Bicocca, Milan,",
    "entities": [
      {
        "text": "University of Milano-Bicocca",
        "label": "ORG"
      },
      {
        "text": "Milan",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "INTRODUCTION: The teach-back method is an effective strategy for enhancing",
    "entities": []
  },
  {
    "text": "explored the impact of combining this educational approach with wearable devices",
    "entities": []
  },
  {
    "text": "AIM: This study aimed to evaluate the effectiveness of a teach-back-based",
    "entities": [
      {
        "text": "AIM",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "educational approach in promoting engagement with wearable devices among",
    "entities": []
  },
  {
    "text": "patients with hypertension.",
    "entities": []
  },
  {
    "text": "METHODS: A longitudinal study was conducted. The study included 76 patients and",
    "entities": [
      {
        "text": "76",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "included three phases. In the first phase (T0), patients received training about",
    "entities": [
      {
        "text": "three",
        "label": "CARDINAL"
      },
      {
        "text": "first",
        "label": "ORDINAL"
      },
      {
        "text": "T0",
        "label": "PRODUCT"
      }
    ]
  },
  {
    "text": "the use of two wearable technology devices through the teach-back method.",
    "entities": [
      {
        "text": "two",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Immediately afterward, participants completed the TWente Engagement with",
    "entities": []
  },
  {
    "text": "E-health Technologies Scale (TWEETS) to measure engagement at T0. Patient",
    "entities": [
      {
        "text": "Technologies Scale",
        "label": "PERSON"
      },
      {
        "text": "T0",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "engagement was reassessed at 6 (T1) and 12 weeks (T2) after the educational",
    "entities": [
      {
        "text": "6",
        "label": "CARDINAL"
      },
      {
        "text": "T1",
        "label": "NORP"
      },
      {
        "text": "12 weeks",
        "label": "DATE"
      },
      {
        "text": "T2",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "training. A repeated-measures ANOVA was performed to compare the mean scores",
    "entities": [
      {
        "text": "ANOVA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "across the three phases.",
    "entities": [
      {
        "text": "three",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "RESULTS: The statistical analysis revealed no significant change in the TWEETS",
    "entities": [
      {
        "text": "TWEETS",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "score between T0 and T1 (p = 0.42). However, the score significantly decreased",
    "entities": [
      {
        "text": "T0",
        "label": "PRODUCT"
      },
      {
        "text": "0.42",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "at T2 compared to the previous two time points (p < 0.002).",
    "entities": [
      {
        "text": "T2",
        "label": "CARDINAL"
      },
      {
        "text": "two",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "CONCLUSIONS: Our results suggest that the teach-back method is effective for",
    "entities": []
  },
  {
    "text": "maintaining patient engagement in the short to medium term. However, its impact",
    "entities": []
  },
  {
    "text": "appears to decrease over time. Nurses can use the teach-back method to support",
    "entities": []
  },
  {
    "text": "education and enhance engagement with digital technology among hypertensive",
    "entities": []
  },
  {
    "text": "patients. Further research is needed to explore whether combining teach-back",
    "entities": []
  },
  {
    "text": "with additional strategies, such as gamification, telemedicine, remote",
    "entities": []
  },
  {
    "text": "monitoring, or peer support, can help sustain long-term patient engagement with",
    "entities": []
  },
  {
    "text": "digital health technologies.",
    "entities": [
      {
        "text": "digital health technologies",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: Declarations. Institutional Review Board",
    "entities": [
      {
        "text": "Institutional Review Board",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Statement: The study was conducted in accordance with the Declaration of",
    "entities": [
      {
        "text": "the Declaration of\n",
        "label": "WORK_OF_ART"
      }
    ]
  },
  {
    "text": "Helsinki and approved by the Ethics Committee of IRCCS Istituto Auxologico",
    "entities": [
      {
        "text": "the Ethics Committee of IRCCS Istituto Auxologico",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Italiano (protocol code n. 2021_03_23_15, 23rd march, 2023). Informed Consent:",
    "entities": [
      {
        "text": "2021_03_23_15, 23rd march, 2023",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "Informed consent was obtained from all subjects involved in the study. Use of",
    "entities": []
  },
  {
    "text": "Artificial Intelligence: AI or AI-assisted tools were not used in drafting any",
    "entities": [
      {
        "text": "AI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "aspect of this manuscript. Conflict of interest: The authors declare no",
    "entities": []
  },
  {
    "text": "conflicts of interest.",
    "entities": []
  },
  {
    "text": "From Type 2 Diabetes Mellitus To Diabetic Cardiomyopathy - A Systematic Review",
    "entities": []
  },
  {
    "text": "On The Role Of MicroRNA.",
    "entities": [
      {
        "text": "The Role Of MicroRNA",
        "label": "WORK_OF_ART"
      }
    ]
  },
  {
    "text": "(1)Department of Cardiology, Hypertension and Internal Medicine, Medical",
    "entities": [
      {
        "text": "Cardiology, Hypertension and Internal Medicine, Medical\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "University of Warsaw, Warszawa, Poland.",
    "entities": [
      {
        "text": "University of Warsaw",
        "label": "ORG"
      },
      {
        "text": "Warszawa",
        "label": "GPE"
      },
      {
        "text": "Poland",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Department of Cardiology, Hypertension and Internal Medicine, Medical",
    "entities": [
      {
        "text": "Cardiology, Hypertension and Internal Medicine, Medical\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "University of Warsaw, Warszawa, Poland. dominika.klmczak@wum.edu.pl.",
    "entities": [
      {
        "text": "University of Warsaw",
        "label": "ORG"
      },
      {
        "text": "Warszawa",
        "label": "GPE"
      },
      {
        "text": "Poland",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Department of Clinical Chemistry and Laboratory Diagnostics, Medical",
    "entities": [
      {
        "text": "Clinical Chemistry and Laboratory Diagnostics",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "University of Warsaw, 02-097, Warsaw, Poland.",
    "entities": [
      {
        "text": "University of Warsaw",
        "label": "ORG"
      },
      {
        "text": "02",
        "label": "CARDINAL"
      },
      {
        "text": "Warsaw",
        "label": "GPE"
      },
      {
        "text": "Poland",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Department of Heart Failure and Cardiac Rehabilitation, Medical University of",
    "entities": [
      {
        "text": "Heart Failure",
        "label": "ORG"
      },
      {
        "text": "Cardiac Rehabilitation",
        "label": "ORG"
      },
      {
        "text": "Medical University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "PURPOSE OF REVIEW: Diabetes mellitus (DM) is a growing global health concern,",
    "entities": [
      {
        "text": "PURPOSE OF REVIEW",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "and diabetic cardiomyopathy (DCM) affects up to 12% of individuals with",
    "entities": [
      {
        "text": "up to 12%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "diabetes, leading to myocardial hypertrophy, ventricular remodeling, and",
    "entities": []
  },
  {
    "text": "contractile dysfunction, ultimately progressing to heart failure (HF). This",
    "entities": []
  },
  {
    "text": "review explores the role of microRNAs (miRNAs) in DCM development and their",
    "entities": []
  },
  {
    "text": "potential as diagnostic and therapeutic biomarkers.",
    "entities": []
  },
  {
    "text": "RECENT FINDINGS: MicroRNAs, short single-stranded non-coding RNAs, are key",
    "entities": []
  },
  {
    "text": "regulators of various pathophysiological processes in DCM. By modulating gene",
    "entities": []
  },
  {
    "text": "expression, they influence critical signaling pathways involved in inflammation,",
    "entities": []
  },
  {
    "text": "apoptosis, pyroptosis, oxidative stress, and fibrosis, all of which contribute",
    "entities": []
  },
  {
    "text": "to DCM progression. Emerging research suggests that miRNAs could serve as",
    "entities": []
  },
  {
    "text": "early-stage biomarkers for asymptomatic DCM and may offer novel therapeutic",
    "entities": []
  },
  {
    "text": "targets. This systematic review compiles current findings from both animal and",
    "entities": []
  },
  {
    "text": "human studies on the role of miRNAs in DCM. It highlights their potential in the",
    "entities": []
  },
  {
    "text": "early diagnosis and treatment of DCM, underscoring the need for further research",
    "entities": [
      {
        "text": "DCM",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "to translate these insights into clinical applications.",
    "entities": []
  },
  {
    "text": "DOI: 10.1007/s11892-025-01590-6",
    "entities": [
      {
        "text": "10.1007",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "PMID: 40663215 [Indexed for MEDLINE]",
    "entities": [
      {
        "text": "40663215",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: Declarations. Ethical Approval: This article",
    "entities": [
      {
        "text": "Ethical Approval",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "does not contain any studies with human or animal subjects performed by any of",
    "entities": []
  },
  {
    "text": "the authors. Conflict of Interest: The authors declare no competing interests.",
    "entities": []
  },
  {
    "text": "Human and Animal Rights and Informed Consent: This article does not contain any",
    "entities": []
  },
  {
    "text": "studies with human or animal subjects performed by any of the authors.",
    "entities": []
  },
  {
    "text": "69. Pediatr Cardiol. 2025 Jul 15. doi: 10.1007/s00246-025-03939-w. Online ahead",
    "entities": [
      {
        "text": "69",
        "label": "CARDINAL"
      },
      {
        "text": "Pediatr Cardiol",
        "label": "ORG"
      },
      {
        "text": "2025",
        "label": "CARDINAL"
      },
      {
        "text": "15",
        "label": "CARDINAL"
      },
      {
        "text": "10.1007",
        "label": "CARDINAL"
      },
      {
        "text": "025-03939-w.",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Long-Term Outcome Following Prenatal Diagnosis of Transposition of the Great",
    "entities": []
  },
  {
    "text": "Lillitos P(1), Moriarty G(1), Witter T(1), Austin C(1), Miller O(1), Sharland",
    "entities": [
      {
        "text": "Lillitos P(1",
        "label": "PERSON"
      },
      {
        "text": "Moriarty G(1",
        "label": "WORK_OF_ART"
      },
      {
        "text": "Witter T(1",
        "label": "PERSON"
      },
      {
        "text": "Austin",
        "label": "PERSON"
      },
      {
        "text": "Miller",
        "label": "PERSON"
      },
      {
        "text": "Sharland",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(1)Department of Congenital Heart Disease, Evelina London Children's Hospital,",
    "entities": [
      {
        "text": "Congenital Heart Disease",
        "label": "ORG"
      },
      {
        "text": "Evelina London Children's Hospital",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Guy's & St Thomas' NHS Trust, Westminster Bridge Road, London, SE1 7EH, UK.",
    "entities": [
      {
        "text": "Guy's & St Thomas' NHS Trust",
        "label": "ORG"
      },
      {
        "text": "Westminster Bridge Road",
        "label": "FAC"
      },
      {
        "text": "London",
        "label": "GPE"
      },
      {
        "text": "7EH",
        "label": "GPE"
      },
      {
        "text": "UK",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)School of Biomedical Engineering & Imaging Sciences, King's College London,",
    "entities": [
      {
        "text": "Biomedical Engineering & Imaging Sciences",
        "label": "ORG"
      },
      {
        "text": "King's College London",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "London, UK.",
    "entities": [
      {
        "text": "London",
        "label": "GPE"
      },
      {
        "text": "UK",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Department of Congenital Heart Disease, Evelina London Children's Hospital,",
    "entities": [
      {
        "text": "Evelina London Children's Hospital",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(4)School of Biomedical Engineering & Imaging Sciences, King's College London,",
    "entities": [
      {
        "text": "Biomedical Engineering & Imaging Sciences",
        "label": "ORG"
      },
      {
        "text": "King's College London",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "London, UK. trisha.v.vigneswaran@kcl.ac.uk.",
    "entities": [
      {
        "text": "London",
        "label": "GPE"
      },
      {
        "text": "UK",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Outcomes following the arterial switch operation (ASO) are well documented.",
    "entities": [
      {
        "text": "ASO",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Survival and long-term morbidity for fetuses diagnosed with dextro-transposition",
    "entities": []
  },
  {
    "text": "of the great arteries (d-TGA) are less reported. We aimed to document survival,",
    "entities": []
  },
  {
    "text": "reinterventions and morbidity for prenatally diagnosed d-TGA to inform prenatal",
    "entities": []
  },
  {
    "text": "counseling. Fetuses with d-TGA with or without ventricular septal defect (VSD)",
    "entities": [
      {
        "text": "VSD",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "diagnosed between 1995 and 2022 at our institution were reviewed. Outcomes were",
    "entities": [
      {
        "text": "between 1995 and 2022",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "compared to postnatally diagnosed patients undergoing intervention during the",
    "entities": []
  },
  {
    "text": "same era. Two hundred and seven fetuses were diagnosed resulting in 201",
    "entities": [
      {
        "text": "Two hundred and seven",
        "label": "CARDINAL"
      },
      {
        "text": "201",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "livebirths, 2 intrauterine demise, and 4 pregnancy terminations. There were 137",
    "entities": [
      {
        "text": "2",
        "label": "CARDINAL"
      },
      {
        "text": "4",
        "label": "CARDINAL"
      },
      {
        "text": "137",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "(68.2%) with isolated d-TGA and 64 (31.8%) with d-TGA-VSD. Median birthweight",
    "entities": [
      {
        "text": "68.2%",
        "label": "PERCENT"
      },
      {
        "text": "64",
        "label": "DATE"
      },
      {
        "text": "31.8%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "3.21 kg (IQR 2.94-3.5 kg), and median birth gestation 38 weeks (IQR 38-39).",
    "entities": [
      {
        "text": "3.21 kg",
        "label": "QUANTITY"
      },
      {
        "text": "38 weeks",
        "label": "DATE"
      },
      {
        "text": "IQR",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Preoperative balloon atrial septostomy (BAS) was performed in 126/201(62.7%). No",
    "entities": [
      {
        "text": "BAS",
        "label": "PERSON"
      },
      {
        "text": "126/201(62.7%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "patients died prior to BAS. Three died before ASO following BAS. ASO was",
    "entities": [
      {
        "text": "BAS",
        "label": "PERSON"
      },
      {
        "text": "Three",
        "label": "CARDINAL"
      },
      {
        "text": "ASO",
        "label": "ORG"
      },
      {
        "text": "BAS",
        "label": "PERSON"
      },
      {
        "text": "ASO",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "performed in 198/201(98.5%) with 45/198(22.7%) having concomitant VSD closure.",
    "entities": [
      {
        "text": "198/201(98.5%",
        "label": "PERCENT"
      },
      {
        "text": "45/198(22.7%",
        "label": "PERCENT"
      },
      {
        "text": "VSD",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Thirty-day survival for ASO was 95.5%. Survival over the study period was",
    "entities": [
      {
        "text": "Thirty-day",
        "label": "DATE"
      },
      {
        "text": "ASO",
        "label": "ORG"
      },
      {
        "text": "95.5%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "186/201(92.5%). During the same period, 91 infants were referred for surgery",
    "entities": [
      {
        "text": "186/201(92.5%",
        "label": "PERCENT"
      },
      {
        "text": "91",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "with postnatal diagnosis, and 90 underwent ASO. There was no significant",
    "entities": [
      {
        "text": "90",
        "label": "CARDINAL"
      },
      {
        "text": "ASO",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "difference in 30-day or long-term survival following ASO according to timing of",
    "entities": [
      {
        "text": "30-day",
        "label": "DATE"
      },
      {
        "text": "ASO",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "diagnosis. Three prenatally diagnosed patients undergoing the ASO were lost to",
    "entities": [
      {
        "text": "Three",
        "label": "CARDINAL"
      },
      {
        "text": "ASO",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "follow up. There was no significant difference in reintervention rates",
    "entities": []
  },
  {
    "text": "prenatally diagnosed patients included myocardial dysfunction 3/195(1.5%),",
    "entities": [
      {
        "text": "3/195(1.5%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "pulmonary hypertension 1/195(0.5%), supraventricular tachycardia 3/195(1.5%),",
    "entities": [
      {
        "text": "pulmonary",
        "label": "PERSON"
      },
      {
        "text": "1/195(0.5%",
        "label": "PERCENT"
      },
      {
        "text": "3/195(1.5%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "neurological morbidity 9/195(4.6%), and autism 11/195(5.6%), and none were",
    "entities": [
      {
        "text": "9/195(4.6%",
        "label": "PERCENT"
      },
      {
        "text": "11/195(5.6%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "statistically different to the postnatal group. Survival following prenatal",
    "entities": []
  },
  {
    "text": "diagnosis of d-TGA is good. In the prenatally diagnosed cohort there were no",
    "entities": [
      {
        "text": "TGA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "deaths prior to BAS. Three died after BAS, with one of these deaths attributable",
    "entities": [
      {
        "text": "BAS",
        "label": "PERSON"
      },
      {
        "text": "Three",
        "label": "CARDINAL"
      },
      {
        "text": "BAS",
        "label": "PERSON"
      },
      {
        "text": "one",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "to newborn hypoxia between BAS and ASO. Following ASO, most patients survive",
    "entities": [
      {
        "text": "BAS",
        "label": "PERSON"
      },
      {
        "text": "ASO",
        "label": "ORG"
      },
      {
        "text": "ASO",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "into third decade following prenatal diagnosis. Reintervention occurred in 9.2%.",
    "entities": [
      {
        "text": "third decade",
        "label": "DATE"
      },
      {
        "text": "9.2%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "Neurological and behavioral morbidity affected approximately 1 in 20 patients.",
    "entities": [
      {
        "text": "20",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Outcomes for those with prenatal diagnosis of d-TGA are comparable with the",
    "entities": []
  },
  {
    "text": "patients that undergo ASO following postnatal diagnosis, but this excludes",
    "entities": [
      {
        "text": "ASO",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "patients with a postnatal diangosis who did not survive to cardiac intervention.",
    "entities": []
  },
  {
    "text": "This data will be helpful for prenatal counseling.",
    "entities": []
  },
  {
    "text": "\u00a9 2025. Crown.",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "Crown",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "COVID-19 pandemic impact on clinical condition capture in real-world data: an",
    "entities": []
  },
  {
    "text": "assessment framework.",
    "entities": []
  },
  {
    "text": "(1)Department of Pharmaceutical Outcomes and Policy, College of Pharmacy,",
    "entities": [
      {
        "text": "Pharmaceutical Outcomes",
        "label": "ORG"
      },
      {
        "text": "Policy, College of Pharmacy",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "University of Florida, Gainesville, FL, United States of America.",
    "entities": [
      {
        "text": "University of Florida",
        "label": "ORG"
      },
      {
        "text": "Gainesville",
        "label": "GPE"
      },
      {
        "text": "FL",
        "label": "ORG"
      },
      {
        "text": "United States of America",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Department of Population Medicine, Harvard Medical School and Harvard Pilgrim",
    "entities": [
      {
        "text": "Population Medicine",
        "label": "ORG"
      },
      {
        "text": "Harvard Medical School",
        "label": "ORG"
      },
      {
        "text": "Harvard Pilgrim",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Health Care Institute, Boston, MA, United States of America.",
    "entities": [
      {
        "text": "Health Care Institute",
        "label": "ORG"
      },
      {
        "text": "Boston",
        "label": "GPE"
      },
      {
        "text": "MA",
        "label": "GPE"
      },
      {
        "text": "United States of America",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Background The COVID-19 pandemic has impacted healthcare utilization and,",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "consequently, real-world data. In this study, we used analytical and data",
    "entities": []
  },
  {
    "text": "visualization approaches to untangle effects on condition measurement and true",
    "entities": []
  },
  {
    "text": "shifts in the patient population seeking healthcare. Methods We used MerativeTM",
    "entities": []
  },
  {
    "text": "MarketScan\u00ae 2018-2020 commercial claims data to develop 24 monthly cohorts of",
    "entities": [
      {
        "text": "2018-2020",
        "label": "DATE"
      },
      {
        "text": "24",
        "label": "CARDINAL"
      },
      {
        "text": "monthly",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "patients aged \u226518 years with 12 months baseline enrollment and an encounter for",
    "entities": [
      {
        "text": "years",
        "label": "DATE"
      },
      {
        "text": "12 months",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "diabetes, cancer, hypertension, depression, myocardial infarction (MI), atrial",
    "entities": []
  },
  {
    "text": "fibrillation (Afib), or urinary tract infections (UTI) as the index condition in",
    "entities": [
      {
        "text": "UTI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "a given month. We compared monthly prevalence of each condition in 2020 vs.",
    "entities": [
      {
        "text": "a given month",
        "label": "DATE"
      },
      {
        "text": "monthly",
        "label": "DATE"
      },
      {
        "text": "2020",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "2019. We then imposed 3, 6, and 12-month look-back periods (LBP) to capture",
    "entities": [
      {
        "text": "2019",
        "label": "DATE"
      },
      {
        "text": "3",
        "label": "CARDINAL"
      },
      {
        "text": "6",
        "label": "DATE"
      },
      {
        "text": "12-month",
        "label": "DATE"
      },
      {
        "text": "LBP",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "comorbidities grouped by Clinical Classifications Software Refined (CCSR) or",
    "entities": [
      {
        "text": "Clinical Classifications Software Refined",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "summarized in the Charleson Comorbidity Index (CCI) and conducted similar 2020",
    "entities": [
      {
        "text": "CCI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "varied across conditions with strongest declines for cancer in April 2020",
    "entities": [
      {
        "text": "April 2020",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "(-57.4%) and strongest increases for depression in December 2020 (+11.8%). The",
    "entities": [
      {
        "text": "December 2020",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "mean CCI was higher for most conditions during the spring of 2020 and this",
    "entities": [
      {
        "text": "CCI",
        "label": "GPE"
      },
      {
        "text": "the spring of 2020",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "difference was accentuated by applying a longer LBP. Similar trends were found",
    "entities": []
  },
  {
    "text": "regarding the number of CCSR categories. Conclusion Pandemic-related changes in",
    "entities": [
      {
        "text": "CCSR",
        "label": "PRODUCT"
      }
    ]
  },
  {
    "text": "condition capture were complex, involving both increases and decreases in",
    "entities": []
  },
  {
    "text": "encounters for specific conditions and in comorbidities, along with variations",
    "entities": []
  },
  {
    "text": "in comorbidity capture dependent on look-back periods. We provided a practical",
    "entities": []
  },
  {
    "text": "approach to untangle these phenomena along with open-source algorithms and",
    "entities": []
  },
  {
    "text": "visualization tools to assess these changes and inform study design and",
    "entities": []
  },
  {
    "text": "Johns Hopkins Bloomberg School of Public Health. All rights reserved. For",
    "entities": [
      {
        "text": "Johns Hopkins Bloomberg School of Public Health",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "10.1016/j.mayocp.2025.03.017. Online ahead of print.",
    "entities": [
      {
        "text": "10.1016",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Responses of Kidney Transplant Recipients to Vaccination and Boosting.",
    "entities": []
  },
  {
    "text": "Schinstock CA(6), Isham CR(7), Kumanovics A(7), Ahmad N(8), Simonson RB(8),",
    "entities": [
      {
        "text": "Isham",
        "label": "PERSON"
      },
      {
        "text": "Kumanovics",
        "label": "NORP"
      },
      {
        "text": "Ahmad N(8",
        "label": "PERSON"
      },
      {
        "text": "Simonson",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Ryser MF(8), Tapia-Cealle G(9), Badley AD(10), Stegall MD(4).",
    "entities": [
      {
        "text": "Ryser MF(8",
        "label": "PERSON"
      },
      {
        "text": "Tapia-Cealle G(9",
        "label": "ORG"
      },
      {
        "text": "Badley",
        "label": "ORG"
      },
      {
        "text": "Stegall MD(4",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(1)Department of Surgery and Immunology, Mayo Clinic, Rochester, MN, USA.",
    "entities": [
      {
        "text": "Surgery and Immunology",
        "label": "ORG"
      },
      {
        "text": "Mayo Clinic",
        "label": "ORG"
      },
      {
        "text": "Rochester",
        "label": "GPE"
      },
      {
        "text": "MN,",
        "label": "ORG"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Department of Medicine, Mayo Clinic, Phoenix, AZ, USA.",
    "entities": [
      {
        "text": "Medicine, Mayo Clinic",
        "label": "ORG"
      },
      {
        "text": "Phoenix",
        "label": "GPE"
      },
      {
        "text": "AZ",
        "label": "ORG"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Division of Nephrology and Hypertension, Mayo Clinic, Jacksonville, FL, USA.",
    "entities": [
      {
        "text": "Nephrology and Hypertension",
        "label": "ORG"
      },
      {
        "text": "Mayo Clinic",
        "label": "ORG"
      },
      {
        "text": "Jacksonville",
        "label": "GPE"
      },
      {
        "text": "FL",
        "label": "ORG"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Department of Surgery and Immunology, Mayo Clinic, Rochester, MN, USA.",
    "entities": [
      {
        "text": "Surgery and Immunology",
        "label": "ORG"
      },
      {
        "text": "Mayo Clinic",
        "label": "ORG"
      },
      {
        "text": "Rochester",
        "label": "GPE"
      },
      {
        "text": "MN,",
        "label": "ORG"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(5)Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.",
    "entities": [
      {
        "text": "Health Sciences Research",
        "label": "ORG"
      },
      {
        "text": "Mayo Clinic",
        "label": "ORG"
      },
      {
        "text": "Rochester",
        "label": "GPE"
      },
      {
        "text": "MN,",
        "label": "ORG"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(6)Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN, USA.",
    "entities": [
      {
        "text": "Nephrology and Hypertension",
        "label": "ORG"
      },
      {
        "text": "Mayo Clinic",
        "label": "ORG"
      },
      {
        "text": "Rochester",
        "label": "GPE"
      },
      {
        "text": "MN,",
        "label": "ORG"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(7)Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN,",
    "entities": [
      {
        "text": "Laboratory Medicine and Pathology",
        "label": "ORG"
      },
      {
        "text": "Mayo Clinic",
        "label": "ORG"
      },
      {
        "text": "Rochester",
        "label": "GPE"
      },
      {
        "text": "MN",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(8)Janssen Scientific Affairs, LLC, Titusville, NJ, USA.",
    "entities": [
      {
        "text": "Scientific Affairs",
        "label": "ORG"
      },
      {
        "text": "LLC",
        "label": "ORG"
      },
      {
        "text": "Titusville",
        "label": "PERSON"
      },
      {
        "text": "NJ",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(9)Janssen Vaccines and Prevention, Leiden, the Netherlands.",
    "entities": [
      {
        "text": "9)Janssen",
        "label": "CARDINAL"
      },
      {
        "text": "Vaccines and Prevention",
        "label": "ORG"
      },
      {
        "text": "Leiden",
        "label": "GPE"
      },
      {
        "text": "Netherlands",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(10)Division of Infectious Diseases, Mayo Clinic, Rochester, MN, USA.",
    "entities": [
      {
        "text": "Mayo Clinic",
        "label": "ORG"
      },
      {
        "text": "Rochester",
        "label": "GPE"
      },
      {
        "text": "MN,",
        "label": "ORG"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "OBJECTIVE: To assess heterologous booster (HB) with Janssen Ad26.COV2.S in",
    "entities": [
      {
        "text": "HB",
        "label": "ORG"
      },
      {
        "text": "Janssen",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "kidney transplant recipients (KTRs) with low antibody levels after multiple",
    "entities": [
      {
        "text": "KTRs",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "PATIENTS AND METHODS: This multicenter study examined anti-spike protein",
    "entities": []
  },
  {
    "text": "antibody levels in KTRs with two or more doses of mRNA vaccinations. Enrollment",
    "entities": [
      {
        "text": "two",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "was from April 11, 2022, to September 19, 2023. Kidney transplant recipients",
    "entities": [
      {
        "text": "April 11, 2022",
        "label": "DATE"
      },
      {
        "text": "September 19, 2023",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "with low levels (LL, 0.4-250 IU/mL) were offered HB with Janssen Ad26.COV2.S",
    "entities": [
      {
        "text": "LL",
        "label": "ORG"
      },
      {
        "text": "0.4-250",
        "label": "CARDINAL"
      },
      {
        "text": "HB",
        "label": "ORG"
      },
      {
        "text": "Janssen Ad26.COV2.S\n",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "vaccine. Those with undetectable levels (UL, <0.4 IU/mL) were randomized to HB",
    "entities": [
      {
        "text": "HB",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "with or without immunosuppression adjustment. The primary endpoint was",
    "entities": []
  },
  {
    "text": "anti-spike protein antibody levels greater than 250 IU/mL (high level [HL]) at",
    "entities": []
  },
  {
    "text": "28 days after HB. Subset analysis included lymphocyte, immunoglobulin, and",
    "entities": [
      {
        "text": "28 days",
        "label": "DATE"
      },
      {
        "text": "HB",
        "label": "ORG"
      },
      {
        "text": "immunoglobulin",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "COVID-19-specific T- and B-cell levels.",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "RESULTS: Of the 419 unique KTRs assessed, 80.0% (n=335) were HL, 12.9% (n=54)",
    "entities": [
      {
        "text": "419",
        "label": "CARDINAL"
      },
      {
        "text": "80.0%",
        "label": "PERCENT"
      },
      {
        "text": "HL",
        "label": "GPE"
      },
      {
        "text": "12.9%",
        "label": "PERCENT"
      },
      {
        "text": "n=54",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "were LL, and 7.2% (n=30) were UL. All KTRs vaccinated pretransplantation had",
    "entities": [
      {
        "text": "LL",
        "label": "ORG"
      },
      {
        "text": "7.2%",
        "label": "PERCENT"
      },
      {
        "text": "UL",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "detectable levels. Twenty-eight days after HB, 62.9% (n=22 of 35) of patients",
    "entities": [
      {
        "text": "Twenty-eight days",
        "label": "DATE"
      },
      {
        "text": "HB",
        "label": "ORG"
      },
      {
        "text": "62.9%",
        "label": "PERCENT"
      },
      {
        "text": "n=22",
        "label": "GPE"
      },
      {
        "text": "35",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "with LL achieved HL. Although 9 of 20 (45%) patients with UL achieved LL, none",
    "entities": [
      {
        "text": "LL",
        "label": "ORG"
      },
      {
        "text": "9",
        "label": "CARDINAL"
      },
      {
        "text": "45%",
        "label": "PERCENT"
      },
      {
        "text": "UL",
        "label": "ORG"
      },
      {
        "text": "LL",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "achieved HL by 28 days despite mycophenolate mofetil cessation before HB.",
    "entities": [
      {
        "text": "28 days",
        "label": "DATE"
      },
      {
        "text": "HB",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Undetectable level was associated with fewer T and B cells in many subsets and",
    "entities": []
  },
  {
    "text": "fewer COVID-19-specific memory B cells.",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "CONCLUSION: Most KTRs had HL anti-spike protein antibodies after two or more",
    "entities": [
      {
        "text": "two",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "mRNA vaccinations due to vaccinations with or without prior infection. Many LL",
    "entities": [
      {
        "text": "LL",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "patients responded to HB. No UL reached HL; likely due to severely impaired",
    "entities": [
      {
        "text": "HB",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "immune system. In this KTR population, a potential durable antibody response was",
    "entities": [
      {
        "text": "KTR",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "identified if vaccinated before transplantation. Ultimately, monitoring antibody",
    "entities": []
  },
  {
    "text": "levels after vaccination might identify patients who could benefit from",
    "entities": []
  },
  {
    "text": "alternative prophylaxis strategies.",
    "entities": []
  },
  {
    "text": "Copyright \u00a9 2025 Mayo Foundation for Medical Education and Research. Published",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "Mayo Foundation for Medical Education",
        "label": "ORG"
      },
      {
        "text": "Research",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "by Elsevier Inc. All rights reserved.",
    "entities": [
      {
        "text": "Elsevier Inc.",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Gestational Exposure to Particulate Matter and Preeclampsia Risk: Evidence from",
    "entities": [
      {
        "text": "Gestational Exposure to",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "a Meta-Analysis and Mendelian Randomization Study.",
    "entities": [
      {
        "text": "Meta-Analysis",
        "label": "ORG"
      },
      {
        "text": "Mendelian Randomization Study",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(1)Department of Obstetrics and Gynecology, Union Hospital, Tongji Medical",
    "entities": [
      {
        "text": "Obstetrics and Gynecology, Union Hospital",
        "label": "ORG"
      },
      {
        "text": "Tongji Medical",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "College, Huazhong University of Science and Technology, Wuhan, China.",
    "entities": [
      {
        "text": "College, Huazhong University of Science and Technology",
        "label": "ORG"
      },
      {
        "text": "Wuhan",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Shenzhen Huazhong University of Science and Technology Research Institute,",
    "entities": [
      {
        "text": "Huazhong University of Science and Technology Research Institute",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(3)Department of Prenatal Diagnosis Center, Union Hospital, Tongji Medical",
    "entities": [
      {
        "text": "Prenatal Diagnosis Center, Union Hospital",
        "label": "ORG"
      },
      {
        "text": "Tongji Medical",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Preeclampsia (PE) is a severe hypertensive disorder that occurs during",
    "entities": [
      {
        "text": "Preeclampsia",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "pregnancy. Exposure to particulate matter (PM), particularly fine particles such",
    "entities": []
  },
  {
    "text": "as PM2.5/PM10, has been investigated as a potential environmental risk factor",
    "entities": []
  },
  {
    "text": "for its development. In this study, we employed both meta-analysis and Mendelian",
    "entities": [
      {
        "text": "Mendelian",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "randomization (MR) to investigate the relationship between PM exposure and PE",
    "entities": [
      {
        "text": "PE",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "risk. The meta-analysis of 26 studies (>2 million pregnancies) found modest",
    "entities": [
      {
        "text": "26",
        "label": "CARDINAL"
      },
      {
        "text": "2 million",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "associations between PM exposure and PE risk. In particular, PM2.5 exposure",
    "entities": [
      {
        "text": "PE",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "during the second trimester (OR = 1.03, 95% CI: 1.01-1.04) and PM10 exposure (OR",
    "entities": [
      {
        "text": "second",
        "label": "ORDINAL"
      },
      {
        "text": "1.03",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "1.01-1.04",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "= 1.06, 95% CI: 1.00-1.12) showed significant associations. Subgroup and",
    "entities": [
      {
        "text": "1.06",
        "label": "DATE"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "1.00-1.12",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "meta-regression analyses revealed that regional differences, particularly",
    "entities": []
  },
  {
    "text": "between Europe and Asia, were major contributors to heterogeneity, while",
    "entities": [
      {
        "text": "Europe",
        "label": "LOC"
      },
      {
        "text": "Asia",
        "label": "LOC"
      }
    ]
  },
  {
    "text": "publication year showed minimal impact. In contrast, no significant associations",
    "entities": [
      {
        "text": "publication year",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "were found for PM exposure during the first and third trimesters, with greater",
    "entities": [
      {
        "text": "the first and third trimesters",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "statistical uncertainty likely due to heterogeneity in study design and exposure",
    "entities": []
  },
  {
    "text": "assessment methods. The MR analysis, using genetic instruments from European",
    "entities": [
      {
        "text": "European",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "between PM exposure and PE risk (PM2.5: OR = 1.128, 95% CI: -0.593- 0.834; PM10:",
    "entities": [
      {
        "text": "PE",
        "label": "ORG"
      },
      {
        "text": "1.128",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "PERSON"
      },
      {
        "text": "0.834",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "OR = 0.668, 95% CI: -1.482-0.675). These findings suggest that while PM",
    "entities": [
      {
        "text": "0.668",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "exposure, particularly during mid-pregnancy, may be associated with increased PE",
    "entities": []
  },
  {
    "text": "risk in observational studies, the lack of a confirmed causal link in MR",
    "entities": [
      {
        "text": "MR",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "analysis indicates potential influence from residual confounding, exposure",
    "entities": []
  },
  {
    "text": "misclassification, and study heterogeneity. Therefore, the observed associations",
    "entities": []
  },
  {
    "text": "should be interpreted with caution.",
    "entities": []
  },
  {
    "text": "\u00a9 2025 The Author(s). The Journal of Clinical Hypertension published by Wiley",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "The Journal of Clinical Hypertension",
        "label": "ORG"
      },
      {
        "text": "Wiley",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "PMID: 40662997 [Indexed for MEDLINE]",
    "entities": [
      {
        "text": "40662997",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "The Association Between the Hemoglobin Glycation Index and Cardiometabolic",
    "entities": [
      {
        "text": "Cardiometabolic",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Diseases: A Mini-Review.",
    "entities": [
      {
        "text": "Mini-Review",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(1)Department of Cardiology, Jiangbin Hospital of Guangxi Zhuang Autonomous",
    "entities": [
      {
        "text": "Cardiology",
        "label": "ORG"
      },
      {
        "text": "Jiangbin Hospital",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(2)Department of Cardiology, Affiliated Hospital of Guilin Medical University,",
    "entities": [
      {
        "text": "2)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Cardiology",
        "label": "ORG"
      },
      {
        "text": "Affiliated Hospital of Guilin Medical University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(3)Department of Cardiology and Macrovascular Disease, Beijing Tiantan Hospital,",
    "entities": [
      {
        "text": "Cardiology and Macrovascular Disease",
        "label": "ORG"
      },
      {
        "text": "Beijing Tiantan Hospital",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Capital Medical University, Beijing, China.",
    "entities": [
      {
        "text": "Capital Medical University",
        "label": "ORG"
      },
      {
        "text": "Beijing",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Senior Department of Cardiology, the Sixth Medical Center, Chinese PLA",
    "entities": [
      {
        "text": "4)Senior Department of Cardiology",
        "label": "ORG"
      },
      {
        "text": "the Sixth Medical Center",
        "label": "ORG"
      },
      {
        "text": "Chinese",
        "label": "NORP"
      },
      {
        "text": "PLA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "General Hospital, Beijing, China.",
    "entities": [
      {
        "text": "General Hospital",
        "label": "ORG"
      },
      {
        "text": "Beijing",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "The hemoglobin glycation index (HGI) has emerged as a pivotal biomarker for",
    "entities": []
  },
  {
    "text": "evaluating long-term glycemic control, offering a more comprehensive assessment",
    "entities": []
  },
  {
    "text": "compared with conventional glycated hemoglobin (HbA1c) measurements. Elevated",
    "entities": []
  },
  {
    "text": "HGI levels are significantly correlated with the incidence of cardiometabolic",
    "entities": []
  },
  {
    "text": "diseases (CMDs). This review synthesizes current evidence on the clinical",
    "entities": []
  },
  {
    "text": "utility of the HGI across coronary artery disease (CAD), hypertension, heart",
    "entities": [
      {
        "text": "HGI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "nonalcoholic fatty liver disease (NAFLD), thereby providing clinicians with an",
    "entities": [
      {
        "text": "clinicians",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "enhanced framework for precise disease stratification, therapeutic optimization,",
    "entities": []
  },
  {
    "text": "and prognostic prediction.",
    "entities": []
  },
  {
    "text": "PMID: 40662995 [Indexed for MEDLINE]",
    "entities": [
      {
        "text": "40662995",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "74. AIDS. 2025 Jul 15. doi: 10.1097/QAD.0000000000004298. Online ahead of print.",
    "entities": [
      {
        "text": "74",
        "label": "CARDINAL"
      },
      {
        "text": "2025",
        "label": "CARDINAL"
      },
      {
        "text": "15",
        "label": "CARDINAL"
      },
      {
        "text": "10.1097",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Risk factors of incident physical frailty in middle-aged and older people with",
    "entities": []
  },
  {
    "text": "and without HIV: evidence from the CHART cohort.",
    "entities": [
      {
        "text": "CHART",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(1)Department of Epidemiology, School of Public Health, and Key Laboratory of",
    "entities": [
      {
        "text": "Epidemiology, School of Public Health",
        "label": "ORG"
      },
      {
        "text": "Key Laboratory",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Public Health Safety of Ministry of Education, Fudan University, Shanghai,",
    "entities": [
      {
        "text": "Public Health Safety of Ministry of Education",
        "label": "ORG"
      },
      {
        "text": "Fudan University",
        "label": "ORG"
      },
      {
        "text": "Shanghai",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)School of Public Health, Key Laboratory of Tropical Translational Medicine of",
    "entities": []
  },
  {
    "text": "Ministry of Education, Hainan Medical University, Haikou 571199, Hainan",
    "entities": [
      {
        "text": "Ministry of Education",
        "label": "ORG"
      },
      {
        "text": "Hainan Medical University",
        "label": "ORG"
      },
      {
        "text": "Hainan",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Province, China.",
    "entities": [
      {
        "text": "Province",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Taizhou City Center for Disease Control and Prevention, Zhejiang Province,",
    "entities": [
      {
        "text": "3)Taizhou City Center for Disease Control and Prevention",
        "label": "ORG"
      },
      {
        "text": "Zhejiang Province",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Shanghai Institute of Infectious Diseases and Biosecurity, Fudan University,",
    "entities": [
      {
        "text": "4)Shanghai Institute of Infectious Diseases",
        "label": "ORG"
      },
      {
        "text": "Fudan University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(5)Yi-Wu Research Institute, Fudan University, Shanghai, China.",
    "entities": [
      {
        "text": "5)Yi-Wu Research Institute",
        "label": "ORG"
      },
      {
        "text": "Fudan University",
        "label": "ORG"
      },
      {
        "text": "Shanghai",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "OBJECTIVE: This study aimed to identify risk factors for physical frailty",
    "entities": []
  },
  {
    "text": "incidence among people with HIV (PWH) and HIV-negative individuals and further",
    "entities": [
      {
        "text": "PWH",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "explore the dynamic relationship between major chronic diseases and frailty.",
    "entities": []
  },
  {
    "text": "METHODS: PWH and HIV-negative individuals aged \u226540 years from the Comparative",
    "entities": [
      {
        "text": "PWH",
        "label": "ORG"
      },
      {
        "text": "years",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "HIV and Aging Research in Taizhou (CHART) cohort were included. Univariate and",
    "entities": [
      {
        "text": "Aging Research",
        "label": "ORG"
      },
      {
        "text": "Taizhou",
        "label": "GPE"
      },
      {
        "text": "CHART",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "multivariate Cox regression models were used to estimate the hazard ratio (HR)",
    "entities": []
  },
  {
    "text": "and 95% confidence interval (CI) of the association between risk factors and",
    "entities": [
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "physical frailty.",
    "entities": []
  },
  {
    "text": "RESULTS: A total of 3,968 participants (1,279 cases and 2,689 controls) were",
    "entities": [
      {
        "text": "3,968",
        "label": "CARDINAL"
      },
      {
        "text": "1,279",
        "label": "CARDINAL"
      },
      {
        "text": "2,689",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "included. Regardless of HIV status, the overall trend of physical frailty",
    "entities": []
  },
  {
    "text": "incidence density increased with age, and aging significantly elevated the risk",
    "entities": []
  },
  {
    "text": "of frailty. Central obesity (aHR=2.15, 95% CI: 1.09-4.23), hypertension",
    "entities": [
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "1.09",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "(aHR=2.06, 95% CI: 1.03-4.11) and current unsuppressed HIV viral load (aHR=2.20,",
    "entities": [
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "1.03-4.11",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "95% CI: 1.01-4.80) increased the risk of frailty incident among PWH, while",
    "entities": [
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "1.01",
        "label": "CARDINAL"
      },
      {
        "text": "PWH",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "depression (aHR=1.93, 95% CI: 1.06-3.50) and diabetes (aHR=1.85, 95% CI:",
    "entities": [
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "PERSON"
      },
      {
        "text": "1.06-3.50",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "1.18-2.90) increased the risk of frailty among HIV-negative controls. Dynamic",
    "entities": [
      {
        "text": "1.18",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Change analyses showed that incident depression, incident neurocognitive",
    "entities": []
  },
  {
    "text": "impairment, and persistent hypertension during a 3.18-year follow-up were",
    "entities": [
      {
        "text": "3.18-year",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "associated with a higher risk of frailty among PWH. In contrast, incident",
    "entities": [
      {
        "text": "PWH",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "depression, persistent depression, and persistent diabetes were significantly",
    "entities": []
  },
  {
    "text": "associated with frailty incidence among HIV-negative controls.",
    "entities": []
  },
  {
    "text": "CONCLUSIONS: Aging was significantly associated with a higher risk of physical",
    "entities": []
  },
  {
    "text": "frailty regardless of HIV status. Risk factors and the association between",
    "entities": []
  },
  {
    "text": "dynamic changes in major chronic diseases and frailty were different between",
    "entities": []
  },
  {
    "text": "HIV-positive and HIV-negative individuals.",
    "entities": []
  },
  {
    "text": "Copyright \u00a9 2025 Wolters Kluwer Health, Inc. All rights reserved.",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "Wolters Kluwer Health, Inc.",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "75. Int J Clin Pharmacol Ther. 2025 Jul 15. doi: 10.5414/CP204796. Online ahead",
    "entities": [
      {
        "text": "75",
        "label": "CARDINAL"
      },
      {
        "text": "2025",
        "label": "CARDINAL"
      },
      {
        "text": "15",
        "label": "CARDINAL"
      },
      {
        "text": "10.5414",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Cardiovascular toxicity associated with sedative drug use: Post-market",
    "entities": []
  },
  {
    "text": "pharmacovigilance study with disproportionality analysis.",
    "entities": []
  },
  {
    "text": "OBJECTIVE: To compare the toxicity of sedatives in critically ill intensive care",
    "entities": []
  },
  {
    "text": "unit patients and investigate safety concerns using the United States Food and",
    "entities": [
      {
        "text": "the United States Food",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Drug Administration Adverse Event Reporting System and VigiBase databases.",
    "entities": [
      {
        "text": "VigiBase",
        "label": "PRODUCT"
      }
    ]
  },
  {
    "text": "MATERIALS AND METHODS: Disproportionality analysis was used to assess the",
    "entities": []
  },
  {
    "text": "relationships among midazolam, propofol, and dexmedetomidine and suspected",
    "entities": []
  },
  {
    "text": "adverse drug reactions. Adverse drug reactions related to sedation in the",
    "entities": []
  },
  {
    "text": "intensive care unit were identified through systematic organ classification and",
    "entities": []
  },
  {
    "text": "assessed using Standardized Regulatory Activities Medical Dictionary Analysis",
    "entities": [
      {
        "text": "Standardized Regulatory Activities Medical Dictionary Analysis",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "RESULTS: A total of 12,102 adverse drug reactions were identified with",
    "entities": [
      {
        "text": "12,102",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "midazolam, propofol, or dexmedetomidine as the primary suspected drug. The",
    "entities": []
  },
  {
    "text": "cardiovascular system accounted for a significant proportion of the drug",
    "entities": []
  },
  {
    "text": "reaction systems with strong signals. The strongest preferred term was neonatal",
    "entities": []
  },
  {
    "text": "hypertension (N = 9; information component = 7.11 (95% confidence interval:",
    "entities": [
      {
        "text": "9",
        "label": "CARDINAL"
      },
      {
        "text": "7.11",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "5.97 - 7.87)), propofol infusion syndrome (N = 482; information",
    "entities": [
      {
        "text": "5.97",
        "label": "CARDINAL"
      },
      {
        "text": "482",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "component = 10.88 (95% confidence interval: 10.73 - 10.99)), and the",
    "entities": [
      {
        "text": "10.88",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "10.73 - 10.99",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "respectively. The Standardized Regulatory Activities Medical Dictionary Analysis",
    "entities": [
      {
        "text": "The Standardized Regulatory Activities Medical Dictionary Analysis",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Queries with the strongest signal across all sedatives were torsade de pointes",
    "entities": []
  },
  {
    "text": "and shock-associated conditions (N = 679; information component = 4.24 (95%",
    "entities": [
      {
        "text": "679",
        "label": "CARDINAL"
      },
      {
        "text": "4.24",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "CONCLUSION: These findings highlight the need for clinicians to consider",
    "entities": [
      {
        "text": "clinicians",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "cardiovascular toxicity when administering sedatives in the intensive care unit,",
    "entities": []
  },
  {
    "text": "as different sedatives exhibit different adverse reaction profiles.",
    "entities": []
  },
  {
    "text": "DOI: 10.5414/CP204796",
    "entities": [
      {
        "text": "10.5414",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "76. Blood Press. 2025 Jul 15:1-17. doi: 10.1080/08037051.2025.2533456. Online",
    "entities": [
      {
        "text": "76",
        "label": "CARDINAL"
      },
      {
        "text": "Blood Press",
        "label": "ORG"
      },
      {
        "text": "2025",
        "label": "CARDINAL"
      },
      {
        "text": "15:1-17",
        "label": "DATE"
      },
      {
        "text": "10.1080/08037051.2025.2533456",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Evaluation of race-free eGFR equations in individuals of different ethnicity.",
    "entities": []
  },
  {
    "text": "(1)Department of Cardiovascular Medicine, Shanghai Key Laboratory of",
    "entities": [
      {
        "text": "Cardiovascular Medicine",
        "label": "ORG"
      },
      {
        "text": "Shanghai Key Laboratory",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Hypertension, Shanghai Institute of Hypertension, State Key Laboratory of",
    "entities": [
      {
        "text": "Hypertension",
        "label": "ORG"
      },
      {
        "text": "Shanghai Institute of Hypertension",
        "label": "ORG"
      },
      {
        "text": "State Key Laboratory",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Medical Genomics, National Research Centre for Translational Medicine, Ruijin",
    "entities": [
      {
        "text": "Medical Genomics",
        "label": "ORG"
      },
      {
        "text": "National Research Centre for Translational Medicine",
        "label": "ORG"
      },
      {
        "text": "Ruijin",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.",
    "entities": [
      {
        "text": "Shanghai Jiaotong University School of Medicine",
        "label": "ORG"
      },
      {
        "text": "Shanghai",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Non-Profit Research Alliance for the Promotion of Preventive Medicine,",
    "entities": [
      {
        "text": "2)Non-Profit Research Alliance",
        "label": "MONEY"
      },
      {
        "text": "the Promotion of Preventive Medicine",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(3)Research Unit Environment and Health, KU Leuven Department of Public Health",
    "entities": [
      {
        "text": "Unit Environment and Health",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "and Primary Care, University of Leuven, Leuven, Belgium.",
    "entities": [
      {
        "text": "Primary Care",
        "label": "ORG"
      },
      {
        "text": "University of Leuven",
        "label": "ORG"
      },
      {
        "text": "Leuven",
        "label": "GPE"
      },
      {
        "text": "Belgium",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Centre for Environmental Sciences, Hasselt University, Diepenbeek, Belgium.",
    "entities": [
      {
        "text": "Environmental Sciences",
        "label": "ORG"
      },
      {
        "text": "Hasselt University",
        "label": "ORG"
      },
      {
        "text": "Diepenbeek",
        "label": "PERSON"
      },
      {
        "text": "Belgium",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(5)Hypertension in Africa Research Team (HART); North-West University,",
    "entities": [
      {
        "text": "Africa Research Team",
        "label": "ORG"
      },
      {
        "text": "HART",
        "label": "ORG"
      },
      {
        "text": "North-West University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Potchefstroom, South Africa.",
    "entities": [
      {
        "text": "South Africa",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(6)SAMRC Extramural Unit for Hypertension and Cardiovascular Disease, Faculty of",
    "entities": [
      {
        "text": "Extramural Unit for Hypertension and Cardiovascular Disease, Faculty",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Health Sciences, North-West University, Potchefstroom, South Africa.",
    "entities": [
      {
        "text": "Health Sciences",
        "label": "ORG"
      },
      {
        "text": "North-West University",
        "label": "ORG"
      },
      {
        "text": "Potchefstroom",
        "label": "GPE"
      },
      {
        "text": "South Africa",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(7)Circulatory Health Research Laboratory, College of Health Sciences,",
    "entities": [
      {
        "text": "Health Research Laboratory",
        "label": "ORG"
      },
      {
        "text": "College of Health Sciences",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "University of Abuja, Gwagwalada, Nigeria.",
    "entities": [
      {
        "text": "University of Abuja, Gwagwalada, Nigeria",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(9)School of Population Health, University of New South Wales; The George",
    "entities": [
      {
        "text": "Population Health, University of New South Wales",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Institute for Global Health.",
    "entities": [
      {
        "text": "Institute for Global Health",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(10)Hypertension Unit, Department of Internal Medicine, University of Kinshasa,",
    "entities": [
      {
        "text": "10)Hypertension Unit",
        "label": "ORG"
      },
      {
        "text": "Department of Internal Medicine, University of Kinshasa",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Hospital, Kinshasa, Democratic Republic of Congo.",
    "entities": [
      {
        "text": "Kinshasa",
        "label": "GPE"
      },
      {
        "text": "Democratic Republic of Congo",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(11)The First Department of Cardiology, Interventional Electrocardiology and",
    "entities": [
      {
        "text": "Department of Cardiology",
        "label": "ORG"
      },
      {
        "text": "Interventional Electrocardiology",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Hypertension, Jagiellonian University Medical College, Krak\u00f3w, Poland.",
    "entities": [
      {
        "text": "Jagiellonian University Medical College",
        "label": "ORG"
      },
      {
        "text": "Krak\u00f3w",
        "label": "PERSON"
      },
      {
        "text": "Poland",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(12)Biomedical Sciences Group, Faculty of Medicine, University of Leuven,",
    "entities": [
      {
        "text": "12)Biomedical Sciences Group",
        "label": "ORG"
      },
      {
        "text": "Faculty of Medicine, University of Leuven",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "BACKGROUND: Glomerular filtration rate (eGFR) derived from serum creatinine",
    "entities": []
  },
  {
    "text": "(eGFRcr), cystatin C (eGFRcys), or both (eGFRcr-cys) by race-free equations are",
    "entities": []
  },
  {
    "text": "recommended staging chronic kidney disease (CKD). The current study aimed to",
    "entities": []
  },
  {
    "text": "compare these race-free eGFR equations for screening for low-grade CKD in Blacks",
    "entities": [
      {
        "text": "Blacks",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "and non-Blacks and to evaluate their association with mortality.",
    "entities": [
      {
        "text": "non-Blacks",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "METHODS: Race-free eGFR equations were evaluated in four studies with specific",
    "entities": [
      {
        "text": "four",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "inclusion criteria based on the original research goals: African-PREDICT",
    "entities": [
      {
        "text": "African-PREDICT",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "(341/380 healthy Black/White South Africans), FLEMENGHO (709 White",
    "entities": [
      {
        "text": "341/380",
        "label": "CARDINAL"
      },
      {
        "text": "Black/White South Africans",
        "label": "ORG"
      },
      {
        "text": "FLEMENGHO",
        "label": "ORG"
      },
      {
        "text": "709",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "community-dwelling Flemish), NHANES (1760/7931 Black and non-Black adult",
    "entities": [
      {
        "text": "Flemish",
        "label": "NORP"
      },
      {
        "text": "NHANES",
        "label": "ORG"
      },
      {
        "text": "1760/7931",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Americans), and 401 Black African patients hospitalised in Mbuji Mayi,",
    "entities": [
      {
        "text": "Americans",
        "label": "NORP"
      },
      {
        "text": "401",
        "label": "CARDINAL"
      },
      {
        "text": "Black African",
        "label": "NORP"
      },
      {
        "text": "Mbuji Mayi",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Democratic Republic of Congo. The intraclass correlation coefficient and Bland",
    "entities": [
      {
        "text": "Democratic Republic of Congo",
        "label": "GPE"
      },
      {
        "text": "Bland",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "and Altman statistics were used to assess consistency between eGFR equations and",
    "entities": [
      {
        "text": "Altman",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "multivariable logistic or Cox regression to evaluate their association with",
    "entities": []
  },
  {
    "text": "mortality.",
    "entities": []
  },
  {
    "text": "RESULTS: Intraindividual discordance between eGFRs was larger in Black than",
    "entities": [
      {
        "text": "Black",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "non-Black NHANES and African-PREDICT participants. In NHANES, eGFRcr-cys was",
    "entities": [
      {
        "text": "non-Black NHANES",
        "label": "ORG"
      },
      {
        "text": "African-PREDICT",
        "label": "NORP"
      },
      {
        "text": "NHANES",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "greater than eGFRcr, but smaller than eGFRcys, and replacing eGFRcr-cys by",
    "entities": []
  },
  {
    "text": "eGFRcr moved 25% Blacks and 15% non-Blacks to a higher (worse) eGFR KDIGO stage.",
    "entities": [
      {
        "text": "25%",
        "label": "PERCENT"
      },
      {
        "text": "15%",
        "label": "PERCENT"
      },
      {
        "text": "non-Blacks",
        "label": "ORG"
      },
      {
        "text": "KDIGO",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "In African-PREDICT and FLEMENGO, half of the measured creatinine clearance to",
    "entities": [
      {
        "text": "African-PREDICT",
        "label": "NORP"
      },
      {
        "text": "FLEMENGO",
        "label": "ORG"
      },
      {
        "text": "half",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "eGFR ratios fell outside the expected 1.1-1.2 band. In NHANES, multivariable",
    "entities": [
      {
        "text": "1.1",
        "label": "CARDINAL"
      },
      {
        "text": "NHANES",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "hazard ratios for total and cardiovascular mortality in relation to CKD grade",
    "entities": []
  },
  {
    "text": "were all lower than unity for grade-1 CKD and greater than unity for grade \u22653",
    "entities": []
  },
  {
    "text": "(p < 0.0001) without any racial difference (0.11 \u2264 p \u2264 0.98). These NHANES",
    "entities": [
      {
        "text": "0.11",
        "label": "CARDINAL"
      },
      {
        "text": "NHANES",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "findings were consistent, if CKD stage was replaced by eGFR and in subgroup",
    "entities": []
  },
  {
    "text": "analyses. Whereas eGFRcys and eGFRcr-cys refined models, eGFRcr did not.",
    "entities": []
  },
  {
    "text": "CONCLUSIONS: The NHANES mortality outcomes support the use of eGFRcys and",
    "entities": [
      {
        "text": "NHANES",
        "label": "ORG"
      },
      {
        "text": "eGFRcys",
        "label": "LANGUAGE"
      }
    ]
  },
  {
    "text": "eGFRcr-cys. However, large intraindividual variability between eGFR estimates",
    "entities": [
      {
        "text": "eGFR",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "may lead to KDIGO eGFR stage misclassification and calls for caution in the",
    "entities": [
      {
        "text": "KDIGO",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "opportunistic or systematic screening for CKD in asymptomatic individuals with",
    "entities": [
      {
        "text": "CKD",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "prevention as objective.",
    "entities": []
  },
  {
    "text": "Plain Language Summary: Glomerular filtration rate reflects the ability to",
    "entities": []
  },
  {
    "text": "remove excess water and waste by the kidney and can be estimated from serum",
    "entities": []
  },
  {
    "text": "creatinine (eGFR). However, serum creatinine is affected by muscle mass, dietary",
    "entities": []
  },
  {
    "text": "habits and other factors that cluster by race and lead to overestimation of eGFR",
    "entities": []
  },
  {
    "text": "and underestimation of the risk of kidney disease in Black individuals. Serum",
    "entities": [
      {
        "text": "Serum\n",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "cystatin C is less affected by these confounders. Equations to compute eGFR from",
    "entities": [
      {
        "text": "cystatin C",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "serum cystatin C or both serum creatinine and cystatin C without considering",
    "entities": [
      {
        "text": "serum cystatin C",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "race are currently recommended. This study evaluated these race-free equations",
    "entities": []
  },
  {
    "text": "to compute eGFR in multi-ethnic study populations recruited in South Africa,",
    "entities": [
      {
        "text": "South Africa",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Belgium, the Democratic Republic of the Congo and the United States. The new",
    "entities": [
      {
        "text": "Belgium",
        "label": "GPE"
      },
      {
        "text": "the Democratic Republic of the",
        "label": "GPE"
      },
      {
        "text": "Congo",
        "label": "GPE"
      },
      {
        "text": "the United States",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "methods produce eGFR estimates, which predict mortality and have near perfect",
    "entities": []
  },
  {
    "text": "reproducibility in the population as a whole. However, this study also",
    "entities": []
  },
  {
    "text": "identified large intraindividual differences between eGFR estimates that may",
    "entities": [
      {
        "text": "eGFR",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "lead to misclassification of patients with regard to their renal function. These",
    "entities": []
  },
  {
    "text": "observations call for caution in the clinical application of equations to derive",
    "entities": []
  },
  {
    "text": "eGFR from serum markers and highlight the need for further research to optimise",
    "entities": []
  },
  {
    "text": "the prevention and management of chronic kidney disease.",
    "entities": []
  },
  {
    "text": "The use of the Odds Ratio Product (ORP) and self-reported data to detect",
    "entities": []
  },
  {
    "text": "(2)Danish Center for Sleep Medicine, Department of Clinical Neurophysiology,",
    "entities": [
      {
        "text": "Center for Sleep Medicine, Department of Clinical Neurophysiology",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(3)Sleep Science Department, Cerebra Medical LTD., 1470 Willson Place, Winnipeg,",
    "entities": [
      {
        "text": "Science Department",
        "label": "ORG"
      },
      {
        "text": "Cerebra Medical LTD",
        "label": "ORG"
      },
      {
        "text": "1470",
        "label": "DATE"
      },
      {
        "text": "Willson Place",
        "label": "PERSON"
      },
      {
        "text": "Winnipeg",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(4)Department of Psychology, Faculty of Arts, University of Calgary, 2500",
    "entities": [
      {
        "text": "Psychology, Faculty of Arts",
        "label": "ORG"
      },
      {
        "text": "University of Calgary",
        "label": "ORG"
      },
      {
        "text": "2500",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "University Drive NW, Calgary, AB T2N 1 N4, Canada.",
    "entities": [
      {
        "text": "University Drive NW",
        "label": "ORG"
      },
      {
        "text": "Calgary",
        "label": "GPE"
      },
      {
        "text": "N4",
        "label": "NORP"
      },
      {
        "text": "Canada",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(5)Department of Psychology, Faculty of Social Sciences, Brock University, 1812",
    "entities": [
      {
        "text": "5)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Psychology, Faculty of Social Sciences",
        "label": "ORG"
      },
      {
        "text": "Brock University",
        "label": "ORG"
      },
      {
        "text": "1812",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "Sir Isaac Brock Way, St Catharines, ON L2S 3A1, Canada.",
    "entities": [
      {
        "text": "Isaac Brock Way",
        "label": "PERSON"
      },
      {
        "text": "St Catharines",
        "label": "PERSON"
      },
      {
        "text": "L2S 3A1",
        "label": "ORG"
      },
      {
        "text": "Canada",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(6)School of Psychological Science, University of Western Australia, Perth, WA,",
    "entities": [
      {
        "text": "Psychological Science, University of Western Australia",
        "label": "ORG"
      },
      {
        "text": "Perth",
        "label": "GPE"
      },
      {
        "text": "WA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(7)Department of Psychiatry and Behavioral Sciences, University of Texas Health",
    "entities": [
      {
        "text": "Psychiatry",
        "label": "ORG"
      },
      {
        "text": "Behavioral Sciences",
        "label": "ORG"
      },
      {
        "text": "University of Texas Health",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Science Center at San Antonio, 7703 Floyd Curl Dr, San Antonio, TX 78229, United",
    "entities": [
      {
        "text": "San Antonio",
        "label": "GPE"
      },
      {
        "text": "7703",
        "label": "DATE"
      },
      {
        "text": "Floyd Curl Dr",
        "label": "PERSON"
      },
      {
        "text": "San Antonio",
        "label": "GPE"
      },
      {
        "text": "TX 78229",
        "label": "ORG"
      },
      {
        "text": "United",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "States.",
    "entities": [
      {
        "text": "States",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "STUDY OBJECTIVES: To evaluate the utility of the Odds Ratio Product (ORP) in",
    "entities": [
      {
        "text": "the Odds Ratio Product (ORP",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "differentiating comorbid insomnia and sleep apnea (COMISA) from obstructive",
    "entities": []
  },
  {
    "text": "sleep apnea (OSA) and chronic insomnia (CIN).",
    "entities": [
      {
        "text": "CIN",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "METHODS: We retrospectively analyzed 9750 patients in four groups: 1) 1152",
    "entities": [
      {
        "text": "9750",
        "label": "CARDINAL"
      },
      {
        "text": "four",
        "label": "CARDINAL"
      },
      {
        "text": "1",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "controls; 2) 2395 with CIN; 3) 2297 with OSA; and 4) 3906 with COMISA. CIN was",
    "entities": [
      {
        "text": "2",
        "label": "CARDINAL"
      },
      {
        "text": "2395",
        "label": "DATE"
      },
      {
        "text": "CIN",
        "label": "ORG"
      },
      {
        "text": "3) 2297",
        "label": "DATE"
      },
      {
        "text": "OSA",
        "label": "ORG"
      },
      {
        "text": "4) 3906",
        "label": "DATE"
      },
      {
        "text": "COMISA",
        "label": "ORG"
      },
      {
        "text": "CIN",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "defined as difficulty initiating/maintaining sleep with daytime",
    "entities": [
      {
        "text": "daytime",
        "label": "TIME"
      }
    ]
  },
  {
    "text": "fatigue/sleepiness occurring \"often\"/\"always\". OSA was defined as an",
    "entities": []
  },
  {
    "text": "apnea-hypopnea index >5 on polysomnography. ORP, computed every 3 seconds from",
    "entities": [
      {
        "text": "5",
        "label": "CARDINAL"
      },
      {
        "text": "ORP",
        "label": "ORG"
      },
      {
        "text": "every 3 seconds",
        "label": "TIME"
      }
    ]
  },
  {
    "text": "polysomnography, was analyzed alongside sleep metrics, comorbidities, and sleep",
    "entities": []
  },
  {
    "text": "habits. Associations were assessed using univariate multinomial logistic",
    "entities": []
  },
  {
    "text": "regression, followed by stepwise regression to identify independent predictors",
    "entities": []
  },
  {
    "text": "of COMISA versus OSA or CIN. Machine learning models classified COMISA, OSA, and",
    "entities": [
      {
        "text": "CIN",
        "label": "ORG"
      },
      {
        "text": "COMISA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "CIN as distinct clinical groups.",
    "entities": [
      {
        "text": "CIN",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "RESULTS: ORP-derived features showed stronger associations with COMISA than",
    "entities": [
      {
        "text": "COMISA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "traditional sleep metrics (except N3 latency). Independent objective predictors",
    "entities": [
      {
        "text": "N3",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "of COMISA included male sex (OR = 1.31, 95% CI = [1.16, 1.47]), BMI (1.27,",
    "entities": [
      {
        "text": "1.31",
        "label": "DATE"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "1.16",
        "label": "CARDINAL"
      },
      {
        "text": "1.47",
        "label": "CARDINAL"
      },
      {
        "text": "BMI",
        "label": "ORG"
      },
      {
        "text": "1.27",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "[1.25, 1.29]), N3 latency (1.21, [1.13, 1.29]), age (1.17, [1.16, 1.19]), peak",
    "entities": [
      {
        "text": "1.25",
        "label": "CARDINAL"
      },
      {
        "text": "1.29",
        "label": "CARDINAL"
      },
      {
        "text": "N3",
        "label": "NORP"
      },
      {
        "text": "1.21",
        "label": "CARDINAL"
      },
      {
        "text": "1.13",
        "label": "CARDINAL"
      },
      {
        "text": "1.29",
        "label": "CARDINAL"
      },
      {
        "text": "1.17",
        "label": "CARDINAL"
      },
      {
        "text": "1.16",
        "label": "CARDINAL"
      },
      {
        "text": "1.19",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "ORP during spontaneous arousals (1.12, [1.01, 1.25]), and time in ORP decile 7",
    "entities": [
      {
        "text": "ORP",
        "label": "ORG"
      },
      {
        "text": "1.12",
        "label": "CARDINAL"
      },
      {
        "text": "1.01",
        "label": "CARDINAL"
      },
      {
        "text": "1.25",
        "label": "CARDINAL"
      },
      {
        "text": "ORP",
        "label": "ORG"
      },
      {
        "text": "7",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "(1.10, [1.07, 1.13]). Subjective predictors included depression, hypertension,",
    "entities": [
      {
        "text": "1.10",
        "label": "CARDINAL"
      },
      {
        "text": "1.07",
        "label": "CARDINAL"
      },
      {
        "text": "1.13",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "allergy, headache, sleep aid/alcohol use, sleepiness, and lower sleep duration.",
    "entities": []
  },
  {
    "text": "Machine learning achieved overall accuracy of 61.2% (p<.05), with sensitivity of",
    "entities": [
      {
        "text": "61.2%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "CONCLUSIONS: ORP is a promising objective marker for COMISA, distinguishing it",
    "entities": [
      {
        "text": "ORP",
        "label": "ORG"
      },
      {
        "text": "COMISA",
        "label": "LOC"
      }
    ]
  },
  {
    "text": "from OSA more effectively than sleep metrics but separating COMISA from CIN",
    "entities": [
      {
        "text": "OSA",
        "label": "ORG"
      },
      {
        "text": "CIN",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "poorly.",
    "entities": []
  },
  {
    "text": "Sleep Research Society. All rights reserved. For commercial re-use, please",
    "entities": [
      {
        "text": "Sleep Research Society",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "contact reprints@oup.com for reprints and translation rights for reprints. All",
    "entities": []
  },
  {
    "text": "other permissions can be obtained through our RightsLink service via the",
    "entities": []
  },
  {
    "text": "Permissions link on the article page on our site\u2014for further information please",
    "entities": []
  },
  {
    "text": "78. Am J Physiol Renal Physiol. 2025 Jul 15. doi: 10.1152/ajprenal.00032.2025.",
    "entities": [
      {
        "text": "78",
        "label": "CARDINAL"
      },
      {
        "text": "2025",
        "label": "CARDINAL"
      },
      {
        "text": "15",
        "label": "CARDINAL"
      },
      {
        "text": "10.1152",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Valosin-Containing Protein (VCP) in Cilia Morphology: a novel target in ADPKD.",
    "entities": [
      {
        "text": "Valosin-Containing Protein",
        "label": "ORG"
      },
      {
        "text": "VCP",
        "label": "ORG"
      },
      {
        "text": "Cilia Morphology",
        "label": "ORG"
      },
      {
        "text": "ADPKD",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(1)Department of Nephrology and Medical Intensive Care, Charit\u00e9 -",
    "entities": [
      {
        "text": "Nephrology and Medical Intensive Care",
        "label": "ORG"
      },
      {
        "text": "Charit\u00e9",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "(2)Yale University School of Medicine, New Haven, CT.",
    "entities": [
      {
        "text": "University School of Medicine",
        "label": "ORG"
      },
      {
        "text": "New Haven",
        "label": "GPE"
      },
      {
        "text": "CT",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(3)Division of Renal Diseases and Hypertension, Department of Medicine,",
    "entities": [
      {
        "text": "Renal Diseases",
        "label": "ORG"
      },
      {
        "text": "Hypertension, Department of Medicine",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "University of Colorado, Anschutz Medical Campus, Aurora, Colorado.",
    "entities": [
      {
        "text": "University of Colorado",
        "label": "ORG"
      },
      {
        "text": "Anschutz Medical Campus",
        "label": "ORG"
      },
      {
        "text": "Aurora",
        "label": "GPE"
      },
      {
        "text": "Colorado",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)BIH Biomedical Innovation Academy, Berlin Institute of Health at Charit\u00e9-",
    "entities": [
      {
        "text": "Biomedical Innovation Academy",
        "label": "ORG"
      },
      {
        "text": "Berlin Institute of Health",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Autosomal dominant polycystic kidney disease (ADPKD) is a hereditary disorder",
    "entities": [
      {
        "text": "ADPKD",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "leading to kidney cyst formation and loss of kidney function. The major",
    "entities": []
  },
  {
    "text": "causative genes Pkd1 and Pkd2 encode for the ciliary proteins Polycystin-1 (PC1)",
    "entities": [
      {
        "text": "Pkd2",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "and Polycystin-2 (PC2), respectively, which are involved in ciliary functions.",
    "entities": []
  },
  {
    "text": "Within PKD1-defective cells, the accumulation of misfolded PC1 proteins triggers",
    "entities": []
  },
  {
    "text": "the unfolded protein response (UPR). Among the pathways activated, the",
    "entities": [
      {
        "text": "UPR",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "ER-associated degradation (ERAD), mediated by proteins such as",
    "entities": [
      {
        "text": "ER",
        "label": "ORG"
      },
      {
        "text": "ERAD",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "valosin-containing protein (VCP), aims to alleviate the unfolded or misfolded",
    "entities": [
      {
        "text": "VCP",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "protein burden. Our study investigates the genetic relationship between VCP and",
    "entities": [
      {
        "text": "VCP",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "PC1-dependent cystogenesis. We found that the pharmacological inhibition of VCP",
    "entities": [
      {
        "text": "VCP",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "ameliorates the cystic phenotype in Pkd1-knockout mice. This effect is",
    "entities": []
  },
  {
    "text": "associated with increased ER stress-dependent apoptosis in PC1-deficient cells.",
    "entities": [
      {
        "text": "ER",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Additionally, we discovered that VCP is localized in the primary cilia and its",
    "entities": [
      {
        "text": "VCP",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "inhibition affects cilia assembly and reduces the cilia length.",
    "entities": []
  },
  {
    "text": "79. Am J Hematol. 2025 Jul 15. doi: 10.1002/ajh.70005. Online ahead of print.",
    "entities": [
      {
        "text": "79",
        "label": "CARDINAL"
      },
      {
        "text": "2025",
        "label": "CARDINAL"
      },
      {
        "text": "15",
        "label": "CARDINAL"
      },
      {
        "text": "10.1002/ajh.70005",
        "label": "QUANTITY"
      }
    ]
  },
  {
    "text": "Anti-ADAMTS13 Antibodies Trajectory is Associated With ADAMTS13 Recovery in",
    "entities": [
      {
        "text": "Anti-ADAMTS13 Antibodies Trajectory",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Immune-Mediated TTP.",
    "entities": [
      {
        "text": "Immune-Mediated TTP",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Augusto JF(24), Legendre M(25), Moranne O(26), Philipponnet C(27), Cador B(28),",
    "entities": [
      {
        "text": "Legendre M(25",
        "label": "PERSON"
      },
      {
        "text": "Moranne",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Bouzid R(1), Joly BS(1)(29)(30), Veyradier A(1)(29)(30), Coppo P(1)(29)(31);",
    "entities": [
      {
        "text": "Bouzid R(1",
        "label": "PERSON"
      },
      {
        "text": "Joly",
        "label": "PERSON"
      },
      {
        "text": "Veyradier A(1)(29)(30",
        "label": "PERSON"
      },
      {
        "text": "Coppo P(1)(29)(31",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "French Reference Center for Thrombotic Microangiopathies.",
    "entities": [
      {
        "text": "French Reference Center for Thrombotic Microangiopathies",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Mediterranean Centre for Molecular Medicine, Control of Gene Expression (COdEX),",
    "entities": [
      {
        "text": "Mediterranean Centre for Molecular Medicine",
        "label": "FAC"
      },
      {
        "text": "Control of Gene Expression",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "INSERM U1065, Nice, France.",
    "entities": [
      {
        "text": "U1065",
        "label": "GPE"
      },
      {
        "text": "Nice",
        "label": "GPE"
      },
      {
        "text": "France",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Current triplet regimens associating therapeutic plasma exchange (TPE),",
    "entities": [
      {
        "text": "TPE",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "immunosuppression with corticosteroids and rituximab, and caplacizumab have",
    "entities": []
  },
  {
    "text": "dramatically improved the outcome of immune-mediated thrombotic thrombocytopenic",
    "entities": []
  },
  {
    "text": "purpura (iTTP). However, nearly half of the patients require extended",
    "entities": [
      {
        "text": "purpura (iTTP",
        "label": "ORG"
      },
      {
        "text": "nearly half",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "raising cost and tolerance concerns. Therefore, we investigated whether",
    "entities": []
  },
  {
    "text": "anti-ADAMTS13 antibodies titer and their trajectory during the acute phase of",
    "entities": [
      {
        "text": "anti-ADAMTS13",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "the disease could predict ADAMTS13 improvement (i.e., activity \u2265 20% before",
    "entities": [
      {
        "text": "ADAMTS13",
        "label": "NORP"
      },
      {
        "text": "\u2265",
        "label": "PERSON"
      },
      {
        "text": "20%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "day-30 post-TPE). From a cohort of 286 patients receiving the triplet regimen,",
    "entities": [
      {
        "text": "day-30 post-TPE",
        "label": "ORG"
      },
      {
        "text": "286",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "we identified on diagnosis a cut-off value for anti-ADAMTS13 IgG antibodies of",
    "entities": []
  },
  {
    "text": "90.5 U/mL, with a modest discriminating ability (AUC: 0.57) for predicting",
    "entities": [
      {
        "text": "90.5",
        "label": "CARDINAL"
      },
      {
        "text": "U/mL",
        "label": "ORG"
      },
      {
        "text": "0.57",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "long-term response, precluding its use to guide therapeutic strategies.",
    "entities": []
  },
  {
    "text": "Nonetheless, the analysis of anti-ADAMTS13 IgG antibodies titer trajectory from",
    "entities": [
      {
        "text": "anti-ADAMTS13",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "diagnosis revealed that the proportion of iTTP patients with ADAMTS13 activity",
    "entities": [
      {
        "text": "iTTP",
        "label": "ORG"
      },
      {
        "text": "ADAMTS13",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "improvement was higher in patients who decreased (Dec+) their antibodies titer",
    "entities": []
  },
  {
    "text": "within the 7-14 days interval post-TPE compared to those without decrease (Dec-)",
    "entities": [
      {
        "text": "7-14 days",
        "label": "DATE"
      },
      {
        "text": "post-TPE",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(65% vs. 25% of cases, respectively, p < 0.001), a finding confirmed in a",
    "entities": [
      {
        "text": "65%",
        "label": "PERCENT"
      },
      {
        "text": "25%",
        "label": "PERCENT"
      },
      {
        "text": "p < 0.001",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "validation cohort (N = 51). These results highlight the possibility of",
    "entities": [
      {
        "text": "51",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "intensifying immunosuppression in an early period post-TPE to shorten time to",
    "entities": [
      {
        "text": "post-TPE",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "ADAMTS13 activity recovery. Close monitoring of anti-ADAMTS13 antibodies titer",
    "entities": [
      {
        "text": "anti-ADAMTS13",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "may guide immunomodulation strategies, including additional courses of B-cell",
    "entities": []
  },
  {
    "text": "depleting agents when appropriate.",
    "entities": []
  },
  {
    "text": "\u00a9 2025 The Author(s). American Journal of Hematology published by Wiley",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "American Journal of Hematology",
        "label": "ORG"
      },
      {
        "text": "Wiley",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Artificial intelligence in cardiovascular pharmacotherapy: applications and",
    "entities": []
  },
  {
    "text": "perspectives.",
    "entities": []
  },
  {
    "text": "(1)Cardiology Department, University Hospital Virgen de la Victoria, Instituto",
    "entities": [
      {
        "text": "1)Cardiology Department",
        "label": "ORG"
      },
      {
        "text": "University Hospital Virgen de la Victoria",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(2)Department of Biomedical and Dental Sciences and of Morphological and",
    "entities": [
      {
        "text": "Biomedical",
        "label": "ORG"
      },
      {
        "text": "Dental Sciences",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Functional Images, University of Messina, Messina 98122, Italy.",
    "entities": [
      {
        "text": "Functional Images, University of Messina",
        "label": "ORG"
      },
      {
        "text": "Italy",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Department of Medicine and Dermatology, University of Malaga, M\u00e1laga, Spain.",
    "entities": [
      {
        "text": "Medicine and Dermatology, University of Malaga, M\u00e1laga",
        "label": "ORG"
      },
      {
        "text": "Spain",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(5)Institute of Cardiology, ASST Spedali Civili di Brescia, Department of",
    "entities": [
      {
        "text": "Cardiology",
        "label": "GPE"
      },
      {
        "text": "ASST Spedali Civili",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Medical and Surgical Specialties, Radiological Sciences, and Public Health,",
    "entities": [
      {
        "text": "Radiological Sciences",
        "label": "ORG"
      },
      {
        "text": "Public Health",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "University of Brescia, Brescia, Italy.",
    "entities": [
      {
        "text": "University of Brescia",
        "label": "ORG"
      },
      {
        "text": "Brescia",
        "label": "GPE"
      },
      {
        "text": "Italy",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(6)Division of Cardiology, Cardiovascular and Thoracic Department, Citt\u00e0 della",
    "entities": [
      {
        "text": "Cardiovascular",
        "label": "ORG"
      },
      {
        "text": "Thoracic Department",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Salute e della Scienza Hospital and University of Turin, Turin, Italy.",
    "entities": [
      {
        "text": "Scienza Hospital",
        "label": "ORG"
      },
      {
        "text": "University of Turin",
        "label": "ORG"
      },
      {
        "text": "Turin",
        "label": "GPE"
      },
      {
        "text": "Italy",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(7)1st Department of Cardiology, Medical University of Warsaw, Warsaw, Poland.",
    "entities": [
      {
        "text": "7)1st Department of Cardiology, Medical University of Warsaw",
        "label": "ORG"
      },
      {
        "text": "Warsaw",
        "label": "GPE"
      },
      {
        "text": "Poland",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(8)Department of Radiology, University of Cagliari, Cagliari, Italy.",
    "entities": [
      {
        "text": "Radiology, University of Cagliari",
        "label": "ORG"
      },
      {
        "text": "Cagliari",
        "label": "GPE"
      },
      {
        "text": "Italy",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(11)Department of Translational Medical Sciences, University of Campania 'Luigi",
    "entities": [
      {
        "text": "11)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Translational Medical Sciences",
        "label": "ORG"
      },
      {
        "text": "University of Campania '",
        "label": "ORG"
      },
      {
        "text": "Luigi",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(12)Division of Clinical Cardiology, A.O.R.N. \"Sant\u00b4Anna e San Sebastiano\",",
    "entities": [
      {
        "text": "12)Division",
        "label": "CARDINAL"
      },
      {
        "text": "Clinical Cardiology",
        "label": "ORG"
      },
      {
        "text": "A.O.R.N.",
        "label": "ORG"
      },
      {
        "text": "Sant\u00b4Anna",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Caserta 81100, Italy.",
    "entities": [
      {
        "text": "81100",
        "label": "DATE"
      },
      {
        "text": "Italy",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(14)Cardiovascular Research Chair, UAB, Barcelona, Spain.",
    "entities": [
      {
        "text": "14)Cardiovascular Research Chair",
        "label": "ORG"
      },
      {
        "text": "UAB",
        "label": "GPE"
      },
      {
        "text": "Barcelona",
        "label": "GPE"
      },
      {
        "text": "Spain",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(16)Zena and Michael A. Wiener Cardiovascular Institute (R.M.), Icahn School of",
    "entities": [
      {
        "text": "16)Zena",
        "label": "CARDINAL"
      },
      {
        "text": "Michael A. Wiener Cardiovascular Institute",
        "label": "PERSON"
      },
      {
        "text": "R.M.",
        "label": "ORG"
      },
      {
        "text": "Icahn School of\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Medicine at Mount Sinai, New York, NY, USA.",
    "entities": [
      {
        "text": "Mount Sinai",
        "label": "FAC"
      },
      {
        "text": "New York",
        "label": "GPE"
      },
      {
        "text": "NY",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(17)Division of Cardiology, University of Florida College of Medicine,",
    "entities": [
      {
        "text": "Cardiology, University of Florida College of Medicine",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(18)Royal Brompton & Harefield Hospitals and Cardiovascular Academic Group,",
    "entities": [
      {
        "text": "18)Royal",
        "label": "CARDINAL"
      },
      {
        "text": "Brompton & Harefield Hospitals",
        "label": "ORG"
      },
      {
        "text": "Cardiovascular Academic Group",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "King's College, London, UK.",
    "entities": [
      {
        "text": "King's College",
        "label": "ORG"
      },
      {
        "text": "London",
        "label": "GPE"
      },
      {
        "text": "UK",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(19)Center for Molecular Cardiology, University of Zurich, Zurich, Switzerland.",
    "entities": [
      {
        "text": "19)Center",
        "label": "CARDINAL"
      },
      {
        "text": "Molecular Cardiology",
        "label": "ORG"
      },
      {
        "text": "University of Zurich",
        "label": "ORG"
      },
      {
        "text": "Zurich",
        "label": "GPE"
      },
      {
        "text": "Switzerland",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "95123, Italy.",
    "entities": [
      {
        "text": "95123",
        "label": "DATE"
      },
      {
        "text": "Italy",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Recent advances in artificial intelligence (AI) have shown great potential in",
    "entities": [
      {
        "text": "AI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "improving cardiovascular pharmacotherapy by optimizing drug selection,",
    "entities": []
  },
  {
    "text": "predicting therapeutic efficacy and adverse effects, ultimately improving",
    "entities": []
  },
  {
    "text": "patient outcomes. Leveraging techniques like machine learning and in silico",
    "entities": []
  },
  {
    "text": "modelling, AI can identify populations likely to benefit from specific",
    "entities": [
      {
        "text": "AI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "treatments, expedite novel drug discovery and reduce costs. Computational",
    "entities": []
  },
  {
    "text": "methods can also facilitate the detection of drug interactions and tailor",
    "entities": []
  },
  {
    "text": "interventions based on real-world data, supporting personalized care. Artificial",
    "entities": []
  },
  {
    "text": "intelligence-based approaches also show promise in streamlining clinical trial",
    "entities": []
  },
  {
    "text": "design and execution, leveraging on real-time data on patient responsiveness,",
    "entities": []
  },
  {
    "text": "enhancing recruitment efficiency. However, in order to fully realize these",
    "entities": []
  },
  {
    "text": "benefits, robust validation across diverse patient populations is necessary to",
    "entities": []
  },
  {
    "text": "ensure accuracy and generalizability. In addition, addressing concerns regarding",
    "entities": []
  },
  {
    "text": "data quality, privacy, and bias is equally critical to avoid exacerbating",
    "entities": []
  },
  {
    "text": "existing healthcare disparities. Scientific societies and regulatory agencies",
    "entities": []
  },
  {
    "text": "must ultimately establish standardized frameworks for data management, model",
    "entities": []
  },
  {
    "text": "certification, and transparency, to enable safe and effective integration of AI",
    "entities": [
      {
        "text": "AI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "into clinical practice. This manuscript aims at systematically reviewing the",
    "entities": []
  },
  {
    "text": "current state-of-the-art applications of AI in cardiovascular pharmacotherapy,",
    "entities": [
      {
        "text": "AI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "describing their current potential in guiding treatment decisions, refine trial",
    "entities": []
  },
  {
    "text": "methodologies and support drug discovery.",
    "entities": []
  },
  {
    "text": "European Society of Cardiology.",
    "entities": [
      {
        "text": "European Society of Cardiology",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Female- and age-specific reference values for blood pressure and its",
    "entities": []
  },
  {
    "text": "relationship with cardiac aberrations after preeclampsia.",
    "entities": [
      {
        "text": "preeclampsia",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(1)Department of Obstetrics and Gynaecology, Maastricht University Medical",
    "entities": [
      {
        "text": "Obstetrics and Gynaecology",
        "label": "ORG"
      },
      {
        "text": "Maastricht University Medical",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Centre+ (MUMC+), Maastricht, the Netherlands.",
    "entities": [
      {
        "text": "Maastricht",
        "label": "GPE"
      },
      {
        "text": "Netherlands",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Cardiovascular Research Institute Maastricht (CARIM), Maastricht University,",
    "entities": [
      {
        "text": "Research Institute Maastricht",
        "label": "ORG"
      },
      {
        "text": "Maastricht University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Maastricht, the Netherlands.",
    "entities": [
      {
        "text": "Maastricht",
        "label": "GPE"
      },
      {
        "text": "Netherlands",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)GROW School for Oncology and Reproduction, Maastricht University, Maastricht,",
    "entities": [
      {
        "text": "3)GROW School for Oncology and Reproduction",
        "label": "ORG"
      },
      {
        "text": "Maastricht University",
        "label": "ORG"
      },
      {
        "text": "Maastricht",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "the Netherlands.",
    "entities": [
      {
        "text": "Netherlands",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Department of Cardiology, MUMC+, Maastricht, the Netherlands.",
    "entities": [
      {
        "text": "Cardiology",
        "label": "ORG"
      },
      {
        "text": "Maastricht",
        "label": "GPE"
      },
      {
        "text": "Netherlands",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(5)Department of Cardiology, Zuyderland Medical Centre, Heerlen, the",
    "entities": [
      {
        "text": "5)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Zuyderland Medical Centre",
        "label": "ORG"
      },
      {
        "text": "Heerlen",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(6)Department of Obstetrics and Gynaecology, Radboud University Medical Centre",
    "entities": [
      {
        "text": "Obstetrics and Gynaecology",
        "label": "ORG"
      },
      {
        "text": "Radboud University Medical Centre",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(Radboudumc), Nijmegen, the Netherlands.",
    "entities": [
      {
        "text": "Nijmegen",
        "label": "PERSON"
      },
      {
        "text": "Netherlands",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(7)Department of Cardiology, Thorax Centre, Cardiovascular Institute, Erasmus",
    "entities": [
      {
        "text": "Cardiology",
        "label": "ORG"
      },
      {
        "text": "Thorax Centre",
        "label": "GPE"
      },
      {
        "text": "Cardiovascular Institute",
        "label": "ORG"
      },
      {
        "text": "Erasmus",
        "label": "PRODUCT"
      }
    ]
  },
  {
    "text": "Medical Centre, Rotterdam, the Netherlands.",
    "entities": [
      {
        "text": "Medical Centre",
        "label": "FAC"
      },
      {
        "text": "Rotterdam",
        "label": "GPE"
      },
      {
        "text": "Netherlands",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "AIMS: Cardiovascular risk increases progressively increases from lower blood",
    "entities": []
  },
  {
    "text": "thresholds for hypertension. In this study, we established female- and",
    "entities": []
  },
  {
    "text": "age-specific thresholds for hypertension and assessed its association with",
    "entities": []
  },
  {
    "text": "subclinical cardiac aberrations in a high-risk female group of women after",
    "entities": []
  },
  {
    "text": "METHODS: A standardized cross-sectional cardiovascular assessment was performed",
    "entities": []
  },
  {
    "text": "among former pregnant women, including 30-minutes BP measurement and",
    "entities": [
      {
        "text": "30-minutes",
        "label": "TIME"
      },
      {
        "text": "BP",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "transthoracic echocardiography to assess cardiac function and remodelling. Women",
    "entities": []
  },
  {
    "text": "with a history of normotensive pregnancy constituted the cardiovascular healthy",
    "entities": []
  },
  {
    "text": "reference group, in whom we established thresholds for elevated BP (\u226595th",
    "entities": [
      {
        "text": "BP (\u226595th\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "percentile). The risk for subclinical cardiac aberrations in case of elevated BP",
    "entities": [
      {
        "text": "BP",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "was evaluated among former preeclamptic women.",
    "entities": []
  },
  {
    "text": "RESULTS: A number of 463 women were included in the healthy reference group and",
    "entities": [
      {
        "text": "463",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "951 formerly preeclamptic women (43\u00b18 and 39\u00b18 years, respectively).",
    "entities": [
      {
        "text": "951",
        "label": "CARDINAL"
      },
      {
        "text": "43\u00b18",
        "label": "CARDINAL"
      },
      {
        "text": "39\u00b18 years",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "Female-specific thresholds defining hypertension were 132.8 mmHg systolic or",
    "entities": [
      {
        "text": "132.8",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "81.0 mmHg diastolic. Among former preeclamptic women, systolic BP levels above",
    "entities": [
      {
        "text": "81.0",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "\u2265132.8 mmHg but below current diagnostic threshold for hypertension (<140 mmHg)",
    "entities": [
      {
        "text": "140",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "significantly associated with increased odds for left ventricular concentric",
    "entities": []
  },
  {
    "text": "remodelling (OR= 2.1, 95% CI 1.1-4.2), diastolic dysfunction (OR = 4.5",
    "entities": [
      {
        "text": "2.1",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "1.1-4.2",
        "label": "CARDINAL"
      },
      {
        "text": "4.5",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "(1.4-14.2)), and subclinical heart failure (OR= 2.3, 95% CI 1.2-4.2).",
    "entities": [
      {
        "text": "1.4",
        "label": "CARDINAL"
      },
      {
        "text": "2.3",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "1.2-4.2",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "CONCLUSION: For relatively young women, female-specific thresholds for",
    "entities": []
  },
  {
    "text": "hypertension are lower than ESC/ESH guidelines (\u2265133/81 versus \u2265140/90 mmHg),",
    "entities": [
      {
        "text": "ESC/ESH",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "and associate with cardiac dysfunction in formerly preeclamptic women. Sex- and",
    "entities": []
  },
  {
    "text": "age-tailored interpretation of BP improves prevention of heart failure",
    "entities": [
      {
        "text": "BP",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "development and progression among high-risk women.",
    "entities": []
  },
  {
    "text": "Plain Language Summary: In women, sex- and age-guided interpretation of blood",
    "entities": []
  },
  {
    "text": "pressure will enhance timely detection of increased cardiovascular risks, and",
    "entities": []
  },
  {
    "text": "improve personalized prevention of cardiovascular disease development and",
    "entities": []
  },
  {
    "text": "progression. Female-specific reference values for hypertension are \u2265133/81 mmHg,",
    "entities": []
  },
  {
    "text": "and thereby lower than the current ESC/ESH guidelines state (\u2265140/90",
    "entities": [
      {
        "text": "ESC/ESH",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "mmHg).Levels in-between these distinct thresholds relate to subclinical cardiac",
    "entities": [
      {
        "text": "mmHg).Levels",
        "label": "PRODUCT"
      }
    ]
  },
  {
    "text": "abnormalities in high-risk women, amongst left ventricular hypertrophy, left",
    "entities": []
  },
  {
    "text": "ventricular concentric remodeling, diastolic dysfunction and heart failure stage",
    "entities": []
  },
  {
    "text": "B among former preeclamptic women at preterm high-risk.",
    "entities": []
  },
  {
    "text": "European Society of Cardiology. All rights reserved. For commercial re-use,",
    "entities": [
      {
        "text": "European Society of Cardiology",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Tolerability and Adverse Effects in a Specialized Heart Failure",
    "entities": []
  },
  {
    "text": "Guideline-Directed Medical Therapy Optimization Program.",
    "entities": [
      {
        "text": "Guideline-Directed Medical Therapy Optimization Program",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(1)Penn State College of Medicine, Hershey, Pennsylvania, USA.",
    "entities": [
      {
        "text": "State College of Medicine",
        "label": "ORG"
      },
      {
        "text": "Hershey",
        "label": "GPE"
      },
      {
        "text": "Pennsylvania",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Division of Cardiology, Heart & Vascular Institute, Penn State Hershey",
    "entities": [
      {
        "text": "Cardiology, Heart & Vascular Institute",
        "label": "ORG"
      },
      {
        "text": "Penn State Hershey",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Medical Center, Hershey, Pennsylvania, USA.",
    "entities": [
      {
        "text": "Hershey",
        "label": "GPE"
      },
      {
        "text": "Pennsylvania",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "BACKGROUND: Utilization of heart failure (HF) guideline-directed medical therapy",
    "entities": []
  },
  {
    "text": "(GDMT) to target doses is suboptimal, with studies citing adverse effects (AEs),",
    "entities": [
      {
        "text": "GDMT",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "physiological factors, and therapeutic inertia as potential contributing",
    "entities": []
  },
  {
    "text": "factors. The objective of our study was to explore tolerability and GDMT",
    "entities": [
      {
        "text": "GDMT",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "titration-limiting AEs in a specialized heart failure optimization program",
    "entities": []
  },
  {
    "text": "implemented at our institution.",
    "entities": []
  },
  {
    "text": "METHODS: We studied the baseline characteristics of 254 patients who",
    "entities": [
      {
        "text": "254",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "successfully completed our program and analyzed the frequency and severity of",
    "entities": []
  },
  {
    "text": "the four most common GDMT-related AEs: hypotension, bradycardia, hyperkalemia,",
    "entities": [
      {
        "text": "four",
        "label": "CARDINAL"
      },
      {
        "text": "GDMT",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "and renal dysfunction.",
    "entities": []
  },
  {
    "text": "RESULTS: Patients who achieved target doses were younger, more likely to have",
    "entities": []
  },
  {
    "text": "nonischemic HF, less likely to have a recent HF-related hospitalization, had",
    "entities": [
      {
        "text": "HF",
        "label": "ORG"
      },
      {
        "text": "HF",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "less coronary artery disease, and were more likely to be obese. Multivariate",
    "entities": []
  },
  {
    "text": "analyses revealed significant associations between beta blocker suboptimal",
    "entities": []
  },
  {
    "text": "dosing (< 50% of target dose) and older age (odds ratio [OR]: 1.04; 95%",
    "entities": [
      {
        "text": "50%",
        "label": "PERCENT"
      },
      {
        "text": "1.04",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "(OR: 2.57; 95% CI: 1.18-5.58; p = 0.017), and absence of hypertension (OR: 0.39;",
    "entities": [
      {
        "text": "2.57",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "1.18-5.58",
        "label": "CARDINAL"
      },
      {
        "text": "0.017",
        "label": "CARDINAL"
      },
      {
        "text": "0.39",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "95% CI: 0.17-0.89; p = 0.025). For angiotensin converting enzyme",
    "entities": [
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "0.17-0.89",
        "label": "CARDINAL"
      },
      {
        "text": "0.025",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "inhibitors/angiotensin II receptor blockers/angiotensin receptor neprilysin",
    "entities": [
      {
        "text": "neprilysin\n",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "inhibitors, suboptimal dosing was associated with the presence of atrial",
    "entities": []
  },
  {
    "text": "fibrillation (OR: 2.08; 95% CI: 1.04-4.17; p = 0.039). Of the patients who",
    "entities": [
      {
        "text": "2.08",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "1.04",
        "label": "CARDINAL"
      },
      {
        "text": "0.039",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "completed the program, 59.1% encountered at least one AE that hindered the",
    "entities": [
      {
        "text": "59.1%",
        "label": "PERCENT"
      },
      {
        "text": "at least one",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "titration to target GDMT doses.",
    "entities": [
      {
        "text": "GDMT",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "CONCLUSION: Our findings highlight the complexities of GDMT optimization within",
    "entities": [
      {
        "text": "GDMT",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "a specialized program and the need for standardized definitions of GDMT-related",
    "entities": [
      {
        "text": "GDMT",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "\u00a9 2025 The Author(s). Clinical Cardiology published by Wiley Periodicals LLC.",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "Clinical Cardiology",
        "label": "ORG"
      },
      {
        "text": "Wiley Periodicals",
        "label": "ORG"
      },
      {
        "text": "LLC",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "PMID: 40662449 [Indexed for MEDLINE]",
    "entities": [
      {
        "text": "40662449",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "83. Diabetes Obes Metab. 2025 Jul 15. doi: 10.1111/dom.16618. Online ahead of",
    "entities": [
      {
        "text": "83",
        "label": "CARDINAL"
      },
      {
        "text": "Obes Metab",
        "label": "PERSON"
      },
      {
        "text": "2025",
        "label": "CARDINAL"
      },
      {
        "text": "15",
        "label": "CARDINAL"
      },
      {
        "text": "10.1111",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Novel oral agents in anti-obesity pharmacotherapy: A narrative review.",
    "entities": []
  },
  {
    "text": "(1)Institute of Endocrinology, Metabolism and Hypertension, Tel Aviv Sourasky",
    "entities": [
      {
        "text": "Tel Aviv Sourasky",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(2)Department of Nutrition Sciences, School of Health Sciences, Ariel",
    "entities": [
      {
        "text": "Nutrition Sciences",
        "label": "ORG"
      },
      {
        "text": "School of Health Sciences",
        "label": "ORG"
      },
      {
        "text": "Ariel\n",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "University, Ariel, Israel.",
    "entities": [
      {
        "text": "Ariel",
        "label": "GPE"
      },
      {
        "text": "Israel",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.",
    "entities": [
      {
        "text": "Medicine",
        "label": "GPE"
      },
      {
        "text": "Tel Aviv University",
        "label": "ORG"
      },
      {
        "text": "Tel Aviv",
        "label": "GPE"
      },
      {
        "text": "Israel",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Albert Einstein College of Medicine, Montefiore Clinical Diabetes Center,",
    "entities": [
      {
        "text": "Einstein College of Medicine",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Bronx, New York, USA.",
    "entities": [
      {
        "text": "Bronx",
        "label": "GPE"
      },
      {
        "text": "New York",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Obesity remains a critical global health issue with profound medical and",
    "entities": []
  },
  {
    "text": "economic implications. While injectable medications such as semaglutide",
    "entities": []
  },
  {
    "text": "(Wegovy\u00ae) and tirzepatide (Zepbound\u00ae) have demonstrated significant efficacy,",
    "entities": []
  },
  {
    "text": "the development of novel oral anti-obesity agents presents additional",
    "entities": []
  },
  {
    "text": "therapeutic potential. This narrative review examines recent advances in oral",
    "entities": []
  },
  {
    "text": "pharmacotherapy for obesity, focusing on mechanisms of action, clinical",
    "entities": []
  },
  {
    "text": "effectiveness, anticipated benefits and side effects. A systematic search of",
    "entities": []
  },
  {
    "text": "PubMed, Cochrane Library, Google Scholar and ClinicalTrials.gov identified",
    "entities": [
      {
        "text": "PubMed",
        "label": "ORG"
      },
      {
        "text": "Cochrane Library",
        "label": "PERSON"
      },
      {
        "text": "Google Scholar",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "relevant studies published between January 2023 and June 2025, including",
    "entities": [
      {
        "text": "January 2023 and June 2025",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "randomized controlled trials and clinical investigations of emerging oral",
    "entities": []
  },
  {
    "text": "agents. We have selected emerging oral compounds, currently undergoing clinical",
    "entities": []
  },
  {
    "text": "evaluation but not yet approved by the Food and Drug Administration (FDA). These",
    "entities": [
      {
        "text": "the Food and Drug Administration",
        "label": "ORG"
      },
      {
        "text": "FDA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "include oral GLP-1 RAs, peptides and small molecules, and non-incretin-based",
    "entities": [
      {
        "text": "GLP-1",
        "label": "PRODUCT"
      },
      {
        "text": "non-incretin-based\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "therapies targeting the melanocortin-4 receptor and the endocannabinoid system,",
    "entities": []
  },
  {
    "text": "among others. Several agents have demonstrated promising efficacy, achieving",
    "entities": []
  },
  {
    "text": "weight loss of \u226510% in clinical trials while also exhibiting favourable safety",
    "entities": [
      {
        "text": "\u226510%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "profiles. Emerging oral therapies could complement or serve as alternatives to",
    "entities": []
  },
  {
    "text": "approved injectable treatments, particularly for long-term weight management.",
    "entities": []
  },
  {
    "text": "They may enhance patient access, adherence and satisfaction, thereby broadening",
    "entities": []
  },
  {
    "text": "the scope of pharmacological interventions in obesity care. Ongoing research is",
    "entities": []
  },
  {
    "text": "crucial to confirm the long-term safety, effectiveness and clinical role of",
    "entities": []
  },
  {
    "text": "these agents within comprehensive obesity management strategies. By",
    "entities": []
  },
  {
    "text": "contextualizing these developments, this review underscores the growing promise",
    "entities": []
  },
  {
    "text": "of oral pharmacotherapy in addressing the global obesity epidemic.",
    "entities": []
  },
  {
    "text": "\u00a9 2025 John Wiley & Sons Ltd.",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "John Wiley & Sons Ltd.",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "84. Cardiovasc Res. 2025 Jul 15:cvaf125. doi: 10.1093/cvr/cvaf125. Online ahead",
    "entities": [
      {
        "text": "84",
        "label": "CARDINAL"
      },
      {
        "text": "Cardiovasc Res",
        "label": "ORG"
      },
      {
        "text": "15",
        "label": "CARDINAL"
      },
      {
        "text": "10.1093",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Prevalence of hypertension in Africa in the last two decades: Systematic review",
    "entities": [
      {
        "text": "Africa",
        "label": "LOC"
      },
      {
        "text": "the last two decades",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "and meta-analysis.",
    "entities": []
  },
  {
    "text": "(1)Department of Medicine, Federal Teaching Hospital, Ido-Ekiti, Nigeria.",
    "entities": [
      {
        "text": "Medicine, Federal Teaching Hospital",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(2)College of Medicine and Health Sciences, Afe Babalola University, Ado-Ekiti,",
    "entities": [
      {
        "text": "2)College",
        "label": "CARDINAL"
      },
      {
        "text": "Medicine and Health Sciences",
        "label": "ORG"
      },
      {
        "text": "Afe Babalola University",
        "label": "ORG"
      },
      {
        "text": "Ado-Ekiti",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(3)Seoul National University 08826 Seoul, Republic of Korea.",
    "entities": [
      {
        "text": "National University 08826 Seoul, Republic of Korea",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(4)Translational Gerontology Branch, National Institute on Aging, Baltimore,",
    "entities": [
      {
        "text": "4)Translational Gerontology Branch",
        "label": "LOC"
      },
      {
        "text": "National Institute on Aging,",
        "label": "ORG"
      },
      {
        "text": "Baltimore",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(5)Department of Epidemiology and Medical Statistics, University of Ibadan,",
    "entities": [
      {
        "text": "Epidemiology and Medical Statistics",
        "label": "ORG"
      },
      {
        "text": "University of Ibadan",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(6)School of Infection & Immunity, College of Medical, Veterinary and Life",
    "entities": [
      {
        "text": "Infection & Immunity",
        "label": "ORG"
      },
      {
        "text": "College of Medical",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Sciences, University of Glasgow, Glasgow, United Kingdom.",
    "entities": [
      {
        "text": "University of Glasgow",
        "label": "ORG"
      },
      {
        "text": "Glasgow",
        "label": "GPE"
      },
      {
        "text": "United Kingdom",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(7)Department of Pharmacy, School of Medicine and Surgery, University of Naples",
    "entities": [
      {
        "text": "Pharmacy, School of Medicine and Surgery, University of Naples",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Federico II, Naples, Italy.",
    "entities": [
      {
        "text": "Federico II",
        "label": "PERSON"
      },
      {
        "text": "Naples",
        "label": "GPE"
      },
      {
        "text": "Italy",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(8)Alliance for Medical Research in Africa (AMedRA), Dakar, Senegal.",
    "entities": [
      {
        "text": "Medical Research",
        "label": "ORG"
      },
      {
        "text": "Africa",
        "label": "LOC"
      },
      {
        "text": "Dakar, Senegal",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(9)Institute of Health and Development (ISED), Cheikh Anta Diop University,",
    "entities": [
      {
        "text": "Health and Development (ISED",
        "label": "ORG"
      },
      {
        "text": "Cheikh Anta Diop University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(10)Department of Biomedical Informatics, Emory University School of Medicine,",
    "entities": [
      {
        "text": "10)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Biomedical Informatics",
        "label": "ORG"
      },
      {
        "text": "Emory University School of Medicine",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(11)Department of Public Health, School of Medicine and Surgery, University of",
    "entities": [
      {
        "text": "11)Department of Public Health, School of Medicine and Surgery, University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Naples Federico II, Naples, Italy.",
    "entities": [
      {
        "text": "Naples Federico II",
        "label": "PERSON"
      },
      {
        "text": "Naples",
        "label": "GPE"
      },
      {
        "text": "Italy",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(12)Centre for Cardiovascular Sciences, Queens Medical Research Institute,",
    "entities": [
      {
        "text": "12)Centre",
        "label": "CARDINAL"
      },
      {
        "text": "Cardiovascular Sciences",
        "label": "ORG"
      },
      {
        "text": "Queens Medical Research Institute",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "University of Edinburgh, United Kingdom.",
    "entities": [
      {
        "text": "University of Edinburgh",
        "label": "ORG"
      },
      {
        "text": "United Kingdom",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(13)Department of Internal Medicine; Centre for Medical Genomics Omicron,",
    "entities": [
      {
        "text": "13)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Internal Medicine",
        "label": "ORG"
      },
      {
        "text": "Centre for Medical Genomics Omicron",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Jagiellonian University Collegium Medicum, Krakow, Poland.",
    "entities": [
      {
        "text": "Jagiellonian University Collegium Medicum",
        "label": "ORG"
      },
      {
        "text": "Krakow",
        "label": "GPE"
      },
      {
        "text": "Poland",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(14)Africa-Europe CoRE in Non-Communicable Diseases & Multimorbidity, African",
    "entities": [
      {
        "text": "Non-Communicable Diseases & Multimorbidity",
        "label": "ORG"
      },
      {
        "text": "African",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "Research Universities Alliance (ARUA) & The Guild of European Research-intensive",
    "entities": [
      {
        "text": "Research Universities Alliance",
        "label": "ORG"
      },
      {
        "text": "European Research",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Universities, Glasgow, UK.",
    "entities": [
      {
        "text": "Glasgow",
        "label": "GPE"
      },
      {
        "text": "UK",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(15)School of Cardiovascular & Metabolic Health, College of Medical, Veterinary",
    "entities": [
      {
        "text": "15)School",
        "label": "CARDINAL"
      },
      {
        "text": "Cardiovascular & Metabolic Health, College of Medical",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "and Life Sciences, University of Glasgow, Glasgow, United Kingdom.",
    "entities": [
      {
        "text": "Life Sciences",
        "label": "ORG"
      },
      {
        "text": "University of Glasgow",
        "label": "ORG"
      },
      {
        "text": "Glasgow",
        "label": "GPE"
      },
      {
        "text": "United Kingdom",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(16)Department of Medicine, College of Medicine, University College Hospital,",
    "entities": [
      {
        "text": "16)Department of Medicine, College of Medicine, University College Hospital",
        "label": "MONEY"
      }
    ]
  },
  {
    "text": "University of Ibadan, 200284, Ibadan, Nigeria.",
    "entities": [
      {
        "text": "University of Ibadan, 200284,",
        "label": "ORG"
      },
      {
        "text": "Ibadan",
        "label": "GPE"
      },
      {
        "text": "Nigeria",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(17)Center for Genomic and Precision Medicine, College of Medicine, University",
    "entities": [
      {
        "text": "17)Center",
        "label": "CARDINAL"
      },
      {
        "text": "Genomic and Precision Medicine, College of Medicine, University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(18)School of Medicine, Lebanese American University of Beirut, Lebanon.",
    "entities": [
      {
        "text": "18)School",
        "label": "CARDINAL"
      },
      {
        "text": "Lebanese American University",
        "label": "ORG"
      },
      {
        "text": "Lebanon",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(19)Blossom Specialist Medical Center, Ibadan, Nigeria.",
    "entities": [
      {
        "text": "19)Blossom",
        "label": "CARDINAL"
      },
      {
        "text": "Specialist Medical Center",
        "label": "ORG"
      },
      {
        "text": "Ibadan",
        "label": "GPE"
      },
      {
        "text": "Nigeria",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "AIMS: Despite being the most common cardiovascular risk factor, the actual",
    "entities": []
  },
  {
    "text": "burden of hypertension is poorly characterized in Africa. We meta-analyzed the",
    "entities": [
      {
        "text": "Africa",
        "label": "LOC"
      }
    ]
  },
  {
    "text": "most extensive pooled data to determine the overall prevalence of hypertension",
    "entities": []
  },
  {
    "text": "in Africa.",
    "entities": [
      {
        "text": "Africa",
        "label": "LOC"
      }
    ]
  },
  {
    "text": "METHODS AND RESULTS: Following PRISMA guidelines, we systematically searched",
    "entities": []
  },
  {
    "text": "Google Scholar, PubMed, ScienceDirect, and Web of Science databases to retrieve",
    "entities": [
      {
        "text": "Google Scholar",
        "label": "ORG"
      },
      {
        "text": "PubMed",
        "label": "ORG"
      },
      {
        "text": "ScienceDirect",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "prevalence studies only on hypertension among Africans published between 2002",
    "entities": [
      {
        "text": "Africans",
        "label": "NORP"
      },
      {
        "text": "between 2002",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "and 2023. Furthermore, we meta-analyzed the crude and age-adjusted prevalences",
    "entities": [
      {
        "text": "2023",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "of hypertension using a random effect model due to the expected high",
    "entities": []
  },
  {
    "text": "heterogeneity, with logit transformation of the original",
    "entities": []
  },
  {
    "text": "proportions.Seventy-eight (out of an initial 779 screened) articles with",
    "entities": [
      {
        "text": "Seventy-eight",
        "label": "CARDINAL"
      },
      {
        "text": "779",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "complete data were included, with a total number of hypertension cases of 71,004",
    "entities": [
      {
        "text": "71,004",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "and a denominator population of 286,575, mostly from community-based studies in",
    "entities": [
      {
        "text": "286,575",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "23 countries. The pooled crude prevalence of hypertension was 28\u2e315/100 persons",
    "entities": [
      {
        "text": "23",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "[95% confidence interval (CI): 25\u2e313%-31\u2e318%] and a 95% prediction interval of",
    "entities": [
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "PERSON"
      },
      {
        "text": "25\u2e313%-31\u2e318%",
        "label": "PERCENT"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "7\u2e316%-65\u2e316%; the pooled prevalence increased with age and was highest among the",
    "entities": [
      {
        "text": "7\u2e316%-65\u2e316%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "aged \u226575 years: 51\u2e314% (95%CI: 42\u2e310%-60\u2e316%) and remained highest in the Southern",
    "entities": [
      {
        "text": "51\u2e314%",
        "label": "PERCENT"
      },
      {
        "text": "42\u2e310%-60\u2e316%",
        "label": "PERCENT"
      },
      {
        "text": "Southern",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "Africa region overall (34\u2e318%) and in the last decade (2013-2023; 44\u2e315%). The",
    "entities": [
      {
        "text": "Africa",
        "label": "LOC"
      },
      {
        "text": "34\u2e318%",
        "label": "PERCENT"
      },
      {
        "text": "the last decade",
        "label": "DATE"
      },
      {
        "text": "2013-2023",
        "label": "DATE"
      },
      {
        "text": "44\u2e315%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "point estimate of the pooled crude prevalence was higher among urban dwellers,",
    "entities": []
  },
  {
    "text": "32\u2e319% (95%CI: 26\u2e318%-39\u2e315%), than rural residents, 26\u2e313% (95%CI: 20\u2e314%-33\u2e313%). In",
    "entities": [
      {
        "text": "32\u2e319%",
        "label": "PERCENT"
      },
      {
        "text": "26\u2e318%-39\u2e315%",
        "label": "PERCENT"
      },
      {
        "text": "26\u2e313%",
        "label": "PERCENT"
      },
      {
        "text": "20\u2e314%-33\u2e313%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "a subset of twenty-one articles reporting age stratification consistent with the",
    "entities": [
      {
        "text": "twenty-one",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "WHO standard population, the pooled age-standardized prevalence was 27\u2e312/100",
    "entities": [
      {
        "text": "27\u2e312/100",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "CONCLUSION: The burden of hypertension remains high, especially in urban areas",
    "entities": []
  },
  {
    "text": "and with increasing age. Frequent screening and treatment are recommended,",
    "entities": []
  },
  {
    "text": "especially in urban areas.",
    "entities": []
  },
  {
    "text": "Insulin resistance factors associated with differentiated thyroid carcinoma and",
    "entities": [
      {
        "text": "Insulin",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "malignant cytology: serum thyroxine as an associated factor.",
    "entities": []
  },
  {
    "text": "(1)Faculty of Medicine, Pontifical Catholic University of Campinas, Campinas,",
    "entities": [
      {
        "text": "Medicine, Pontifical Catholic University of Campinas",
        "label": "ORG"
      },
      {
        "text": "Campinas",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Division of Endocrinology, Department of Internal Medicine, Faculty of",
    "entities": [
      {
        "text": "Endocrinology, Department of Internal Medicine, Faculty of\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "BACKGROUND: Factors related to cardiovascular risk and insulin sensitivity seem",
    "entities": []
  },
  {
    "text": "to be related to the increase in the number of thyroid cancer (TC) diagnosis,",
    "entities": []
  },
  {
    "text": "but there is a lack of studies to corroborate these hypotheses.",
    "entities": []
  },
  {
    "text": "METHODS: This observational and cross-sectional study evaluated",
    "entities": []
  },
  {
    "text": "ultrasonographic, clinical, cytological and anatomopathological characteristics",
    "entities": []
  },
  {
    "text": "of thyroid nodules (TN) related with factors indicative of cardiovascular risk",
    "entities": [
      {
        "text": "TN",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(CVR), serum lipids, and glucose profiles through medical records, and",
    "entities": [
      {
        "text": "CVR",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "interviews during routine medical consultation.",
    "entities": []
  },
  {
    "text": "RESULTS: The study included 160 TN patients, 85.53% women, 41.3% with obesity,",
    "entities": [
      {
        "text": "160",
        "label": "CARDINAL"
      },
      {
        "text": "TN",
        "label": "ORG"
      },
      {
        "text": "85.53%",
        "label": "PERCENT"
      },
      {
        "text": "41.3%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "24.18% with type 2 Diabetes Mellitus, 63.4% with arterial hypertension, 9.15%",
    "entities": [
      {
        "text": "24.18%",
        "label": "PERCENT"
      },
      {
        "text": "2",
        "label": "CARDINAL"
      },
      {
        "text": "63.4%",
        "label": "PERCENT"
      },
      {
        "text": "9.15%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "with previous CVR, 38.16% with dyslipidemia. 38.5% had Papillary TC, 8.5%",
    "entities": [
      {
        "text": "CVR",
        "label": "PRODUCT"
      },
      {
        "text": "38.16%",
        "label": "PERCENT"
      },
      {
        "text": "38.5%",
        "label": "PERCENT"
      },
      {
        "text": "Papillary TC",
        "label": "PERSON"
      },
      {
        "text": "8.5%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "Follicular TC. Regarding cytology categories (Bethesda,B), 34.64% BII, 8.5%",
    "entities": [
      {
        "text": "Bethesda",
        "label": "GPE"
      },
      {
        "text": "34.64%",
        "label": "PERCENT"
      },
      {
        "text": "BII",
        "label": "ORG"
      },
      {
        "text": "8.5%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "BIII, 11.11% BIV, 26.8% BV, 8.5% BVI. Microcalcifications were associated with",
    "entities": [
      {
        "text": "BIII",
        "label": "ORG"
      },
      {
        "text": "11.11%",
        "label": "PERCENT"
      },
      {
        "text": "BIV",
        "label": "ORG"
      },
      {
        "text": "26.8%",
        "label": "PERCENT"
      },
      {
        "text": "BV",
        "label": "ORG"
      },
      {
        "text": "8.5%",
        "label": "PERCENT"
      },
      {
        "text": "BVI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "higher Framingham and ASCVD CVR Scores, fasting glucose and glycated hemoglobin.",
    "entities": [
      {
        "text": "Framingham",
        "label": "PERSON"
      },
      {
        "text": "ASCVD CVR Scores",
        "label": "LAW"
      }
    ]
  },
  {
    "text": "BII TN had lower fasting glucose; BIII greater glycated hemoglobin; and BIV",
    "entities": [
      {
        "text": "BII",
        "label": "ORG"
      },
      {
        "text": "BIII",
        "label": "ORG"
      },
      {
        "text": "BIV",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "higher both CVR scores. Framingham Score was lower in papillary TC, abdominal",
    "entities": [
      {
        "text": "CVR",
        "label": "LAW"
      },
      {
        "text": "Framingham Score",
        "label": "ORG"
      },
      {
        "text": "TC",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "waist was lower in follicular TC. Higher FT4 increased 4.7 times the chance of",
    "entities": [
      {
        "text": "TC",
        "label": "PERSON"
      },
      {
        "text": "4.7",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "malignant cytology. Higher HDL was an associated factor for malignant cytology",
    "entities": [
      {
        "text": "HDL",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(OR = 1.064) and higher FT4 for Differentiated TC (OR = 7.409).",
    "entities": [
      {
        "text": "1.064",
        "label": "CARDINAL"
      },
      {
        "text": "Differentiated TC",
        "label": "PERSON"
      },
      {
        "text": "7.409",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "CONCLUSION: TN with greater malignant potential on ultrasound and cytology were",
    "entities": [
      {
        "text": "TN",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "associated with greater CVR and altered glucose metabolism. Larger goiters and",
    "entities": [
      {
        "text": "CVR",
        "label": "PRODUCT"
      }
    ]
  },
  {
    "text": "multiple nodules were related to factors indicative of insulin resistance.",
    "entities": []
  },
  {
    "text": "Malignant cytology was related to hormonal factors that induce greater cell",
    "entities": []
  },
  {
    "text": "replication, such as thyroxine and insulin resistance.",
    "entities": []
  },
  {
    "text": "PMID: 40662255 [Indexed for MEDLINE]",
    "entities": [
      {
        "text": "40662255",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "86. J Clin Exp Neuropsychol. 2025 Jul 15:1-14. doi:",
    "entities": [
      {
        "text": "86",
        "label": "CARDINAL"
      },
      {
        "text": "Clin Exp Neuropsychol",
        "label": "PERSON"
      },
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "15:1",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "10.1080/13803395.2025.2527341. Online ahead of print.",
    "entities": []
  },
  {
    "text": "The role of inflammation, chronic pain, and hypertension on cognitive",
    "entities": []
  },
  {
    "text": "functioning in an underserved, rural population: a Project FRONTIER study.",
    "entities": [
      {
        "text": "Project FRONTIER",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(1)Department of Psychological and Brain Sciences, University of Louisville,",
    "entities": [
      {
        "text": "Psychological and Brain Sciences",
        "label": "ORG"
      },
      {
        "text": "University of Louisville",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(2)Department of Psychological Science, Texas Tech University, Lubbock, TX, USA.",
    "entities": [
      {
        "text": "Psychological Science",
        "label": "ORG"
      },
      {
        "text": "Texas Tech University",
        "label": "ORG"
      },
      {
        "text": "Lubbock",
        "label": "GPE"
      },
      {
        "text": "TX",
        "label": "ORG"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Department of Pharmacology and Neuroscience, School of Medicine, Texas Tech",
    "entities": [
      {
        "text": "School of Medicine",
        "label": "ORG"
      },
      {
        "text": "Texas Tech",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "University Health Sciences Center, Lubbock, TX, USA.",
    "entities": [
      {
        "text": "University Health Sciences Center",
        "label": "ORG"
      },
      {
        "text": "Lubbock",
        "label": "GPE"
      },
      {
        "text": "TX",
        "label": "ORG"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Garrison Institute on Aging, Texas Tech University Health Sciences Center,",
    "entities": [
      {
        "text": "Institute on Aging",
        "label": "ORG"
      },
      {
        "text": "Texas Tech University Health Sciences Center",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(5)Department of Psychology, University of Central Oklahoma, Edmond, OK, USA.",
    "entities": [
      {
        "text": "5)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Psychology, University of Central Oklahoma",
        "label": "ORG"
      },
      {
        "text": "Edmond",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(6)Department of Kinesiology and Sport Management, Texas Tech University,",
    "entities": [
      {
        "text": "Kinesiology and Sport Management",
        "label": "ORG"
      },
      {
        "text": "Texas Tech University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(7)Center of Excellence for Translational Neuroscience and Therapeutics, Texas",
    "entities": [
      {
        "text": "Excellence for Translational Neuroscience and Therapeutics",
        "label": "ORG"
      },
      {
        "text": "Texas",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Tech University Health Sciences Center, Lubbock, TX, USA.",
    "entities": [
      {
        "text": "Tech University Health Sciences Center",
        "label": "ORG"
      },
      {
        "text": "Lubbock",
        "label": "GPE"
      },
      {
        "text": "TX",
        "label": "ORG"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "BACKGROUND: Inflammation, chronic pain, and hypertension have been identified as",
    "entities": []
  },
  {
    "text": "risk factors for cognitive decline; few studies have examined the interplay",
    "entities": []
  },
  {
    "text": "between multiple risk factors and even fewer have considered these factors in",
    "entities": []
  },
  {
    "text": "underserved rural populations.",
    "entities": []
  },
  {
    "text": "OBJECTIVE: This study analyzed the relationships between inflammation, chronic",
    "entities": []
  },
  {
    "text": "pain, and hypertension with cognitive functioning in an underserved, primarily",
    "entities": []
  },
  {
    "text": "Hispanic, rural population from Project FRONTIER (Facing Rural Obstacles to",
    "entities": [
      {
        "text": "Hispanic",
        "label": "NORP"
      },
      {
        "text": "Project FRONTIER (Facing Rural Obstacles",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Healthcare Now Through Intervention, Education, & Research).",
    "entities": [
      {
        "text": "Education",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "METHODS: This epidemiological study enrolled 1,864 participants",
    "entities": [
      {
        "text": "1,864",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "(Mage = 59.68 years, SDage = 12.21) living in five rural counties in West Texas.",
    "entities": [
      {
        "text": "59.68 years",
        "label": "DATE"
      },
      {
        "text": "12.21",
        "label": "CARDINAL"
      },
      {
        "text": "five",
        "label": "CARDINAL"
      },
      {
        "text": "West Texas",
        "label": "LOC"
      }
    ]
  },
  {
    "text": "completed five cognitive evaluations (i.e. the Repeatable Battery for the",
    "entities": [
      {
        "text": "five",
        "label": "CARDINAL"
      },
      {
        "text": "the Repeatable Battery",
        "label": "PRODUCT"
      }
    ]
  },
  {
    "text": "Assessment of Neuropsychological Status, the Trails Making Test A and B, and",
    "entities": [
      {
        "text": "the Trails Making Test A",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Clock Drawing 1 and 2), and attended a medical examination during which a",
    "entities": [
      {
        "text": "Clock",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "physician confirmed existing medical conditions (e.g. hypertension) and",
    "entities": []
  },
  {
    "text": "collected a blood sample for further analysis (e.g. inflammation markers).",
    "entities": []
  },
  {
    "text": "RESULTS: Analysis via MANOVA revealed a multivariate effect of inflammation",
    "entities": []
  },
  {
    "text": "(V = .02, F(4, 969) = 3.72, p = .006) and a multivariate effect of hypertension",
    "entities": [
      {
        "text": "969",
        "label": "CARDINAL"
      },
      {
        "text": "3.72",
        "label": "CARDINAL"
      },
      {
        "text": ".006",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "(V = .03, F(4, 969) = 6.69, p < .001). There was no multivariate effect for",
    "entities": [
      {
        "text": "969",
        "label": "CARDINAL"
      },
      {
        "text": "6.69",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "chronic pain (V = .01, F(4,969) = 2.18, p = .07) and no significant two way or",
    "entities": [
      {
        "text": "F(4,969",
        "label": "GPE"
      },
      {
        "text": "2.18",
        "label": "CARDINAL"
      },
      {
        "text": "two",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "three way interaction. Post-hoc ANOVAs further illustrated the relationships",
    "entities": [
      {
        "text": "three",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "between specific cognitive functioning domains and inflammation or hypertension.",
    "entities": []
  },
  {
    "text": "CONCLUSIONS: The current study findings suggest that underserved rural",
    "entities": []
  },
  {
    "text": "findings in urban populations. Inflammation and hypertension are important",
    "entities": []
  },
  {
    "text": "clinical considerations as risk factors for cognitive decline. Future research",
    "entities": []
  },
  {
    "text": "should explore interventions that support rural-dwelling individuals impacted by",
    "entities": []
  },
  {
    "text": "Pulmonary Hypertension Global Patient Survey: A Call to Action 2025.",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "M(5), Meszaros G(6), Stone M(7), MacDonald L(8), Moledina S(8), Howard L(9),",
    "entities": [
      {
        "text": "Stone",
        "label": "ORG"
      },
      {
        "text": "MacDonald L(8",
        "label": "PERSON"
      },
      {
        "text": "Moledina",
        "label": "PERSON"
      },
      {
        "text": "Howard L(9",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(1)Victor Phillip Dahdaleh Heart & Lung Research Institute University of",
    "entities": [
      {
        "text": "Phillip Dahdaleh Heart & Lung Research Institute University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(2)Royal Papworth Hospital NHS Foundation Trust Cambridge UK.",
    "entities": [
      {
        "text": "Papworth Hospital NHS Foundation Trust",
        "label": "ORG"
      },
      {
        "text": "Cambridge",
        "label": "GPE"
      },
      {
        "text": "UK",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Royal Statistical Society London UK.",
    "entities": [
      {
        "text": "3)Royal",
        "label": "CARDINAL"
      },
      {
        "text": "Statistical Society",
        "label": "ORG"
      },
      {
        "text": "London",
        "label": "GPE"
      },
      {
        "text": "UK",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Pulmonary Hypertension Association Europe Vienna Austria.",
    "entities": [
      {
        "text": "Hypertension Association",
        "label": "ORG"
      },
      {
        "text": "Vienna Austria",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(5)European Health Centre Otwock Otwock Poland.",
    "entities": [
      {
        "text": "Health Centre Otwock Otwock",
        "label": "ORG"
      },
      {
        "text": "Poland",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(6)European Reference Networks Lung Frankfurt Germany.",
    "entities": [
      {
        "text": "Frankfurt Germany",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(7)Translational Health Science iOWNA London UK.",
    "entities": [
      {
        "text": "Health Science",
        "label": "ORG"
      },
      {
        "text": "London",
        "label": "GPE"
      },
      {
        "text": "UK",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(8)Great Ormond Street Hospital London UK.",
    "entities": [
      {
        "text": "Ormond Street Hospital",
        "label": "FAC"
      },
      {
        "text": "London",
        "label": "GPE"
      },
      {
        "text": "UK",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(9)Hammersmith Hospital Imperial College Healthcare NHS Trust London UK.",
    "entities": [
      {
        "text": "Hospital Imperial College Healthcare NHS Trust",
        "label": "ORG"
      },
      {
        "text": "London",
        "label": "GPE"
      },
      {
        "text": "UK",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(10)Alliance for Pulmonary Hypertension Brussels Belgium.",
    "entities": [
      {
        "text": "10)Alliance",
        "label": "CARDINAL"
      },
      {
        "text": "Brussels Belgium",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(12)Children's University Hospital Geneva Geneva Switzerland.",
    "entities": [
      {
        "text": "12)Children",
        "label": "CARDINAL"
      },
      {
        "text": "University Hospital Geneva",
        "label": "FAC"
      },
      {
        "text": "Geneva",
        "label": "GPE"
      },
      {
        "text": "Switzerland",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(13)Pulmonary Hypertension Association Washington DC USA.",
    "entities": [
      {
        "text": "Hypertension Association",
        "label": "ORG"
      },
      {
        "text": "Washington DC USA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Non-high-density lipoprotein cholesterol predicts cardiovascular risk better",
    "entities": []
  },
  {
    "text": "than remnant cholesterol in patients with type 2 diabetes mellitus.",
    "entities": [
      {
        "text": "2",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "(1)Department of Chemical Pathology, School of Medical Sciences, College of",
    "entities": [
      {
        "text": "Chemical Pathology",
        "label": "ORG"
      },
      {
        "text": "School of Medical Sciences",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Health and Allied Sciences, University of Cape Coast, Cape Coast, Ghana.",
    "entities": [
      {
        "text": "Allied Sciences",
        "label": "ORG"
      },
      {
        "text": "University of Cape Coast",
        "label": "ORG"
      },
      {
        "text": "Cape Coast",
        "label": "GPE"
      },
      {
        "text": "Ghana",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Department of Medical Biochemistry, School of Medical Sciences, College of",
    "entities": [
      {
        "text": "Medical Biochemistry, School of Medical Sciences",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(3)Department of Internal Medicine and Therapeutics, School of Medical Sciences,",
    "entities": [
      {
        "text": "Internal Medicine and Therapeutics, School of Medical Sciences",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "College of Health and Allied Sciences, University of Cape Coast, Cape Coast,",
    "entities": [
      {
        "text": "College of Health",
        "label": "ORG"
      },
      {
        "text": "Allied Sciences",
        "label": "ORG"
      },
      {
        "text": "University of Cape Coast",
        "label": "ORG"
      },
      {
        "text": "Cape Coast",
        "label": "LOC"
      }
    ]
  },
  {
    "text": "(4)Department of Community Medicine, School of Medical Sciences, College of",
    "entities": [
      {
        "text": "Community Medicine, School of Medical Sciences",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(5)Department of Microbiology and Immunology, School of Medical Sciences,",
    "entities": [
      {
        "text": "Microbiology and Immunology, School of Medical Sciences",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "BACKGROUND: Cardiovascular disease (CVD) is a leading cause of morbidity in",
    "entities": []
  },
  {
    "text": "patients with type 2 diabetes mellitus (T2DM). Non-high-density lipoprotein",
    "entities": [
      {
        "text": "2",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "cholesterol (non-HDL-c) and remnant cholesterol (RC) have emerged as promising",
    "entities": [
      {
        "text": "non-HDL",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "markers of atherogenic risk, but their comparative predictive performance",
    "entities": []
  },
  {
    "text": "remains uncertain, particularly in resource-limited settings.",
    "entities": []
  },
  {
    "text": "OBJECTIVE: This study evaluated the predictive value of non-HDL-c and RC for",
    "entities": [
      {
        "text": "non-HDL-c and RC",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "atherosclerotic cardiovascular disease (ASCVD) risk and associated inflammatory",
    "entities": []
  },
  {
    "text": "and metabolic disturbances in T2DM patients.",
    "entities": [
      {
        "text": "T2DM",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "METHODS: A cross-sectional study was conducted among 154 T2DM patients attending",
    "entities": [
      {
        "text": "154",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "the outpatient diabetic clinic at the Effia Nkwanta Regional Hospital, Ghana.",
    "entities": [
      {
        "text": "the Effia Nkwanta Regional Hospital",
        "label": "FAC"
      },
      {
        "text": "Ghana",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Non-HDL-c and RC were calculated from fasting lipid profiles. The TyG index was",
    "entities": [
      {
        "text": "Non-HDL",
        "label": "ORG"
      },
      {
        "text": "TyG",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "used as a surrogate for insulin resistance. ASCVD risk was assessed using the",
    "entities": []
  },
  {
    "text": "Framingham risk score. Logistic regression and ROC analysis were performed to",
    "entities": [
      {
        "text": "Framingham",
        "label": "PERSON"
      },
      {
        "text": "ROC",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "assess predictive utility. Subgroup analyses were conducted based on BMI,",
    "entities": [
      {
        "text": "BMI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "hypertension, and TyG index.",
    "entities": [
      {
        "text": "TyG",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "RESULTS: Non-HDL-C was significantly associated with higher ASCVD risk and",
    "entities": [
      {
        "text": "Non-HDL-C",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "elevated hs-CRP and resistin levels, while RC showed weaker, non-significant",
    "entities": [
      {
        "text": "hs-CRP",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "associations. Non-HDL-c had a higher AUC (0.78 vs. 0.62), sensitivity, and",
    "entities": [
      {
        "text": "Non-HDL",
        "label": "ORG"
      },
      {
        "text": "0.78",
        "label": "CARDINAL"
      },
      {
        "text": "0.62",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "specificity. Nearly half of participants (49.4%) had elevated TyG index (>8.7).",
    "entities": [
      {
        "text": "Nearly half",
        "label": "CARDINAL"
      },
      {
        "text": "49.4%",
        "label": "PERCENT"
      },
      {
        "text": "TyG",
        "label": "ORG"
      },
      {
        "text": "8.7",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Non-HDL-C consistently outperformed RC across subgroups.",
    "entities": [
      {
        "text": "Non-HDL-C",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "CONCLUSION: Non-HDL-c is a stronger and more practical predictor of ASCVD risk",
    "entities": [
      {
        "text": "Non-HDL-c",
        "label": "ORG"
      },
      {
        "text": "ASCVD",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "than RC in T2DM patients, particularly in settings with limited access to",
    "entities": [
      {
        "text": "T2DM",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "advanced lipid testing. Its use alongside the TyG index offers a cost-effective",
    "entities": [
      {
        "text": "TyG",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "approach for enhancing cardiovascular risk stratification in diabetes care.",
    "entities": []
  },
  {
    "text": "89. Malays Fam Physician. 2025 Jun 13;20:38. doi: 10.51866/oa.830. eCollection",
    "entities": [
      {
        "text": "89",
        "label": "CARDINAL"
      },
      {
        "text": "2025",
        "label": "CARDINAL"
      },
      {
        "text": "10.51866",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Prevalence and factors associated with poor sleep quality among patients with",
    "entities": []
  },
  {
    "text": "hypertension in a primary care clinic: A cross-sectional study.",
    "entities": []
  },
  {
    "text": "(2)MD, MMed (Family Medicine), PhD, Department of Family Medicine, Faculty of",
    "entities": [
      {
        "text": "2)MD",
        "label": "CARDINAL"
      },
      {
        "text": "Family Medicine",
        "label": "ORG"
      },
      {
        "text": "PhD",
        "label": "WORK_OF_ART"
      },
      {
        "text": "Department of Family Medicine, Faculty of\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Medicine and Health Sciences, Universiti Putra Malaysia, Serdang, Selangor,",
    "entities": [
      {
        "text": "Medicine and Health Sciences",
        "label": "ORG"
      },
      {
        "text": "Universiti Putra Malaysia",
        "label": "GPE"
      },
      {
        "text": "Serdang",
        "label": "GPE"
      },
      {
        "text": "Selangor",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "(3)Malaysian Research Institute on Ageing, Faculty of Medicine and Health",
    "entities": [
      {
        "text": "3)Malaysian Research Institute on Ageing, Faculty of Medicine and Health\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(4)Department of Medical Sciences, School of Healthcare and Medical Sciences,",
    "entities": [
      {
        "text": "Medical Sciences",
        "label": "ORG"
      },
      {
        "text": "School of Healthcare and Medical Sciences",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Sunway University, Bandar Sunway, Malaysia.",
    "entities": [
      {
        "text": "Sunway University",
        "label": "ORG"
      },
      {
        "text": "Bandar Sunway",
        "label": "PERSON"
      },
      {
        "text": "Malaysia",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(5)Research Centre of Excellence Nutrition and Non-communicable Diseases,",
    "entities": [
      {
        "text": "Centre of Excellence Nutrition",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Faculty of Medicine and Health Sciences, UPM, Malaysia. Email:",
    "entities": [
      {
        "text": "Faculty of Medicine and Health Sciences",
        "label": "ORG"
      },
      {
        "text": "UPM",
        "label": "GPE"
      },
      {
        "text": "Malaysia",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "INTRODUCTION: International research has consistently shown that individuals",
    "entities": []
  },
  {
    "text": "with hypertension experience significantly impaired sleep quality, but there is",
    "entities": []
  },
  {
    "text": "a lack of study in this field in Malaysia. This study aimed to assess the",
    "entities": [
      {
        "text": "Malaysia",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "prevalence and associated factors of poor sleep quality among patients with",
    "entities": []
  },
  {
    "text": "hypertension in a primary care clinic in Malaysia.",
    "entities": [
      {
        "text": "Malaysia",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "METHODS: A cross-sectional study was conducted among patients with hypertension",
    "entities": []
  },
  {
    "text": "aged 18 years and above in a public health clinic from December 2023 to February",
    "entities": [
      {
        "text": "18 years",
        "label": "DATE"
      },
      {
        "text": "December 2023 to February",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "2024. Systematic random sampling was used to recruit participants.",
    "entities": [
      {
        "text": "2024",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "Sociodemographic data and relevant information were obtained using the",
    "entities": []
  },
  {
    "text": "Pittsburgh Sleep Quality Index; Depression, Anxiety and Stress Scale-21; and",
    "entities": [
      {
        "text": "Pittsburgh Sleep Quality Index",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "STOP-BANG questionnaire. The Statistical Package for the Social Sciences version",
    "entities": [
      {
        "text": "The Statistical Package",
        "label": "ORG"
      },
      {
        "text": "Social Sciences",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "27 was used to conduct multiple logistic regression analysis of the determinants",
    "entities": [
      {
        "text": "27",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "of poor sleep quality.",
    "entities": []
  },
  {
    "text": "RESULTS: A total of 335 participants were recruited, yielding a 98.2% response",
    "entities": [
      {
        "text": "335",
        "label": "CARDINAL"
      },
      {
        "text": "98.2%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "rate. The mean participant age was 58 years, and 63% were women. The prevalence",
    "entities": [
      {
        "text": "58 years",
        "label": "DATE"
      },
      {
        "text": "63%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "of poor sleep quality was 87.2%. Multiple logistic regression showed that",
    "entities": [
      {
        "text": "87.2%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "anxiety symptoms (odds ratio [OR] = 12.279, 95% confidence interval [CI] =",
    "entities": [
      {
        "text": "12.279",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "1.573-95.883, P=0.017), low monthly household income (OR=3.573, 95% CI=",
    "entities": [
      {
        "text": "1.573-95.883",
        "label": "TIME"
      },
      {
        "text": "monthly",
        "label": "DATE"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "1.627-7.847, P=0.002), lack of exercise (0R=2.530, 95% CI=1.108-5.775, P=0.028)",
    "entities": [
      {
        "text": "1.627",
        "label": "CARDINAL"
      },
      {
        "text": "0R=2.530",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "and risk of obstructive sleep apnoea (OR=2.521, 95% CI=1.176-5.402, P=0.017)",
    "entities": [
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI=1.176-5.402",
        "label": "PRODUCT"
      }
    ]
  },
  {
    "text": "were associated with poor sleep quality.",
    "entities": []
  },
  {
    "text": "CONCLUSION: Poor sleep quality is prevalent among patients with hypertension and",
    "entities": []
  },
  {
    "text": "is associated with adverse cardiovascular events. Increased awareness among",
    "entities": []
  },
  {
    "text": "primary care physicians would allow early identification of patients at risk for",
    "entities": []
  },
  {
    "text": "early intervention.",
    "entities": []
  },
  {
    "text": "\u00a9 Academy of Family Physicians of Malaysia.",
    "entities": [
      {
        "text": "Academy of Family Physicians",
        "label": "ORG"
      },
      {
        "text": "Malaysia",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: There are no conflicts of interest to declare.",
    "entities": []
  },
  {
    "text": "Impact of Maternal and Neonatal Factors on Thyroid-Stimulating Hormone",
    "entities": [
      {
        "text": "Thyroid-Stimulating Hormone",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Concentrations in Newborns in Eastern Morocco.",
    "entities": [
      {
        "text": "Newborns",
        "label": "GPE"
      },
      {
        "text": "Eastern Morocco",
        "label": "LOC"
      }
    ]
  },
  {
    "text": "Wahoud F(1), Amrani R(1).",
    "entities": [
      {
        "text": "Wahoud",
        "label": "GPE"
      },
      {
        "text": "Amrani R(1",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(1)Maternal Child and Mental Health Research Laboratory, Mohammed First",
    "entities": [
      {
        "text": "Child and Mental Health Research Laboratory",
        "label": "WORK_OF_ART"
      },
      {
        "text": "Mohammed First\n",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "University, Faculty of Medicine and Pharmacy, Oujda, MAR.",
    "entities": [
      {
        "text": "University, Faculty of Medicine and Pharmacy,",
        "label": "ORG"
      },
      {
        "text": "Oujda",
        "label": "ORG"
      },
      {
        "text": "MAR",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "INTRODUCTION: Congenital hypothyroidism (CH) is a major preventable cause of",
    "entities": []
  },
  {
    "text": "intellectual disability. Neonatal screening based on thyroid-stimulating hormone",
    "entities": []
  },
  {
    "text": "(TSH) levels enables early detection and intervention. While maternal health",
    "entities": [
      {
        "text": "TSH",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "conditions and exposures during pregnancy are known to affect newborn TSH",
    "entities": [
      {
        "text": "TSH",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "levels, the newborn's own characteristics may also influence these results.",
    "entities": []
  },
  {
    "text": "METHODS: A cross-sectional study was conducted on 1,119 mothers and their",
    "entities": [
      {
        "text": "1,119",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "newborns in the region of Eastern Morocco. A survey was conducted to collect",
    "entities": [
      {
        "text": "Eastern Morocco",
        "label": "LOC"
      }
    ]
  },
  {
    "text": "sociodemographic data, anthropometric data, and medical history. For the",
    "entities": []
  },
  {
    "text": "newborns, in addition to a clinical examination, heel prick samples were",
    "entities": []
  },
  {
    "text": "collected on blotting papers, and an immunofluorimetric method was used to",
    "entities": []
  },
  {
    "text": "RESULTS: The analysis of maternal factors revealed a highly significant",
    "entities": []
  },
  {
    "text": "association between maternal thyroid dysfunction and TSH concentrations in",
    "entities": [
      {
        "text": "TSH",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "newborns (p < 0.001, OR = 11.365). Drug use during pregnancy was also strongly",
    "entities": [
      {
        "text": "11.365",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "associated (p = 0.014, OR = 3.230), especially anti-thyroid treatment (p <",
    "entities": [
      {
        "text": "0.014",
        "label": "CARDINAL"
      },
      {
        "text": "3.230",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "0.001, OR = 18.218). Conversely, other factors, such as anthropometric",
    "entities": [
      {
        "text": "0.001",
        "label": "CARDINAL"
      },
      {
        "text": "18.218",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "indicators and pregnancy-related conditions (hypertension, diabetes), showed no",
    "entities": []
  },
  {
    "text": "statistically significant association. As for neonatal factors, high TSH levels",
    "entities": [
      {
        "text": "TSH",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "were significantly more frequent in preterm infants (p = 0.006, OR = 4.09),",
    "entities": [
      {
        "text": "0.006",
        "label": "CARDINAL"
      },
      {
        "text": "4.09",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "whereas no significant associations were found with other factors (sex, birth",
    "entities": []
  },
  {
    "text": "weight, or length). Hypotonia and feeding difficulties were more prevalent in",
    "entities": [
      {
        "text": "Hypotonia",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "newborns with elevated TSH but did not reach statistical significance.",
    "entities": [
      {
        "text": "TSH",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "CONCLUSION: Both maternal and neonatal factors may influence neonatal TSH",
    "entities": [
      {
        "text": "TSH",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "values, in particular, prematurity. The results also show the direct impact of",
    "entities": []
  },
  {
    "text": "maternal thyroid disorders on the newborn's thyroid function. This explains the",
    "entities": []
  },
  {
    "text": "importance of contextual interpretation of TSH results in neonatal screening,",
    "entities": [
      {
        "text": "TSH",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "but also the importance of screening and treating maternal thyroid dysfunction",
    "entities": []
  },
  {
    "text": "during pregnancy.",
    "entities": []
  },
  {
    "text": "Copyright \u00a9 2025, Wahoud et al.",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "Wahoud",
        "label": "GPE"
      },
      {
        "text": "al.",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: Human subjects: Consent for treatment and open",
    "entities": []
  },
  {
    "text": "access publication was obtained or waived by all participants in this study.",
    "entities": []
  },
  {
    "text": "Biomedical Research Ethics Committee of Oujda issued approval 04/2023. Animal",
    "entities": [
      {
        "text": "Biomedical Research Ethics Committee of Oujda",
        "label": "ORG"
      },
      {
        "text": "04/2023",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "subjects: All authors have confirmed that this study did not involve animal",
    "entities": []
  },
  {
    "text": "subjects or tissue. Conflicts of interest: In compliance with the ICMJE uniform",
    "entities": [
      {
        "text": "ICMJE",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "disclosure form, all authors declare the following: Payment/services info: All",
    "entities": []
  },
  {
    "text": "authors have declared that no financial support was received from any",
    "entities": []
  },
  {
    "text": "organization for the submitted work. Financial relationships: All authors have",
    "entities": []
  },
  {
    "text": "declared that they have no financial relationships at present or within the",
    "entities": []
  },
  {
    "text": "previous three years with any organizations that might have an interest in the",
    "entities": [
      {
        "text": "previous three years",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "submitted work. Other relationships: All authors have declared that there are no",
    "entities": []
  },
  {
    "text": "other relationships or activities that could appear to have influenced the",
    "entities": []
  },
  {
    "text": "submitted work.",
    "entities": []
  },
  {
    "text": "Cardiovascular-Renal-Hepatic-Metabolic Syndrome: Interlinked Pathophysiology and",
    "entities": [
      {
        "text": "Cardiovascular-Renal-Hepatic-Metabolic Syndrome: Interlinked Pathophysiology",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Integrated Management Approach.",
    "entities": [
      {
        "text": "Integrated Management Approach",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Interdisciplinary research has revealed that heart, kidney, liver, and metabolic",
    "entities": []
  },
  {
    "text": "diseases share interlinked pathological mechanisms, including inflammation,",
    "entities": []
  },
  {
    "text": "oxidative stress, insulin resistance, and endothelial health issues. However,",
    "entities": []
  },
  {
    "text": "integrated care for these diseases is challenging due to different symptoms,",
    "entities": []
  },
  {
    "text": "diagnostic rules, and treatment options. The review aims to study the common",
    "entities": []
  },
  {
    "text": "mechanisms behind cardiovascular-renal-hepatic-metabolic syndrome and explore",
    "entities": []
  },
  {
    "text": "ways to coordinate management. When these systems work poorly together, damage",
    "entities": []
  },
  {
    "text": "can form a vicious cycle, increasing hypertension, chronic kidney disease,",
    "entities": []
  },
  {
    "text": "non-alcoholic fatty liver disease, and metabolic syndrome. Changes in medicine,",
    "entities": []
  },
  {
    "text": "daily lifestyle, and drugs can interrupt the pathological cascade. However,",
    "entities": []
  },
  {
    "text": "clinical practice is hindered by patient presentations, lack of teamwork across",
    "entities": []
  },
  {
    "text": "healthcare specialties, and incomplete therapy plans. Gut-organ axis dysfunction",
    "entities": []
  },
  {
    "text": "and inflammation play a significant role in multiple organ diseases, and prompt",
    "entities": []
  },
  {
    "text": "risk assessment and early intervention can prevent heart damage.",
    "entities": []
  },
  {
    "text": "Copyright \u00a9 2025, Arragan Lezama et al.",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "Arragan Lezama",
        "label": "ORG"
      },
      {
        "text": "al.",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: Conflicts of interest: In compliance with the",
    "entities": []
  },
  {
    "text": "Porto-Sinusoidal Vascular Liver Disease Associated With Trastuzumab Emtansine: A",
    "entities": [
      {
        "text": "Porto-Sinusoidal Vascular Liver Disease Associated With Trastuzumab Emtansine",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(2)Medical Sciences, University of Aveiro, Aveiro, PRT.",
    "entities": [
      {
        "text": "2)Medical Sciences",
        "label": "ORG"
      },
      {
        "text": "University of Aveiro",
        "label": "ORG"
      },
      {
        "text": "Aveiro",
        "label": "GPE"
      },
      {
        "text": "PRT",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "characterised by alterations in the portal and sinusoidal vasculature in the",
    "entities": []
  },
  {
    "text": "absence of cirrhosis, often associated with immune conditions, haematological",
    "entities": []
  },
  {
    "text": "disorders, or medication exposure. We describe a 69-year-old woman with a",
    "entities": [
      {
        "text": "69-year-old",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "history of human epidermal growth factor receptor 2 (HER2)-positive invasive",
    "entities": [
      {
        "text": "2",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "breast cancer, treated with 15 cycles of trastuzumab emtansine (T-DM1) from",
    "entities": [
      {
        "text": "15",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "January to October 2020. From the third cycle, she developed an increase in",
    "entities": [
      {
        "text": "January to October 2020",
        "label": "DATE"
      },
      {
        "text": "third",
        "label": "ORDINAL"
      }
    ]
  },
  {
    "text": "aminotransferase levels to three times the upper limit of normal, which",
    "entities": [
      {
        "text": "three",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "normalized after discontinuation of T-DM1 due to cancer progression. Two years",
    "entities": [
      {
        "text": "Two years",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "later, she presented to the emergency department with hepatic encephalopathy,",
    "entities": []
  },
  {
    "text": "lower limb oedema, and signs of portal hypertension. Laboratory tests showed",
    "entities": []
  },
  {
    "text": "thrombocytopenia and a cytocholestatic pattern, and hepatic venous pressure",
    "entities": [
      {
        "text": "thrombocytopenia",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "gradient confirmed portal hypertension. Liver biopsy revealed histological",
    "entities": []
  },
  {
    "text": "features consistent with PSVD without cirrhosis. A diagnosis of drug-induced",
    "entities": []
  },
  {
    "text": "PSVD was made, likely secondary to T-DM1. The patient was treated with diuretics",
    "entities": []
  },
  {
    "text": "and lactulose, with marked clinical improvement and no further complications",
    "entities": []
  },
  {
    "text": "over one year of follow-up. This case underscores the importance of considering",
    "entities": [
      {
        "text": "one year",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "PSVD in patients with unexplained liver dysfunction and portal hypertension",
    "entities": []
  },
  {
    "text": "following cancer therapy.",
    "entities": []
  },
  {
    "text": "Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all",
    "entities": [
      {
        "text": "ICMJE",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "authors declare the following: Payment/services info: All authors have declared",
    "entities": []
  },
  {
    "text": "that no financial support was received from any organization for the submitted",
    "entities": []
  },
  {
    "text": "work. Financial relationships: All authors have declared that they have no",
    "entities": []
  },
  {
    "text": "financial relationships at present or within the previous three years with any",
    "entities": [
      {
        "text": "the previous three years",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "organizations that might have an interest in the submitted work. Other",
    "entities": []
  },
  {
    "text": "eCollection 2025 Jul.",
    "entities": [
      {
        "text": "eCollection",
        "label": "ORG"
      },
      {
        "text": "2025 Jul.",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "Clinical and prognostic role of tricuspid regurgitation in incident patients",
    "entities": []
  },
  {
    "text": "with pulmonary arterial hypertension.",
    "entities": []
  },
  {
    "text": "Haji G(6), Davies R(6), Howard L(6), Lo Giudice F(6).",
    "entities": [
      {
        "text": "Haji",
        "label": "PERSON"
      },
      {
        "text": "Howard L(6",
        "label": "PERSON"
      },
      {
        "text": "Lo Giudice F(6",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(2)S. Ghio and M.M. Moschella contributed equally as joint first authors.",
    "entities": [
      {
        "text": "M.M. Moschella",
        "label": "PERSON"
      },
      {
        "text": "first",
        "label": "ORDINAL"
      }
    ]
  },
  {
    "text": "(3)Department of Respiratory Medicine, Royal Brompton Hospital, Guy's and St",
    "entities": [
      {
        "text": "Respiratory Medicine",
        "label": "ORG"
      },
      {
        "text": "Royal Brompton Hospital",
        "label": "ORG"
      },
      {
        "text": "Guy",
        "label": "PERSON"
      },
      {
        "text": "St\n",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Thomas' NHS Foundation Trust, London, UK.",
    "entities": [
      {
        "text": "Thomas' NHS Foundation Trust",
        "label": "ORG"
      },
      {
        "text": "London",
        "label": "GPE"
      },
      {
        "text": "UK",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Isontina and University Hospital of Trieste, Trieste, Italy.",
    "entities": [
      {
        "text": "Isontina",
        "label": "GPE"
      },
      {
        "text": "University Hospital of Trieste, Trieste",
        "label": "ORG"
      },
      {
        "text": "Italy",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(5)Division of Cardiology, Foggia University Hospital, Foggia, Italy.",
    "entities": [
      {
        "text": "Cardiology",
        "label": "GPE"
      },
      {
        "text": "Foggia University Hospital",
        "label": "ORG"
      },
      {
        "text": "Foggia",
        "label": "GPE"
      },
      {
        "text": "Italy",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(6)Department of Cardiology, National Pulmonary Hypertension Service,",
    "entities": [
      {
        "text": "Cardiology",
        "label": "ORG"
      },
      {
        "text": "National Pulmonary Hypertension Service",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Hammersmith Hospital, Imperial College NHS Trust, London, UK.",
    "entities": [
      {
        "text": "Hammersmith Hospital",
        "label": "ORG"
      },
      {
        "text": "Imperial College NHS Trust",
        "label": "ORG"
      },
      {
        "text": "London",
        "label": "GPE"
      },
      {
        "text": "UK",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "AIM: The clinical and prognostic role of tricuspid regurgitation (TR) in",
    "entities": [
      {
        "text": "AIM",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "patients with pulmonary arterial hypertension (PAH) is still underappreciated.",
    "entities": [
      {
        "text": "PAH",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "The main objective of the present study was to assess the prognostic value of TR",
    "entities": [
      {
        "text": "TR",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "METHODS: Consecutive incident PAH patients were enrolled from 2011 to 2021.",
    "entities": [
      {
        "text": "PAH",
        "label": "ORG"
      },
      {
        "text": "2011",
        "label": "DATE"
      },
      {
        "text": "2021",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "Patients underwent right heart catheterisation (RHC), cardiopulmonary exercise",
    "entities": [
      {
        "text": "RHC",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "test (CPET), echocardiography including the degree of TR, tricuspid annular",
    "entities": [
      {
        "text": "CPET",
        "label": "ORG"
      },
      {
        "text": "TR",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "plane systolic excursion (TAPSE), ratio of TAPSE to systolic pulmonary artery",
    "entities": []
  },
  {
    "text": "pressure (sPAP), right ventricular (RV) areas and right atrial area. The primary",
    "entities": []
  },
  {
    "text": "end-point of survival analysis was all-cause death.",
    "entities": []
  },
  {
    "text": "RESULTS: Compared with patients with mild TR or no TR, those with TR of moderate",
    "entities": [
      {
        "text": "TR",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "degree or more had a worse TAPSE and TAPSE/sPAP, similar RV areas at",
    "entities": []
  },
  {
    "text": "echocardiography, worse peak oxygen consumption at CPET, and higher right atrial",
    "entities": [
      {
        "text": "CPET",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "pressure and pulmonary vascular resistance at RHC. TR of a moderate degree or",
    "entities": [
      {
        "text": "RHC",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "more was the only echocardiographic parameter associated with poor survival on",
    "entities": []
  },
  {
    "text": "Cox regression analyses (hazard ratio 3.34, 95% CI 1.73-6.45; p<0.001). The",
    "entities": [
      {
        "text": "3.34",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "1.73-6.45",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "assessment of TR severity was crucial to determine the prognosis of patients who",
    "entities": [
      {
        "text": "TR",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "would have been categorised as low risk based on normal values of TAPSE or",
    "entities": [
      {
        "text": "TAPSE",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "CONCLUSION: In treatment-naive PAH patients, TR is an important",
    "entities": [
      {
        "text": "PAH",
        "label": "ORG"
      },
      {
        "text": "TR",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "echocardiographic prognostic indicator. In particular, as an emerging concept,",
    "entities": []
  },
  {
    "text": "assessment of severity of TR is critical to stratify the prognosis of patients",
    "entities": []
  },
  {
    "text": "who would have been considered at low risk based on normal values of TAPSE or of",
    "entities": []
  },
  {
    "text": "TAPSE/sPAP.",
    "entities": []
  },
  {
    "text": "Copyright \u00a9The authors 2025.",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: Conflict of interest: None declared.",
    "entities": []
  },
  {
    "text": "94. Front Pediatr. 2025 Jun 30;13:1527281. doi: 10.3389/fped.2025.1527281.",
    "entities": [
      {
        "text": "94",
        "label": "CARDINAL"
      },
      {
        "text": "Front Pediatr",
        "label": "ORG"
      },
      {
        "text": "2025",
        "label": "CARDINAL"
      },
      {
        "text": "Jun",
        "label": "PERSON"
      },
      {
        "text": "10.3389",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Burden of pulmonary arterial hypertension in children globally, regionally, and",
    "entities": []
  },
  {
    "text": "nationally (1990-2021): results from the global burden of disease study.",
    "entities": [
      {
        "text": "1990-2021",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "(1)Department of Cardiology, Kunming Children's Hospital, Kunming City, Yunnan,",
    "entities": [
      {
        "text": "Cardiology",
        "label": "GPE"
      },
      {
        "text": "Kunming Children's Hospital",
        "label": "ORG"
      },
      {
        "text": "Kunming City",
        "label": "GPE"
      },
      {
        "text": "Yunnan",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Department of Respiratory Medicine, Kunming Children's Hospital, Kunming",
    "entities": [
      {
        "text": "Respiratory Medicine",
        "label": "ORG"
      },
      {
        "text": "Kunming Children's Hospital",
        "label": "ORG"
      },
      {
        "text": "Kunming",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "City, Yunnan, China.",
    "entities": [
      {
        "text": "Yunnan",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Department of Cardiology, The First Affiliated Hospital of Kunming Medical",
    "entities": [
      {
        "text": "Cardiology",
        "label": "ORG"
      },
      {
        "text": "The First Affiliated Hospital of Kunming Medical",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "University, Kunming City, Yunnan, China.",
    "entities": [
      {
        "text": "Kunming City",
        "label": "GPE"
      },
      {
        "text": "Yunnan",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "INTRODUCTION: Pediatric pulmonary arterial hypertension (PAH) is a rare and",
    "entities": [
      {
        "text": "PAH",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "severe disorder characterized by obstructive vascular changes that can lead to",
    "entities": []
  },
  {
    "text": "right heart failure. The clinical presentation and underlying causes of",
    "entities": []
  },
  {
    "text": "pediatric PAH differ significantly from those in adults, often involving",
    "entities": [
      {
        "text": "PAH",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "congenital heart disease and developmental lung disorders, such as",
    "entities": []
  },
  {
    "text": "bronchopulmonary dysplasia (BPD). Despite advances in treatment, pediatric PAH",
    "entities": [
      {
        "text": "bronchopulmonary dysplasia",
        "label": "PERSON"
      },
      {
        "text": "BPD",
        "label": "ORG"
      },
      {
        "text": "PAH",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "remains underrecognized globally.",
    "entities": []
  },
  {
    "text": "METHODS: This study analyzed global, regional, and national trends in pediatric",
    "entities": []
  },
  {
    "text": "PAH from 1990 to 2021 using data from the Global Burden of Disease (GBD)",
    "entities": [
      {
        "text": "PAH",
        "label": "ORG"
      },
      {
        "text": "1990",
        "label": "DATE"
      },
      {
        "text": "2021",
        "label": "DATE"
      },
      {
        "text": "the Global Burden of Disease",
        "label": "FAC"
      },
      {
        "text": "GBD",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "RESULTS: The findings indicate a stable prevalence rate globally, with a slight",
    "entities": []
  },
  {
    "text": "increase in the absolute number of cases. Significantly, reductions were",
    "entities": []
  },
  {
    "text": "observed in both mortality and disability-adjusted life years (DALYs) associated",
    "entities": [
      {
        "text": "DALYs",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "with pediatric PAH, with mortality decreasing by 57.66% and DALYs by 63.59% over",
    "entities": [
      {
        "text": "PAH",
        "label": "ORG"
      },
      {
        "text": "57.66%",
        "label": "PERCENT"
      },
      {
        "text": "63.59%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "the study period, indicating progress in mitigating the disease burden.",
    "entities": []
  },
  {
    "text": "Substantial regional disparities were identified, with low-income regions,",
    "entities": []
  },
  {
    "text": "particularly Low Socio-Demographic Index (SDI) areas, experiencing the highest",
    "entities": []
  },
  {
    "text": "mortality and DALY rates. In contrast, high-middle SDI regions showed the",
    "entities": []
  },
  {
    "text": "greatest reductions in disease burden. The highest prevalence and burden were",
    "entities": []
  },
  {
    "text": "observed in South Asia, the Caribbean, and parts of Sub-Saharan Africa, with",
    "entities": [
      {
        "text": "South Asia",
        "label": "LOC"
      },
      {
        "text": "Caribbean",
        "label": "LOC"
      },
      {
        "text": "Africa",
        "label": "LOC"
      }
    ]
  },
  {
    "text": "China, India, and Haiti bearing the greatest national burdens.",
    "entities": [
      {
        "text": "China",
        "label": "GPE"
      },
      {
        "text": "India",
        "label": "GPE"
      },
      {
        "text": "Haiti",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "DISCUSSION: These findings highlight the necessity for targeted health",
    "entities": []
  },
  {
    "text": "interventions, especially in low-resource settings, to improve early diagnosis,",
    "entities": []
  },
  {
    "text": "intervention, and treatment.",
    "entities": []
  },
  {
    "text": "DOI: 10.3389/fped.2025.1527281",
    "entities": [
      {
        "text": "10.3389",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Incidence, Associated Abnormalities, and Outcomes of Dextrocardia: A",
    "entities": [
      {
        "text": "Associated Abnormalities",
        "label": "ORG"
      },
      {
        "text": "Outcomes of Dextrocardia",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Registry-based Study in Saudi Arabia.",
    "entities": [
      {
        "text": "Saudi Arabia",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(1)Department of Internal Medicine, Medical Collage, University of Ha'il',",
    "entities": [
      {
        "text": "Internal Medicine, Medical Collage",
        "label": "ORG"
      },
      {
        "text": "University of Ha'il'",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(2)Department of Cardiology, Prince Sultan Cardiac Center, Riyadh, Saudi Arabia.",
    "entities": [
      {
        "text": "2)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Cardiology",
        "label": "ORG"
      },
      {
        "text": "Prince Sultan Cardiac Center",
        "label": "ORG"
      },
      {
        "text": "Riyadh",
        "label": "GPE"
      },
      {
        "text": "Saudi Arabia",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Department of Emergency, Critical Care and Anesthesia, College of Medicine,",
    "entities": [
      {
        "text": "Emergency, Critical Care",
        "label": "ORG"
      },
      {
        "text": "Anesthesia",
        "label": "GPE"
      },
      {
        "text": "College of Medicine",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(4)Department of Cardiology, King Saud Medical City, Riyadh, Saudi Arabia.",
    "entities": [
      {
        "text": "Cardiology",
        "label": "GPE"
      },
      {
        "text": "Riyadh",
        "label": "GPE"
      },
      {
        "text": "Saudi Arabia",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(5)Transplant Infectious Disease, Organ Transplant Center, King Faisal",
    "entities": [
      {
        "text": "Organ Transplant Center",
        "label": "PERSON"
      },
      {
        "text": "King Faisal",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Specialist Hospital & Research Centre, Riyadh, Saudi Arabia.",
    "entities": [
      {
        "text": "Specialist Hospital & Research Centre",
        "label": "ORG"
      },
      {
        "text": "Riyadh",
        "label": "GPE"
      },
      {
        "text": "Saudi Arabia",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(6)Department of Internal Medicine, Security Forces Hospital, Riyadh, Saudi",
    "entities": [
      {
        "text": "Internal Medicine, Security Forces Hospital",
        "label": "ORG"
      },
      {
        "text": "Riyadh",
        "label": "GPE"
      },
      {
        "text": "Saudi",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "(8)Adult Critical Care Medicine Department, King Faisal Specialist Hospital &",
    "entities": [
      {
        "text": "Critical Care Medicine Department",
        "label": "ORG"
      },
      {
        "text": "King Faisal Specialist Hospital &\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Research Centre, Riyadh, Saudi Arabia.",
    "entities": [
      {
        "text": "Research Centre",
        "label": "ORG"
      },
      {
        "text": "Riyadh",
        "label": "GPE"
      },
      {
        "text": "Saudi Arabia",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(9)Cardiac Sciences Department, College of Medicine, King Saud University,",
    "entities": [
      {
        "text": "9)Cardiac Sciences Department",
        "label": "ORG"
      },
      {
        "text": "College of Medicine",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(10)Department of Medicine, King Faisal Specialist Hospital & Research Centre,",
    "entities": [
      {
        "text": "10)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Faisal Specialist Hospital & Research Centre",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(11)Department of Pediatric Cardiology, Prince Sultan Cardiac Center, Riyadh,",
    "entities": [
      {
        "text": "11)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Prince Sultan Cardiac Center",
        "label": "ORG"
      },
      {
        "text": "Riyadh",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(12)Hypertension and Cardiovascular Risk Research Center, Medical and Surgical",
    "entities": [
      {
        "text": "12)Hypertension",
        "label": "CARDINAL"
      },
      {
        "text": "Cardiovascular Risk Research Center",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Sciences Department, Alma Mater Studiorum University of Bologna, Bologna, Italy.",
    "entities": [
      {
        "text": "Sciences Department",
        "label": "ORG"
      },
      {
        "text": "Alma Mater Studiorum University",
        "label": "ORG"
      },
      {
        "text": "Bologna",
        "label": "GPE"
      },
      {
        "text": "Italy",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(14)Department of Cardiology, King Faisal Specialist Hospital & Research Centre,",
    "entities": [
      {
        "text": "14)Department",
        "label": "CARDINAL"
      },
      {
        "text": "King Faisal Specialist Hospital & Research Centre",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "OBJECTIVE: Dextrocardia refers to the right-sided positioning of the heart",
    "entities": [
      {
        "text": "Dextrocardia",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "during embryonic development and may occur in isolation or in association with",
    "entities": []
  },
  {
    "text": "visceral malposition or other malformations. However, few studies have",
    "entities": []
  },
  {
    "text": "investigated this condition. This study aimed to determine the incidence of",
    "entities": []
  },
  {
    "text": "cardiac and non-cardiac malformations, as well as to analyze long-term follow-up",
    "entities": [
      {
        "text": "cardiac",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "and survival outcomes in patients with dextrocardia.",
    "entities": []
  },
  {
    "text": "METHODS: This was a retrospective chart review of dextrocardia cases at King",
    "entities": []
  },
  {
    "text": "Faisal Specialist Hospital & Research Centre in Riyadh, Saudi Arabia from April",
    "entities": [
      {
        "text": "Faisal Specialist Hospital & Research Centre",
        "label": "ORG"
      },
      {
        "text": "Riyadh",
        "label": "GPE"
      },
      {
        "text": "Saudi Arabia",
        "label": "GPE"
      },
      {
        "text": "April",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "22, 1975, to December 31, 2016. A total of 259,246 transthoracic echocardiograms",
    "entities": [
      {
        "text": "22, 1975",
        "label": "DATE"
      },
      {
        "text": "December 31, 2016",
        "label": "DATE"
      },
      {
        "text": "259,246",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "from that period were reviewed, and 357 patients were included in the analysis.",
    "entities": [
      {
        "text": "357",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "RESULTS: The incidence of dextrocardia was approximately 1 in 28,571 pregnancies",
    "entities": [
      {
        "text": "28,571",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "(0.35 per 10,000 pregnancies). Most patients with dextrocardia were between 2",
    "entities": [
      {
        "text": "0.35",
        "label": "CARDINAL"
      },
      {
        "text": "10,000",
        "label": "CARDINAL"
      },
      {
        "text": "2",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "and 18 years old (n = 252, 70.6 %). The most common type was isolated",
    "entities": [
      {
        "text": "18 years old",
        "label": "DATE"
      },
      {
        "text": "252",
        "label": "CARDINAL"
      },
      {
        "text": "70.6 %",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "dextrocardia (situs solitus), followed by situs inversus totalis, and situs",
    "entities": [
      {
        "text": "dextrocardia",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "ambiguous. The most common congenital cyanotic heart diseases were double outlet",
    "entities": []
  },
  {
    "text": "right ventricle (n = 55, 15.5 %) and pulmonary atresia (n = 35, 9.8 %). The most",
    "entities": [
      {
        "text": "55",
        "label": "DATE"
      },
      {
        "text": "15.5 %",
        "label": "PERCENT"
      },
      {
        "text": "pulmonary atresia",
        "label": "PERSON"
      },
      {
        "text": "35",
        "label": "DATE"
      },
      {
        "text": "9.8 %",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "common acyanotic congenital abnormalities were ventricular (n = 152, 42.7 %) and",
    "entities": [
      {
        "text": "152",
        "label": "CARDINAL"
      },
      {
        "text": "42.7 %",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "atrial (n = 121, 34.2 %) septal defects. Overall survival in the study",
    "entities": [
      {
        "text": "121",
        "label": "CARDINAL"
      },
      {
        "text": "34.2 %",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "population was approximately 83 %. Survival rates varied by situs type, with the",
    "entities": [
      {
        "text": "approximately 83 %",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "highest rates observed in patients with situs inversus (96 %), followed by those",
    "entities": [
      {
        "text": "96 %",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "with situs solitus (91 %), and situs ambiguous (55 %). Moderate to severe",
    "entities": [
      {
        "text": "91 %",
        "label": "PERCENT"
      },
      {
        "text": "55 %",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "pulmonary hypertension was significantly associated with a reduction in overall",
    "entities": [
      {
        "text": "pulmonary",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "survival. The most common non-cardiac anomalies observed were gastrointestinal",
    "entities": []
  },
  {
    "text": "and urogenital abnormalities.",
    "entities": []
  },
  {
    "text": "CONCLUSION: This study describes the largest regional cohort of patients with",
    "entities": []
  },
  {
    "text": "dextrocardia, providing important insights into dextrocardia and outcomes of",
    "entities": []
  },
  {
    "text": "different intracardiac defects in our community. Our findings confirm that",
    "entities": []
  },
  {
    "text": "complex congenital cardiac disease is more common in patients with situs solitus",
    "entities": []
  },
  {
    "text": "and isomerism group. Patients in the isomerism group (12.6 %) had significantly",
    "entities": [
      {
        "text": "12.6 %",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "higher mortality rates compared to those in the situs solitus (7.6 %) and situs",
    "entities": [
      {
        "text": "7.6 %",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "inversus (3.7 %) groups.",
    "entities": [
      {
        "text": "3.7 %",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "\u00a9 2025 Saudi Heart Association.",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "Saudi Heart Association",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: Conflict of interest: The authors declare that",
    "entities": []
  },
  {
    "text": "the research was conducted in the absence of any commercial or financial",
    "entities": []
  },
  {
    "text": "relationships that could be construed as a potential conflict of interest.",
    "entities": []
  },
  {
    "text": "Adaptation of ACMG/AMP Guidelines for Clinical Classification of BMPR2 Variants",
    "entities": []
  },
  {
    "text": "in Pulmonary Arterial Hypertension Resolves Variants of Unclear Pathogenicity in",
    "entities": [
      {
        "text": "Pulmonary Arterial Hypertension Resolves Variants of Unclear Pathogenicity",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "D(6), Balachandar S(3), Coulet F(7)(8), Day K(3), Eyries M(8), Macaya D(9),",
    "entities": [
      {
        "text": "D(6",
        "label": "PERSON"
      },
      {
        "text": "Balachandar S(3",
        "label": "PERSON"
      },
      {
        "text": "Coulet",
        "label": "ORG"
      },
      {
        "text": "Day K(3",
        "label": "DATE"
      },
      {
        "text": "Macaya",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Shaukat M(1)(2), Southgate L(4), Tenorio-Castano J(10)(11)(12), Chung WK(13),",
    "entities": [
      {
        "text": "Southgate",
        "label": "PERSON"
      },
      {
        "text": "Chung",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(1)Center for Pulmonary Hypertension, Thoraxklinik-Heidelberg gGmbH, Heidelberg",
    "entities": [
      {
        "text": "Thoraxklinik-Heidelberg",
        "label": "PERSON"
      },
      {
        "text": "Heidelberg",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "University Hospital and Translational Lung Research Center (TLRC), German Center",
    "entities": [
      {
        "text": "University Hospital",
        "label": "ORG"
      },
      {
        "text": "Translational Lung Research Center",
        "label": "ORG"
      },
      {
        "text": "TLRC",
        "label": "ORG"
      },
      {
        "text": "German Center",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(2)Laboratory for Molecular Genetic Diagnostics, Institute of Human Genetics,",
    "entities": [
      {
        "text": "2)Laboratory",
        "label": "CARDINAL"
      },
      {
        "text": "Molecular Genetic Diagnostics, Institute of Human Genetics",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(3)Division of Pulmonary, Critical Care, Sleep and Occupational Medicine,",
    "entities": [
      {
        "text": "Pulmonary, Critical Care",
        "label": "ORG"
      },
      {
        "text": "Sleep and Occupational Medicine",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Department of Medicine, Indiana University School of Medicine, Indianapolis,",
    "entities": [
      {
        "text": "Department of Medicine",
        "label": "ORG"
      },
      {
        "text": "Indiana University School of Medicine",
        "label": "ORG"
      },
      {
        "text": "Indianapolis",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)School of Health & Medical Sciences, City St George's, University of London,",
    "entities": [
      {
        "text": "Health & Medical Sciences",
        "label": "ORG"
      },
      {
        "text": "University of London",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(5)Department of Medicine, School of Clinical Medicine, University of Cambridge,",
    "entities": [
      {
        "text": "Medicine, School of Clinical Medicine",
        "label": "ORG"
      },
      {
        "text": "University of Cambridge",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Victor Phillip Dahdaleh Heart & Lung Research Institute, Cambridge, UK.",
    "entities": [
      {
        "text": "Victor Phillip Dahdaleh Heart",
        "label": "PERSON"
      },
      {
        "text": "Cambridge",
        "label": "GPE"
      },
      {
        "text": "UK",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(6)Department of Genetics, University Medical Centre Utrecht, Utrecht",
    "entities": [
      {
        "text": "Genetics, University Medical Centre Utrecht",
        "label": "ORG"
      },
      {
        "text": "Utrecht",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "University, Utrecht, the Netherlands.",
    "entities": [
      {
        "text": "Utrecht",
        "label": "GPE"
      },
      {
        "text": "Netherlands",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(7)Saint-Antoine Research Centre, Sorbonne University, Paris, France.",
    "entities": [
      {
        "text": "7)Saint-Antoine Research Centre",
        "label": "ORG"
      },
      {
        "text": "Sorbonne University",
        "label": "ORG"
      },
      {
        "text": "Paris",
        "label": "GPE"
      },
      {
        "text": "France",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(8)Genetics Department, AP-HP Sorbonne University, Paris, France.",
    "entities": [
      {
        "text": "(8)Genetics Department",
        "label": "ORG"
      },
      {
        "text": "AP-HP Sorbonne University",
        "label": "ORG"
      },
      {
        "text": "Paris",
        "label": "GPE"
      },
      {
        "text": "France",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(9)GeneDx Inc., Gaithersburg, Maryland, USA.",
    "entities": [
      {
        "text": "9)GeneDx Inc.",
        "label": "ORG"
      },
      {
        "text": "Gaithersburg",
        "label": "GPE"
      },
      {
        "text": "Maryland",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(10)Institute of Medical and Molecular Genetics (INGEMM), La Paz University",
    "entities": [
      {
        "text": "10)Institute",
        "label": "CARDINAL"
      },
      {
        "text": "La Paz University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Hospital, IDiPAZ, Autonoma University of Madrid, Madrid, Spain.",
    "entities": [
      {
        "text": "Autonoma University of Madrid",
        "label": "ORG"
      },
      {
        "text": "Madrid",
        "label": "GPE"
      },
      {
        "text": "Spain",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(11)Biomedical Research Network Centre for Rare Diseases (CIBERER), Carlos III",
    "entities": [
      {
        "text": "11)Biomedical Research Network Centre for Rare Diseases",
        "label": "ORG"
      },
      {
        "text": "Carlos III",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Health Institute, Madrid, Spain.",
    "entities": [
      {
        "text": "Health Institute",
        "label": "ORG"
      },
      {
        "text": "Madrid",
        "label": "GPE"
      },
      {
        "text": "Spain",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(12)ITHACA, European Reference Network, Brussels, Belgium.",
    "entities": [
      {
        "text": "12)ITHACA",
        "label": "CARDINAL"
      },
      {
        "text": "European Reference Network",
        "label": "ORG"
      },
      {
        "text": "Brussels",
        "label": "GPE"
      },
      {
        "text": "Belgium",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(13)Division of Genetics and Genomics, Department of Pediatrics, Boston",
    "entities": [
      {
        "text": "Genetics and Genomics, Department of Pediatrics",
        "label": "ORG"
      },
      {
        "text": "Boston",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Children's Hospital and Harvard Medical School, Boston, Massachusetts, USA.",
    "entities": [
      {
        "text": "Harvard Medical School",
        "label": "ORG"
      },
      {
        "text": "Boston",
        "label": "GPE"
      },
      {
        "text": "Massachusetts",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Pulmonary arterial hypertension (PAH) is a rare disease that can be caused by",
    "entities": [
      {
        "text": "PAH",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "pathogenic variants, most frequently in the bone Morphogenetic Protein Receptor",
    "entities": [
      {
        "text": "Morphogenetic Protein Receptor",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Type 2 (BMPR2) gene. We formed a ClinGen variant curation expert panel to devise",
    "entities": [
      {
        "text": "BMPR2",
        "label": "PERSON"
      },
      {
        "text": "ClinGen",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "guidelines for the clinical interpretation of BMPR2 variants identified in PAH",
    "entities": [
      {
        "text": "BMPR2",
        "label": "PERSON"
      },
      {
        "text": "PAH",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "patients. The general ACMG/AMP variant classification criteria were refined for",
    "entities": [
      {
        "text": "ACMG",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "PAH and adapted to BMPR2 following ClinGen procedures. Subsequently, these",
    "entities": [
      {
        "text": "PAH",
        "label": "ORG"
      },
      {
        "text": "BMPR2",
        "label": "ORG"
      },
      {
        "text": "ClinGen",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "specifications were tested independently by three members of the curation expert",
    "entities": [
      {
        "text": "three",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "panel on 28 representative BMPR2 variants selected from ClinVar and then",
    "entities": [
      {
        "text": "28",
        "label": "CARDINAL"
      },
      {
        "text": "BMPR2",
        "label": "PERSON"
      },
      {
        "text": "ClinVar",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "presented and discussed in the plenum. Application of the final BMPR2 variant",
    "entities": [
      {
        "text": "BMPR2",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "specifications resolved six of nine variants (66%) where multiple ClinVar",
    "entities": [
      {
        "text": "six",
        "label": "CARDINAL"
      },
      {
        "text": "nine",
        "label": "CARDINAL"
      },
      {
        "text": "66%",
        "label": "PERCENT"
      },
      {
        "text": "ClinVar",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "classifications included a variant of uncertain significance, with all six being",
    "entities": [
      {
        "text": "six",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "reclassified as Benign or Likely Benign. Four splice site variants underwent",
    "entities": [
      {
        "text": "Benign or Likely Benign",
        "label": "WORK_OF_ART"
      },
      {
        "text": "Four",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "clinically consequential reclassification based on the presence or absence of",
    "entities": []
  },
  {
    "text": "supporting mRNA splicing data. These variant specifications provide an",
    "entities": []
  },
  {
    "text": "international framework and a valuable tool for BMPR2 variant classification",
    "entities": [
      {
        "text": "BMPR2",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "that can be applied to increase confidence and consistency in BMPR2",
    "entities": [
      {
        "text": "BMPR2",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Copyright \u00a9 2025 Christina A. Eichstaedt et al. Human Mutation published by John",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "Christina A. Eichstaedt",
        "label": "PERSON"
      },
      {
        "text": "al.",
        "label": "ORG"
      },
      {
        "text": "John\n",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Wiley & Sons Ltd.",
    "entities": [
      {
        "text": "Wiley & Sons Ltd.",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "PMID: 40661831 [Indexed for MEDLINE]",
    "entities": [
      {
        "text": "40661831",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: CAE received honoraria for lectures and",
    "entities": [
      {
        "text": "CAE",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "presentations from OMT and MSD, consulting fees from MSD. CAE is coinventor of",
    "entities": [
      {
        "text": "OMT",
        "label": "ORG"
      },
      {
        "text": "MSD",
        "label": "ORG"
      },
      {
        "text": "MSD",
        "label": "ORG"
      },
      {
        "text": "CAE",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "the issued European patent \u201cGene panel specific for pulmonary hypertension and",
    "entities": [
      {
        "text": "European",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "its uses\u201d (EP3507380). CAE works at a laboratory that performs fee for service",
    "entities": [
      {
        "text": "CAE",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "testing in genes that have been specified by the ClinGen PH VCEP. FC works at a",
    "entities": [
      {
        "text": "ClinGen",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "French healthcare hospital (Piti\u00e9-Salp\u00eatri\u00e8re Hospital in Paris) laboratory",
    "entities": [
      {
        "text": "French",
        "label": "NORP"
      },
      {
        "text": "Piti\u00e9-Salp\u00eatri\u00e8re Hospital",
        "label": "ORG"
      },
      {
        "text": "Paris",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "which performs noncommercial fee for service testing in BMPR2 and other PAH",
    "entities": [
      {
        "text": "BMPR2",
        "label": "GPE"
      },
      {
        "text": "PAH",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "genes. DD works at a Dutch healthcare hospital laboratory which performs",
    "entities": [
      {
        "text": "Dutch",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "noncommercial fee for service testing in BMPR2 and other PAH genes. ME worked at",
    "entities": [
      {
        "text": "BMPR2",
        "label": "GPE"
      },
      {
        "text": "PAH",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "a French healthcare hospital laboratory which performs noncommercial fee for",
    "entities": [
      {
        "text": "French",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "service testing in BMPR2 and other PAH genes. DM works for GeneDx, a laboratory",
    "entities": [
      {
        "text": "BMPR2",
        "label": "GPE"
      },
      {
        "text": "PAH",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "that performs fee for service genetic testing. WKC serves on the Board of",
    "entities": [
      {
        "text": "WKC",
        "label": "ORG"
      },
      {
        "text": "the Board of\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Directors of Prime Medicine. GMV and SB were graduate students at the time the",
    "entities": [
      {
        "text": "GMV",
        "label": "ORG"
      },
      {
        "text": "SB",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "study was performed but are now employed by fee for service genetic testing",
    "entities": []
  },
  {
    "text": "companies, Tempus and Baylor Genetics, respectively. MAA, SB, KMD, and GMV",
    "entities": [
      {
        "text": "Tempus",
        "label": "PERSON"
      },
      {
        "text": "Baylor Genetics",
        "label": "PERSON"
      },
      {
        "text": "MAA",
        "label": "ORG"
      },
      {
        "text": "SB",
        "label": "GPE"
      },
      {
        "text": "KMD",
        "label": "ORG"
      },
      {
        "text": "GMV",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "received salary support from the National Institutes of Health. All other",
    "entities": [
      {
        "text": "the National Institutes of Health",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "authors declare no conflict of interest.",
    "entities": []
  },
  {
    "text": "Efficacy and safety of cadonilimab (PD-1/CTLA-4 bi-specific antibody) and",
    "entities": []
  },
  {
    "text": "adjuvant anti-angiogenesis therapy in treated, recurrent, or metastatic cervical",
    "entities": []
  },
  {
    "text": "(1)Department of Radiotherapy, The Affiliated Yantai Yuhuangding Hospital of",
    "entities": [
      {
        "text": "Radiotherapy",
        "label": "ORG"
      },
      {
        "text": "The Affiliated Yantai Yuhuangding Hospital",
        "label": "FAC"
      }
    ]
  },
  {
    "text": "Qingdao University, Yantai, China.",
    "entities": [
      {
        "text": "Qingdao University",
        "label": "ORG"
      },
      {
        "text": "Yantai",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Department of Gynecology, The Affiliated Yantai Yuhuangding Hospital of",
    "entities": []
  },
  {
    "text": "(3)Department of Head and Neck Surgery, MD Anderson Cancer Center, Houston, TX,",
    "entities": [
      {
        "text": "MD Anderson Cancer Center",
        "label": "PERSON"
      },
      {
        "text": "Houston",
        "label": "GPE"
      },
      {
        "text": "TX",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "United States.",
    "entities": [
      {
        "text": "United States",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Department of General Surgery, Anqiu Maternal and Child Health Hospital,",
    "entities": [
      {
        "text": "Surgery",
        "label": "PERSON"
      },
      {
        "text": "Anqiu Maternal and Child Health Hospital",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(5)Department of Otorhinolaryngology, Qilu Hospital of Shandong University,",
    "entities": [
      {
        "text": "5)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Otorhinolaryngology, Qilu Hospital of Shandong University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(6)National Health Commission (NHC) Key Laboratory of Otorhinolaryngology,",
    "entities": [
      {
        "text": "6)National Health Commission",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Shandong University, Jinan, Shandong, China.",
    "entities": [
      {
        "text": "Shandong University",
        "label": "ORG"
      },
      {
        "text": "Jinan",
        "label": "GPE"
      },
      {
        "text": "Shandong",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(7)Department of Radiotherapy, Yantaishan Hospital, Yantai, China.",
    "entities": [
      {
        "text": "Radiotherapy",
        "label": "GPE"
      },
      {
        "text": "Yantaishan Hospital",
        "label": "ORG"
      },
      {
        "text": "Yantai",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "BACKGROUND: Combined immunotherapy and antiangiogenic therapy have exhibited",
    "entities": []
  },
  {
    "text": "synergistic antitumor effects in several cancers. The prognosis of recurrent or",
    "entities": []
  },
  {
    "text": "metastatic cervical cancer (r/mCC) is poor, especially for patients with prior",
    "entities": []
  },
  {
    "text": "multi-line treatments. This study aimed to evaluate the efficacy and safety of",
    "entities": []
  },
  {
    "text": "cadonilimab(PD-1/CTLA-4 bispecific)with anti-angiogenesis adjuvant therapy",
    "entities": []
  },
  {
    "text": "(bevacizumab or anlotinib) in pretreated patients with r/mCC.",
    "entities": []
  },
  {
    "text": "METHODS: Nineteen patients treated with cadonilimab plus bevacizumab or",
    "entities": [
      {
        "text": "Nineteen",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "anlotinib with or without chemotherapy were included. Cadonilimab was",
    "entities": [
      {
        "text": "Cadonilimab",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "administered at dose of 10mg/kg intravenously. Patients receiving",
    "entities": [
      {
        "text": "10mg",
        "label": "ORDINAL"
      }
    ]
  },
  {
    "text": "anti-angiogenic therapy received either bevacizumab or anlotinib administered",
    "entities": []
  },
  {
    "text": "orally. The safety, objective response rate (ORR), progression-free survival",
    "entities": []
  },
  {
    "text": "(PFS) and overall survival (OS) were assessed.",
    "entities": []
  },
  {
    "text": "RESULTS: The median follow-up was 15.5 months study patients. Among all 19",
    "entities": [
      {
        "text": "15.5 months",
        "label": "DATE"
      },
      {
        "text": "19",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "achieved partial response (PR) and 4 patients (21.1%) achieved stable disease",
    "entities": [
      {
        "text": "4",
        "label": "CARDINAL"
      },
      {
        "text": "21.1%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "(SD), with an ORR of 21.1% and DCR of 42.1%. Moreover, the median PFS was 10.5",
    "entities": [
      {
        "text": "21.1%",
        "label": "PERCENT"
      },
      {
        "text": "DCR",
        "label": "ORG"
      },
      {
        "text": "42.1%",
        "label": "PERCENT"
      },
      {
        "text": "10.5",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "months (95% CI: 6.1-14.9 months) and 1-year OS rate was 78.3%. Proteinuria",
    "entities": [
      {
        "text": "months",
        "label": "DATE"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "6.1-14.9 months",
        "label": "DATE"
      },
      {
        "text": "1-year",
        "label": "DATE"
      },
      {
        "text": "78.3%",
        "label": "PERCENT"
      },
      {
        "text": "Proteinuria",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(47.4%) and hypertension (42.2%) were the most common treatment-related adverse",
    "entities": [
      {
        "text": "47.4%",
        "label": "PERCENT"
      },
      {
        "text": "42.2%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "events (TRAE), with 5 (26.3%) patients experiencing Grade 3 TRAEs, while no",
    "entities": [
      {
        "text": "TRAE",
        "label": "GPE"
      },
      {
        "text": "5",
        "label": "CARDINAL"
      },
      {
        "text": "26.3%",
        "label": "PERCENT"
      },
      {
        "text": "Grade 3 TRAEs",
        "label": "PRODUCT"
      }
    ]
  },
  {
    "text": "treatment related deaths were observed.",
    "entities": []
  },
  {
    "text": "CONCLUSIONS: This is the first report exploring the efficacy and safety of",
    "entities": [
      {
        "text": "first",
        "label": "ORDINAL"
      }
    ]
  },
  {
    "text": "treating patients concurrently with Cadonilimab plus bevacizumab or anlotinib",
    "entities": [
      {
        "text": "Cadonilimab",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "with heavily pretreated r/mCC. The findings suggest that this regimen might be",
    "entities": []
  },
  {
    "text": "potentially efficacious and safe with relatively manageable toxicity. Further",
    "entities": []
  },
  {
    "text": "trials with a control arm are required to validate our findings.",
    "entities": []
  },
  {
    "text": "Copyright \u00a9 2025 Zhou, Liu, Zuo, Naseem, Li, Wang, Meng and Song.",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "Liu",
        "label": "PERSON"
      },
      {
        "text": "Zuo",
        "label": "PERSON"
      },
      {
        "text": "Naseem",
        "label": "PERSON"
      },
      {
        "text": "Li",
        "label": "PERSON"
      },
      {
        "text": "Wang",
        "label": "PERSON"
      },
      {
        "text": "Meng",
        "label": "PERSON"
      },
      {
        "text": "Song",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: The remaining authors declare that the research",
    "entities": []
  },
  {
    "text": "was conducted in the absence of any commercial or financial relationships that",
    "entities": []
  },
  {
    "text": "could be construed as a potential conflict of interest.",
    "entities": []
  },
  {
    "text": "98. Ther Adv Neurol Disord. 2025 Jul 12;18:17562864251351100. doi:",
    "entities": [
      {
        "text": "98",
        "label": "CARDINAL"
      },
      {
        "text": "Ther Adv Neurol Disord",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Real-world outcomes following dual antiplatelet therapy in mild-to-moderate",
    "entities": []
  },
  {
    "text": "ischemic stroke with anterior versus posterior circulation infarct: a READAPT",
    "entities": [
      {
        "text": "READAPT",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "study propensity matched analysis.",
    "entities": []
  },
  {
    "text": "(1)Department of Biotechnological and Applied Clinical Sciences, University of",
    "entities": [
      {
        "text": "Biotechnological",
        "label": "LOC"
      },
      {
        "text": "Applied Clinical Sciences",
        "label": "ORG"
      },
      {
        "text": "University of\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(2)Department of Brain Sciences, Imperial College London, London, UK.",
    "entities": [
      {
        "text": "Brain Sciences",
        "label": "ORG"
      },
      {
        "text": "Imperial College London",
        "label": "ORG"
      },
      {
        "text": "London",
        "label": "GPE"
      },
      {
        "text": "UK",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Department of Stroke and Neuroscience, Charing Cross Hospital, Imperial",
    "entities": [
      {
        "text": "Stroke and Neuroscience",
        "label": "GPE"
      },
      {
        "text": "Charing Cross Hospital",
        "label": "ORG"
      },
      {
        "text": "Imperial",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "College London NHS Healthcare Trust, London, UK.",
    "entities": [
      {
        "text": "College London NHS Healthcare Trust",
        "label": "ORG"
      },
      {
        "text": "London",
        "label": "GPE"
      },
      {
        "text": "UK",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(5)Department of Neurology, Santa Corona Hospital, Pietra Ligure, Italy.",
    "entities": [
      {
        "text": "Neurology",
        "label": "GPE"
      },
      {
        "text": "Santa Corona Hospital",
        "label": "ORG"
      },
      {
        "text": "Pietra Ligure",
        "label": "PERSON"
      },
      {
        "text": "Italy",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(7)Department of Neurology, ASST Ospedale Maggiore di Crema, Crema, Italy.",
    "entities": [
      {
        "text": "Neurology",
        "label": "ORG"
      },
      {
        "text": "Italy",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(10)Department of Systems Medicine, Tor Vergata University, Rome, Italy.",
    "entities": [
      {
        "text": "10)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Tor Vergata University",
        "label": "ORG"
      },
      {
        "text": "Rome",
        "label": "GPE"
      },
      {
        "text": "Italy",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(11)Stroke Unit, \"F. Puca\" AOU Consorziale Policlinico, Bari, Italy.",
    "entities": [
      {
        "text": "11)Stroke",
        "label": "CARDINAL"
      },
      {
        "text": "Consorziale Policlinico",
        "label": "PERSON"
      },
      {
        "text": "Bari",
        "label": "GPE"
      },
      {
        "text": "Italy",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Rotondo, Italy.",
    "entities": [
      {
        "text": "Rotondo",
        "label": "GPE"
      },
      {
        "text": "Italy",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(14)Stroke Unit, AORN Antonio Cardarelli, Naples, Italy.",
    "entities": [
      {
        "text": "14)Stroke Unit",
        "label": "ORG"
      },
      {
        "text": "Antonio Cardarelli",
        "label": "PERSON"
      },
      {
        "text": "Naples",
        "label": "GPE"
      },
      {
        "text": "Italy",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(15)Department of Neurology, Di Venere Hospital, Bari, Italy.",
    "entities": [
      {
        "text": "15)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Di Venere Hospital",
        "label": "ORG"
      },
      {
        "text": "Bari",
        "label": "GPE"
      },
      {
        "text": "Italy",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(18)Department of Neurology, AOOR Villa Sofia-Cervello, Palermo, Italy.",
    "entities": [
      {
        "text": "18)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Villa Sofia-Cervello",
        "label": "ORG"
      },
      {
        "text": "Palermo",
        "label": "GPE"
      },
      {
        "text": "Italy",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(19)Department of Medicine and Surgery, University of Parma, Parma, Italy.",
    "entities": [
      {
        "text": "University of Parma",
        "label": "ORG"
      },
      {
        "text": "Parma",
        "label": "GPE"
      },
      {
        "text": "Italy",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(20)Stroke Care Program, Department of Emergencies, Parma University Hospital,",
    "entities": [
      {
        "text": "20)Stroke Care Program",
        "label": "ORG"
      },
      {
        "text": "Department of Emergencies",
        "label": "ORG"
      },
      {
        "text": "Parma University Hospital",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Parma, Italy.",
    "entities": [
      {
        "text": "Parma",
        "label": "NORP"
      },
      {
        "text": "Italy",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(22)Department of Neurology, ASST-Ovest Milanese, Legnano, Italy.",
    "entities": [
      {
        "text": "22)Department",
        "label": "CARDINAL"
      },
      {
        "text": "ASST",
        "label": "GPE"
      },
      {
        "text": "Legnano",
        "label": "PERSON"
      },
      {
        "text": "Italy",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(24)Unit of Clinical Neurology, Department of Neuroscience and Rehabilitation,",
    "entities": [
      {
        "text": "24)Unit",
        "label": "CARDINAL"
      },
      {
        "text": "Clinical Neurology",
        "label": "ORG"
      },
      {
        "text": "Department of Neuroscience",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "University of Ferrara, Ferrara, Italy.",
    "entities": [
      {
        "text": "University of Ferrara,",
        "label": "ORG"
      },
      {
        "text": "Ferrara",
        "label": "GPE"
      },
      {
        "text": "Italy",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(26)Stroke Unit, \"M. R. Dimiccoli\" Hospital, Barletta, Italy.",
    "entities": [
      {
        "text": "26)Stroke Unit",
        "label": "ORG"
      },
      {
        "text": "Barletta",
        "label": "GPE"
      },
      {
        "text": "Italy",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(27)Stroke Unit, Department of Neurology, E. Agnelli Hospital, Pinerolo, Italy.",
    "entities": [
      {
        "text": "27)Stroke Unit",
        "label": "ORG"
      },
      {
        "text": "Department of Neurology",
        "label": "ORG"
      },
      {
        "text": "E. Agnelli Hospital",
        "label": "ORG"
      },
      {
        "text": "Pinerolo",
        "label": "GPE"
      },
      {
        "text": "Italy",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(28)Stroke Unit, S. Eugenio Hospital, Rome, Italy.",
    "entities": [
      {
        "text": "28)Stroke",
        "label": "CARDINAL"
      },
      {
        "text": "S. Eugenio Hospital",
        "label": "PERSON"
      },
      {
        "text": "Rome",
        "label": "GPE"
      },
      {
        "text": "Italy",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(29)Department of Neurology, Cazzavillan Hospital, Arzignano, Italy.",
    "entities": [
      {
        "text": "29)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Cazzavillan Hospital",
        "label": "PERSON"
      },
      {
        "text": "Arzignano",
        "label": "ORG"
      },
      {
        "text": "Italy",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(31)Department of Neurology, Umberto I Hospital, Siracusa, Italy.",
    "entities": [
      {
        "text": "Siracusa",
        "label": "GPE"
      },
      {
        "text": "Italy",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(33)Experimental and Clinical Medicine Department, Marche Polytechnic",
    "entities": [
      {
        "text": "33)Experimental and Clinical Medicine Department",
        "label": "ORG"
      },
      {
        "text": "Marche Polytechnic",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "University, Ancona, Italy.",
    "entities": [
      {
        "text": "Ancona",
        "label": "GPE"
      },
      {
        "text": "Italy",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(34)Neurology Unit, San Luca Hospital, Lucca and Castelnuovo Garfagnana, Italy.",
    "entities": [
      {
        "text": "San Luca Hospital",
        "label": "ORG"
      },
      {
        "text": "Lucca",
        "label": "GPE"
      },
      {
        "text": "Castelnuovo Garfagnana",
        "label": "GPE"
      },
      {
        "text": "Italy",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(35)Stroke Unit, Policlinico Umberto I Hospital, Rome, Italy.",
    "entities": [
      {
        "text": "35)Stroke",
        "label": "CARDINAL"
      },
      {
        "text": "Policlinico Umberto I Hospital",
        "label": "ORG"
      },
      {
        "text": "Rome",
        "label": "GPE"
      },
      {
        "text": "Italy",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Novara, Italy.",
    "entities": [
      {
        "text": "Novara",
        "label": "GPE"
      },
      {
        "text": "Italy",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(38)Stroke Unit, Careggi University Hospital, Florence, Italy.",
    "entities": [
      {
        "text": "38)Stroke",
        "label": "CARDINAL"
      },
      {
        "text": "Careggi University Hospital",
        "label": "ORG"
      },
      {
        "text": "Florence",
        "label": "GPE"
      },
      {
        "text": "Italy",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(39)Department of Neurology, San Giacomo Hospital, Novi Ligure, Italy.",
    "entities": [
      {
        "text": "39)Department",
        "label": "CARDINAL"
      },
      {
        "text": "San Giacomo Hospital",
        "label": "ORG"
      },
      {
        "text": "Italy",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(40)Stroke Unit, SS. Biagio e Arrigo, Alessandria, Italy.",
    "entities": [
      {
        "text": "40)Stroke",
        "label": "CARDINAL"
      },
      {
        "text": "SS",
        "label": "ORG"
      },
      {
        "text": "Biagio",
        "label": "PERSON"
      },
      {
        "text": "Arrigo, Alessandria, Italy",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(41)Department of Cardiocerebrovascular Diseases, ASST Ospedale Maggiore di",
    "entities": [
      {
        "text": "Cardiocerebrovascular Diseases",
        "label": "ORG"
      },
      {
        "text": "ASST Ospedale Maggiore",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Crema, Crema, Italy.",
    "entities": [
      {
        "text": "Italy",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(42)Department of Neurology, San Jacopo Hospital, Pistoia, Italy.",
    "entities": [
      {
        "text": "42)Department",
        "label": "CARDINAL"
      },
      {
        "text": "San Jacopo Hospital",
        "label": "ORG"
      },
      {
        "text": "Pistoia",
        "label": "GPE"
      },
      {
        "text": "Italy",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(43)Department of Neurology, Antonio Perrino Hospital, Brindisi, Italy.",
    "entities": [
      {
        "text": "Antonio Perrino Hospital",
        "label": "PERSON"
      },
      {
        "text": "Brindisi",
        "label": "GPE"
      },
      {
        "text": "Italy",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(44)Department of Neurology, Sant'Andrea Hospital, Rome, Italy.",
    "entities": [
      {
        "text": "Hospital",
        "label": "GPE"
      },
      {
        "text": "Rome",
        "label": "GPE"
      },
      {
        "text": "Italy",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(45)Neurology Unit, \"Infermi\" Hospital, Rimini, Italy.",
    "entities": [
      {
        "text": "45)Neurology Unit",
        "label": "ORG"
      },
      {
        "text": "Infermi",
        "label": "WORK_OF_ART"
      },
      {
        "text": "Rimini",
        "label": "GPE"
      },
      {
        "text": "Italy",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(46)Stroke Unit, \"S.Spirito\" Hospital, Pescara, Italy.",
    "entities": [
      {
        "text": "46)Stroke Unit",
        "label": "ORG"
      },
      {
        "text": "Hospital",
        "label": "WORK_OF_ART"
      },
      {
        "text": "Pescara",
        "label": "GPE"
      },
      {
        "text": "Italy",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Brescia, Italy.",
    "entities": [
      {
        "text": "Brescia",
        "label": "GPE"
      },
      {
        "text": "Italy",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(48)Department of Neurology IRCCS-INRCA, Ancona, Italy.",
    "entities": [
      {
        "text": "Ancona",
        "label": "GPE"
      },
      {
        "text": "Italy",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(49)Department of Neurology, SS Annunziata Hospital, Chieti, Italy.",
    "entities": [
      {
        "text": "Annunziata Hospital",
        "label": "PERSON"
      },
      {
        "text": "Chieti",
        "label": "GPE"
      },
      {
        "text": "Italy",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(51)Department of Neurology, Civil Hospital, Cittadella, Italy.",
    "entities": [
      {
        "text": "51)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Civil Hospital",
        "label": "ORG"
      },
      {
        "text": "Cittadella",
        "label": "GPE"
      },
      {
        "text": "Italy",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(53)Department of Neurology, St Misericordia Hospital, Rovigo, Italy.",
    "entities": [
      {
        "text": "St Misericordia Hospital",
        "label": "ORG"
      },
      {
        "text": "Rovigo",
        "label": "GPE"
      },
      {
        "text": "Italy",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(55)Department of Neurology, A. Murri Fermo Hospital, Fermo, Italy.",
    "entities": [
      {
        "text": "Fermo",
        "label": "GPE"
      },
      {
        "text": "Italy",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(56)Stroke Unit, Azienda Ospedaliera San Camillo Forlanini, Rome, Italy.",
    "entities": [
      {
        "text": "56)Stroke Unit",
        "label": "ORG"
      },
      {
        "text": "Azienda Ospedaliera",
        "label": "ORG"
      },
      {
        "text": "San Camillo Forlanini",
        "label": "PERSON"
      },
      {
        "text": "Rome",
        "label": "GPE"
      },
      {
        "text": "Italy",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(57)Department of Neurology, San Filippo Neri Hospital, Rome, Italy.",
    "entities": [
      {
        "text": "Neurology",
        "label": "ORG"
      },
      {
        "text": "San Filippo Neri Hospital",
        "label": "ORG"
      },
      {
        "text": "Rome",
        "label": "GPE"
      },
      {
        "text": "Italy",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(58)Department of Neurology, General Regional Hospital \"F. Miulli,\" Acquaviva",
    "entities": [
      {
        "text": "58)Department",
        "label": "CARDINAL"
      },
      {
        "text": "General Regional Hospital",
        "label": "ORG"
      },
      {
        "text": "Acquaviva",
        "label": "PRODUCT"
      }
    ]
  },
  {
    "text": "(61)Stroke Unit, AOU Sassari, Sassari, Italy.",
    "entities": [
      {
        "text": "61)Stroke Unit",
        "label": "ORG"
      },
      {
        "text": "Sassari",
        "label": "PERSON"
      },
      {
        "text": "Sassari",
        "label": "PERSON"
      },
      {
        "text": "Italy",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(62)Neurology Unit, Apuane Hospital, Massa Carrara, Italy.",
    "entities": [
      {
        "text": "62)Neurology Unit,",
        "label": "ORG"
      },
      {
        "text": "Apuane Hospital",
        "label": "ORG"
      },
      {
        "text": "Massa Carrara",
        "label": "PERSON"
      },
      {
        "text": "Italy",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(63)Department of Neurology, Vito Fazzi Hospital, Lecce, Italy.",
    "entities": [
      {
        "text": "63)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Vito Fazzi Hospital",
        "label": "ORG"
      },
      {
        "text": "Lecce",
        "label": "GPE"
      },
      {
        "text": "Italy",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(64)Department of Neurology, Mirano Hospital, Mirano, Italy.",
    "entities": [
      {
        "text": "64)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Mirano Hospital",
        "label": "ORG"
      },
      {
        "text": "Mirano",
        "label": "GPE"
      },
      {
        "text": "Italy",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(66)Department of Neurology, Fatebenefratelli Hospital, Rome, Italy.",
    "entities": [
      {
        "text": "66)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Fatebenefratelli Hospital",
        "label": "ORG"
      },
      {
        "text": "Rome",
        "label": "GPE"
      },
      {
        "text": "Italy",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(67)Department of Neurology, SS Annunziata Hospital, Savigliano, Italy.",
    "entities": [
      {
        "text": "67)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Annunziata Hospital",
        "label": "PERSON"
      },
      {
        "text": "Savigliano",
        "label": "GPE"
      },
      {
        "text": "Italy",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(68)Emergency Department, Stroke Unit, Umberto I Hospital, University La",
    "entities": [
      {
        "text": "68)Emergency Department",
        "label": "ORG"
      },
      {
        "text": "Stroke Unit",
        "label": "ORG"
      },
      {
        "text": "Umberto I Hospital",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(70)Department of Biotechnological and Applied Clinical Sciences, University of",
    "entities": [
      {
        "text": "Biotechnological",
        "label": "LOC"
      },
      {
        "text": "Applied Clinical Sciences",
        "label": "ORG"
      },
      {
        "text": "University of\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "BACKGROUND: Dual antiplatelet therapy (DAPT) is a cornerstone of secondary",
    "entities": [
      {
        "text": "DAPT",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "prevention in patients with minor ischemic stroke or high-risk transient",
    "entities": []
  },
  {
    "text": "ischemic attack. The effectiveness and safety of DAPT may differ between",
    "entities": [
      {
        "text": "DAPT",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "patients with posterior (PCI) and anterior circulation infarct (ACI).",
    "entities": []
  },
  {
    "text": "OBJECTIVES: We aimed to compare short-term outcomes following DAPT between",
    "entities": [
      {
        "text": "DAPT",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "mild-to-moderate stroke patients with PCI versus ACI.",
    "entities": []
  },
  {
    "text": "DESIGN: Propensity-matched analysis from a prospective real-world multicentric",
    "entities": []
  },
  {
    "text": "cohort study (READAPT).",
    "entities": [
      {
        "text": "READAPT",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "METHODS: We included patients with noncardioembolic mild-to-moderate stroke",
    "entities": []
  },
  {
    "text": "(National Institute of Health Stroke Scale of 0-10) who initiated DAPT within",
    "entities": [
      {
        "text": "National Institute of Health Stroke Scale",
        "label": "ORG"
      },
      {
        "text": "0-10",
        "label": "CARDINAL"
      },
      {
        "text": "DAPT",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "48 h of symptom onset. Patients were categorized into ACI or PCI based on the",
    "entities": [
      {
        "text": "48",
        "label": "CARDINAL"
      },
      {
        "text": "ACI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "infarct(s) location on brain neuroimaging. The primary effectiveness outcome was",
    "entities": []
  },
  {
    "text": "the 90-day risk of ischemic stroke or other vascular events. The secondary",
    "entities": [
      {
        "text": "90-day",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "effectiveness outcomes were the 90-day modified Rankin Scale (mRS) score",
    "entities": [
      {
        "text": "90-day",
        "label": "DATE"
      },
      {
        "text": "Rankin Scale",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "distribution, 24-h early neurological improvement or deterioration, and",
    "entities": [
      {
        "text": "24",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "all-cause mortality. The safety outcomes included the 90-day risk of any",
    "entities": [
      {
        "text": "90-day",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "bleedings and 24-h hemorrhagic transformation.",
    "entities": [
      {
        "text": "24",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "RESULTS: We matched 281 PCI patients with 651 ACI patients. The 90-day risk of",
    "entities": [
      {
        "text": "281",
        "label": "CARDINAL"
      },
      {
        "text": "651",
        "label": "CARDINAL"
      },
      {
        "text": "90-day",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "ischemic stroke or other vascular events was low and similar between PCI and ACI",
    "entities": [
      {
        "text": "PCI",
        "label": "ORG"
      },
      {
        "text": "ACI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "groups (3.1% vs 2.9%, respectively; hazard ratio 0.98, (95% confidence interval",
    "entities": [
      {
        "text": "3.1%",
        "label": "PERCENT"
      },
      {
        "text": "2.9%",
        "label": "PERCENT"
      },
      {
        "text": "0.98",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "(CI) 0.45-2.14); p = 0.845). Patients with PCI had worse 90-day mRS ordinal",
    "entities": [
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "0.45",
        "label": "CARDINAL"
      },
      {
        "text": "0.845",
        "label": "CARDINAL"
      },
      {
        "text": "PCI",
        "label": "ORG"
      },
      {
        "text": "90-day",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "distribution compared to those with ACI (odds ratio 1.18 (95% CI 1.01-1.39);",
    "entities": [
      {
        "text": "ACI",
        "label": "ORG"
      },
      {
        "text": "1.18",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "1.01-1.39",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "p = 0.046). There were no differences in other secondary outcomes. Safety",
    "entities": [
      {
        "text": "0.046",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "outcomes had low incidence and did not differ between groups (any bleedings:",
    "entities": []
  },
  {
    "text": "3.2% vs 2.6%; 24-h hemorrhagic transformation: 1.8% vs 1.2%). We found no",
    "entities": [
      {
        "text": "3.2%",
        "label": "PERCENT"
      },
      {
        "text": "2.6%",
        "label": "PERCENT"
      },
      {
        "text": "24",
        "label": "CARDINAL"
      },
      {
        "text": "1.8%",
        "label": "PERCENT"
      },
      {
        "text": "1.2%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "differences in the risk of ischemic stroke or other vascular events between",
    "entities": []
  },
  {
    "text": "patients with PCI and ACI across subgroups defined by sex, age, presumed stroke",
    "entities": [
      {
        "text": "PCI",
        "label": "ORG"
      },
      {
        "text": "ACI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "etiology, stroke severity, prestroke mRS, hypertension, diabetes, acute",
    "entities": []
  },
  {
    "text": "reperfusion therapies, DAPT loading dose, or presence of symptomatic",
    "entities": [
      {
        "text": "DAPT",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "CONCLUSION: Our findings suggest that effectiveness and safety outcomes after",
    "entities": []
  },
  {
    "text": "DAPT in patients with mild-to-moderate noncardioembolic ischemic stroke are",
    "entities": []
  },
  {
    "text": "consistent regardless of infarct location in the anterior or posterior",
    "entities": []
  },
  {
    "text": "circulation territory. However, patients with PCI may experience worse",
    "entities": [
      {
        "text": "PCI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "short-term functional outcome.",
    "entities": []
  },
  {
    "text": "\u00a9 The Author(s), 2025.",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: Dr M.G.Piscaglia reports grants from Sanofi",
    "entities": [
      {
        "text": "M.G.Piscaglia",
        "label": "PERSON"
      },
      {
        "text": "Sanofi",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Genzyme; grants from Roche Health Solutions Inc.; grants from Novartis Pharma;",
    "entities": [
      {
        "text": "Roche Health Solutions Inc.",
        "label": "ORG"
      },
      {
        "text": "Novartis Pharma",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "grants from Biogen; and grants from Merck Company Foundation. Dr M.Paciaroni",
    "entities": [
      {
        "text": "Biogen",
        "label": "ORG"
      },
      {
        "text": "Merck Company Foundation",
        "label": "ORG"
      },
      {
        "text": "Dr M.Paciaroni\n",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "reports compensation from Boehringer Ingelheim for other services; compensation",
    "entities": [
      {
        "text": "Boehringer Ingelheim",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "from Pfizer Canada Inc. for other services; compensation from Bristol-Myers",
    "entities": [
      {
        "text": "Pfizer Canada Inc.",
        "label": "ORG"
      },
      {
        "text": "Bristol-Myers",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Squibb for other services; compensation from iRhythm Technologies for other",
    "entities": [
      {
        "text": "iRhythm Technologies",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "services; compensation from Sanofi-Aventis U.S. LLC for other services; and",
    "entities": [
      {
        "text": "Sanofi",
        "label": "GPE"
      },
      {
        "text": "U.S.",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "compensation from Daiichi Sankyo Europe GmbH for other services. Dr A.Zini",
    "entities": [
      {
        "text": "Daiichi Sankyo Europe GmbH",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "reports compensation from Bayer Healthcare for other services; compensation from",
    "entities": [
      {
        "text": "Bayer Healthcare",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Boehringer Ingelheim for consultant services; compensation from Alexion",
    "entities": [
      {
        "text": "Boehringer Ingelheim",
        "label": "ORG"
      },
      {
        "text": "Alexion",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Pharmaceuticals for consultant services; and compensation from CSL Behring for",
    "entities": [
      {
        "text": "CSL Behring",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "consultant services. Dr R.Ornello reports grants from Novartis; compensation",
    "entities": [
      {
        "text": "Dr R.Ornello",
        "label": "ORG"
      },
      {
        "text": "Novartis",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "from Teva Pharmaceutical Industries for other services; compensation from AbbVie",
    "entities": [
      {
        "text": "Teva Pharmaceutical Industries",
        "label": "ORG"
      },
      {
        "text": "AbbVie",
        "label": "LAW"
      }
    ]
  },
  {
    "text": "for data and safety monitoring services; compensation from Teva Pharmaceutical",
    "entities": [
      {
        "text": "Teva Pharmaceutical",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Industries for other services; compensation from Eli Lilly and Company for other",
    "entities": [
      {
        "text": "Eli Lilly and Company",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "services; compensation from Novartis for other services; compensation from H.",
    "entities": [
      {
        "text": "Novartis",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Lundbeck A S for other services; compensation from Eli Lilly for data and safety",
    "entities": [
      {
        "text": "Lundbeck A S",
        "label": "ORG"
      },
      {
        "text": "Eli Lilly",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "monitoring services; grants from Pfizer; grants from Allergan; travel support",
    "entities": [
      {
        "text": "Pfizer",
        "label": "ORG"
      },
      {
        "text": "Allergan",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "from Teva Pharmaceutical Industries; and compensation from Teva Pharmaceutical",
    "entities": [
      {
        "text": "Teva Pharmaceutical Industries",
        "label": "ORG"
      },
      {
        "text": "Teva Pharmaceutical",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Industries for consultant services. Dr S.Sacco reports compensation from",
    "entities": []
  },
  {
    "text": "Novartis for other services; compensation from Novo Nordisk for consultant",
    "entities": [
      {
        "text": "Novo Nordisk",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "services; compensation from Boehringer Ingelheim for consultant services;",
    "entities": [
      {
        "text": "Boehringer Ingelheim",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "compensation from Teva Pharmaceutical Industries for consultant services;",
    "entities": [
      {
        "text": "Teva Pharmaceutical Industries",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "compensation from Allergan for consultant services; employment by Universit\u00e0",
    "entities": [
      {
        "text": "Allergan",
        "label": "GPE"
      },
      {
        "text": "Universit\u00e0",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "compensation from Allergan for consultant services; compensation from Pfizer",
    "entities": [
      {
        "text": "Allergan",
        "label": "GPE"
      },
      {
        "text": "Pfizer",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Canada Inc. for consultant services; compensation from Abbott Canada for",
    "entities": [
      {
        "text": "Canada Inc.",
        "label": "ORG"
      },
      {
        "text": "Abbott Canada",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "consultant services; compensation from H. Lundbeck A S for consultant services;",
    "entities": [
      {
        "text": "H. Lundbeck A S",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "compensation from AstraZeneca for consultant services; and compensation from Eli",
    "entities": [
      {
        "text": "AstraZeneca",
        "label": "ORG"
      },
      {
        "text": "Eli",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Lilly and Company for consultant services. The other authors report no",
    "entities": [
      {
        "text": "Lilly",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "conflicts.",
    "entities": []
  },
  {
    "text": "99. Risk Manag Healthc Policy. 2025 Jul 10;18:2361-2375. doi:",
    "entities": [
      {
        "text": "99",
        "label": "CARDINAL"
      },
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "10;18:2361-2375",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "10.2147/RMHP.S515019. eCollection 2025.",
    "entities": [
      {
        "text": "10.2147",
        "label": "CARDINAL"
      },
      {
        "text": "2025",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "Analysis of the Current Status of Self-Management Behaviors and Factors",
    "entities": [
      {
        "text": "Self-Management Behaviors",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Affecting Self-Management in Elderly Empty Nesters with Comorbid Hypertension",
    "entities": [
      {
        "text": "Affecting Self-Management",
        "label": "ORG"
      },
      {
        "text": "Comorbid Hypertension",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "and Type 2 Diabetes Mellitus, a Cross-Sectional Study From the Community.",
    "entities": [
      {
        "text": "Cross-Sectional Study From the Community",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(1)College of Nursing, Gansu University of Chinese Medicine, Lanzhou, Gansu,",
    "entities": [
      {
        "text": "Nursing",
        "label": "GPE"
      },
      {
        "text": "Gansu University of Chinese Medicine",
        "label": "ORG"
      },
      {
        "text": "Lanzhou",
        "label": "GPE"
      },
      {
        "text": "Gansu",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "People's Republic of China.",
    "entities": []
  },
  {
    "text": "(2)College of Nursing, Jiamusi Vocational College, Jiamusi, Heilongjiang,",
    "entities": [
      {
        "text": "2)College",
        "label": "CARDINAL"
      },
      {
        "text": "Nursing",
        "label": "GPE"
      },
      {
        "text": "Jiamusi Vocational College",
        "label": "ORG"
      },
      {
        "text": "Jiamusi",
        "label": "GPE"
      },
      {
        "text": "Heilongjiang",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "PURPOSE: This study aimed to investigate disease self-management and its",
    "entities": [
      {
        "text": "PURPOSE",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "influencing factors among empty nesters with comorbid hypertension and type 2",
    "entities": [
      {
        "text": "2",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "diabetes mellitus in the Chinese community.",
    "entities": [
      {
        "text": "Chinese",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "PATIENTS AND METHODS: A questionnaire was administered to 385 empty nesters in",
    "entities": [
      {
        "text": "385",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "the community with comorbid hypertension and type 2 diabetes mellitus, including",
    "entities": [
      {
        "text": "2",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "general information about the patients, the conditions of hypertension and type",
    "entities": []
  },
  {
    "text": "2 diabetes mellitus, and self-management scores. The results were analysed using",
    "entities": [
      {
        "text": "2",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "independent samples t-test, one-way ANOVA and multiple linear regression.",
    "entities": [
      {
        "text": "one",
        "label": "CARDINAL"
      },
      {
        "text": "ANOVA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "RESULTS: Disease self-management ability among 360 empty nesters in the",
    "entities": [
      {
        "text": "360",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "community with comorbid hypertension and type 2 diabetes mellitus was low to",
    "entities": [
      {
        "text": "2",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "moderate level. The results of the multiple linear regression analysis showed",
    "entities": []
  },
  {
    "text": "that age, education, healthcare payment method, and systolic blood pressure were",
    "entities": []
  },
  {
    "text": "common influences on self-management of the two diseases; hypertension",
    "entities": [
      {
        "text": "two",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "classification, body mass index, and 2-hour postprandial blood glucose were",
    "entities": [
      {
        "text": "2-hour",
        "label": "TIME"
      }
    ]
  },
  {
    "text": "influences on self-management of hypertension; and diabetes treatment method and",
    "entities": []
  },
  {
    "text": "residence mode were influences on self-management of type 2 diabetes mellitus.",
    "entities": [
      {
        "text": "2",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "CONCLUSION: Primary healthcare providers need to pay close attention to the",
    "entities": []
  },
  {
    "text": "self-management skills of empty nesters with comorbid hypertension and type 2",
    "entities": [
      {
        "text": "2",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "diabetes mellitus in the community, especially in terms of disease monitoring",
    "entities": []
  },
  {
    "text": "and dietary management. Effective self-management health education, including",
    "entities": []
  },
  {
    "text": "sustained and effective lifestyle interventions, should be provided as early as",
    "entities": []
  },
  {
    "text": "possible for those living alone, newly diagnosed, less educated, and with",
    "entities": []
  },
  {
    "text": "limited healthcare resources, and the addition of elements of Chinese medicine",
    "entities": [
      {
        "text": "Chinese",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "health management, can also be considered to play a role in integrating",
    "entities": [
      {
        "text": "health management",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "prevention and treatment.",
    "entities": []
  },
  {
    "text": "Conflict of interest statement: The authors declare that there is no conflict of",
    "entities": []
  },
  {
    "text": "interest in this work.",
    "entities": []
  },
  {
    "text": "100. Vasc Health Risk Manag. 2025 Jul 9;21:519-544. doi: 10.2147/VHRM.S521564.",
    "entities": [
      {
        "text": "100",
        "label": "CARDINAL"
      },
      {
        "text": "Vasc Health Risk Manag",
        "label": "ORG"
      },
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "10.2147",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "The Existing Interventions to Promote Self-Care and Self-Monitoring Preventing",
    "entities": [
      {
        "text": "The Existing Interventions to Promote Self-Care and Self-Monitoring Preventing\n",
        "label": "WORK_OF_ART"
      }
    ]
  },
  {
    "text": "Hypertension Among Thai Risk People: A Scoping Review.",
    "entities": []
  },
  {
    "text": "(1)Department of Gerontological Nursing, Faculty of Nursing, Khon Kaen",
    "entities": [
      {
        "text": "Gerontological Nursing, Faculty of Nursing",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "University, Khon Kaen, Thailand.",
    "entities": [
      {
        "text": "Khon Kaen",
        "label": "PERSON"
      },
      {
        "text": "Thailand",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Department of Systems, Populations, and Leadership, School of Nursing,",
    "entities": [
      {
        "text": "Leadership, School of Nursing",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "University of Michigan, Ann Arbor, MI, USA.",
    "entities": [
      {
        "text": "University of Michigan",
        "label": "ORG"
      },
      {
        "text": "Ann Arbor",
        "label": "GPE"
      },
      {
        "text": "MI",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Department of Medicine, Faculty of Medicine, Khon Kaen University, Khon Kaen,",
    "entities": [
      {
        "text": "Medicine, Faculty of Medicine",
        "label": "ORG"
      },
      {
        "text": "Kaen University",
        "label": "ORG"
      },
      {
        "text": "Khon Kaen",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Thailand.",
    "entities": [
      {
        "text": "Thailand",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Department of Nursing, Faculty of Health Sciences, Universitas Esa Unggul",
    "entities": [
      {
        "text": "Nursing, Faculty of Health Sciences",
        "label": "ORG"
      },
      {
        "text": "Universitas",
        "label": "ORG"
      },
      {
        "text": "Esa Unggul",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(5)Department of Medicine, Princess Srisavangavadhana Faculty of Medicine,",
    "entities": []
  },
  {
    "text": "Chulabhorn Royal Academy, Bangkok, Thailand.",
    "entities": [
      {
        "text": "Chulabhorn Royal Academy",
        "label": "ORG"
      },
      {
        "text": "Bangkok",
        "label": "GPE"
      },
      {
        "text": "Thailand",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(6)Department of Adult and Geriatric Nursing, Princess Agrarajakumari College of",
    "entities": [
      {
        "text": "Adult",
        "label": "ORG"
      },
      {
        "text": "Geriatric Nursing",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Nursing, Chulabhorn Royal Academy, Bangkok, Thailand.",
    "entities": [
      {
        "text": "Chulabhorn Royal Academy",
        "label": "ORG"
      },
      {
        "text": "Bangkok",
        "label": "GPE"
      },
      {
        "text": "Thailand",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(8)Nursing Department, Chumphae Hospital, Chumphae, Khon Kaen, Thailand.",
    "entities": [
      {
        "text": "Chumphae Hospital",
        "label": "ORG"
      },
      {
        "text": "Chumphae",
        "label": "PERSON"
      },
      {
        "text": "Khon Kaen",
        "label": "PERSON"
      },
      {
        "text": "Thailand",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Hypertension affects one-third of the worldwide adult population and is a major",
    "entities": [
      {
        "text": "Hypertension",
        "label": "ORG"
      },
      {
        "text": "one-third",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "contributor to premature mortality in Thailand. However, hypertension is mainly",
    "entities": [
      {
        "text": "Thailand",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "preventable, highlighting the need for effective prevention strategies to",
    "entities": []
  },
  {
    "text": "mitigate this critical health concern. This scoping review aimed to identify",
    "entities": []
  },
  {
    "text": "existing knowledge gaps and provide a comprehensive understanding of",
    "entities": []
  },
  {
    "text": "hypertension prevention interventions. Keywords were identified, and an",
    "entities": []
  },
  {
    "text": "unrestricted search for empirical studies was conducted until December 20, 2024.",
    "entities": [
      {
        "text": "December 20, 2024",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "The search strategy encompassed 11 databases. Ultimately, studies focusing on",
    "entities": [
      {
        "text": "11",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "preventive interventions targeting the Thai population at risk of hypertension",
    "entities": [
      {
        "text": "Thai",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "were included in this review. Finally, we included 41 studies: 35 in community",
    "entities": [
      {
        "text": "41",
        "label": "CARDINAL"
      },
      {
        "text": "35",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "settings, two in hospital clinics, and four in Buddhist temples. The total",
    "entities": [
      {
        "text": "two",
        "label": "CARDINAL"
      },
      {
        "text": "four",
        "label": "CARDINAL"
      },
      {
        "text": "Buddhist",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "number of participants was 16,401, ranging from 32 to 4,786, aged between 18 and",
    "entities": [
      {
        "text": "16,401",
        "label": "CARDINAL"
      },
      {
        "text": "32",
        "label": "CARDINAL"
      },
      {
        "text": "4,786",
        "label": "CARDINAL"
      },
      {
        "text": "between 18",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "74. Research designs comprised 32 quasi-experimental studies, seven randomized",
    "entities": [
      {
        "text": "74",
        "label": "CARDINAL"
      },
      {
        "text": "32",
        "label": "CARDINAL"
      },
      {
        "text": "seven",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "controlled trials, one action research, and one research and development.",
    "entities": [
      {
        "text": "one",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Researchers primarily delivered interventions. The interventions focused on",
    "entities": []
  },
  {
    "text": "hypertension monitoring, knowledge promotion, health behavior modification,",
    "entities": []
  },
  {
    "text": "social support, and counseling, emphasizing preventive behaviors, nutrition",
    "entities": []
  },
  {
    "text": "promotion, and disease awareness. Researchers commonly took outcome measurements",
    "entities": []
  },
  {
    "text": "before and 12 weeks after intervention. Manuals, logbooks, and lectures with",
    "entities": [
      {
        "text": "before and 12 weeks",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "presentation slides were the primary platforms. Finally, knowledge, behaviors,",
    "entities": []
  },
  {
    "text": "and biomarkers were the most frequently assessed outcomes. This scoping review",
    "entities": []
  },
  {
    "text": "provided recommendations that future research should expand intervention",
    "entities": []
  },
  {
    "text": "strategies, emphasize biomarkers, adopt modern delivery methods like AI chatbots",
    "entities": [
      {
        "text": "AI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "and mobile apps, and include follow-ups beyond 12 weeks to ensure lasting",
    "entities": [
      {
        "text": "12 weeks",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "PMID: 40661694 [Indexed for MEDLINE]",
    "entities": [
      {
        "text": "40661694",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: There is no conflict of interest in conducting",
    "entities": []
  },
  {
    "text": "this scoping review and regarding the publication of this paper.",
    "entities": []
  }
]